data_1z66_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z66 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 335' ' ' THR . 7.2 t . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.918 0.39 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.451 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 39.4 p90 -60.8 116.32 4.34 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.306 0.574 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 303' ' ' THR . 14.3 t -173.48 -166.59 0.33 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.118 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 13.7 t -61.19 114.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 144.64 55.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.909 0.861 . . . . 0.0 112.201 -170.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.623 ' OD1' HG21 ' A' ' 310' ' ' THR . 9.7 t0 -59.76 141.58 54.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.704 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.24 -11.8 44.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.735 -175.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.623 HG21 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -105.41 -1.15 25.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 46.2 mttp -83.77 -30.08 26.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -86.92 147.93 25.56 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.678 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.1 p -135.5 145.26 46.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.524 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.477 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.9 m-90 -53.49 96.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.862 0.726 . . . . 0.0 111.462 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 76.9 tttt -87.84 -35.08 17.99 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.876 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.3 ttm180 -159.07 113.71 2.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.238 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.05 80.04 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 119.188 -0.434 . . . . 0.0 109.957 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.552 ' HD3' ' HE2' ' A' ' 328' ' ' MET . 3.3 Cg_exo -41.83 119.1 1.05 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.706 2.271 . . . . 0.0 112.461 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.689 ' O ' HG21 ' A' ' 327' ' ' VAL . 2.3 m -139.61 142.41 37.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.322 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -40.66 130.77 2.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.863 0.465 . . . . 0.0 111.02 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 327' ' ' VAL . 79.8 p -65.82 -23.75 66.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.61 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.37 -0.57 27.99 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.438 -174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -126.89 -56.46 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.348 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.31 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.548 0.689 . . . . 0.0 110.498 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.708 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 11.1 p -92.0 -172.04 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.953 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.468 HG13 ' C ' ' A' ' 319' ' ' THR . 15.4 t -129.7 148.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.387 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.865 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -130.55 158.15 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 122.743 0.417 . . . . 0.0 110.978 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.642 ' HE1' ' HB ' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -136.79 163.47 30.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.876 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 2.5 mt-10 -130.3 135.1 47.73 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.913 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.84 146.21 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.982 0.42 . . . . 0.0 111.367 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.11 145.8 18.55 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.484 ' H ' ' HD1' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -89.78 178.34 6.27 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.569 0.7 . . . . 0.0 111.326 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.3 m -149.32 28.5 0.81 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.367 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 165.56 -70.52 0.19 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 119.663 -1.256 . . . . 0.0 113.946 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 336' ' ' ARG . 41.1 m -58.65 136.43 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.956 0.503 . . . . 0.0 112.15 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.616 ' O ' HG21 ' A' ' 335' ' ' THR . 12.3 ptm180 -70.19 170.4 10.36 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.442 171.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.674 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.9 97.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.975 3.117 . . . . 0.0 114.759 -171.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.536 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 6.3 p -113.47 152.76 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.297 -172.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 306' ' ' VAL . 9.2 mpt_? -82.41 105.41 13.45 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.557 HG22 ' HG3' ' A' ' 364' ' ' MET . 28.3 pt -87.31 131.43 44.29 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.602 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.39 84.34 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.053 2.502 . . . . 0.0 112.364 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.643 HG13 HG11 ' A' ' 385' ' ' VAL . 19.3 m -96.72 129.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.796 0.807 . . . . 0.0 111.253 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 35.6 ptt180 -140.21 -172.44 3.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.486 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -159.37 143.41 15.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.286 0.565 . . . . 0.0 111.416 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.405 HG21 HD12 ' A' ' 382' ' ' ILE . 16.0 m -119.69 171.31 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.06 116.38 32.41 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 3.7 p-80 40.14 60.11 1.84 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.928 0.768 . . . . 0.0 112.459 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.558 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.9 3.92 24.65 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.609 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.25 118.88 45.06 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.546 0.673 . . . . 0.0 111.164 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.71 55.33 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.067 2.511 . . . . 0.0 111.445 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' HG11 ' A' ' 352' ' ' VAL . 8.8 pt-20 -86.07 -35.78 20.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.868 0.842 . . . . 0.0 108.895 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.581 HG11 ' HG3' ' A' ' 351' ' ' GLU . 6.7 p -155.66 122.93 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.745 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.2 107.77 0.27 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.185 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.882 HG12 HD23 ' A' ' 376' ' ' LEU . 31.4 m -88.65 5.2 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.394 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.486 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.84 82.7 5.89 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.349 0.595 . . . . 0.0 110.645 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.719 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 36.8 mtm -97.61 90.37 4.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.7 mt -75.93 117.01 17.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.473 -165.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.644 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.3 mm -68.95 -22.13 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -131.38 85.42 53.32 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.776 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -87.28 41.68 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.376 2.718 . . . . 0.0 114.035 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -165.61 73.55 1.34 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.221 0.534 . . . . 0.0 110.557 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.55 ' HB2' HD12 ' A' ' 340' ' ' ILE . 91.7 Cg_endo -87.67 120.2 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.411 2.074 . . . . 0.0 112.586 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.8 p -115.21 140.72 48.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.952 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.674 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 54.9 mtm -95.04 113.63 25.35 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.355 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.526 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 39.5 mt-10 -104.24 -165.8 1.18 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.506 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.478 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -55.2 -17.74 4.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -105.06 2.52 29.56 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.5 0.667 . . . . 0.0 110.368 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.491 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 98.02 -158.63 20.7 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.88 -1.84 74.53 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.953 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.0 -129.62 32.49 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -115.63 142.03 47.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.296 0.57 . . . . 0.0 110.801 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.636 HD11 HG11 ' A' ' 342' ' ' VAL . 2.0 mt -120.12 130.9 73.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.573 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.865 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.1 mt-10 -103.92 135.97 44.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 110.451 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.7 ' HE1' ' HB3' ' A' ' 381' ' ' ASN . 4.4 ppp? -147.46 159.33 43.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.512 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.719 ' O ' ' HB2' ' A' ' 356' ' ' MET . 0.1 OUTLIER -172.89 167.12 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.557 . . . . 0.0 112.269 174.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.957 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.1 tp -164.82 156.85 13.75 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 172.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.957 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 47.2 Cg_exo -37.08 138.2 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.766 2.31 . . . . 0.0 112.798 172.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.617 ' HA ' HE22 ' A' ' 394' ' ' GLN . 89.1 Cg_exo -34.92 136.45 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 125.08 3.853 . . . . 0.0 114.985 -174.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.21 -150.94 22.24 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.463 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.3 m-20 -108.08 105.64 15.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.146 0.473 . . . . 0.0 110.484 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.7 ' HB3' ' HE1' ' A' ' 374' ' ' MET . 10.0 m120 -105.0 125.1 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.031 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.063 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.44 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.642 ' HB ' ' HE1' ' A' ' 328' ' ' MET . 22.4 mt -91.54 135.67 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -115.46 91.91 3.75 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.135 178.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.643 HG11 HG13 ' A' ' 342' ' ' VAL . 6.3 t -83.79 92.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.64 0.12 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.867 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -110.57 -15.66 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.067 0.461 . . . . 0.0 110.108 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.4 OUTLIER -63.29 139.96 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.8 p30 -149.41 148.1 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.587 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.8 OUTLIER -171.77 122.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 173.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.063 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 11.2 tt0 -76.82 148.89 36.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -143.54 129.52 19.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.484 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -86.34 112.18 21.18 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.617 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -102.19 126.47 49.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.428 -169.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.675 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 35.4 p90 -65.46 117.08 7.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.65 0.738 . . . . 0.0 110.332 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t -168.63 -171.25 1.37 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.65 109.29 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 140.05 56.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.469 0.652 . . . . 0.0 111.551 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.444 ' OD2' HG21 ' A' ' 310' ' ' THR . 13.8 t70 -64.84 143.95 57.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.645 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -64.34 -11.93 37.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.176 -1.375 . . . . 0.0 113.484 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.444 HG21 ' OD2' ' A' ' 308' ' ' ASP . 3.7 t -104.92 12.22 32.7 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.059 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.442 ' HE2' ' HA3' ' A' ' 334' ' ' GLY . 25.7 mtpp -101.63 1.36 37.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 2.4 p90 -125.53 169.38 12.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.3 t -149.2 162.37 40.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.951 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.533 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.3 m-90 -69.74 111.04 5.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -86.21 -36.26 19.55 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.525 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 11.3 ttm180 -164.6 120.99 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.138 175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.447 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -66.25 161.12 59.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.522 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.82 116.08 0.39 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.769 2.313 . . . . 0.0 112.013 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.522 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.5 m -131.9 134.34 45.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.173 -172.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.45 127.4 24.9 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.3 p -66.8 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 -171.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.7 -4.34 42.77 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 325' ' ' THR . 4.7 m-70 -139.71 59.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.548 0.213 . . . . 0.0 111.432 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 74.13 -24.73 0.2 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 323' ' ' HIS . 21.4 p -101.33 -171.39 1.98 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.301 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.74 153.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.402 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.934 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -134.8 154.48 36.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.877 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.653 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -137.69 161.86 35.39 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 16.2 tt0 -134.15 131.26 38.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.96 145.46 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.623 0.249 . . . . 0.0 111.3 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.91 135.19 11.53 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.302 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.591 ' CE1' ' HD2' ' A' ' 312' ' ' PHE . 1.3 m-85 -122.08 172.75 8.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 70.8 m -157.25 52.84 0.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.442 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -163.86 -74.69 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.35 -1.405 . . . . 0.0 113.766 170.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.51 ' HB ' ' HE1' ' A' ' 364' ' ' MET . 3.8 m -57.53 144.23 37.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.437 0.695 . . . . 0.0 111.919 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.675 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 13.9 ptm180 -76.69 168.9 24.08 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.555 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 364' ' ' MET . 1.0 OUTLIER -27.26 98.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.008 3.139 . . . . 0.0 114.373 -173.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.777 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 26.9 p -110.58 173.49 6.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.784 -169.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -90.37 102.32 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.909 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.852 HD13 ' HB3' ' A' ' 364' ' ' MET . 58.6 mt -74.67 122.96 88.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.575 0.226 . . . . 0.0 111.08 -176.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.6 81.75 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.471 2.114 . . . . 0.0 112.4 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 340' ' ' ILE . 6.4 m -102.9 126.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 111.504 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 21.0 ptt180 -139.07 -178.24 5.25 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.48 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -156.93 135.96 11.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.629 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.16 174.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -104.67 115.89 31.1 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 15.8 p80 42.98 55.45 4.44 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.913 0.758 . . . . 0.0 112.575 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.794 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.68 11.09 56.6 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.881 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.91 118.02 30.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.468 -0.43 . . . . 0.0 110.679 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.17 61.91 5.0 Favored 'Trans proline' 0 N--CA 1.463 -0.324 0 C-N-CA 123.024 2.483 . . . . 0.0 111.268 172.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.86 -38.68 12.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.8 p -151.45 126.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.296 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -60.75 106.37 0.56 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.783 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.8 m -88.01 3.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.36 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.48 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.68 82.0 4.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.56 0.695 . . . . 0.0 110.747 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.811 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 2.5 tpt -98.91 83.5 2.93 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.3 mt -68.05 125.92 27.85 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.118 -169.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 6.2 mm -70.03 -23.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.399 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 13.0 m -138.63 92.95 11.21 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.057 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -91.75 41.04 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.386 2.724 . . . . 0.0 113.624 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.94 65.84 5.85 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.264 0.554 . . . . 0.0 110.098 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.683 ' HB3' HG21 ' A' ' 372' ' ' ILE . 97.2 Cg_endo -87.95 118.0 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.414 2.076 . . . . 0.0 113.168 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.4 p -110.0 134.5 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.412 171.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.852 ' HB3' HD13 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -107.14 149.94 27.12 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.542 -176.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -111.03 -168.53 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.827 1.329 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.601 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -64.91 -16.04 62.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 174.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 366' ' ' ASN . 89.1 m-20 -86.47 -11.44 51.78 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.306 0.574 . . . . 0.0 110.171 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 113.2 -167.67 12.38 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.707 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 364' ' ' MET . . . -81.49 -15.18 76.79 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.986 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.4 -127.62 23.8 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.128 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.95 133.31 50.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.072 0.463 . . . . 0.0 111.184 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.683 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -125.12 165.14 22.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.934 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.1 mt-10 -134.43 137.28 43.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.216 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.77 159.74 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -175.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.849 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -179.0 160.12 1.05 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 123.022 0.201 . . . . 0.0 110.579 174.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.811 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.8 tp -158.94 150.67 17.0 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.811 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.6 Cg_exo -32.93 136.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.49 2.793 . . . . 0.0 113.604 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.502 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.1 Cg_exo -35.79 128.75 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.851 1 C-N-CA 125.725 4.283 . . . . 0.0 114.951 -169.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.5 -134.41 2.89 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.406 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 14.7 m-20 -127.12 102.0 6.77 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.53 ' HB2' ' HE1' ' A' ' 374' ' ' MET . 7.8 m120 -102.88 123.0 45.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.102 0.477 . . . . 0.0 109.987 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.995 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.79 129.75 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 29.7 mt -91.65 131.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.414 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.4 OUTLIER -108.03 91.47 3.66 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.039 174.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.479 HG11 HG13 ' A' ' 342' ' ' VAL . 7.6 t -83.86 94.6 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.61 -97.49 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.952 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -104.73 -19.89 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.173 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.533 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.1 tp -64.31 146.43 54.41 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.4 p30 -158.84 143.22 15.66 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.492 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -166.18 124.69 1.51 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.421 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.995 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.5 tm0? -78.35 143.2 37.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.906 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -145.37 114.54 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.366 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 27.3 p90 -74.38 125.8 29.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.502 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -120.08 140.53 50.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.67 0.748 . . . . 0.0 112.731 -171.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.314 168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.421 0.629 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -69.53 120.36 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.676 -0.64 . . . . 0.0 110.124 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.3 t -171.29 -167.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.719 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.45 113.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 143.78 55.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.791 0.805 . . . . 0.0 110.812 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' A' ' 310' ' ' THR . 12.0 t70 -80.29 150.65 29.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.273 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 387' ' ' ASP . 10.8 ptmt -58.51 -18.58 30.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.017 -173.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.554 HG21 ' OD1' ' A' ' 308' ' ' ASP . 10.0 t -100.19 -0.22 39.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.58 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.3 mmmt -80.86 -33.79 34.2 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -93.84 154.55 17.67 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.154 0.502 . . . . 0.0 111.535 -178.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 388' ' ' LEU . 8.9 t -144.38 150.62 38.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.283 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -64.98 112.76 3.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.225 0.536 . . . . 0.0 111.999 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.481 ' HG2' ' OE2' ' A' ' 329' ' ' GLU . 38.2 tttm -94.99 -28.54 15.09 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 72.1 ttt180 -168.89 110.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.628 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -63.2 160.47 39.94 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.43 -175.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.678 ' HG3' HD11 ' A' ' 383' ' ' ILE . 69.6 Cg_exo -30.78 118.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.922 3.081 . . . . 0.0 113.498 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.555 ' O ' HG21 ' A' ' 327' ' ' VAL . 23.9 m -137.21 134.55 36.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.738 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.548 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 14.3 t70 -52.16 130.17 29.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.945 0.402 . . . . 0.0 110.497 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 99.9 p -69.75 -24.14 63.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.354 -173.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 102.49 -12.68 56.82 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -125.11 57.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 4.9 p-10 47.41 23.08 0.32 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.131 0.972 . . . . 0.0 113.529 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.557 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -127.43 -172.7 2.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.566 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.7 OUTLIER -128.92 152.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.882 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.737 HG12 ' HG2' ' A' ' 373' ' ' GLU . 25.8 m -137.6 153.26 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.687 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.672 ' HE3' HD11 ' A' ' 372' ' ' ILE . 18.0 ptt? -136.52 158.15 45.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.4 tt0 -121.29 118.82 30.49 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.263 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.82 148.86 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -120.49 157.07 15.88 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.87 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.75 178.74 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.825 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 311' ' ' LYS . 37.6 p -136.2 -3.04 2.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.0 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 161.06 11.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 119.207 -1.473 . . . . 0.0 115.782 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.58 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 39.8 m -113.08 127.48 56.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.138 0.969 . . . . 0.0 109.903 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.575 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.6 ptt180 -75.03 171.48 11.6 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.033 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.9 OUTLIER -25.51 92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.986 3.124 . . . . 0.0 114.8 -166.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 363' ' ' THR . 9.2 p -110.54 144.72 38.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.709 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 6.1 mpt_? -73.47 103.95 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.737 HG21 ' HG3' ' A' ' 364' ' ' MET . 21.1 pt -88.28 128.71 52.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.252 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . 0.402 ' HD2' ' CE1' ' A' ' 312' ' ' PHE . 58.4 Cg_endo -74.5 82.53 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.73 2.287 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.611 HG13 HG11 ' A' ' 385' ' ' VAL . 13.5 m -98.57 113.7 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.694 0.759 . . . . 0.0 111.31 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -123.09 -178.74 4.05 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.476 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -154.6 142.27 19.88 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.195 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.5 m -114.38 169.65 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -112.44 116.79 30.86 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.974 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 380' ' ' ASP . 4.8 t-160 63.95 39.07 8.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.6 0.562 . . . . 0.0 109.902 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 70.2 5.76 54.98 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.427 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.37 51.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 117.201 0.501 . . . . 0.0 111.348 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.91 52.62 4.08 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.293 2.662 . . . . 0.0 112.298 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.63 -53.38 4.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.661 0.743 . . . . 0.0 109.108 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.33 117.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.603 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.8 t30 -53.29 108.67 0.35 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.244 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.856 ' HA ' HD23 ' A' ' 376' ' ' LEU . 31.9 m -87.13 8.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.476 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -81.69 80.89 7.91 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.515 0.674 . . . . 0.0 110.718 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.643 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 37.9 mtt -102.39 81.05 2.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.2 mt -63.68 125.25 23.68 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.271 -169.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 375' ' ' GLN . 4.6 mm -65.47 -20.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.4 m -136.61 92.27 15.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.489 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' A' ' 357' ' ' LEU . 80.0 Cg_endo -92.07 48.93 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.6 2.867 . . . . 0.0 114.739 -168.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -170.47 70.11 0.56 Allowed Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 109.918 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.436 ' HB3' HG21 ' A' ' 372' ' ' ILE . 86.2 Cg_endo -90.91 138.32 2.4 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.949 2.433 . . . . 0.0 113.822 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 17.2 p -123.98 143.09 50.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.651 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.737 ' HG3' HG21 ' A' ' 340' ' ' ILE . 53.7 mtm -95.86 128.82 43.08 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.121 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 mm-40 -93.2 -172.22 2.89 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.348 1.03 . . . . 0.0 112.245 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.6 ' C ' HD21 ' A' ' 366' ' ' ASN . 0.3 OUTLIER -66.25 -6.23 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.838 174.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.4 t-20 -112.87 -2.1 14.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.31 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 105.31 -175.34 21.87 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.0 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -75.29 -37.72 41.22 Favored Glycine 0 CA--C 1.509 -0.306 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.494 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.76 -124.11 6.46 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.431 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.2 134.94 45.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.106 0.479 . . . . 0.0 111.559 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.672 HD11 ' HE3' ' A' ' 328' ' ' MET . 0.9 OUTLIER -128.7 155.33 40.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.737 ' HG2' HG12 ' A' ' 327' ' ' VAL . 33.8 mt-10 -125.09 138.34 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.875 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.634 ' HE2' HD13 ' A' ' 383' ' ' ILE . 0.1 OUTLIER -153.59 157.18 39.3 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.908 0.483 . . . . 0.0 110.709 -174.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.835 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -170.07 163.72 9.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 173.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.044 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.9 tp -165.51 163.41 12.97 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 1.044 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 72.1 Cg_exo -27.83 133.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.103 3.202 . . . . 0.0 114.348 168.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.83 ' HB3' ' HB2' ' A' ' 395' ' ' LYS . 5.2 Cg_exo -37.09 138.46 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.857 4.371 . . . . 0.0 115.362 -175.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 147.05 -179.76 23.73 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.063 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.5 m-20 -69.02 104.26 2.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 117.791 0.796 . . . . 0.0 110.561 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -94.34 112.54 24.33 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.031 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -114.78 127.56 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.863 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.678 HD11 ' HG3' ' A' ' 318' ' ' PRO . 21.8 mt -92.74 132.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.992 -175.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.67 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.6 OUTLIER -104.58 92.57 4.35 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.062 174.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.3 t -81.23 86.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.98 -91.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.533 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.531 ' HB2' ' HE3' ' A' ' 309' ' ' LYS . 10.5 t70 -108.75 -15.01 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 109.809 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.4 mp -64.35 147.93 51.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.8 p-10 -158.34 140.87 14.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.585 0.231 . . . . 0.0 111.127 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.622 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -167.88 121.7 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.24 174.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.031 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 70.6 mt-30 -70.83 150.96 45.29 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.548 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 12.1 t-105 -151.04 110.7 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.985 169.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.9 p90 -74.39 111.36 9.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.652 0.739 . . . . 0.0 109.8 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.569 ' NE2' ' HG2' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -99.11 146.27 26.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.139 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.83 ' HB2' ' HB3' ' A' ' 378' ' ' PRO . 71.7 mmtt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.197 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.512 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 25.1 p90 -64.74 129.82 41.23 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.92 -0.488 . . . . 0.0 110.062 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.4 t 176.78 -173.61 0.1 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 17.3 t -69.56 106.09 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.3 OUTLIER -68.86 156.68 38.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.682 0.754 . . . . 0.0 112.393 -167.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.671 ' OD2' HG21 ' A' ' 310' ' ' THR . 18.4 t70 -67.8 143.16 55.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.494 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -66.11 -22.39 66.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.494 -170.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.671 HG21 ' OD2' ' A' ' 308' ' ' ASP . 2.6 t -100.0 -6.23 26.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.635 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 29.3 mtpp -83.02 38.19 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -175.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -123.93 173.69 8.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.261 0.553 . . . . 0.0 111.497 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 10.0 t -157.13 135.43 11.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.478 170.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -55.16 110.87 0.74 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.839 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.657 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 1.1 tpmt? -92.36 -41.68 10.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.406 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 69.9 ttt180 -161.16 126.16 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -71.2 162.57 71.84 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.648 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.441 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 4.9 Cg_exo -40.37 122.69 1.32 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.609 2.206 . . . . 0.0 111.718 175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.502 ' O ' HG21 ' A' ' 327' ' ' VAL . 12.3 m -142.85 142.17 31.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.259 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.12 125.58 6.66 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.176 0.298 . . . . 0.0 110.487 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.535 ' HB3' HG11 ' A' ' 327' ' ' VAL . 94.9 p -66.79 -20.15 65.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.902 -174.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.89 -2.19 79.29 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -140.01 55.33 1.64 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 110.97 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 72.96 12.92 5.02 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.716 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.1 p -144.62 -166.78 2.47 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.481 -0.137 . . . . 0.0 110.699 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.96 155.19 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.86 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.664 HG12 ' HG3' ' A' ' 373' ' ' GLU . 17.9 m -137.5 160.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.655 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.413 ' HE3' ' HB2' ' A' ' 328' ' ' MET . 10.5 ptm -141.39 165.1 28.43 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.5 tt0 -130.19 124.68 33.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 385' ' ' VAL . 14.1 m -128.78 141.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.169 0.509 . . . . 0.0 111.599 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.03 161.04 14.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.674 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.0 OUTLIER -108.5 179.9 4.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.907 0.86 . . . . 0.0 112.833 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.2 t -98.8 -42.79 7.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.363 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.8 41.11 0.04 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.245 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 307' ' ' CYS . 13.7 m -114.32 119.9 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.118 0.459 . . . . 0.0 110.33 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.539 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.6 ptm180 -69.87 171.22 7.73 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.253 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.05 92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 124.184 3.256 . . . . 0.0 114.532 -169.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 363' ' ' THR . 20.8 p -114.34 164.1 14.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.274 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 20.8 mmt180 -86.59 99.03 11.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.753 HG13 HG21 ' A' ' 342' ' ' VAL . 16.7 pt -81.0 130.03 64.97 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.548 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.94 78.97 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.173 1.915 . . . . 0.0 112.354 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.91 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -98.25 121.62 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.832 0.825 . . . . 0.0 112.411 175.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -126.67 -176.69 3.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.326 171.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.59 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.9 134.47 15.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.348 0.594 . . . . 0.0 110.647 176.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.74 167.63 4.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.37 114.41 28.66 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.349 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 57.35 46.79 17.78 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 123.721 0.638 . . . . 0.0 110.621 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 64.75 13.84 57.02 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.837 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 351' ' ' GLU . 46.9 t -114.66 112.95 45.2 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.51 0.655 . . . . 0.0 111.301 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.64 52.56 2.51 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.627 2.885 . . . . 0.0 112.134 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.439 ' HB2' HG11 ' A' ' 349' ' ' VAL . 10.5 tp10 -90.93 -51.59 5.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.945 0.879 . . . . 0.0 108.828 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.8 118.51 29.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.115 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -61.03 107.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.719 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.733 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 27.0 m -89.53 6.58 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.59 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.95 83.37 6.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.466 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -99.82 91.98 5.09 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 29.6 mt -73.24 118.7 16.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.208 -167.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -66.66 -22.95 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.361 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -131.12 93.43 30.36 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.951 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.71 43.3 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.035 2.49 . . . . 0.0 113.035 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.455 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 66.6 t30 -150.54 61.03 4.48 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.543 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.621 ' HB2' HD13 ' A' ' 340' ' ' ILE . 73.9 Cg_endo -88.53 118.96 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.528 2.152 . . . . 0.0 112.789 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 53.2 p -124.42 149.63 46.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.377 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.959 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 71.3 mtm -94.61 133.8 37.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.413 ' HB3' HD21 ' A' ' 366' ' ' ASN . 1.2 mm-40 -109.46 -168.72 1.37 Allowed 'General case' 0 C--N 1.318 -0.795 0 O-C-N 124.551 1.157 . . . . 0.0 111.891 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.0 OUTLIER -52.51 -23.73 6.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -109.43 -7.93 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.077 -0.389 . . . . 0.0 111.156 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 127.75 -178.14 17.18 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.959 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -63.12 -29.66 75.09 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.63 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.9 -123.42 6.58 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.347 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -103.55 147.28 27.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.191 0.519 . . . . 0.0 111.644 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.9 mt -136.54 137.67 47.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.962 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.731 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.7 mp0 -107.29 135.52 48.66 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.292 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.656 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -152.45 158.09 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.619 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.9 tp60 -176.04 145.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.725 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.752 HD23 ' HD2' ' A' ' 377' ' ' PRO . 0.8 OUTLIER -146.25 142.48 17.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 167.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.752 ' HD2' HD23 ' A' ' 376' ' ' LEU . 28.2 Cg_exo -23.94 136.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.844 3.696 . . . . 0.0 115.004 177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.784 ' HA ' HE22 ' A' ' 394' ' ' GLN . 6.3 Cg_exo -37.11 134.2 0.41 Allowed 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 125.79 4.327 . . . . 0.0 114.97 -171.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 161.51 -124.6 1.33 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.995 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.453 ' HB3' HE21 ' A' ' 391' ' ' GLN . 11.7 m-20 -132.29 101.78 5.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.484 ' HB2' ' HE2' ' A' ' 374' ' ' MET . 7.9 m120 -104.57 124.75 49.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.041 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.55 134.28 66.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.656 HD12 ' HG2' ' A' ' 374' ' ' MET . 41.9 mt -95.27 134.1 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.176 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.23 94.24 4.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.133 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.91 HG11 HG11 ' A' ' 342' ' ' VAL . 2.8 t -84.82 72.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.64 -80.66 0.77 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.504 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 1.9 t70 -110.54 -30.08 7.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.51 141.77 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.537 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.4 p30 -150.73 154.27 37.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -170.08 116.07 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 175.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.041 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -73.13 139.97 46.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.438 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.449 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 29.9 t-105 -136.67 137.72 40.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.158 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -94.97 117.32 29.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.784 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.32 146.09 38.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.886 0.374 . . . . 0.0 110.495 -177.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 395' ' ' LYS . 1.9 ttpm? . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.496 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 335' ' ' THR . 6.8 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.569 ' HB3' ' HD2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -70.84 108.48 4.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.783 0.802 . . . . 0.0 110.617 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.5 t -168.43 -167.18 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.582 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.69 113.43 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 170.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.98 144.23 56.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.658 0.742 . . . . 0.0 111.174 -171.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.93 148.33 40.15 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.13 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.731 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.81 -12.88 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.888 -173.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.469 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.5 t -98.15 -6.21 31.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.567 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.7 mmmt -75.9 -36.16 59.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.628 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -94.4 148.79 21.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 111.106 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.9 t -139.11 162.19 35.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.56 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.466 ' CZ3' ' HA ' ' A' ' 317' ' ' ALA . 93.8 m95 -67.37 111.39 4.02 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.947 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 73.3 tttt -102.52 -39.8 6.95 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.014 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.628 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 70.7 ttt180 -157.0 118.35 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.51 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.466 ' HA ' ' CZ3' ' A' ' 314' ' ' TRP . . . -67.42 161.21 66.83 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.462 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 383' ' ' ILE . 74.0 Cg_exo -36.34 110.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.223 2.616 . . . . 0.0 113.251 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.538 ' O ' HG21 ' A' ' 327' ' ' VAL . 7.5 m -134.9 137.45 43.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.591 -173.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.4 131.66 13.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.162 0.505 . . . . 0.0 111.509 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 88.1 p -66.89 -23.32 65.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.77 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.05 -11.64 31.73 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -100.77 -54.13 2.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.516 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 21.9 t70 170.08 -24.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.323 1.058 . . . . 0.0 109.035 -171.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.542 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.46 -169.95 2.25 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.462 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.601 HG12 HE22 ' A' ' 394' ' ' GLN . 2.1 t -127.73 154.38 38.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.024 0.44 . . . . 0.0 111.001 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.668 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.3 m -135.22 156.61 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.76 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.573 ' SD ' HG22 ' A' ' 330' ' ' VAL . 2.0 ppp? -135.65 154.63 51.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.947 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 9.7 tt0 -126.44 123.13 37.17 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.116 0.484 . . . . 0.0 110.601 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.573 HG21 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -123.7 148.83 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.51 -177.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.23 139.35 15.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.78 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.445 ' H ' ' HD1' ' A' ' 332' ' ' PHE . 0.8 OUTLIER -91.13 179.27 5.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.345 0.573 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.7 p -135.55 -17.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.118 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.99 -47.28 0.06 OUTLIER Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.339 -1.41 . . . . 0.0 114.213 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.663 HG23 HG21 ' A' ' 303' ' ' THR . 26.3 m -56.27 125.27 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.213 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.569 ' HD2' ' HB3' ' A' ' 304' ' ' TYR . 0.0 OUTLIER -69.44 163.22 60.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 118.14 -0.933 . . . . 0.0 108.891 176.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.48 97.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.148 3.232 . . . . 0.0 114.688 -169.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 363' ' ' THR . 6.8 p -114.07 150.89 33.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.969 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -75.4 108.06 7.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.729 HG22 ' HG3' ' A' ' 364' ' ' MET . 28.8 pt -91.48 128.58 46.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.106 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.33 89.57 1.18 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.099 2.533 . . . . 0.0 112.881 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 372' ' ' ILE . 19.1 m -101.05 124.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.415 0.626 . . . . 0.0 110.938 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -132.78 -175.62 3.83 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.21 137.46 18.44 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.59 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 382' ' ' ILE . 10.7 m -115.23 166.82 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.54 117.74 34.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.535 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.5 t60 59.7 40.08 20.27 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.395 0.434 . . . . 0.0 110.519 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 69.1 6.96 55.77 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.231 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.1 113.09 62.75 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.897 0.349 . . . . 0.0 111.051 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.46 55.87 4.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.929 2.42 . . . . 0.0 111.88 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.32 -53.49 4.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.029 0.919 . . . . 0.0 108.621 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.6 120.89 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.787 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -54.37 107.99 0.33 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.663 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 376' ' ' LEU . 2.6 m -87.9 -8.65 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.85 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.462 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -60.02 96.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.471 0.653 . . . . 0.0 112.222 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.64 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 67.4 mtm -108.18 85.38 2.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 45.4 mt -73.41 124.37 25.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.377 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.8 mm -69.62 -20.53 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.3 m -145.74 97.13 4.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.999 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -92.47 37.91 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.483 2.788 . . . . 0.0 113.288 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -144.53 63.04 10.42 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.883 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.657 ' HB3' HG21 ' A' ' 372' ' ' ILE . 88.4 Cg_endo -86.1 131.45 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.564 2.176 . . . . 0.0 113.016 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -130.4 142.16 50.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.399 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.752 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 59.0 mtm -95.24 117.08 29.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.722 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 38.5 mt-10 -100.12 -165.47 1.22 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.898 1.374 . . . . 0.0 109.886 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.602 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -62.8 -15.0 52.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 0.0 111.314 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.602 ' N ' HD21 ' A' ' 366' ' ' ASN . 87.1 m-20 -96.7 6.44 48.69 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.184 0.516 . . . . 0.0 109.678 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 83.48 -155.19 32.1 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.573 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -68.43 -16.43 69.4 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.826 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 71.45 -87.18 0.42 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.705 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.02 143.32 15.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.099 0.476 . . . . 0.0 109.871 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.805 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 1.8 mt -119.57 157.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.668 ' HG2' HG12 ' A' ' 327' ' ' VAL . 37.0 mt-10 -126.34 130.94 51.78 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.806 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.805 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -155.26 160.56 40.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.928 -173.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.857 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -163.71 148.19 10.54 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 167.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -132.22 163.59 49.27 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -169.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 378' ' ' PRO . 3.5 Cg_endo -48.16 126.67 13.87 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.625 2.217 . . . . 0.0 112.147 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.5 Cg_exo -38.81 128.62 1.26 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.69 3.594 . . . . 0.0 113.711 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 134.32 -172.57 21.76 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.362 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.817 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.4 m-20 -71.21 101.44 2.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.931 0.365 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.523 ' HB2' HD22 ' A' ' 376' ' ' LEU . 31.9 m-80 -118.04 163.39 16.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.031 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -146.24 144.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.631 -173.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.837 HD11 ' HG3' ' A' ' 318' ' ' PRO . 21.5 mt -100.97 132.96 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.094 0.473 . . . . 0.0 110.339 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -103.84 97.15 7.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.24 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.1 t -86.5 84.68 2.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.32 -85.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.332 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 7.8 t70 -113.09 -16.23 12.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.4 mp -66.14 148.76 51.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.058 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.1 p30 -163.45 126.92 2.73 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.967 0.413 . . . . 0.0 111.494 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -153.75 119.81 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.25 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.031 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 41.5 tt0 -87.39 142.38 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.424 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.476 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 0.6 OUTLIER -153.33 141.02 19.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.817 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 7.7 p90 -74.55 107.08 6.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.288 0.566 . . . . 0.0 110.661 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.651 ' HG3' HD22 ' A' ' 376' ' ' LEU . 1.7 mm100 -85.1 145.07 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 tptm . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.819 172.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 335' ' ' THR . 7.7 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.751 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.3 p90 -58.97 130.94 49.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 110.181 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.7 t -177.58 -165.45 0.11 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 306' ' ' VAL . 6.0 p -69.02 107.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.549 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.5 OUTLIER -68.4 136.24 53.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.818 0.818 . . . . 0.0 110.877 -174.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.535 ' OD1' HG21 ' A' ' 310' ' ' THR . 8.7 t70 -65.92 147.75 52.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.924 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.776 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -61.56 -13.37 21.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.248 -177.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.535 HG21 ' OD1' ' A' ' 308' ' ' ASP . 15.3 t -104.29 6.19 35.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 41.4 mtpt -106.36 17.42 23.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.776 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.5 OUTLIER -132.74 158.32 42.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.2 t -138.71 154.08 48.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.503 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.514 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.5 m-90 -63.8 98.49 0.2 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.367 0.604 . . . . 0.0 110.885 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -83.51 -32.42 25.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 37.6 ttm180 -165.24 116.12 1.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.255 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.507 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -64.42 163.6 24.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.344 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 4.0 Cg_exo -41.7 117.91 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.638 2.226 . . . . 0.0 112.107 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.586 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.7 m -135.49 144.52 46.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.345 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.82 130.3 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 327' ' ' VAL . 80.6 p -71.15 -18.64 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.93 -2.59 72.53 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 9.1 t60 -109.09 -52.88 2.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 19.0 t70 169.19 -25.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.311 1.053 . . . . 0.0 108.915 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.455 ' CB ' HG13 ' A' ' 358' ' ' ILE . 9.4 p -92.83 -168.28 1.92 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.004 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.68 150.92 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.684 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -131.85 163.7 36.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.979 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.4 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -142.39 163.99 31.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 4.0 tt0 -132.06 126.68 34.42 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.656 0.597 . . . . 0.0 110.1 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.91 153.9 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.723 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.38 152.27 16.84 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.999 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.565 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -89.93 165.86 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.227 0.514 . . . . 0.0 111.798 -174.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 35.3 m -115.6 8.03 14.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.338 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 147.61 13.11 0.15 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.458 -1.354 . . . . 0.0 115.2 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.549 ' HB ' ' SG ' ' A' ' 307' ' ' CYS . 98.4 m -114.29 132.71 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.292 1.046 . . . . 0.0 110.586 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.751 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 28.0 ptt180 -75.94 173.11 7.72 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.027 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.713 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.62 93.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 124.051 3.167 . . . . 0.0 115.166 -168.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 1.8 p -110.8 150.78 28.63 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.035 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.28 108.75 3.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.578 ' HB ' ' HG3' ' A' ' 364' ' ' MET . 15.6 tt -92.4 119.24 68.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 121.013 0.435 . . . . 0.0 110.24 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.47 82.23 2.13 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.987 2.458 . . . . 0.0 112.535 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.665 HG13 HG11 ' A' ' 385' ' ' VAL . 29.8 m -98.93 128.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.384 0.611 . . . . 0.0 111.477 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 32.0 ptt180 -135.17 -176.13 4.15 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.558 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.68 141.58 22.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.255 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 14.6 m -120.47 168.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.44 34.11 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.049 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.55 ' HA ' ' OD2' ' A' ' 380' ' ' ASP . 5.4 t60 56.91 46.54 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.514 0.509 . . . . 0.0 111.381 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 61.79 14.44 44.24 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.642 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 347' ' ' HIS . 38.7 t -115.78 115.86 41.13 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.155 0.478 . . . . 0.0 111.216 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.16 51.29 3.8 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.231 2.62 . . . . 0.0 112.228 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.61 ' HG3' HG11 ' A' ' 352' ' ' VAL . 8.8 pt-20 -85.07 -41.4 15.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.739 0.781 . . . . 0.0 109.222 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.61 HG11 ' HG3' ' A' ' 351' ' ' GLU . 4.4 p -144.11 118.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.602 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -55.78 108.09 0.41 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.932 ' HA ' HD21 ' A' ' 376' ' ' LEU . 28.2 m -84.99 0.18 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.124 0.487 . . . . 0.0 110.293 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.558 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.36 82.97 3.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.216 0.532 . . . . 0.0 110.835 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.742 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 8.5 tpt -97.59 91.96 5.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 166.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 39.3 mt -74.49 120.37 19.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.454 -165.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.662 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.6 mm -70.32 -19.01 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 61.7 m -128.25 81.89 69.61 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.252 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -86.18 43.92 1.18 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.14 2.56 . . . . 0.0 113.811 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.14 67.62 0.41 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.447 ' O ' HG21 ' A' ' 340' ' ' ILE . 68.9 Cg_endo -91.49 134.91 1.65 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.816 2.344 . . . . 0.0 114.01 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 2.8 p -116.65 155.94 27.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.93 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.907 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 76.7 mtp -95.43 103.72 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.981 0.42 . . . . 0.0 109.868 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -79.72 -165.56 0.83 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.732 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.52 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -46.85 -30.86 2.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -122.69 25.72 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.757 -0.59 . . . . 0.0 111.289 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.723 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.09 -177.6 20.37 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.008 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.907 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.12 -25.09 53.35 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.395 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.09 -110.98 3.71 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.642 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -108.1 131.9 54.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.152 0.501 . . . . 0.0 111.721 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.622 HD11 HG11 ' A' ' 342' ' ' VAL . 1.2 mt -134.98 141.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.684 ' HG2' HG12 ' A' ' 327' ' ' VAL . 30.9 mt-10 -114.46 137.09 52.28 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.492 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.481 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -144.46 156.08 44.03 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.742 ' O ' ' HB3' ' A' ' 356' ' ' MET . 24.1 tp60 -175.65 144.92 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.709 0.29 . . . . 0.0 110.96 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.028 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.2 tp -147.15 160.07 40.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 164.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 1.028 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 38.7 Cg_exo -29.47 133.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.147 3.231 . . . . 0.0 114.579 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.581 ' HA ' HE22 ' A' ' 394' ' ' GLN . 73.0 Cg_exo -35.37 135.69 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.016 1 C-N-CA 125.441 4.094 . . . . 0.0 115.562 -176.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.61 -135.71 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.55 ' OD2' ' HA ' ' A' ' 347' ' ' HIS . 4.7 p-10 -131.17 107.47 9.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.162 0.982 . . . . 0.0 109.977 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.502 ' N ' HD21 ' A' ' 381' ' ' ASN . 0.8 OUTLIER -102.26 128.65 48.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.632 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.993 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -119.63 135.73 59.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.481 HD12 ' HG2' ' A' ' 374' ' ' MET . 42.2 mt -91.07 129.48 41.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.873 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -108.93 91.84 3.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.971 176.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.665 HG11 HG13 ' A' ' 342' ' ' VAL . 9.3 t -83.6 85.6 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.24 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.359 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 3.1 t0 -112.1 -22.64 10.89 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.514 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -64.13 140.08 58.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.226 177.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.445 ' H ' ' HZ2' ' A' ' 314' ' ' TRP . 25.7 p-10 -151.74 139.43 19.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.39 116.98 1.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.993 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 26.9 tt0 -67.38 141.57 57.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.763 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.42 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 27.9 t-105 -139.79 122.11 16.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.121 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 11.8 p90 -79.76 109.07 13.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.077 0.465 . . . . 0.0 109.908 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.581 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -104.11 133.16 49.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.048 0.452 . . . . 0.0 110.511 -178.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.61 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 335' ' ' THR . 6.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.185 0.516 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -57.99 131.15 49.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.792 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.9 t -176.39 -167.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.0 t -68.13 116.65 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 137.22 56.08 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.805 0.812 . . . . 0.0 111.446 -170.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.644 ' OD1' HG21 ' A' ' 310' ' ' THR . 13.4 t0 -60.69 143.33 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.545 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.1 -171.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.644 HG21 ' OD1' ' A' ' 308' ' ' ASP . 2.2 t -108.58 3.96 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.508 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 37.3 mttp -80.19 -21.53 42.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.676 ' HB3' ' HE3' ' A' ' 364' ' ' MET . 0.1 OUTLIER -95.97 154.02 17.46 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.347 0.594 . . . . 0.0 110.958 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.8 t -136.95 156.44 48.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.226 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -59.98 99.9 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.762 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.525 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 27.6 tptp -89.34 -46.42 8.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.428 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 28.5 ttm180 -154.92 122.43 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.792 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.46 157.19 86.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.33 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.407 ' HB2' ' CD2' ' A' ' 392' ' ' TRP . 2.4 Cg_endo -42.24 112.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.111 2.541 . . . . 0.0 112.689 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.534 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.9 m -127.61 144.64 51.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.02 -174.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.75 128.02 6.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 327' ' ' VAL . 93.4 p -64.96 -23.1 67.12 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.521 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.86 -12.4 20.36 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.753 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.0 -40.92 1.98 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -178.0 -28.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.384 0.611 . . . . 0.0 111.667 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.451 ' HB ' HG13 ' A' ' 358' ' ' ILE . 16.7 p -93.31 -170.88 2.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.035 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.835 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.0 OUTLIER -127.62 144.72 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 -177.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.828 HG12 ' HG2' ' A' ' 373' ' ' GLU . 21.9 m -129.23 142.73 43.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.518 ' CE ' HG11 ' A' ' 330' ' ' VAL . 6.7 ptm -125.91 166.88 16.08 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.525 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 15.6 tt0 -136.7 140.54 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.528 HG21 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -139.52 158.89 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.67 0.271 . . . . 0.0 111.335 -178.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -124.86 135.85 9.64 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.629 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.576 ' HD2' ' HA2' ' A' ' 368' ' ' GLY . 2.3 p90 -90.74 178.45 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.192 0.496 . . . . 0.0 109.941 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.0 m -152.45 19.1 0.63 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -160.82 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.486 -1.34 . . . . 0.0 114.11 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 336' ' ' ARG . 67.9 m -70.49 139.98 51.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.683 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 4.8 ptt180 -67.34 175.84 1.42 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 117.611 -1.185 . . . . 0.0 109.013 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.783 ' HA ' ' O ' ' A' ' 364' ' ' MET . 3.7 Cg_exo -26.02 92.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 124.002 3.134 . . . . 0.0 114.247 -174.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 1.6 p -113.34 151.85 30.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.152 -171.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 9.1 mpt_? -69.24 109.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.601 HD13 ' HE1' ' A' ' 364' ' ' MET . 11.3 tt -89.22 118.7 69.4 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 120.946 0.403 . . . . 0.0 110.459 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.8 84.12 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.085 2.523 . . . . 0.0 112.798 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 372' ' ' ILE . 29.8 m -100.7 130.63 49.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 41.0 ptt180 -138.29 -170.26 2.77 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.531 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -155.52 140.89 17.68 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.348 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.83 167.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.44 113.05 26.26 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.886 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 56.68 49.39 14.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.466 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 68.75 2.15 27.78 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.252 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.37 113.05 56.58 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 117.73 0.765 . . . . 0.0 111.484 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.33 63.17 8.69 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.485 2.79 . . . . 0.0 112.906 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.73 -46.01 6.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.622 0.725 . . . . 0.0 109.369 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.92 124.52 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.074 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.5 t30 -63.02 107.98 1.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.58 HG22 ' HB3' ' A' ' 381' ' ' ASN . 34.3 m -90.94 11.56 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.549 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.531 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -83.3 83.19 7.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.548 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 36.7 ttm -96.92 87.26 4.21 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.6 mt -72.48 119.78 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.659 -165.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.711 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -69.79 -14.42 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -142.49 85.93 10.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.552 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 357' ' ' LEU . 96.9 Cg_endo -87.46 46.03 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.328 2.686 . . . . 0.0 113.944 -171.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -163.13 62.68 1.2 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.027 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.471 ' O ' HG22 ' A' ' 340' ' ' ILE . 86.1 Cg_endo -86.02 129.44 3.39 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.167 1.912 . . . . 0.0 113.405 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -116.96 150.56 38.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.502 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.783 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 0.5 OUTLIER -99.81 118.78 37.01 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.974 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.94 -165.32 1.24 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 124.929 1.393 . . . . 0.0 110.697 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -21.67 21.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.24 -0.43 38.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.313 0.577 . . . . 0.0 110.437 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.617 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.91 -160.14 13.58 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -65.6 -2.7 11.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 117.606 0.703 . . . . 0.0 112.505 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 56.21 -130.12 48.96 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -172.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 328' ' ' MET . 38.3 p90 -112.36 150.11 31.52 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.997 0.427 . . . . 0.0 110.432 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 2.2 mt -134.0 143.68 37.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.418 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.828 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.0 mt-10 -112.4 139.71 47.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.541 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.6 ppp? -156.86 162.89 39.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.171 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.835 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.89 169.63 6.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.064 0.459 . . . . 0.0 111.829 172.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.771 HD23 ' HD2' ' A' ' 377' ' ' PRO . 1.7 tm? -166.12 141.03 3.8 Favored Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.771 ' HD2' HD23 ' A' ' 376' ' ' LEU . 22.4 Cg_exo -31.36 132.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.849 3.033 . . . . 0.0 114.12 175.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.534 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 6.0 Cg_exo -37.17 130.93 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.154 1 C-N-CA 125.783 4.322 . . . . 0.0 115.016 -170.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.99 -173.32 37.43 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.7 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.8 m-20 -90.1 101.53 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.037 0.419 . . . . 0.0 110.066 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.58 ' HB3' HG22 ' A' ' 354' ' ' VAL . 16.8 m-80 -111.89 -179.64 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.506 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.061 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.77 139.3 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 O-C-N 122.268 -0.27 . . . . 0.0 110.322 178.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.62 ' HB ' ' CE1' ' A' ' 390' ' ' HIS . 29.9 mt -91.04 133.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 389' ' ' ASN . 1.8 t80 -112.95 104.25 12.21 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.651 HG11 HG13 ' A' ' 342' ' ' VAL . 6.2 t -97.01 83.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.86 -88.74 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.516 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.41 -31.18 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.2 mp -63.62 140.92 58.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 5.0 p-10 -140.25 140.62 35.81 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.829 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.62 ' CE1' ' HB ' ' A' ' 383' ' ' ILE . 0.8 OUTLIER -162.86 102.23 1.01 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.597 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.061 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.4 tt0 -81.41 152.23 27.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.404 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.742 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.2 OUTLIER -159.53 150.37 19.47 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 35.5 p90 -94.14 128.94 40.85 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.371 -0.83 . . . . 0.0 109.665 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.784 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -109.39 145.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.022 0.439 . . . . 0.0 110.474 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.47 ' HD3' ' C ' ' A' ' 395' ' ' LYS . 7.2 tmtt? . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.466 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 335' ' ' THR . 8.7 t . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.365 0.602 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.71 113.78 5.11 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.685 0.755 . . . . 0.0 110.098 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.1 t -173.81 -166.45 0.31 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.91 104.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.701 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.6 OUTLIER -74.47 167.23 22.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD2' HG21 ' A' ' 310' ' ' THR . 14.9 t70 -71.89 150.3 44.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.613 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 24.6 pttt -74.5 -19.82 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.613 -167.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.553 HG21 ' OD2' ' A' ' 308' ' ' ASP . 15.3 t -107.69 22.65 15.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.077 0.465 . . . . 0.0 111.625 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -95.64 18.55 12.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -134.23 173.67 11.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.388 0.614 . . . . 0.0 111.187 -178.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 140.81 33.01 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.299 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -54.01 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.518 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.97 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 76.3 tttt -85.89 -43.64 13.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.549 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 24.9 ttm180 -148.84 126.77 11.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.226 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 390' ' ' HIS . . . -70.9 160.64 81.61 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.75 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -42.35 115.39 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.292 1.995 . . . . 0.0 111.467 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.57 ' O ' HG21 ' A' ' 327' ' ' VAL . 5.0 m -134.34 144.61 48.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.732 -172.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -46.3 128.15 9.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 0.0 111.239 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.62 ' HB3' HG11 ' A' ' 327' ' ' VAL . 79.8 p -74.98 -22.05 58.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.451 -173.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.25 84.55 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -169.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -124.81 32.51 5.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.394 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.3 t70 68.9 19.39 8.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.309 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.45 ' HB ' HG13 ' A' ' 358' ' ' ILE . 13.8 p -136.76 -168.26 2.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.51 151.36 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.986 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.9 m -139.44 147.62 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.193 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 383' ' ' ILE . 11.9 ptm -126.7 163.02 24.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.555 171.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.97 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 11.5 tt0 -128.14 127.47 43.06 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.87 138.23 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.062 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -108.6 139.98 15.38 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.82 -179.87 4.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.249 1.025 . . . . 0.0 111.715 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.2 p -129.99 -24.47 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.656 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -144.54 -68.02 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.375 -1.393 . . . . 0.0 115.0 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.701 HG22 ' HB3' ' A' ' 307' ' ' CYS . 7.1 m -56.24 122.19 11.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.811 0.306 . . . . 0.0 111.619 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.446 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.8 ptm180 -74.21 171.82 10.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 117.68 -1.152 . . . . 0.0 108.589 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.98 96.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.955 3.103 . . . . 0.0 114.929 -170.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.734 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.7 p -118.09 165.57 13.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.257 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.47 100.61 12.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.704 HD13 ' HB2' ' A' ' 362' ' ' PRO . 18.9 pt -74.6 128.65 85.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.79 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.24 82.09 1.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.669 2.246 . . . . 0.0 112.089 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.625 HG11 HD11 ' A' ' 372' ' ' ILE . 20.5 m -97.63 133.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.536 0.684 . . . . 0.0 111.131 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -145.45 -177.73 5.72 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.605 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.15 137.18 18.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.811 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.1 m -113.66 172.76 3.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -100.96 115.9 31.55 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 6.1 p-80 41.38 59.82 2.27 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.887 0.742 . . . . 0.0 112.831 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.813 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 67.97 5.02 37.76 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.898 -0.592 . . . . 0.0 114.226 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 25.3 t -114.52 116.98 43.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 117.386 0.593 . . . . 0.0 111.026 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -74.63 54.44 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.196 2.598 . . . . 0.0 111.471 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.571 ' HG3' HG11 ' A' ' 352' ' ' VAL . 7.8 pt-20 -86.22 -38.96 17.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.776 0.798 . . . . 0.0 108.951 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.571 HG11 ' HG3' ' A' ' 351' ' ' GLU . 5.2 p -151.68 123.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.843 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -56.19 108.05 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.883 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.99 3.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.21 0.529 . . . . 0.0 110.2 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.605 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.93 82.66 5.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.318 -177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -96.15 91.27 5.84 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 20.9 mt -70.8 120.41 16.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.658 -167.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.7 mm -68.52 -21.03 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.287 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 10.3 m -136.98 92.38 14.24 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.845 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.4 43.65 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.218 2.612 . . . . 0.0 112.895 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -150.37 58.65 3.17 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.704 ' HB2' HD13 ' A' ' 340' ' ' ILE . 92.5 Cg_endo -86.86 113.03 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.412 2.074 . . . . 0.0 113.244 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.2 p -114.06 140.09 48.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.913 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.734 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 24.6 ptt? -102.84 126.3 49.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.737 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.03 -166.24 1.18 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.307 -172.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -61.23 -12.88 14.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.2 p30 -101.26 -4.34 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.51 -165.47 12.71 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -78.52 -7.11 88.15 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.145 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 66.59 -120.66 15.35 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.688 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -116.04 140.22 49.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.217 0.532 . . . . 0.0 111.204 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.625 HD11 HG11 ' A' ' 342' ' ' VAL . 1.4 mt -124.42 126.6 72.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.1 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.986 ' HG2' HG12 ' A' ' 327' ' ' VAL . 38.1 mt-10 -104.75 132.58 50.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.217 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.492 ' HE3' ' HB2' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.3 tp60 -174.32 145.08 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.097 0.248 . . . . 0.0 110.592 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.101 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.0 tp -143.59 162.74 40.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 1.101 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 34.5 Cg_exo -36.48 141.8 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.269 2.646 . . . . 0.0 113.492 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.551 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.7 Cg_exo -37.53 134.64 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 125.325 4.017 . . . . 0.0 114.77 -173.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.37 -146.75 13.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.348 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 14.8 m-20 -112.55 101.36 9.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.481 0.641 . . . . 0.0 110.213 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.492 ' HB2' ' HE3' ' A' ' 374' ' ' MET . 6.6 m120 -100.05 118.81 37.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.609 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.054 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.88 133.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 328' ' ' MET . 30.7 mt -93.13 134.02 32.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.461 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.8 OUTLIER -109.74 92.76 4.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.342 174.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 342' ' ' VAL . 5.5 t -81.28 77.99 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.69 -91.68 0.27 Allowed Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.971 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.613 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -106.61 -18.0 14.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.342 0.592 . . . . 0.0 109.643 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.9 OUTLIER -74.37 128.26 35.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.534 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.99 143.68 48.29 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.534 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 0.1 OUTLIER -166.16 120.17 1.14 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.817 0.341 . . . . 0.0 110.806 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.054 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 47.1 tt0 -82.36 146.73 29.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.935 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -141.97 132.97 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.76 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.87 119.48 29.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.551 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -114.3 146.09 40.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.002 0.43 . . . . 0.0 110.343 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 pttt . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.847 -178.366 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.052 0.453 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.529 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 14.6 p90 -60.74 128.81 38.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -176.29 -172.42 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.04 110.44 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.499 ' HB2' ' HE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -68.67 134.73 50.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.684 0.754 . . . . 0.0 112.112 -172.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.621 ' OD1' HG21 ' A' ' 310' ' ' THR . 32.7 t70 -63.51 146.18 54.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.274 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.627 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.83 -14.66 62.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.321 -1.309 . . . . 0.0 114.309 -167.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.621 HG21 ' OD1' ' A' ' 308' ' ' ASP . 9.1 t -106.3 5.38 29.65 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.683 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -89.73 -21.16 22.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.08 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.716 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -95.87 147.45 23.65 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.21 0.529 . . . . 0.0 110.17 172.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 4.3 t -133.25 153.3 51.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.49 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.602 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.9 m-90 -61.98 99.12 0.12 Allowed 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 123.57 0.544 . . . . 0.0 111.232 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.619 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -84.44 -42.59 15.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -156.03 125.58 6.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.894 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.632 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -66.58 167.23 13.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.258 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.55 122.28 1.32 Allowed 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.925 2.417 . . . . 0.0 112.138 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.576 ' O ' HG21 ' A' ' 327' ' ' VAL . 28.8 m -135.35 136.77 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.637 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -46.0 124.65 5.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 111.131 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -36.49 83.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.749 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 130.58 -10.71 5.78 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -114.84 -78.07 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.774 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.26 0.33 0.6 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.086 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.435 ' HB ' HG13 ' A' ' 358' ' ' ILE . 20.9 p -119.9 -174.28 2.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.142 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.4 153.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.884 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.788 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.6 m -133.44 163.99 36.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.557 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.712 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -147.71 153.71 39.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.649 -178.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.619 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 26.4 tt0 -129.6 118.07 21.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.597 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.712 HG13 ' SD ' ' A' ' 328' ' ' MET . 2.3 m -122.63 150.56 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.542 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.69 136.37 12.94 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.783 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.538 ' HB3' ' HE3' ' A' ' 364' ' ' MET . 0.4 OUTLIER -90.93 -179.44 5.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.594 0.712 . . . . 0.0 111.241 -176.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.9 m -119.64 -25.78 5.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.993 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.21 -19.53 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.357 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 5.5 m -75.3 134.75 40.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.021 0.91 . . . . 0.0 112.446 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.628 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.1 OUTLIER -78.3 173.7 7.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.611 171.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -25.46 95.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 124.021 3.147 . . . . 0.0 114.745 -173.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 305' ' ' THR . 21.8 p -110.67 166.87 10.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.336 -174.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.7 mpt_? -93.75 104.6 16.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.65 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 362' ' ' PRO . 5.7 mt -75.79 123.82 88.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 81.42 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.311 2.007 . . . . 0.0 111.686 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.628 HG11 HD11 ' A' ' 372' ' ' ILE . 14.5 m -100.58 133.62 43.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.416 0.627 . . . . 0.0 111.586 -177.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -143.24 -175.53 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.453 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -156.92 143.21 18.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.249 0.547 . . . . 0.0 111.459 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.4 m -115.17 172.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.5 115.67 31.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 2.6 p-80 37.86 64.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.665 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.44 6.34 33.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.419 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 38.9 t -115.69 113.66 42.45 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 117.616 0.708 . . . . 0.0 111.467 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.72 69.07 5.4 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.08 2.52 . . . . 0.0 111.364 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -95.19 -49.02 5.68 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.13 131.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.391 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 42.8 t30 -60.1 107.91 0.7 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.023 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.903 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.3 m -85.26 1.62 4.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 110.65 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.453 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.23 82.93 6.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.073 0.463 . . . . 0.0 110.479 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.04 92.24 5.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 28.5 mt -70.25 124.85 25.16 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.773 -165.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.686 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.0 mm -69.75 -21.53 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.702 -1.135 . . . . 0.0 107.994 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.8 m -137.33 94.82 11.97 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.7 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -86.01 41.22 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.396 2.731 . . . . 0.0 113.256 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.31 70.62 2.97 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.393 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.895 ' HB2' HD13 ' A' ' 340' ' ' ILE . 95.6 Cg_endo -82.19 133.6 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.492 2.128 . . . . 0.0 112.434 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.0 p -129.12 141.28 51.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.208 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.687 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 74.1 mtp -96.0 130.51 42.98 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.5 -168.72 1.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.271 0.982 . . . . 0.0 111.837 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.439 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -70.08 -5.62 28.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.435 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 366' ' ' ASN . 65.4 m-80 -113.52 9.12 17.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.4 0.619 . . . . 0.0 109.871 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.58 -165.75 16.77 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.246 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.53 -12.86 70.56 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.035 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.47 -119.25 10.03 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.6 m-85 -121.87 131.51 54.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.688 0.756 . . . . 0.0 111.606 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.834 ' HB ' ' HE2' ' A' ' 374' ' ' MET . 1.9 mt -106.17 157.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.788 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.2 mt-10 -126.87 129.15 47.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.867 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.834 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 0.4 OUTLIER -147.99 156.41 42.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.531 -172.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.561 HE21 ' H ' ' A' ' 376' ' ' LEU . 26.6 tp60 -177.65 146.73 0.46 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.645 0.259 . . . . 0.0 110.873 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.943 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.9 tp -145.26 154.46 53.77 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.943 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 41.5 Cg_exo -26.87 133.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 124.476 3.451 . . . . 0.0 115.134 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.679 ' HA ' HE22 ' A' ' 394' ' ' GLN . 54.6 Cg_exo -35.58 128.73 0.32 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 125.134 3.889 . . . . 0.0 115.114 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 167.68 -135.25 3.56 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.984 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.437 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 23.2 m-20 -119.72 101.03 7.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.156 0.478 . . . . 0.0 110.226 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.81 125.36 48.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.102 0.477 . . . . 0.0 109.893 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.079 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -124.15 129.13 74.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 16.9 mt -91.77 130.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.921 0.391 . . . . 0.0 110.66 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.8 m-85 -99.35 92.46 5.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.88 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.433 HG11 HG13 ' A' ' 342' ' ' VAL . 14.6 t -79.92 84.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.96 -86.62 0.13 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.479 -171.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.618 ' CB ' ' HD3' ' A' ' 309' ' ' LYS . 31.0 t0 -116.71 -19.77 9.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.324 0.583 . . . . 0.0 109.479 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.8 OUTLIER -59.34 142.83 51.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.164 174.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.3 p30 -152.32 138.78 18.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.804 0.335 . . . . 0.0 110.755 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -165.17 126.39 2.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.12 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.079 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.0 tt0 -79.04 152.01 31.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.448 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 19.9 t-105 -147.61 120.69 8.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.887 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -73.98 114.26 12.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.679 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.27 144.06 42.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.699 -177.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.246 0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.414 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 335' ' ' THR . 4.8 t . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.79 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 16.4 p90 -61.56 123.47 17.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.141 0.496 . . . . 0.0 110.958 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 11.6 t -171.93 -167.61 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.21 115.37 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.09 156.09 38.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.874 0.845 . . . . 0.0 111.665 -172.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 311' ' ' LYS . 12.8 t70 -90.77 147.19 23.38 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.749 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.75 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.49 -13.56 14.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.063 -175.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 4.8 t -101.0 5.44 43.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 111.14 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.787 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 29.5 mttt -105.33 13.04 31.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.75 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -128.19 143.83 51.07 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 168.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -128.82 154.18 46.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.62 113.98 3.02 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.82 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.908 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 63.3 tttt -112.29 -53.91 2.67 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -140.71 117.89 11.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -63.22 161.37 32.76 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.09 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 2.1 Cg_endo -44.69 119.59 2.36 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.643 2.229 . . . . 0.0 111.949 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.606 ' O ' HG21 ' A' ' 327' ' ' VAL . 21.7 m -131.0 139.13 49.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.367 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.58 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 111.445 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 96.5 p -67.27 -21.8 65.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.487 -174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.36 -18.73 30.07 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.482 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -105.72 -54.23 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.058 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.59 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.739 0.781 . . . . 0.0 110.687 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.851 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 32.8 p -103.76 -168.19 1.47 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.689 -174.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.894 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.1 t -125.5 151.53 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.699 HG12 ' HG3' ' A' ' 373' ' ' GLU . 18.4 m -136.32 144.89 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 123.31 0.644 . . . . 0.0 110.004 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.471 ' CE ' HG11 ' A' ' 330' ' ' VAL . 6.5 ptm -131.66 169.55 16.01 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.359 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.908 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 4.6 tt0 -136.39 133.04 36.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.144 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.471 HG11 ' CE ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -131.42 154.53 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.203 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.36 138.79 14.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.902 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.787 ' HA ' ' O ' ' A' ' 311' ' ' LYS . 1.2 p90 -99.69 177.47 5.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.731 0.765 . . . . 0.0 110.815 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t -164.69 45.71 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.044 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.487 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -176.85 -63.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.905 172.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 338' ' ' CYS . 27.6 m -86.98 129.1 35.03 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.79 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 6.1 ptm180 -64.78 169.1 5.75 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.166 171.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.72 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.53 94.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.056 3.17 . . . . 0.0 114.383 -168.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 4.7 p -111.79 151.81 28.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.844 -173.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.3 mpt_? -73.39 108.39 6.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.525 HG12 HG12 ' A' ' 342' ' ' VAL . 14.4 tt -85.19 126.98 65.95 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.64 -175.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.62 82.17 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.557 2.171 . . . . 0.0 112.092 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 372' ' ' ILE . 16.5 m -103.21 122.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 111.271 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 17.8 ptt-85 -129.85 -173.98 3.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.559 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -155.59 139.49 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.399 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 382' ' ' ILE . 10.4 m -113.04 171.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.43 28.51 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.495 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 34.4 t-80 51.24 55.41 9.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.004 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.618 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 63.7 8.6 28.06 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.634 0.614 . . . . 0.0 114.634 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.46 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 52.4 t -110.2 111.53 57.91 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 117.821 0.81 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.3 Cg_exo -77.89 46.29 2.02 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.475 2.783 . . . . 0.0 112.912 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -92.21 -53.46 4.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.487 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.03 111.4 35.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.203 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 40.2 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.773 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.706 ' HA ' HD23 ' A' ' 376' ' ' LEU . 35.6 m -90.17 6.5 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.675 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.559 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -78.61 83.33 4.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.384 0.612 . . . . 0.0 110.35 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.677 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.8 ttp -102.8 87.9 3.07 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.9 mt -72.3 122.82 21.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.093 -165.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -67.96 -22.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 52.9 m -128.97 85.98 58.63 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.154 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.21 40.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.948 2.432 . . . . 0.0 113.925 -170.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -170.56 69.77 0.55 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.13 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.502 ' O ' HG22 ' A' ' 340' ' ' ILE . 70.0 Cg_endo -85.09 137.87 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.299 1.999 . . . . 0.0 112.84 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.4 p -119.54 145.93 45.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.654 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 74.4 mtp -95.82 107.55 19.81 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.855 0.36 . . . . 0.0 110.193 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 46.1 mt-10 -88.02 -167.32 1.84 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.079 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.633 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -63.73 -14.33 51.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 366' ' ' ASN . 84.5 m-20 -101.29 12.97 36.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.5 0.667 . . . . 0.0 109.885 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.56 -162.27 27.87 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -67.45 -16.48 67.42 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.41 -124.45 18.94 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 328' ' ' MET . 2.7 p90 -116.83 135.53 53.67 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 2.7 mt -122.14 134.6 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.759 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.734 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.6 mp0 -103.05 133.01 48.89 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.191 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.579 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.8 ppp? -148.72 160.04 43.55 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.894 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -176.84 166.75 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.7 172.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.855 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.4 tp -164.9 151.34 9.22 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.855 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.3 Cg_exo -36.08 143.25 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.24 2.627 . . . . 0.0 113.595 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.673 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.7 Cg_exo -37.04 135.69 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.768 1 C-N-CA 125.52 4.147 . . . . 0.0 115.032 -170.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.47 -151.27 21.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.391 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.3 m-20 -109.93 101.24 10.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.212 0.506 . . . . 0.0 110.435 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.563 ' HB3' ' HE1' ' A' ' 374' ' ' MET . 8.6 m120 -101.36 122.96 44.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.965 0.412 . . . . 0.0 109.945 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.069 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.4 130.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.579 HD12 ' HG2' ' A' ' 374' ' ' MET . 37.9 mt -89.01 126.93 42.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.075 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.494 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.02 92.49 4.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.814 174.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.605 HG11 HG13 ' A' ' 342' ' ' VAL . 23.0 t -83.47 90.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.45 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.084 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -106.87 -22.7 12.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.161 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.542 HD23 ' HE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -66.14 141.11 58.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.617 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -135.66 142.42 45.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.542 ' HE1' HD23 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -163.05 102.76 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.069 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 16.9 tt0 -76.75 149.25 36.34 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -144.94 142.39 29.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.429 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -99.16 111.06 23.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.673 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -96.79 129.16 44.26 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.651 -175.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.582 ' HD3' ' HB3' ' A' ' 378' ' ' PRO . 47.5 tttm . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.938 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.448 HG21 HG23 ' A' ' 335' ' ' THR . 5.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.087 0.47 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.435 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 11.5 p90 -62.57 118.57 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t -179.57 -170.31 0.16 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.76 106.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.7 146.94 52.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.531 0.681 . . . . 0.0 112.452 -168.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.496 ' OD1' HG21 ' A' ' 310' ' ' THR . 13.1 t70 -62.34 137.87 58.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.368 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.74 -23.21 67.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.256 -170.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.496 HG21 ' OD1' ' A' ' 308' ' ' ASP . 2.7 t -94.75 -4.91 46.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 111.363 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 24.4 mtpp -88.57 49.4 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 0.0 111.366 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.476 ' HZ ' HD12 ' A' ' 340' ' ' ILE . 1.8 m-85 -139.46 169.13 18.32 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.253 -177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -157.93 138.46 12.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.536 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.95 107.78 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.576 0.703 . . . . 0.0 111.527 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 315' ' ' LYS . 46.7 tptt -83.98 -36.81 22.93 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.438 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 9.2 ttm180 -160.04 109.18 1.76 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.833 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.43 156.41 52.38 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.185 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 392' ' ' TRP . 6.5 Cg_exo -32.72 118.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.931 3.087 . . . . 0.0 113.605 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.586 ' O ' HG21 ' A' ' 327' ' ' VAL . 15.2 m -143.52 144.38 31.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.887 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -44.44 136.55 4.11 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 111.478 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.586 ' HB3' HG11 ' A' ' 327' ' ' VAL . 67.2 p -69.43 -23.52 63.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.968 -173.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.92 -1.42 88.8 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -171.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -107.27 -54.76 2.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.12 -32.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.002 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.498 ' CB ' HG13 ' A' ' 358' ' ' ILE . 1.1 p -95.81 -166.88 1.51 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.845 -175.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.521 HG12 ' NE1' ' A' ' 392' ' ' TRP . 0.9 OUTLIER -109.48 155.99 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.876 176.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.801 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -139.42 174.25 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.115 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.729 ' HE2' HG21 ' A' ' 385' ' ' VAL . 21.5 ptt? -151.71 158.87 43.97 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 25.8 tt0 -120.27 125.82 49.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 312' ' ' PHE . 13.5 m -130.02 137.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.061 0.457 . . . . 0.0 112.03 -173.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.25 13.91 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.548 ' HD1' ' H ' ' A' ' 335' ' ' THR . 0.2 OUTLIER -118.23 179.99 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.451 0.626 . . . . 0.0 111.47 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.9 p -130.47 11.19 5.31 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.86 31.3 0.13 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 119.477 -1.344 . . . . 0.0 115.479 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.834 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 31.0 m -112.67 122.56 48.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.514 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 20.6 ptt180 -76.95 167.02 40.26 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.052 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.13 98.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 124.225 3.283 . . . . 0.0 114.855 -165.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.856 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 13.2 p -109.64 173.13 6.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.552 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.45 102.91 14.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.788 HG23 HG12 ' A' ' 342' ' ' VAL . 48.8 mt -75.89 124.88 88.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.747 0.308 . . . . 0.0 111.575 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.33 82.01 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.884 2.389 . . . . 0.0 111.972 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.788 HG12 HG23 ' A' ' 340' ' ' ILE . 6.1 m -103.23 129.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.572 0.701 . . . . 0.0 111.325 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -142.49 -174.57 4.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.581 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -153.04 138.78 17.91 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.898 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.34 175.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -109.03 114.08 27.52 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.554 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 50.68 47.98 23.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.598 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 67.34 16.7 67.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.484 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.86 109.85 46.98 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 110.861 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 61.76 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.48 2.786 . . . . 0.0 112.274 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -97.48 -47.2 5.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.842 0.829 . . . . 0.0 109.011 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -137.21 124.05 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.563 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.6 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.908 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.905 ' HA ' HD23 ' A' ' 376' ' ' LEU . 31.1 m -89.5 5.77 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.0 110.753 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.581 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.63 84.26 6.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.455 ' HB2' HD12 ' A' ' 376' ' ' LEU . 0.0 OUTLIER -97.5 87.02 3.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 170.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 38.1 mt -68.82 126.53 30.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.582 -167.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.657 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.1 mm -71.22 -20.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 48.6 m -136.45 87.48 21.78 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.933 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -88.4 50.95 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.332 2.688 . . . . 0.0 113.272 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.515 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.0 p-10 -160.49 58.9 1.12 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 1.2 Cg_endo -82.09 139.28 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.582 2.188 . . . . 0.0 112.592 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 338' ' ' CYS . 14.6 p -134.39 142.39 47.16 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.363 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.856 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 17.0 ptp -94.64 130.41 41.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.72 -165.32 1.19 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 124.925 1.391 . . . . 0.0 109.031 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.638 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -55.61 -20.57 14.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.638 ' N ' HD21 ' A' ' 366' ' ' ASN . 12.4 m-20 -108.55 13.12 25.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 0.0 110.696 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.21 -161.18 31.32 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.49 -25.35 74.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.84 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.08 -123.94 7.13 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.92 138.31 47.47 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.656 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 0.8 OUTLIER -129.94 166.14 28.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.801 ' HG2' HG12 ' A' ' 327' ' ' VAL . 46.0 mt-10 -129.49 138.23 51.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.739 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.656 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -152.67 151.82 31.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.073 -174.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.964 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.58 165.91 2.64 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.161 0.288 . . . . 0.0 110.864 173.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.972 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 12.2 tp -164.8 163.94 13.71 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.972 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 63.0 Cg_exo -29.11 131.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.826 3.017 . . . . 0.0 114.343 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.661 ' HB3' ' HD2' ' A' ' 395' ' ' LYS . 6.0 Cg_exo -38.28 139.36 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.825 1 C-N-CA 125.633 4.222 . . . . 0.0 114.938 -175.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.09 -153.08 24.53 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -103.35 109.91 21.71 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.264 0.225 . . . . 0.0 110.691 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.22 172.69 6.76 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.202 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.012 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -165.16 133.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.9 mt -93.8 133.02 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.385 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -107.64 96.97 6.77 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.322 175.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.729 HG21 ' HE2' ' A' ' 328' ' ' MET . 2.8 t -84.92 67.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.86 -84.05 0.58 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.489 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.644 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 15.1 t70 -100.44 -34.99 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.1 mp -61.03 143.34 55.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.8 p30 -159.67 138.47 10.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 126.52 1.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.154 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.012 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 23.7 mt-30 -70.13 153.23 43.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.521 ' NE1' HG12 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -153.94 150.53 28.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.474 171.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.47 136.0 40.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.534 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -132.31 147.37 52.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.772 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.661 ' HD2' ' HB3' ' A' ' 378' ' ' PRO . 23.5 tptm . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.683 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.595 ' HD2' ' HD3' ' A' ' 336' ' ' ARG . 21.5 p90 -53.57 125.83 19.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 111.298 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.7 t -175.9 -175.9 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.172 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.41 105.57 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.535 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.5 OUTLIER -72.35 153.35 41.52 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.501 ' OD1' HG21 ' A' ' 310' ' ' THR . 16.6 t70 -72.3 154.67 40.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.468 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.657 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -70.97 -12.52 61.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.453 -172.279 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.501 HG21 ' OD1' ' A' ' 308' ' ' ASP . 11.5 t -100.05 7.03 44.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.911 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.658 ' HE3' ' CB ' ' A' ' 335' ' ' THR . 3.9 mtpm? -85.31 -27.45 25.94 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.915 -0.491 . . . . 0.0 112.303 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.746 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.7 OUTLIER -102.62 160.12 14.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.646 0.736 . . . . 0.0 111.936 -175.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.0 t -140.37 155.42 46.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.789 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.459 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.5 m-90 -65.33 96.48 0.23 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.254 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.709 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.0 tttt -86.46 -46.76 9.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.738 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 37.0 ttm180 -147.34 98.93 3.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.663 171.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.512 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -55.04 159.17 4.09 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.947 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 7.1 Cg_exo -34.25 115.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.581 2.854 . . . . 0.0 113.596 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.5 m -129.49 134.06 47.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.806 -173.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -47.8 125.1 8.19 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.4 p -67.83 -35.27 78.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.577 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.72 -11.88 18.26 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.724 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -98.51 -71.48 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -171.61 18.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 358' ' ' ILE . 18.1 p -131.74 -167.91 1.94 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.397 -171.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.863 HG22 ' HZ2' ' A' ' 392' ' ' TRP . 1.9 t -130.04 149.78 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.272 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.982 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -135.83 140.96 43.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.394 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 11.1 ptm -130.03 150.84 51.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.958 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.738 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.9 tt0 -116.14 122.56 45.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.754 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 14.5 m -126.28 139.85 50.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.661 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.16 141.49 15.28 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.918 -176.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -90.61 178.68 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.22 0.51 . . . . 0.0 110.561 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.5 t -122.8 -62.78 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.78 -59.66 0.19 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.771 -176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.658 ' CB ' ' HE3' ' A' ' 311' ' ' LYS . 52.1 m -56.72 134.26 54.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.813 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.9 ptm180 -66.8 179.67 0.5 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.755 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.813 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.16 96.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 124.01 3.14 . . . . 0.0 114.573 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 305' ' ' THR . 31.4 p -113.93 160.08 19.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.428 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.02 104.25 9.53 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 362' ' ' PRO . 16.8 tt -87.72 127.47 58.06 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.326 0.584 . . . . 0.0 111.342 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.57 92.44 0.86 Allowed 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.857 2.371 . . . . 0.0 112.504 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.717 HG13 HG11 ' A' ' 385' ' ' VAL . 31.4 m -110.13 135.5 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.897 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 23.7 ptt180 -149.8 -174.2 4.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -156.72 143.21 18.35 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.412 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.48 169.49 10.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.51 114.4 27.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.443 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 27.1 p-80 35.29 61.76 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.684 0.794 . . . . 0.0 112.851 -175.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 76.06 0.09 64.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.402 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.23 114.32 55.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.516 0.658 . . . . 0.0 111.616 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -78.72 58.49 6.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.62 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.602 ' HG2' HG11 ' A' ' 352' ' ' VAL . 9.4 tt0 -83.22 -37.0 24.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.061 0.934 . . . . 0.0 108.823 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.602 HG11 ' HG2' ' A' ' 351' ' ' GLU . 2.1 p -161.06 122.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.49 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -51.82 107.82 0.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.268 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.55 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.7 m -90.4 6.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.688 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.513 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.91 83.39 3.46 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.342 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 16.7 mmt -95.15 85.22 4.25 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.0 mt -68.2 126.23 28.9 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.398 -167.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -71.61 -17.59 19.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.2 m -139.56 91.89 10.56 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.897 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.16 35.33 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.254 2.636 . . . . 0.0 113.511 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -149.52 64.12 6.97 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.102 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.503 ' O ' HG23 ' A' ' 340' ' ' ILE . 69.8 Cg_endo -88.13 128.09 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.583 2.189 . . . . 0.0 113.443 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 12.1 p -122.98 149.45 44.27 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.535 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.7 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 72.4 mtm -95.94 106.32 18.46 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.268 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.625 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 55.4 mm-40 -80.9 -167.64 1.48 Allowed 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.956 1.41 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -65.63 -7.19 13.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 366' ' ' ASN . 9.0 p30 -110.48 -4.84 15.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.444 0.64 . . . . 0.0 109.513 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.18 -166.75 12.71 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.97 -9.6 60.13 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.118 -175.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.78 -114.38 6.38 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.93 117.81 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.185 0.517 . . . . 0.0 111.288 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.821 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 1.6 mt -93.11 143.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.982 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -121.59 132.0 54.43 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.084 -174.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.821 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.9 OUTLIER -153.63 157.29 39.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.59 -171.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.949 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -174.6 168.67 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.224 172.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.836 HD23 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -164.64 143.92 5.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.836 ' HD2' HD23 ' A' ' 376' ' ' LEU . 23.3 Cg_exo -28.82 124.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.805 3.003 . . . . 0.0 114.281 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.635 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.4 Cg_exo -37.39 131.82 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.158 1 C-N-CA 125.475 4.116 . . . . 0.0 114.805 -171.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.68 -161.09 33.45 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.791 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -99.37 101.33 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.925 0.362 . . . . 0.0 111.025 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 354' ' ' VAL . 31.6 m-80 -121.04 -179.64 4.09 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.075 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.014 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.62 141.88 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.543 HD13 ' HE3' ' A' ' 374' ' ' MET . 11.8 mt -96.22 133.55 37.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.626 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -111.9 92.17 3.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.717 HG11 HG13 ' A' ' 342' ' ' VAL . 11.9 t -86.42 90.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.41 -91.87 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.063 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -116.31 -4.7 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.577 HD12 ' HD1' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -78.06 142.38 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 23.9 p-10 -153.81 141.49 19.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.773 0.32 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.507 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.1 t-80 -162.08 116.25 1.86 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.771 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.014 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -78.26 143.19 37.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.544 177.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.863 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.8 OUTLIER -154.32 148.01 25.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -85.42 123.46 30.9 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.635 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -105.73 144.86 31.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.017 0.437 . . . . 0.0 110.806 -176.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.219 -175.454 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.68 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 23.5 p90 -68.52 112.29 5.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.933 0.873 . . . . 0.0 110.6 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 15.3 t -159.21 -165.97 1.71 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.451 -172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.0 113.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 143.89 55.15 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.8 0.81 . . . . 0.0 111.06 -174.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 8.9 t70 -75.44 147.35 39.98 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.325 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.75 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.58 -12.82 11.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.964 -173.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.452 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.2 t -103.66 9.35 37.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.674 0.273 . . . . 0.0 111.399 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 9.5 mtpp -96.39 -23.98 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.75 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -101.31 158.5 16.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 111.227 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 154.77 46.54 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.11 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.514 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 22.6 m-90 -60.36 96.34 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.7 tttm -80.52 -37.94 30.64 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.863 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 67.3 ttt180 -157.81 111.37 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.752 174.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -59.4 155.79 34.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.979 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.772 ' HG3' HD11 ' A' ' 383' ' ' ILE . 30.7 Cg_exo -34.27 115.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 123.294 2.663 . . . . 0.0 113.68 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.548 ' O ' HG21 ' A' ' 327' ' ' VAL . 7.2 m -141.75 138.35 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.707 -171.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.66 131.74 8.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.061 0.458 . . . . 0.0 112.074 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.59 ' HB3' HG11 ' A' ' 327' ' ' VAL . 86.5 p -73.9 -25.28 59.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -176.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.58 -5.35 73.71 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.362 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -119.44 39.22 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 69.97 4.84 4.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.512 0.725 . . . . 0.0 111.977 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 2.7 p -121.54 -170.26 2.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.788 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.4 OUTLIER -127.95 153.63 37.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.985 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.957 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -135.53 157.41 39.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.437 ' HE2' HG11 ' A' ' 330' ' ' VAL . 8.2 ptm -138.19 158.4 44.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 168.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.863 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.1 mt-10 -122.24 135.49 54.76 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.616 HG21 ' HA3' ' A' ' 369' ' ' GLY . 0.2 OUTLIER -132.34 152.27 36.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 177.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.89 149.68 18.15 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.922 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.415 ' H ' ' HD1' ' A' ' 332' ' ' PHE . 1.4 p90 -94.08 178.94 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.291 0.567 . . . . 0.0 110.853 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.4 p -131.68 -17.62 2.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.102 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -170.03 -51.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.306 -1.426 . . . . 0.0 114.119 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 336' ' ' ARG . 24.6 m -57.17 129.66 42.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.68 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 11.7 ptm180 -69.79 167.32 24.52 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 117.982 -1.008 . . . . 0.0 108.514 171.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.79 96.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 123.894 3.062 . . . . 0.0 115.235 -167.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 5.9 p -108.8 147.24 32.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.131 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.39 108.24 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.503 HD13 HG13 ' A' ' 385' ' ' VAL . 12.5 tt -89.49 123.82 65.82 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.559 -176.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.69 92.22 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.902 2.401 . . . . 0.0 112.669 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 372' ' ' ILE . 30.1 m -108.78 125.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.676 0.751 . . . . 0.0 111.451 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -134.19 -177.42 4.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -148.86 135.07 19.28 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.972 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 382' ' ' ILE . 11.4 m -107.88 173.23 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -112.69 115.12 28.06 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.616 -174.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 33.4 t60 57.93 45.82 17.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.381 0.61 . . . . 0.0 110.227 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 68.02 6.57 46.19 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.001 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.16 111.42 60.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 117.361 0.58 . . . . 0.0 111.158 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -76.55 47.85 2.22 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.602 2.868 . . . . 0.0 113.032 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.35 -53.36 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.28 113.73 44.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.031 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 28.3 t30 -70.23 108.71 4.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.749 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.674 HG12 HD21 ' A' ' 376' ' ' LEU . 33.3 m -90.94 10.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.127 -175.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.487 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.23 84.37 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.116 0.484 . . . . 0.0 111.436 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 71.2 mtp -98.85 88.97 4.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 47.5 mt -76.66 120.76 22.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.157 -167.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -68.75 -16.9 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 91.5 m -135.19 87.73 27.75 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.906 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.57 40.36 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.127 2.551 . . . . 0.0 114.307 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.09 68.57 1.83 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.172 0.511 . . . . 0.0 111.389 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.475 ' HG3' HG22 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -85.48 135.59 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.444 2.096 . . . . 0.0 113.081 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.0 OUTLIER -129.72 146.85 51.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.679 174.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 29.0 mtm -94.61 104.98 16.92 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.315 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.6 -166.36 1.37 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.284 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -67.14 -10.59 51.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.147 0.499 . . . . 0.0 110.629 171.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.563 ' N ' HD21 ' A' ' 366' ' ' ASN . 47.0 m-20 -86.89 -7.03 58.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 90.27 -161.04 28.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -166.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.616 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -62.94 -19.77 61.55 Favored Glycine 0 C--N 1.322 -0.223 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.778 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 73.8 -124.68 8.71 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -112.06 127.0 55.77 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.665 HD11 HG11 ' A' ' 342' ' ' VAL . 1.0 OUTLIER -114.91 125.55 72.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.957 ' HG2' HG12 ' A' ' 327' ' ' VAL . 36.2 mt-10 -101.79 134.18 45.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.97 ' HE2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -153.19 160.51 42.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.934 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 178.87 170.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.367 0.417 . . . . 0.0 110.725 177.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.871 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 7.8 tp -161.88 157.35 20.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.871 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 53.4 Cg_exo -39.25 131.74 1.46 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.342 2.028 . . . . 0.0 112.304 169.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.866 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.3 Cg_exo -38.05 129.49 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 125.297 3.998 . . . . 0.0 114.946 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 174.41 -133.57 2.55 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.589 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.67 101.59 7.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.289 0.236 . . . . 0.0 110.561 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -112.35 161.89 16.15 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.095 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.02 138.71 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.97 HD12 ' HE2' ' A' ' 374' ' ' MET . 27.8 mt -94.65 132.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.376 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -109.03 91.71 3.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.2 t -83.88 84.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.34 -88.54 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.055 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.42 -14.17 13.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.226 0.536 . . . . 0.0 109.723 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.0 OUTLIER -68.33 147.19 52.48 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.602 175.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 24.9 p-10 -156.76 140.31 15.87 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.669 0.271 . . . . 0.0 110.66 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.589 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.3 t60 -165.88 115.2 0.99 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.546 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.095 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 44.5 tt0 -85.05 146.54 27.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.048 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 394' ' ' GLN . 0.7 OUTLIER -147.97 150.03 33.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.35 132.78 36.46 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.952 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.466 ' HB3' ' NE1' ' A' ' 392' ' ' TRP . 0.0 OUTLIER -126.73 142.7 51.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 -177.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 12.3 ptmm? . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.656 -0.688 . . . . 0.0 110.773 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.889 0.376 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.808 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.1 p90 -64.43 130.44 43.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.499 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.7 t 178.73 -166.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.83 114.65 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 143.0 56.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.702 0.763 . . . . 0.0 110.757 -173.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.565 ' OD1' ' HG2' ' A' ' 309' ' ' LYS . 5.8 t70 -86.48 150.57 24.18 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.693 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.672 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 23.4 pttm -52.03 -23.2 4.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.521 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 9.0 t -100.92 10.42 41.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.55 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.481 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 26.7 mmmt -92.5 -25.09 18.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.4 OUTLIER -112.44 157.9 20.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.323 0.582 . . . . 0.0 112.153 -176.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -133.92 158.18 44.11 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.717 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.447 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.7 m-90 -62.28 111.81 2.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.373 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -104.12 -40.3 6.21 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.212 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.771 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 32.5 ttm180 -158.74 129.94 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.419 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.43 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -74.28 163.11 70.58 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.234 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 3.0 Cg_exo -37.03 120.41 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.427 ' O ' HG21 ' A' ' 327' ' ' VAL . 23.3 m -136.24 134.8 38.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.526 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -48.14 124.12 7.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.107 0.48 . . . . 0.0 110.946 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.1 p -65.17 -22.88 66.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.189 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.65 34.12 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -99.61 -71.89 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -175.06 21.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.912 0.863 . . . . 0.0 108.952 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.7 p -137.69 -169.18 2.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.418 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.602 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -127.54 151.37 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.234 0.54 . . . . 0.0 111.633 -177.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.4 m -136.6 142.42 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.608 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 9.8 ptm -128.18 164.33 22.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.015 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.5 tt0 -126.46 126.07 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.048 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.42 153.07 32.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.397 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -126.28 144.0 14.78 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.431 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -91.07 179.18 5.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.252 0.549 . . . . 0.0 111.286 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.4 p -143.24 -7.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.868 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 179.14 -3.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 118.648 -1.739 . . . . 0.0 116.068 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.481 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 26.5 m -107.62 124.65 50.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.258 1.029 . . . . 0.0 110.57 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.808 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 9.3 ptm180 -70.73 168.79 17.49 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.399 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.774 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.3 OUTLIER -25.36 94.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 124.259 3.306 . . . . 0.0 114.712 -169.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 363' ' ' THR . 7.0 p -112.77 152.16 29.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.936 -174.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -74.48 106.27 6.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 362' ' ' PRO . 14.1 tt -81.89 129.24 65.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.444 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.37 81.58 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.781 HG13 HD11 ' A' ' 372' ' ' ILE . 15.6 m -102.28 119.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.691 0.758 . . . . 0.0 111.216 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -132.46 -178.68 5.03 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.557 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.36 139.14 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.891 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 11.0 m -111.22 168.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.55 114.52 28.73 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.119 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 50.7 t60 52.9 54.87 9.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.801 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.626 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 62.79 15.84 55.44 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.988 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 46.2 t -118.37 109.64 40.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 117.438 0.619 . . . . 0.0 111.222 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.15 50.27 2.18 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.229 2.619 . . . . 0.0 112.658 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.78 -53.87 3.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.71 115.3 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.298 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -63.26 108.78 1.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.9 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 376' ' ' LEU . 34.6 m -93.93 7.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.034 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.557 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.41 83.27 6.26 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.427 0.632 . . . . 0.0 110.652 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.72 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 46.1 ttp -99.35 90.97 4.73 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.5 mt -71.66 125.1 26.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.532 -167.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 5.1 mm -68.46 -24.06 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.7 m -132.25 91.75 30.71 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.995 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.61 44.16 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.226 2.617 . . . . 0.0 114.057 -169.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.0 67.86 0.8 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.228 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' A' ' 372' ' ' ILE . 73.1 Cg_endo -82.74 133.63 7.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.229 1.952 . . . . 0.0 113.032 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -120.82 144.21 48.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.168 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.724 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 39.3 mtm -95.59 119.92 34.93 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.73 -167.01 1.53 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 124.41 1.069 . . . . 0.0 110.906 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.57 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -66.27 -11.72 52.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.892 176.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 366' ' ' ASN . 82.6 m-20 -99.23 0.23 42.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 109.506 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.24 -162.38 19.95 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -73.73 -16.71 79.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.276 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 67.15 -120.27 13.31 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.4 p90 -120.29 141.2 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.48 0.657 . . . . 0.0 110.902 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.8 ' HB ' ' HE2' ' A' ' 374' ' ' MET . 4.0 mt -115.3 154.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.839 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 41.9 mt-10 -120.36 128.43 53.23 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.819 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.8 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -147.56 162.62 38.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.633 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.767 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 175.74 158.92 0.25 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.004 0.366 . . . . 0.0 110.983 172.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.797 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.0 tp -154.4 149.67 20.74 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 166.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.797 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 33.5 Cg_exo -27.06 125.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.918 3.078 . . . . 0.0 113.522 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -37.53 133.04 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.66 3.573 . . . . 0.0 114.493 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.72 -128.66 1.66 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.268 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.91 100.87 7.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 110.848 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -112.56 125.25 54.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 0.0 109.684 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.077 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.05 131.76 72.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.8 mt -92.32 128.92 43.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.189 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 91.95 3.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.007 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.4 t -83.56 78.28 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.41 -82.63 0.08 OUTLIER Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.423 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 22.3 t70 -106.35 -28.95 10.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.7 mp -63.67 149.43 46.6 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.525 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.7 p30 -163.12 143.12 8.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.245 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -164.95 118.44 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.077 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.2 tm0? -81.54 140.48 34.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.57 -178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.586 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 3.5 t-105 -149.54 147.47 28.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.736 172.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -95.04 119.16 33.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.602 HE22 HG13 ' A' ' 326' ' ' VAL . 4.3 mm100 -85.12 114.44 22.25 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.329 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.271 0.558 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.408 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 42.6 p90 -62.43 121.52 13.46 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.339 0.59 . . . . 0.0 110.128 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.1 t -176.37 -172.11 0.45 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.56 105.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.35 155.08 41.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.621 -168.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.32 141.12 47.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.94 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.719 ' HD2' ' HB2' ' A' ' 387' ' ' ASP . 24.3 pttt -50.95 -27.54 7.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.502 -1.681 . . . . 0.0 114.406 -172.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.9 t -105.21 7.25 33.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.424 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 27.2 mtpp -84.42 -22.65 30.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.443 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -82.63 157.0 23.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.992 0.425 . . . . 0.0 109.894 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -123.29 134.38 54.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.995 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.554 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 31.5 m-90 -50.99 96.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.595 168.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -96.39 -30.2 13.52 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.405 ' HD2' ' OE1' ' A' ' 329' ' ' GLU . 14.8 ttt180 -164.43 113.64 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.107 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.539 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -64.09 164.48 17.72 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 4.2 Cg_exo -39.41 118.35 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.634 2.222 . . . . 0.0 111.86 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.494 ' O ' HG21 ' A' ' 327' ' ' VAL . 22.5 m -130.8 135.14 47.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.21 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.53 127.0 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.9 p -69.2 -16.13 63.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.16 72.87 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 69.5 t60 -108.14 -52.98 2.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.307 -178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 29.6 t70 166.18 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.467 1.127 . . . . 0.0 108.111 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.9 p -93.92 -170.94 2.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.661 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.95 151.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.689 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.0 m -136.04 144.48 33.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.249 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.709 ' SD ' HG11 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -127.58 150.62 49.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 2.6 tt0 -122.13 124.95 45.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.992 0.425 . . . . 0.0 110.514 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.709 HG11 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -122.45 150.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.363 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.52 160.43 15.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 172.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -106.52 178.16 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.078 0.939 . . . . 0.0 110.38 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -133.46 -13.15 2.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.16 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.95 -26.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.201 -1.476 . . . . 0.0 114.695 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.718 ' HB ' ' HE1' ' A' ' 364' ' ' MET . 19.8 m -82.7 135.81 34.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.632 0.716 . . . . 0.0 111.566 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 335' ' ' THR . 9.1 ptt180 -78.71 177.73 2.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -27.38 97.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.775 2.983 . . . . 0.0 114.807 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.837 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 18.1 p -110.24 166.74 10.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.719 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.77 99.3 12.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.579 HG21 HG12 ' A' ' 342' ' ' VAL . 46.1 mt -74.67 120.82 83.41 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.229 -172.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.33 80.27 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.227 1.952 . . . . 0.0 111.661 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 372' ' ' ILE . 9.5 m -99.57 133.26 43.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.088 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.99 -178.07 5.52 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.56 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -155.24 135.29 12.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.77 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.13 163.24 8.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -102.75 114.53 28.86 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.493 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 10.9 t-80 53.9 52.16 13.46 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.486 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 65.8 5.7 26.36 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.888 -0.596 . . . . 0.0 114.188 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 110.6 61.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.391 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.65 54.58 4.84 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.079 2.519 . . . . 0.0 112.091 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.3 -47.72 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.49 0.662 . . . . 0.0 109.55 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.24 119.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.35 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -62.58 109.44 1.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.129 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.653 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 14.1 m -91.58 12.85 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.56 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -84.69 81.82 8.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.71 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 13.1 tpt -101.15 86.33 3.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 170.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 36.9 mt -70.82 126.26 29.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.615 -167.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -71.67 -17.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 15.6 m -140.08 91.46 10.12 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.505 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.44 41.35 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.091 2.527 . . . . 0.0 112.946 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -155.68 61.01 2.67 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' A' ' 342' ' ' VAL . 93.9 Cg_endo -81.34 135.31 9.41 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.271 1.981 . . . . 0.0 112.935 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 25.2 p -131.3 133.65 45.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.717 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.837 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 25.7 ptt? -95.68 131.33 42.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.624 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 29.7 mt-10 -114.52 -165.1 0.98 Allowed 'General case' 0 C--N 1.321 -0.666 0 O-C-N 124.874 1.359 . . . . 0.0 110.318 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.55 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -62.01 -7.82 4.42 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.009 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 366' ' ' ASN . 6.8 p30 -105.81 -3.99 21.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.577 0.703 . . . . 0.0 109.547 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 -166.22 17.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.803 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.15 -9.68 64.12 Favored Glycine 0 CA--C 1.51 -0.266 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.246 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.3 -126.35 30.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 111.361 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 342' ' ' VAL . 2.8 mt -111.71 131.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.062 173.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.689 ' HG2' HG12 ' A' ' 327' ' ' VAL . 45.5 mt-10 -104.16 132.08 50.78 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.135 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.63 ' HE1' ' HB3' ' A' ' 381' ' ' ASN . 4.8 ppp? -148.52 161.99 40.53 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.86 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.35 159.03 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.69 0.281 . . . . 0.0 110.953 173.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.653 ' HG ' ' HA ' ' A' ' 354' ' ' VAL . 0.5 OUTLIER -164.98 143.92 5.52 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.642 ' HD2' HD12 ' A' ' 376' ' ' LEU . 22.2 Cg_exo -24.02 129.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.638 3.559 . . . . 0.0 114.689 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.514 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.6 Cg_exo -36.97 128.61 0.52 Allowed 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 125.583 4.189 . . . . 0.0 114.942 -171.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.09 -152.63 21.95 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.7 m-20 -98.45 101.23 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.974 0.887 . . . . 0.0 110.677 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.63 ' HB3' ' HE1' ' A' ' 374' ' ' MET . 8.2 m120 -96.75 123.81 40.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.946 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -118.54 129.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 374' ' ' MET . 30.5 mt -92.71 133.62 33.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.46 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -107.16 91.82 3.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.358 176.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.5 t -79.36 77.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.82 -83.6 0.48 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.719 ' HB2' ' HD2' ' A' ' 309' ' ' LYS . 20.3 t70 -116.26 -19.96 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.343 0.592 . . . . 0.0 109.55 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.5 OUTLIER -60.28 145.35 47.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.229 173.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.5 p30 -155.41 143.79 20.27 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.591 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.445 ' H ' HG12 ' A' ' 382' ' ' ILE . 2.3 t60 -173.31 123.75 0.39 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.285 0.366 . . . . 0.0 111.271 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.946 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.5 mt-30 -71.58 153.21 42.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.446 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 22.6 t-105 -151.36 119.84 6.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.859 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -74.65 113.25 11.7 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.37 147.54 36.18 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.468 -175.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.286 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 335' ' ' THR . 4.2 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.4 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.7 p90 -57.43 128.53 37.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.202 0.525 . . . . 0.0 110.998 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.0 t -177.42 -171.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.8 105.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.9 OUTLIER -79.06 161.7 26.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.818 0.818 . . . . 0.0 112.766 -171.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.517 ' OD2' HG21 ' A' ' 310' ' ' THR . 13.0 t70 -78.39 155.73 29.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.935 -178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.724 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -76.83 -14.64 59.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.904 -172.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.555 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.4 t -91.19 2.74 56.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.137 0.494 . . . . 0.0 111.192 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 307' ' ' CYS . 5.5 mtpm? -81.3 -44.43 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.981 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.724 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -84.88 159.37 20.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.466 0.651 . . . . 0.0 111.853 -172.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 t -140.04 147.84 40.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.541 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.2 m-90 -52.7 101.59 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.493 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.666 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.1 tttp -90.01 -45.5 9.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 77.9 ttt180 -152.75 118.97 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.692 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.415 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -66.83 162.82 49.0 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.39 -175.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.673 ' HG2' ' O ' ' A' ' 390' ' ' HIS . 53.4 Cg_exo -30.79 116.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.703 2.935 . . . . 0.0 113.558 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.432 ' O ' HG11 ' A' ' 326' ' ' VAL . 52.9 m -127.9 124.84 38.4 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.98 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.27 127.02 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.212 0.53 . . . . 0.0 109.88 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.5 p -68.41 -21.55 64.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.69 -0.19 86.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.514 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -112.38 28.82 8.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 11.7 t70 64.09 24.83 13.61 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.84 0.829 . . . . 0.0 110.05 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.422 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.5 p -140.1 -171.72 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.203 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.946 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -129.71 155.66 41.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 118.201 0.455 . . . . 0.0 111.665 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.8 m -141.2 144.98 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.354 175.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.414 ' HE2' HG11 ' A' ' 330' ' ' VAL . 13.1 ptm -136.62 167.0 22.23 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.465 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.717 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 26.8 tt0 -133.34 128.33 35.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.282 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.414 HG11 ' HE2' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.07 157.58 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.937 0.399 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.92 153.02 17.57 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -95.01 178.78 5.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.342 0.571 . . . . 0.0 110.697 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.1 t -162.86 35.8 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.28 -92.46 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.241 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.66 ' HB ' ' HE3' ' A' ' 311' ' ' LYS . 21.5 m -54.67 134.42 47.13 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.182 0.593 . . . . 0.0 111.966 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.786 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.6 ptt180 -72.14 -177.58 0.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.125 172.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.64 94.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.852 3.035 . . . . 0.0 114.588 -173.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.8 p -116.05 158.06 23.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.788 -172.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -74.84 97.14 3.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.807 HD12 ' HE3' ' A' ' 364' ' ' MET . 10.5 tt -77.34 122.85 86.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -173.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 82.66 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.772 2.314 . . . . 0.0 112.466 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 385' ' ' VAL . 13.1 m -105.76 120.14 56.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.319 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 19.1 ptt180 -129.32 -175.29 3.53 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.53 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -157.16 147.56 21.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.586 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 382' ' ' ILE . 4.9 m -123.32 170.98 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.49 39.27 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.226 -173.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 32.8 t60 56.46 42.4 27.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.261 0.553 . . . . 0.0 110.47 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 67.07 9.94 55.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.423 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.78 107.84 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.115 0.458 . . . . 0.0 110.724 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.3 52.98 2.46 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.431 2.754 . . . . 0.0 112.644 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -97.59 -53.52 3.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.73 115.16 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.237 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.5 t30 -60.0 108.4 0.76 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.033 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.87 ' HA ' HD22 ' A' ' 376' ' ' LEU . 33.7 m -93.01 9.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.53 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -82.57 82.2 8.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.681 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.0 ttp -103.57 93.27 4.84 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 44.1 mt -76.33 125.94 30.09 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.66 -163.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -68.13 -23.62 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 11.9 m -126.4 90.21 50.47 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.82 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 89.2 Cg_endo -85.77 33.57 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.28 2.653 . . . . 0.0 114.317 -167.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -167.6 63.04 0.63 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.317 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.472 ' O ' HG22 ' A' ' 340' ' ' ILE . 61.4 Cg_endo -81.55 139.64 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.31 2.007 . . . . 0.0 113.049 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 20.4 p -124.15 133.01 53.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.73 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.807 ' HE3' HD12 ' A' ' 340' ' ' ILE . 6.5 ptp -95.18 125.1 39.59 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 25.9 mt-10 -81.28 -169.48 2.29 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.471 1.107 . . . . 0.0 111.21 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.479 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -73.93 -4.56 35.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.047 175.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 366' ' ' ASN . 15.6 m120 -100.95 -14.61 17.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.355 0.598 . . . . 0.0 109.659 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.0 -169.85 16.15 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.465 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -77.68 -22.53 69.36 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.545 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.64 -118.45 11.66 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -114.77 143.39 45.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.211 0.529 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.755 ' HB ' ' HE3' ' A' ' 374' ' ' MET . 3.1 mt -123.9 159.29 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.682 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 45.4 mt-10 -126.99 134.74 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.732 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.755 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.2 OUTLIER -149.57 169.81 20.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.977 -175.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.824 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 172.63 155.39 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.159 0.504 . . . . 0.0 111.679 170.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.007 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -160.43 153.53 18.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 165.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 1.007 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 46.9 Cg_exo -16.52 125.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 1 C-N-CA 125.468 4.112 . . . . 0.0 115.843 -175.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 395' ' ' LYS . 60.7 Cg_exo -40.17 139.84 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.692 3.595 . . . . 0.0 114.092 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 393' ' ' PHE . . . 138.93 -163.4 25.91 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -76.4 100.04 5.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.347 0.573 . . . . 0.0 111.239 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -112.75 129.62 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.095 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.99 135.25 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 -179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.609 HD11 ' HG3' ' A' ' 318' ' ' PRO . 25.4 mt -96.1 133.65 36.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.926 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -109.77 91.39 3.63 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.887 175.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -81.84 87.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.97 -95.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.352 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.02 0.84 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.101 0.477 . . . . 0.0 110.549 175.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -75.41 148.28 39.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.1 p30 -159.63 149.12 18.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.568 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.673 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 4.2 t60 -170.81 119.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.849 173.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.095 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.7 tt0 -82.64 134.16 35.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.738 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.531 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.1 t-105 -140.01 143.75 36.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.462 175.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.433 ' CE2' ' HA2' ' A' ' 379' ' ' GLY . 55.8 t80 -87.82 108.24 19.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.946 HE22 HG13 ' A' ' 326' ' ' VAL . 5.6 mm100 -72.82 144.35 47.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.863 ' HZ2' ' HA ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.494 -173.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.636 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 21.8 p90 -60.67 129.6 42.36 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.0 t 178.55 -169.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 59.5 t -60.5 110.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 168.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 142.77 56.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.795 0.807 . . . . 0.0 111.108 -170.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.81 148.6 36.49 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.111 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.747 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.27 -13.23 17.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.935 -172.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.8 t -101.14 -0.61 35.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.5 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 28.5 mmmt -78.4 -36.45 45.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.837 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -89.93 157.57 17.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.266 0.555 . . . . 0.0 111.606 -177.47 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.1 t -142.48 147.5 36.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.02 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -60.28 110.73 1.31 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.395 0.617 . . . . 0.0 112.159 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.53 ' HE3' ' OE1' ' A' ' 329' ' ' GLU . 65.3 tttp -93.54 -34.42 13.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.492 170.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.964 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 64.8 ttt180 -164.33 119.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.91 157.38 75.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.991 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -40.36 117.54 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.395 2.73 . . . . 0.0 112.587 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.524 ' O ' HG21 ' A' ' 327' ' ' VAL . 18.1 m -134.18 132.46 39.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.53 124.83 13.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 111.096 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.45 ' HB3' HG11 ' A' ' 327' ' ' VAL . 87.6 p -57.79 -30.45 65.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.974 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.86 -2.57 41.53 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -105.4 -73.26 0.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -165.87 15.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.607 0.717 . . . . 0.0 109.665 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.679 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 12.3 p -137.69 -166.79 2.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.541 -172.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -126.62 153.17 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.517 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 17.3 m -135.91 145.66 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.717 ' HE3' HG21 ' A' ' 385' ' ' VAL . 17.4 ptt? -135.43 169.59 17.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.964 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 14.0 mt-10 -138.04 136.4 36.8 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.345 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.67 151.07 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.3 155.12 16.33 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.787 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -101.97 -179.84 4.12 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 110.974 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.4 p -137.49 -41.13 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.635 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -156.07 4.58 0.2 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.158 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.5 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 33.1 m -113.12 127.03 56.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 117.425 0.612 . . . . 0.0 110.13 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 14.2 ptm180 -73.38 171.2 11.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.048 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.78 95.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.202 3.268 . . . . 0.0 114.608 -170.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . . . . . . . . . 6.0 p -112.14 154.34 25.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.969 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.412 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.4 mmt180 -74.57 107.83 6.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.652 HG21 HG12 ' A' ' 342' ' ' VAL . 38.8 mm -82.82 119.89 75.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.4 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.63 82.5 2.1 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.67 2.246 . . . . 0.0 112.088 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.652 HG12 HG21 ' A' ' 340' ' ' ILE . 13.9 m -101.5 124.94 55.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.575 0.702 . . . . 0.0 110.879 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.78 -175.38 4.01 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.478 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -153.41 144.62 23.03 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.323 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.65 164.56 15.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -96.83 114.34 25.97 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.126 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 39.25 63.88 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.633 0.773 . . . . 0.0 112.651 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.45 7.99 42.97 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.644 -0.707 . . . . 0.0 114.669 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.66 113.06 47.9 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 117.864 0.832 . . . . 0.0 111.557 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.15 62.19 5.93 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.198 2.599 . . . . 0.0 111.785 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.598 ' HG2' HG11 ' A' ' 352' ' ' VAL . 15.2 tt0 -86.65 -43.56 12.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.158 0.98 . . . . 0.0 108.939 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.598 HG11 ' HG2' ' A' ' 351' ' ' GLU . 1.5 p -158.17 122.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.34 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -51.23 108.5 0.26 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.331 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 1.018 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.44 7.98 4.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.825 -176.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.478 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -82.66 84.18 7.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.182 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.97 84.9 2.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 40.2 mt -68.05 129.55 40.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.166 -165.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.657 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.5 mm -72.62 -23.96 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.2 m -131.52 88.26 43.89 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.715 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.66 53.13 3.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.16 2.573 . . . . 0.0 113.336 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -168.02 69.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.882 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.495 ' HB3' HG21 ' A' ' 372' ' ' ILE . 45.7 Cg_endo -91.1 136.29 1.98 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.552 2.168 . . . . 0.0 112.65 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.1 p -132.42 144.95 50.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.452 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.617 ' HG3' HD12 ' A' ' 340' ' ' ILE . 56.2 mtm -95.95 116.62 29.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 31.9 mt-10 -104.15 -165.68 1.17 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.386 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -59.11 -13.08 5.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.886 0.375 . . . . 0.0 111.769 175.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.2 p30 -103.83 -2.07 26.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.366 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.6 -160.71 22.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.529 ' CA ' ' HG2' ' A' ' 364' ' ' MET . . . -77.27 -11.84 85.15 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.823 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.535 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 65.61 -124.03 26.03 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -125.87 147.47 49.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.869 0.366 . . . . 0.0 110.092 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.696 ' HB ' ' HE3' ' A' ' 374' ' ' MET . 1.0 OUTLIER -128.5 160.46 38.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.657 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 61.4 mt-10 -123.4 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.674 0.273 . . . . 0.0 110.284 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.696 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -153.29 154.6 34.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.913 -174.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.887 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -173.03 167.53 4.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.978 171.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.018 ' HG ' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -168.21 178.08 1.15 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.169 174.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.686 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 52.0 Cg_exo -36.1 131.24 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.748 2.299 . . . . 0.0 113.65 174.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.91 137.39 52.37 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.676 2.918 . . . . 0.0 113.16 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.06 -176.85 29.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.156 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.616 ' HB3' HE21 ' A' ' 391' ' ' GLN . 12.7 m-20 -74.33 101.15 3.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.206 0.202 . . . . 0.0 111.116 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.546 ' CG ' HD12 ' A' ' 376' ' ' LEU . 38.9 m-80 -123.39 153.54 40.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.262 0.553 . . . . 0.0 110.96 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.957 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -134.45 139.89 46.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 -176.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.536 HD13 ' HE2' ' A' ' 374' ' ' MET . 20.8 mt -94.18 132.89 36.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -109.62 92.66 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.026 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.4 t -79.99 76.35 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.69 -81.93 0.16 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.224 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 31.7 t70 -113.44 -12.27 12.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.449 0.642 . . . . 0.0 109.562 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.753 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.8 mp -78.32 148.37 33.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.216 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 4.4 p-10 -155.99 140.82 17.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.781 0.324 . . . . 0.0 111.214 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -166.28 123.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.624 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.957 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 43.4 tt0 -86.84 152.19 22.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.184 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.49 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.0 OUTLIER -159.45 142.94 14.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.672 175.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.3 p90 -90.77 108.06 19.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.755 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.887 ' HG3' HE22 ' A' ' 375' ' ' GLN . 0.1 OUTLIER -70.29 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.544 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 C--O 1.247 0.956 0 O-C-N 124.371 1.044 . . . . 0.0 110.51 -179.286 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -62.36 124.4 20.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.341 0.591 . . . . 0.0 111.416 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -174.32 -169.83 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.36 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.43 106.56 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.2 149.02 43.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.698 0.761 . . . . 0.0 112.191 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' A' ' 310' ' ' THR . 21.2 t0 -72.28 146.51 47.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.129 -178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.729 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.35 -13.28 60.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.949 -167.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.49 HG21 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -97.0 4.1 51.66 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.981 -0.45 . . . . 0.0 112.035 -175.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.793 ' HE3' ' HA3' ' A' ' 334' ' ' GLY . 34.1 mttp -89.2 -28.56 19.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.729 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -84.57 156.47 21.6 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.808 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.3 t -141.36 145.27 35.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.554 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.603 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.1 m-90 -56.06 104.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.269 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.545 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.3 tttt -97.17 -42.88 7.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 38.9 ttt180 -152.55 123.01 7.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.605 173.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -65.74 163.94 31.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.48 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 2.8 Cg_exo -38.52 107.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.39 2.727 . . . . 0.0 112.373 176.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.8 m -115.97 128.49 55.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.296 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -49.23 125.71 11.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.378 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.0 p -70.96 -20.19 62.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -173.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.55 -2.31 70.24 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -171.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.82 27.96 8.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.458 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 64.09 21.16 12.48 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.658 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.445 ' HA ' ' OE1' ' A' ' 375' ' ' GLN . 6.6 p -129.53 -168.53 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.452 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.862 HG13 HE22 ' A' ' 394' ' ' GLN . 0.1 OUTLIER -132.21 150.22 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.339 0.59 . . . . 0.0 112.317 -175.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.73 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -138.56 138.08 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.62 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 14.2 ptm -127.55 162.8 25.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.548 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 30.2 tt0 -126.33 127.96 46.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.433 HG11 ' HE1' ' A' ' 328' ' ' MET . 0.8 OUTLIER -132.76 147.43 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.183 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -106.01 147.8 16.32 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.52 ' HB3' ' HE3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -106.31 179.03 4.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.121 0.961 . . . . 0.0 110.355 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.8 p -152.48 30.72 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.68 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.793 ' HA3' ' HE3' ' A' ' 311' ' ' LYS . . . -170.96 -83.28 0.05 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.876 -1.155 . . . . 0.0 113.764 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 303' ' ' THR . 12.9 m -69.52 128.46 36.59 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.111 0.565 . . . . 0.0 112.424 -172.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.738 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -67.1 176.1 1.27 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.147 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.738 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -24.88 93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.043 3.162 . . . . 0.0 114.538 -171.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 363' ' ' THR . 27.6 p -111.62 166.34 11.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.053 -171.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -87.43 96.81 10.51 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.478 HG22 ' HG2' ' A' ' 362' ' ' PRO . 12.4 tt -80.44 126.03 79.6 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.295 -171.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.31 93.98 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.96 2.44 . . . . 0.0 112.331 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 372' ' ' ILE . 16.7 m -115.01 120.98 66.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.699 0.761 . . . . 0.0 111.384 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 29.8 ptt180 -132.63 -174.35 3.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.53 149.38 22.22 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.723 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 382' ' ' ILE . 11.4 m -122.9 170.28 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.79 114.85 28.28 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.215 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.564 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 17.9 p80 40.04 57.07 2.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.847 . . . . 0.0 112.587 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.655 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 79.71 -10.42 38.7 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.164 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 27.5 t -101.91 114.01 65.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.307 0.554 . . . . 0.0 111.226 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -77.14 38.67 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 123.466 2.777 . . . . 0.0 113.059 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.44 -54.29 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.81 112.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.941 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 36.7 t30 -55.11 108.07 0.37 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.502 171.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.643 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 35.9 m -93.23 8.64 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.142 0.496 . . . . 0.0 111.159 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.528 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.83 82.81 6.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.378 0.609 . . . . 0.0 110.554 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.752 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.1 ttt -102.32 82.26 2.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 30.9 mt -64.26 130.11 42.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.862 -167.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -70.38 -26.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.3 m -131.83 95.95 21.56 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.452 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.477 ' HA ' HD12 ' A' ' 357' ' ' LEU . 4.1 Cg_endo -86.05 27.21 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.524 2.816 . . . . 0.0 113.523 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -147.88 64.32 8.24 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.123 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.478 ' HG2' HG22 ' A' ' 340' ' ' ILE . 90.0 Cg_endo -82.66 144.65 12.61 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.532 2.155 . . . . 0.0 112.884 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 11.4 p -128.55 142.57 51.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.068 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.826 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 56.7 mtp -95.39 110.58 22.59 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.01 -171.29 1.94 Allowed 'General case' 0 C--N 1.32 -0.704 0 O-C-N 124.403 1.065 . . . . 0.0 111.24 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.507 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -66.81 -6.61 16.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.779 174.591 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -110.84 -6.75 14.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.229 0.537 . . . . 0.0 109.972 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.64 -171.92 14.13 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.826 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -64.68 -14.97 59.06 Favored Glycine 0 N--CA 1.458 0.127 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.532 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 72.03 -106.26 1.88 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 328' ' ' MET . 20.8 m-85 -132.33 135.91 46.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.285 0.564 . . . . 0.0 110.996 175.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 4.7 mt -115.32 136.53 51.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.343 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.73 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -106.7 128.63 54.36 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.198 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -144.64 163.14 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.047 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.752 ' O ' ' HB3' ' A' ' 356' ' ' MET . 29.5 tp60 -176.05 152.08 1.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 110.036 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.805 HD21 ' HD2' ' A' ' 377' ' ' PRO . 1.0 OUTLIER -151.78 140.42 13.54 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 170.318 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.805 ' HD2' HD21 ' A' ' 376' ' ' LEU . 27.4 Cg_exo -19.97 130.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 125.144 3.896 . . . . 0.0 114.781 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -37.92 131.91 0.81 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.82 3.68 . . . . 0.0 114.38 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.85 -167.77 32.21 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.295 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 8.1 m-20 -80.57 100.12 8.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.913 0.356 . . . . 0.0 110.899 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' A' ' 376' ' ' LEU . 21.5 m-80 -111.57 138.72 47.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.986 0.422 . . . . 0.0 110.249 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.963 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -135.76 136.42 50.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.557 HD12 ' HG2' ' A' ' 374' ' ' MET . 39.5 mt -95.25 130.78 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.086 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.674 175.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.65 HG11 HG13 ' A' ' 342' ' ' VAL . 6.7 t -84.87 81.9 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.75 -91.15 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.144 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.636 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 6.3 t70 -98.55 -18.89 17.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.613 0.721 . . . . 0.0 109.395 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.618 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.3 mp -76.44 148.85 37.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -154.77 137.21 15.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.036 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -164.59 123.73 1.86 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.751 0.31 . . . . 0.0 110.484 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.963 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -90.3 141.2 28.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.519 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.523 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.2 t-105 -144.64 137.01 26.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.006 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.8 p90 -80.6 110.25 15.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.947 -0.471 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.862 HE22 HG13 ' A' ' 326' ' ' VAL . 5.8 mm100 -74.04 102.27 4.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 395' ' ' LYS . 12.1 ttpp . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.752 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 335' ' ' THR . 2.9 t . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -59.89 126.76 28.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.194 0.521 . . . . 0.0 109.871 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.8 t -179.24 -174.76 0.34 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.3 106.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.52 155.55 40.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.972 0.892 . . . . 0.0 112.608 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.621 ' OD1' HG21 ' A' ' 310' ' ' THR . 11.1 t70 -81.01 140.65 35.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.106 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -60.41 -21.72 62.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.62 -173.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.626 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.6 t -87.05 -4.56 59.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.828 0.346 . . . . 0.0 111.46 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -93.92 16.5 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.804 ' HE2' HG12 ' A' ' 385' ' ' VAL . 1.3 m-85 -102.38 170.66 7.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.675 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -165.65 131.9 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.396 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.437 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -51.68 120.33 5.11 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.398 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 21.3 tptm -110.14 -48.67 3.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.583 172.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -156.1 127.96 7.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.113 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.14 155.67 93.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.823 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 383' ' ' ILE . 84.1 Cg_exo -33.08 113.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.832 3.021 . . . . 0.0 113.153 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.483 ' O ' HG21 ' A' ' 327' ' ' VAL . 20.3 m -128.95 135.06 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.055 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -44.96 124.66 4.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.612 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.5 p -71.47 -22.07 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.67 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.39 -2.62 74.56 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -121.89 33.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.88 16.68 8.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.823 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.513 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 8.5 p -124.23 -168.85 1.86 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.725 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.37 146.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.417 -177.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 14.8 m -128.51 138.83 53.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.101 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 16.4 ptt? -121.55 154.87 36.13 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 23.0 tt0 -114.28 127.66 55.98 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 385' ' ' VAL . 8.4 m -130.43 136.57 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.881 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -111.98 143.39 17.44 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.657 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.682 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.7 OUTLIER -141.44 163.03 34.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.4 m -153.51 65.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.507 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -165.0 -50.71 0.02 OUTLIER Glycine 0 C--O 1.226 -0.356 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.743 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.532 HG21 ' O ' ' A' ' 336' ' ' ARG . 23.3 m -98.6 142.72 29.83 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 122.85 -0.206 . . . . 0.0 110.863 -175.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.667 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 15.3 ptt180 -79.38 168.65 24.94 Favored Pre-proline 0 CA--C 1.527 0.08 0 CA-C-O 117.729 -1.129 . . . . 0.0 108.485 171.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -26.55 96.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.999 3.133 . . . . 0.0 114.449 -170.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.652 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 28.8 p -116.09 164.93 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.477 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -85.31 96.97 9.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 362' ' ' PRO . 12.1 pt -79.77 130.15 68.38 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.297 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . 0.647 ' HD2' ' HZ ' ' A' ' 312' ' ' PHE . 63.9 Cg_endo -75.29 81.94 2.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.725 2.283 . . . . 0.0 112.021 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.705 HG13 HG11 ' A' ' 385' ' ' VAL . 10.5 m -100.22 116.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.993 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 383' ' ' ILE . 20.4 ptt180 -126.61 179.82 5.15 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.482 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -152.06 139.78 19.84 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.818 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.15 171.4 7.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.927 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.59 116.45 32.62 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.446 ' HA ' ' CD ' ' A' ' 391' ' ' GLN . 8.9 p-80 41.04 59.68 2.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.515 0.726 . . . . 0.0 112.703 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.711 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.2 6.4 32.65 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.28 116.59 44.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.591 0.695 . . . . 0.0 111.045 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.09 55.98 3.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.198 2.599 . . . . 0.0 111.753 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.59 -52.22 5.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.64 123.0 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.283 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.76 107.74 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.645 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 32.0 m -92.2 9.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.634 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.482 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -81.25 83.65 6.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.45 84.63 2.22 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.7 mt -74.02 128.32 35.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.816 -165.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.706 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.9 mm -75.94 -19.42 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.5 m -121.74 81.91 41.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.165 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 9.8 Cg_endo -87.23 32.57 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.27 2.647 . . . . 0.0 114.156 -166.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -177.01 70.78 0.23 Allowed Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.588 ' HB2' HD12 ' A' ' 340' ' ' ILE . 45.1 Cg_endo -88.19 136.75 3.55 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.503 2.136 . . . . 0.0 113.587 -176.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 40.5 p -118.1 130.59 56.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.545 175.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.652 ' HE2' ' SG ' ' A' ' 338' ' ' CYS . 0.0 OUTLIER -99.51 143.59 29.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.514 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 31.3 mt-10 -95.04 -179.35 4.79 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.626 0.579 . . . . 0.0 109.941 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -24.79 41.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.49 -3.23 18.3 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.095 -0.378 . . . . 0.0 111.592 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.682 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 144.62 177.05 19.16 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.265 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -97.53 -16.19 35.09 Favored Glycine 0 CA--C 1.507 -0.458 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.905 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 74.52 -126.17 9.01 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -174.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 328' ' ' MET . 79.6 m-85 -105.88 147.38 28.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.02 0.438 . . . . 0.0 111.154 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.4 mt -132.48 152.96 37.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.706 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 30.6 mt-10 -110.81 134.59 52.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.955 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.881 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -145.0 165.35 28.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.725 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -174.03 163.89 4.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.384 0.612 . . . . 0.0 111.449 172.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.696 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.3 tp -165.02 143.87 5.47 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 165.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.696 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 16.2 Cg_exo -31.3 135.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.998 3.132 . . . . 0.0 113.486 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -37.0 128.43 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.704 3.602 . . . . 0.0 114.471 -166.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.11 178.06 35.68 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 0.0 OUTLIER -81.02 99.73 8.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.945 0.872 . . . . 0.0 110.826 -176.209 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.645 ' OD1' ' HB ' ' A' ' 354' ' ' VAL . 18.6 m-80 -108.19 126.7 53.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.302 0.572 . . . . 0.0 110.015 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.975 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.52 137.69 57.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.145 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.881 HD12 ' HG2' ' A' ' 374' ' ' MET . 30.1 mt -99.78 127.1 52.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.792 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -95.64 102.73 14.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.932 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.804 HG12 ' HE2' ' A' ' 312' ' ' PHE . 2.1 t -92.59 78.56 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.295 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 69.56 -85.61 0.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.446 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 34.2 t70 -108.75 -25.58 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.523 0.678 . . . . 0.0 109.325 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.437 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.2 mp -65.45 151.81 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.536 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -151.94 144.35 24.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.79 109.9 0.94 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.111 0.482 . . . . 0.0 111.356 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.975 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.3 tt0 -84.25 149.09 26.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.386 -176.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 4.8 t-105 -158.77 142.27 15.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.822 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.821 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.3 p90 -92.72 114.83 27.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.583 -0.698 . . . . 0.0 110.062 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.616 ' HG2' HD21 ' A' ' 381' ' ' ASN . 5.0 mm100 -72.6 115.42 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.229 -174.826 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 14.2 p90 -70.45 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.6 t -177.14 -171.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.57 107.29 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 340' ' ' ILE . 0.1 OUTLIER -69.15 148.77 49.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.007 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.574 ' OD1' HG21 ' A' ' 310' ' ' THR . 24.2 t0 -72.48 135.76 45.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.288 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.79 -16.1 56.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.574 HG21 ' OD1' ' A' ' 308' ' ' ASP . 8.1 t -96.6 2.41 52.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.132 0.492 . . . . 0.0 111.325 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 29.0 mtpp -95.29 37.48 1.17 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.229 -0.295 . . . . 0.0 111.589 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.812 ' CE1' ' HB ' ' A' ' 330' ' ' VAL . 0.0 OUTLIER -135.9 150.74 49.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.923 0.392 . . . . 0.0 110.994 -176.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 29.2 p -135.35 139.15 44.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.185 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -54.7 105.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.974 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -92.52 -32.34 14.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.877 ' HB2' ' HB2' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -165.31 114.88 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.133 174.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.47 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.07 161.15 42.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.267 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.477 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 2.7 Cg_exo -39.22 119.6 0.5 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.83 2.354 . . . . 0.0 112.341 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.579 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.9 m -139.15 136.94 35.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.67 -173.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.7 133.76 16.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.739 0.304 . . . . 0.0 110.964 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.411 ' HB3' HG11 ' A' ' 327' ' ' VAL . 92.8 p -70.75 -12.04 61.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.785 -172.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 91.74 -7.62 79.26 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -102.19 -59.19 1.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.124 0.488 . . . . 0.0 109.929 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 12.0 t70 170.2 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.394 1.092 . . . . 0.0 108.436 -169.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.414 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.67 -168.72 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.782 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 374' ' ' MET . 2.1 t -125.21 152.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.08 0.467 . . . . 0.0 111.056 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.765 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.5 m -130.45 168.16 23.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.529 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.438 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 1.0 OUTLIER -155.01 157.85 38.25 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.877 ' HB2' ' HB2' ' A' ' 316' ' ' ARG . 4.1 mt-10 -129.01 139.95 51.85 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.452 0.47 . . . . 0.0 110.301 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.812 ' HB ' ' CE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -147.94 146.42 18.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.006 -175.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' A' ' 312' ' ' PHE . . . -117.18 137.43 13.41 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.656 ' HD2' ' H ' ' A' ' 335' ' ' THR . 0.3 OUTLIER -90.0 179.27 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.814 0.816 . . . . 0.0 112.32 -173.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 48.1 t -106.15 -41.86 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 176.73 40.5 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.273 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.656 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 4.8 m -116.07 127.54 54.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.247 0.523 . . . . 0.0 109.856 173.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.681 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -71.17 171.55 8.43 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.076 174.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.52 95.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.974 3.116 . . . . 0.0 114.155 -177.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.56 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 20.1 p -117.38 174.5 6.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.768 -1.56 . . . . 0.0 111.619 -171.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -96.57 101.58 13.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.536 ' CG2' HG12 ' A' ' 342' ' ' VAL . 8.2 mm -80.15 130.78 64.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.257 0.551 . . . . 0.0 112.265 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.88 81.79 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.66 2.24 . . . . 0.0 111.653 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.836 HG23 ' HG2' ' A' ' 362' ' ' PRO . 0.0 OUTLIER -96.84 130.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.423 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -145.35 179.64 7.26 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.52 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -152.2 143.83 23.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.392 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.98 172.06 3.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -108.44 115.51 30.24 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.717 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 57.1 47.42 17.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.623 0.577 . . . . 0.0 110.583 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 68.24 4.54 37.12 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.75 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 40.8 t -107.37 108.19 61.43 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 117.088 0.444 . . . . 0.0 111.2 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -74.2 59.51 4.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.365 2.71 . . . . 0.0 112.419 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.03 -45.81 6.12 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.5 123.62 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.1 t30 -60.34 108.34 0.79 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.694 175.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' A' ' 376' ' ' LEU . 27.1 m -90.5 3.9 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.52 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.97 83.98 3.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.651 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.672 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.5 ttm -100.07 88.0 3.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.896 HD22 ' HE3' ' A' ' 374' ' ' MET . 27.5 mt -66.32 126.52 29.03 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.985 -1.462 . . . . 0.0 111.664 -165.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.7 mm -73.37 -23.78 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.5 m -134.33 98.74 13.72 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.997 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.88 54.2 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.244 2.629 . . . . 0.0 113.379 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.582 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 63.6 t30 -157.96 58.73 1.47 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 172.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.836 ' HG2' HG23 ' A' ' 342' ' ' VAL . 15.0 Cg_exo -72.07 104.39 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.255 1.97 . . . . 0.0 112.155 175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.1 p -110.34 149.16 30.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.669 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 49.0 mtm -95.7 120.76 36.53 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.12 -165.47 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.903 1.377 . . . . 0.0 109.928 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ASN . . . . . 0.554 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -52.3 -25.19 8.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.335 174.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -105.58 10.14 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 110.689 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.9 -156.78 23.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 110.986 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.06 -14.61 59.34 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 66.21 -118.5 11.18 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.045 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -116.47 122.96 46.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.7 OUTLIER -113.24 161.47 12.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.082 177.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.7 mt-10 -132.87 130.92 40.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.896 ' HE3' HD22 ' A' ' 357' ' ' LEU . 4.0 ptp -159.77 151.6 20.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.12 -173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.864 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.43 169.64 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.683 0.278 . . . . 0.0 111.039 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.954 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.0 tp -163.35 159.31 18.05 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.954 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 48.8 Cg_exo -29.97 130.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 113.978 173.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.0 Cg_exo -37.5 129.65 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.182 3.921 . . . . 0.0 114.516 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.19 -129.5 1.83 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.527 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.466 ' HB3' ' OE1' ' A' ' 391' ' ' GLN . 19.7 m-20 -127.49 107.33 9.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.502 0.191 . . . . 0.0 110.647 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.27 127.7 55.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.065 0.46 . . . . 0.0 110.01 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.042 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.64 130.72 74.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.639 HD13 ' SD ' ' A' ' 374' ' ' MET . 9.6 mt -92.11 131.62 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.336 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -102.64 92.0 4.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.267 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.66 76.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.42 -91.28 0.74 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.162 -171.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.65 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 19.6 t70 -110.25 -20.88 12.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.258 0.552 . . . . 0.0 109.96 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 2.1 tp -67.87 145.29 54.76 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.518 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.8 p30 -151.44 147.99 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.802 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.46 123.53 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.024 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.042 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -75.68 144.26 41.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 17.2 t-105 -143.32 130.4 20.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.204 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -82.53 117.34 22.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -117.54 142.66 46.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 111.085 -174.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.675 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 335' ' ' THR . 7.2 t . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.918 0.39 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.451 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 39.4 p90 -60.8 116.32 4.34 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.306 0.574 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 303' ' ' THR . 14.3 t -173.48 -166.59 0.33 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.118 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 13.7 t -61.19 114.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 144.64 55.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.909 0.861 . . . . 0.0 112.201 -170.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.623 ' OD1' HG21 ' A' ' 310' ' ' THR . 9.7 t0 -59.76 141.58 54.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.704 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.24 -11.8 44.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.735 -175.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.623 HG21 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -105.41 -1.15 25.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 46.2 mttp -83.77 -30.08 26.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -86.92 147.93 25.56 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.678 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.1 p -135.5 145.26 46.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.524 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.477 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.9 m-90 -53.49 96.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.862 0.726 . . . . 0.0 111.462 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 76.9 tttt -87.84 -35.08 17.99 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.876 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.3 ttm180 -159.07 113.71 2.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.238 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.05 80.04 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 119.188 -0.434 . . . . 0.0 109.957 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.552 ' HD3' ' HE2' ' A' ' 328' ' ' MET . 3.3 Cg_exo -41.83 119.1 1.05 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.706 2.271 . . . . 0.0 112.461 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.689 ' O ' HG21 ' A' ' 327' ' ' VAL . 2.3 m -139.61 142.41 37.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.322 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -40.66 130.77 2.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.863 0.465 . . . . 0.0 111.02 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 327' ' ' VAL . 79.8 p -65.82 -23.75 66.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.61 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.37 -0.57 27.99 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.438 -174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -126.89 -56.46 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.348 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.31 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.548 0.689 . . . . 0.0 110.498 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.708 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 11.1 p -92.0 -172.04 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.953 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.468 HG13 ' C ' ' A' ' 319' ' ' THR . 15.4 t -129.7 148.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.387 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.865 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -130.55 158.15 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 122.743 0.417 . . . . 0.0 110.978 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.642 ' HE1' ' HB ' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -136.79 163.47 30.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.876 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 2.5 mt-10 -130.3 135.1 47.73 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.913 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.84 146.21 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.982 0.42 . . . . 0.0 111.367 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.11 145.8 18.55 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.484 ' H ' ' HD1' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -89.78 178.34 6.27 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.569 0.7 . . . . 0.0 111.326 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.3 m -149.32 28.5 0.81 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.367 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 165.56 -70.52 0.19 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 119.663 -1.256 . . . . 0.0 113.946 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 336' ' ' ARG . 41.1 m -58.65 136.43 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.956 0.503 . . . . 0.0 112.15 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.616 ' O ' HG21 ' A' ' 335' ' ' THR . 12.3 ptm180 -70.19 170.4 10.36 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.442 171.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.674 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.9 97.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.975 3.117 . . . . 0.0 114.759 -171.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.536 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 6.3 p -113.47 152.76 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.297 -172.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 306' ' ' VAL . 9.2 mpt_? -82.41 105.41 13.45 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.557 HG22 ' HG3' ' A' ' 364' ' ' MET . 28.3 pt -87.31 131.43 44.29 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.602 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.39 84.34 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.053 2.502 . . . . 0.0 112.364 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.643 HG13 HG11 ' A' ' 385' ' ' VAL . 19.3 m -96.72 129.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.796 0.807 . . . . 0.0 111.253 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 35.6 ptt180 -140.21 -172.44 3.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.486 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -159.37 143.41 15.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.286 0.565 . . . . 0.0 111.416 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.405 HG21 HD12 ' A' ' 382' ' ' ILE . 16.0 m -119.69 171.31 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.06 116.38 32.41 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 3.7 p-80 40.14 60.11 1.84 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.928 0.768 . . . . 0.0 112.459 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.558 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.9 3.92 24.65 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.609 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.25 118.88 45.06 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.546 0.673 . . . . 0.0 111.164 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.71 55.33 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.067 2.511 . . . . 0.0 111.445 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' HG11 ' A' ' 352' ' ' VAL . 8.8 pt-20 -86.07 -35.78 20.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.868 0.842 . . . . 0.0 108.895 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.581 HG11 ' HG3' ' A' ' 351' ' ' GLU . 6.7 p -155.66 122.93 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.745 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.2 107.77 0.27 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.185 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.882 HG12 HD23 ' A' ' 376' ' ' LEU . 31.4 m -88.65 5.2 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.394 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.486 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.84 82.7 5.89 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.349 0.595 . . . . 0.0 110.645 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.719 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 36.8 mtm -97.61 90.37 4.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.7 mt -75.93 117.01 17.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.473 -165.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.644 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.3 mm -68.95 -22.13 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -131.38 85.42 53.32 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.776 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -87.28 41.68 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.376 2.718 . . . . 0.0 114.035 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -165.61 73.55 1.34 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.221 0.534 . . . . 0.0 110.557 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.55 ' HB2' HD12 ' A' ' 340' ' ' ILE . 91.7 Cg_endo -87.67 120.2 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.411 2.074 . . . . 0.0 112.586 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.8 p -115.21 140.72 48.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.952 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.674 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 54.9 mtm -95.04 113.63 25.35 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.355 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.526 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 39.5 mt-10 -104.24 -165.8 1.18 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.506 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.478 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -55.2 -17.74 4.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -105.06 2.52 29.56 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.5 0.667 . . . . 0.0 110.368 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.491 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 98.02 -158.63 20.7 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.88 -1.84 74.53 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.953 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.0 -129.62 32.49 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -115.63 142.03 47.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.296 0.57 . . . . 0.0 110.801 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.636 HD11 HG11 ' A' ' 342' ' ' VAL . 2.0 mt -120.12 130.9 73.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.573 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.865 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.1 mt-10 -103.92 135.97 44.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 110.451 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.7 ' HE1' ' HB3' ' A' ' 381' ' ' ASN . 4.4 ppp? -147.46 159.33 43.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.512 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.719 ' O ' ' HB2' ' A' ' 356' ' ' MET . 0.1 OUTLIER -172.89 167.12 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.557 . . . . 0.0 112.269 174.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.957 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.1 tp -164.82 156.85 13.75 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 172.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.957 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 47.2 Cg_exo -37.08 138.2 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.766 2.31 . . . . 0.0 112.798 172.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.617 ' HA ' HE22 ' A' ' 394' ' ' GLN . 89.1 Cg_exo -34.92 136.45 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 125.08 3.853 . . . . 0.0 114.985 -174.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.21 -150.94 22.24 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.463 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.3 m-20 -108.08 105.64 15.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.146 0.473 . . . . 0.0 110.484 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.7 ' HB3' ' HE1' ' A' ' 374' ' ' MET . 10.0 m120 -105.0 125.1 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.031 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.063 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.44 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.642 ' HB ' ' HE1' ' A' ' 328' ' ' MET . 22.4 mt -91.54 135.67 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -115.46 91.91 3.75 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.135 178.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.643 HG11 HG13 ' A' ' 342' ' ' VAL . 6.3 t -83.79 92.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.64 0.12 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.867 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -110.57 -15.66 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.067 0.461 . . . . 0.0 110.108 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.4 OUTLIER -63.29 139.96 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.8 p30 -149.41 148.1 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.587 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.8 OUTLIER -171.77 122.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 173.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.063 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 11.2 tt0 -76.82 148.89 36.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -143.54 129.52 19.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.484 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -86.34 112.18 21.18 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.617 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -102.19 126.47 49.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.428 -169.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.675 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 35.4 p90 -65.46 117.08 7.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.65 0.738 . . . . 0.0 110.332 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t -168.63 -171.25 1.37 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.65 109.29 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 140.05 56.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.469 0.652 . . . . 0.0 111.551 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.444 ' OD2' HG21 ' A' ' 310' ' ' THR . 13.8 t70 -64.84 143.95 57.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.645 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -64.34 -11.93 37.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.176 -1.375 . . . . 0.0 113.484 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.444 HG21 ' OD2' ' A' ' 308' ' ' ASP . 3.7 t -104.92 12.22 32.7 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.059 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.442 ' HE2' ' HA3' ' A' ' 334' ' ' GLY . 25.7 mtpp -101.63 1.36 37.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 2.4 p90 -125.53 169.38 12.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.3 t -149.2 162.37 40.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.951 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.533 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.3 m-90 -69.74 111.04 5.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -86.21 -36.26 19.55 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.525 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 11.3 ttm180 -164.6 120.99 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.138 175.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.447 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -66.25 161.12 59.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.522 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.82 116.08 0.39 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.769 2.313 . . . . 0.0 112.013 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.522 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.5 m -131.9 134.34 45.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.173 -172.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.45 127.4 24.9 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.3 p -66.8 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 -171.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.7 -4.34 42.77 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 325' ' ' THR . 4.7 m-70 -139.71 59.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.548 0.213 . . . . 0.0 111.432 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 74.13 -24.73 0.2 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 323' ' ' HIS . 21.4 p -101.33 -171.39 1.98 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.301 -175.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.74 153.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.402 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.934 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -134.8 154.48 36.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.877 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.653 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -137.69 161.86 35.39 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.525 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 16.2 tt0 -134.15 131.26 38.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.96 145.46 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.623 0.249 . . . . 0.0 111.3 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.91 135.19 11.53 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.302 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.591 ' CE1' ' HD2' ' A' ' 312' ' ' PHE . 1.3 m-85 -122.08 172.75 8.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 70.8 m -157.25 52.84 0.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.442 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -163.86 -74.69 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.35 -1.405 . . . . 0.0 113.766 170.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.51 ' HB ' ' HE1' ' A' ' 364' ' ' MET . 3.8 m -57.53 144.23 37.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.437 0.695 . . . . 0.0 111.919 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.675 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 13.9 ptm180 -76.69 168.9 24.08 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.555 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 364' ' ' MET . 1.0 OUTLIER -27.26 98.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.008 3.139 . . . . 0.0 114.373 -173.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.777 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 26.9 p -110.58 173.49 6.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.784 -169.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -90.37 102.32 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.909 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.852 HD13 ' HB3' ' A' ' 364' ' ' MET . 58.6 mt -74.67 122.96 88.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.575 0.226 . . . . 0.0 111.08 -176.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.6 81.75 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.471 2.114 . . . . 0.0 112.4 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 340' ' ' ILE . 6.4 m -102.9 126.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 111.504 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 21.0 ptt180 -139.07 -178.24 5.25 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.48 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -156.93 135.96 11.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.629 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.16 174.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -104.67 115.89 31.1 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 15.8 p80 42.98 55.45 4.44 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.913 0.758 . . . . 0.0 112.575 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.794 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.68 11.09 56.6 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.881 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.91 118.02 30.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.468 -0.43 . . . . 0.0 110.679 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.17 61.91 5.0 Favored 'Trans proline' 0 N--CA 1.463 -0.324 0 C-N-CA 123.024 2.483 . . . . 0.0 111.268 172.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.86 -38.68 12.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.8 p -151.45 126.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.296 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -60.75 106.37 0.56 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.783 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.8 m -88.01 3.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.36 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.48 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.68 82.0 4.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.56 0.695 . . . . 0.0 110.747 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.811 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 2.5 tpt -98.91 83.5 2.93 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.3 mt -68.05 125.92 27.85 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.118 -169.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.559 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 6.2 mm -70.03 -23.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.399 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 13.0 m -138.63 92.95 11.21 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.057 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -91.75 41.04 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.386 2.724 . . . . 0.0 113.624 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.94 65.84 5.85 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.264 0.554 . . . . 0.0 110.098 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.683 ' HB3' HG21 ' A' ' 372' ' ' ILE . 97.2 Cg_endo -87.95 118.0 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.414 2.076 . . . . 0.0 113.168 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.4 p -110.0 134.5 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.412 171.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.852 ' HB3' HD13 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -107.14 149.94 27.12 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.542 -176.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -111.03 -168.53 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.827 1.329 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.601 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -64.91 -16.04 62.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 174.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 366' ' ' ASN . 89.1 m-20 -86.47 -11.44 51.78 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.306 0.574 . . . . 0.0 110.171 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 113.2 -167.67 12.38 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.707 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 364' ' ' MET . . . -81.49 -15.18 76.79 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.986 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.4 -127.62 23.8 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.128 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.95 133.31 50.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.072 0.463 . . . . 0.0 111.184 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.683 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -125.12 165.14 22.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.934 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.1 mt-10 -134.43 137.28 43.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.216 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.595 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.77 159.74 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -175.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.849 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -179.0 160.12 1.05 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 123.022 0.201 . . . . 0.0 110.579 174.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.811 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.8 tp -158.94 150.67 17.0 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.811 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.6 Cg_exo -32.93 136.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.49 2.793 . . . . 0.0 113.604 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.502 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.1 Cg_exo -35.79 128.75 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.851 1 C-N-CA 125.725 4.283 . . . . 0.0 114.951 -169.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.5 -134.41 2.89 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.406 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 14.7 m-20 -127.12 102.0 6.77 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.53 ' HB2' ' HE1' ' A' ' 374' ' ' MET . 7.8 m120 -102.88 123.0 45.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.102 0.477 . . . . 0.0 109.987 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.995 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.79 129.75 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 29.7 mt -91.65 131.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.414 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.563 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.4 OUTLIER -108.03 91.47 3.66 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.039 174.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.479 HG11 HG13 ' A' ' 342' ' ' VAL . 7.6 t -83.86 94.6 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.61 -97.49 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.952 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -104.73 -19.89 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.173 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.533 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.1 tp -64.31 146.43 54.41 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.4 p30 -158.84 143.22 15.66 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.492 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -166.18 124.69 1.51 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.421 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.995 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.5 tm0? -78.35 143.2 37.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.906 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 26.8 t-105 -145.37 114.54 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.366 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 27.3 p90 -74.38 125.8 29.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.502 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -120.08 140.53 50.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.67 0.748 . . . . 0.0 112.731 -171.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.314 168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.421 0.629 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -69.53 120.36 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.676 -0.64 . . . . 0.0 110.124 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.3 t -171.29 -167.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.719 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.45 113.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 143.78 55.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.791 0.805 . . . . 0.0 110.812 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' A' ' 310' ' ' THR . 12.0 t70 -80.29 150.65 29.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.273 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 387' ' ' ASP . 10.8 ptmt -58.51 -18.58 30.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.017 -173.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.554 HG21 ' OD1' ' A' ' 308' ' ' ASP . 10.0 t -100.19 -0.22 39.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.58 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.3 mmmt -80.86 -33.79 34.2 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.664 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -93.84 154.55 17.67 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.154 0.502 . . . . 0.0 111.535 -178.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 388' ' ' LEU . 8.9 t -144.38 150.62 38.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.283 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -64.98 112.76 3.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.225 0.536 . . . . 0.0 111.999 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.481 ' HG2' ' OE2' ' A' ' 329' ' ' GLU . 38.2 tttm -94.99 -28.54 15.09 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.677 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 72.1 ttt180 -168.89 110.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.628 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -63.2 160.47 39.94 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.43 -175.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.678 ' HG3' HD11 ' A' ' 383' ' ' ILE . 69.6 Cg_exo -30.78 118.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.922 3.081 . . . . 0.0 113.498 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.555 ' O ' HG21 ' A' ' 327' ' ' VAL . 23.9 m -137.21 134.55 36.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.738 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.548 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 14.3 t70 -52.16 130.17 29.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.945 0.402 . . . . 0.0 110.497 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 99.9 p -69.75 -24.14 63.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.354 -173.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 102.49 -12.68 56.82 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -125.11 57.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 4.9 p-10 47.41 23.08 0.32 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.131 0.972 . . . . 0.0 113.529 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.557 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -127.43 -172.7 2.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.566 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.7 OUTLIER -128.92 152.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.882 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.737 HG12 ' HG2' ' A' ' 373' ' ' GLU . 25.8 m -137.6 153.26 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.687 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.672 ' HE3' HD11 ' A' ' 372' ' ' ILE . 18.0 ptt? -136.52 158.15 45.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.677 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.4 tt0 -121.29 118.82 30.49 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.263 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.82 148.86 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -120.49 157.07 15.88 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.87 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.75 178.74 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.825 -177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 311' ' ' LYS . 37.6 p -136.2 -3.04 2.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.0 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 161.06 11.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 119.207 -1.473 . . . . 0.0 115.782 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.58 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 39.8 m -113.08 127.48 56.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.138 0.969 . . . . 0.0 109.903 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.575 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.6 ptt180 -75.03 171.48 11.6 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.033 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.9 OUTLIER -25.51 92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.986 3.124 . . . . 0.0 114.8 -166.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 363' ' ' THR . 9.2 p -110.54 144.72 38.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.709 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 6.1 mpt_? -73.47 103.95 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.737 HG21 ' HG3' ' A' ' 364' ' ' MET . 21.1 pt -88.28 128.71 52.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.252 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.402 ' HD2' ' CE1' ' A' ' 312' ' ' PHE . 58.4 Cg_endo -74.5 82.53 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.73 2.287 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.611 HG13 HG11 ' A' ' 385' ' ' VAL . 13.5 m -98.57 113.7 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.694 0.759 . . . . 0.0 111.31 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -123.09 -178.74 4.05 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.476 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -154.6 142.27 19.88 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.195 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.5 m -114.38 169.65 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -112.44 116.79 30.86 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.974 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 380' ' ' ASP . 4.8 t-160 63.95 39.07 8.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.6 0.562 . . . . 0.0 109.902 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 70.2 5.76 54.98 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.427 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.37 51.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 117.201 0.501 . . . . 0.0 111.348 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.91 52.62 4.08 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.293 2.662 . . . . 0.0 112.298 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.63 -53.38 4.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.661 0.743 . . . . 0.0 109.108 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.33 117.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.603 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.8 t30 -53.29 108.67 0.35 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.244 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.856 ' HA ' HD23 ' A' ' 376' ' ' LEU . 31.9 m -87.13 8.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.476 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -81.69 80.89 7.91 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.515 0.674 . . . . 0.0 110.718 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.643 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 37.9 mtt -102.39 81.05 2.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.2 mt -63.68 125.25 23.68 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.271 -169.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 375' ' ' GLN . 4.6 mm -65.47 -20.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.4 m -136.61 92.27 15.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.489 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' A' ' 357' ' ' LEU . 80.0 Cg_endo -92.07 48.93 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.6 2.867 . . . . 0.0 114.739 -168.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -170.47 70.11 0.56 Allowed Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 109.918 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.436 ' HB3' HG21 ' A' ' 372' ' ' ILE . 86.2 Cg_endo -90.91 138.32 2.4 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.949 2.433 . . . . 0.0 113.822 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 17.2 p -123.98 143.09 50.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.651 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.737 ' HG3' HG21 ' A' ' 340' ' ' ILE . 53.7 mtm -95.86 128.82 43.08 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.121 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 mm-40 -93.2 -172.22 2.89 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.348 1.03 . . . . 0.0 112.245 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.6 ' C ' HD21 ' A' ' 366' ' ' ASN . 0.3 OUTLIER -66.25 -6.23 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.838 174.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.558 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.4 t-20 -112.87 -2.1 14.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.31 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 105.31 -175.34 21.87 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.0 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -75.29 -37.72 41.22 Favored Glycine 0 CA--C 1.509 -0.306 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.494 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.76 -124.11 6.46 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.431 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.2 134.94 45.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.106 0.479 . . . . 0.0 111.559 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.672 HD11 ' HE3' ' A' ' 328' ' ' MET . 0.9 OUTLIER -128.7 155.33 40.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.737 ' HG2' HG12 ' A' ' 327' ' ' VAL . 33.8 mt-10 -125.09 138.34 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.875 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.634 ' HE2' HD13 ' A' ' 383' ' ' ILE . 0.1 OUTLIER -153.59 157.18 39.3 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.908 0.483 . . . . 0.0 110.709 -174.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.835 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -170.07 163.72 9.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 173.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.044 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.9 tp -165.51 163.41 12.97 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 1.044 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 72.1 Cg_exo -27.83 133.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.103 3.202 . . . . 0.0 114.348 168.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.83 ' HB3' ' HB2' ' A' ' 395' ' ' LYS . 5.2 Cg_exo -37.09 138.46 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.857 4.371 . . . . 0.0 115.362 -175.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 147.05 -179.76 23.73 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.063 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.5 m-20 -69.02 104.26 2.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 117.791 0.796 . . . . 0.0 110.561 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -94.34 112.54 24.33 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.031 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -114.78 127.56 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.863 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.678 HD11 ' HG3' ' A' ' 318' ' ' PRO . 21.8 mt -92.74 132.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.992 -175.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.67 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.6 OUTLIER -104.58 92.57 4.35 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.062 174.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.3 t -81.23 86.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.98 -91.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.533 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.531 ' HB2' ' HE3' ' A' ' 309' ' ' LYS . 10.5 t70 -108.75 -15.01 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 109.809 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.4 mp -64.35 147.93 51.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.8 p-10 -158.34 140.87 14.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.585 0.231 . . . . 0.0 111.127 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.622 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -167.88 121.7 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.24 174.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.031 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 70.6 mt-30 -70.83 150.96 45.29 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.548 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 12.1 t-105 -151.04 110.7 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.985 169.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.9 p90 -74.39 111.36 9.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.652 0.739 . . . . 0.0 109.8 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.569 ' NE2' ' HG2' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -99.11 146.27 26.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.139 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.83 ' HB2' ' HB3' ' A' ' 378' ' ' PRO . 71.7 mmtt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.197 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.512 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 25.1 p90 -64.74 129.82 41.23 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.92 -0.488 . . . . 0.0 110.062 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.4 t 176.78 -173.61 0.1 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 17.3 t -69.56 106.09 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.3 OUTLIER -68.86 156.68 38.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.682 0.754 . . . . 0.0 112.393 -167.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.671 ' OD2' HG21 ' A' ' 310' ' ' THR . 18.4 t70 -67.8 143.16 55.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.494 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -66.11 -22.39 66.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.494 -170.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.671 HG21 ' OD2' ' A' ' 308' ' ' ASP . 2.6 t -100.0 -6.23 26.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.635 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 29.3 mtpp -83.02 38.19 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -175.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -123.93 173.69 8.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.261 0.553 . . . . 0.0 111.497 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 10.0 t -157.13 135.43 11.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.478 170.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -55.16 110.87 0.74 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.839 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.657 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 1.1 tpmt? -92.36 -41.68 10.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.406 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 69.9 ttt180 -161.16 126.16 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -71.2 162.57 71.84 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.648 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.441 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 4.9 Cg_exo -40.37 122.69 1.32 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.609 2.206 . . . . 0.0 111.718 175.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.502 ' O ' HG21 ' A' ' 327' ' ' VAL . 12.3 m -142.85 142.17 31.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.259 -172.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.12 125.58 6.66 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.176 0.298 . . . . 0.0 110.487 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.535 ' HB3' HG11 ' A' ' 327' ' ' VAL . 94.9 p -66.79 -20.15 65.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.902 -174.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.89 -2.19 79.29 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -140.01 55.33 1.64 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 110.97 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 72.96 12.92 5.02 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.716 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.1 p -144.62 -166.78 2.47 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.481 -0.137 . . . . 0.0 110.699 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.96 155.19 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.86 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.664 HG12 ' HG3' ' A' ' 373' ' ' GLU . 17.9 m -137.5 160.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.655 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.413 ' HE3' ' HB2' ' A' ' 328' ' ' MET . 10.5 ptm -141.39 165.1 28.43 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.5 tt0 -130.19 124.68 33.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.46 HG12 HG22 ' A' ' 385' ' ' VAL . 14.1 m -128.78 141.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.169 0.509 . . . . 0.0 111.599 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.03 161.04 14.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.674 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.0 OUTLIER -108.5 179.9 4.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.907 0.86 . . . . 0.0 112.833 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.2 t -98.8 -42.79 7.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.363 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.8 41.11 0.04 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.245 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 307' ' ' CYS . 13.7 m -114.32 119.9 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.118 0.459 . . . . 0.0 110.33 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.539 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.6 ptm180 -69.87 171.22 7.73 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.253 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.05 92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 124.184 3.256 . . . . 0.0 114.532 -169.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 363' ' ' THR . 20.8 p -114.34 164.1 14.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.274 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 20.8 mmt180 -86.59 99.03 11.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.753 HG13 HG21 ' A' ' 342' ' ' VAL . 16.7 pt -81.0 130.03 64.97 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.548 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.94 78.97 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.173 1.915 . . . . 0.0 112.354 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.91 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -98.25 121.62 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.832 0.825 . . . . 0.0 112.411 175.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -126.67 -176.69 3.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.326 171.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.59 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.9 134.47 15.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.348 0.594 . . . . 0.0 110.647 176.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.74 167.63 4.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.37 114.41 28.66 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.349 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 57.35 46.79 17.78 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 123.721 0.638 . . . . 0.0 110.621 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 64.75 13.84 57.02 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.837 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.439 HG11 ' HB2' ' A' ' 351' ' ' GLU . 46.9 t -114.66 112.95 45.2 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.51 0.655 . . . . 0.0 111.301 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.64 52.56 2.51 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.627 2.885 . . . . 0.0 112.134 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.439 ' HB2' HG11 ' A' ' 349' ' ' VAL . 10.5 tp10 -90.93 -51.59 5.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.945 0.879 . . . . 0.0 108.828 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.8 118.51 29.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.115 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -61.03 107.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.719 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.733 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 27.0 m -89.53 6.58 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.59 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.95 83.37 6.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.466 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -99.82 91.98 5.09 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 29.6 mt -73.24 118.7 16.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.208 -167.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.731 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -66.66 -22.95 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.361 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -131.12 93.43 30.36 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.951 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.71 43.3 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.035 2.49 . . . . 0.0 113.035 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.455 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 66.6 t30 -150.54 61.03 4.48 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.543 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.621 ' HB2' HD13 ' A' ' 340' ' ' ILE . 73.9 Cg_endo -88.53 118.96 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.528 2.152 . . . . 0.0 112.789 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 53.2 p -124.42 149.63 46.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.377 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.959 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 71.3 mtm -94.61 133.8 37.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.413 ' HB3' HD21 ' A' ' 366' ' ' ASN . 1.2 mm-40 -109.46 -168.72 1.37 Allowed 'General case' 0 C--N 1.318 -0.795 0 O-C-N 124.551 1.157 . . . . 0.0 111.891 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.0 OUTLIER -52.51 -23.73 6.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -109.43 -7.93 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.077 -0.389 . . . . 0.0 111.156 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 127.75 -178.14 17.18 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.959 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -63.12 -29.66 75.09 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.63 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.9 -123.42 6.58 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.347 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -103.55 147.28 27.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.191 0.519 . . . . 0.0 111.644 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.9 mt -136.54 137.67 47.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.962 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.731 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.7 mp0 -107.29 135.52 48.66 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.292 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.656 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -152.45 158.09 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.619 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.9 tp60 -176.04 145.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.725 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.752 HD23 ' HD2' ' A' ' 377' ' ' PRO . 0.8 OUTLIER -146.25 142.48 17.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 167.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.752 ' HD2' HD23 ' A' ' 376' ' ' LEU . 28.2 Cg_exo -23.94 136.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.844 3.696 . . . . 0.0 115.004 177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.784 ' HA ' HE22 ' A' ' 394' ' ' GLN . 6.3 Cg_exo -37.11 134.2 0.41 Allowed 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 125.79 4.327 . . . . 0.0 114.97 -171.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 161.51 -124.6 1.33 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.995 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.453 ' HB3' HE21 ' A' ' 391' ' ' GLN . 11.7 m-20 -132.29 101.78 5.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.484 ' HB2' ' HE2' ' A' ' 374' ' ' MET . 7.9 m120 -104.57 124.75 49.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.041 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.55 134.28 66.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.656 HD12 ' HG2' ' A' ' 374' ' ' MET . 41.9 mt -95.27 134.1 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.176 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.23 94.24 4.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.133 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.91 HG11 HG11 ' A' ' 342' ' ' VAL . 2.8 t -84.82 72.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.64 -80.66 0.77 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.504 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 1.9 t70 -110.54 -30.08 7.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.51 141.77 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.537 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.4 p30 -150.73 154.27 37.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -170.08 116.07 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 175.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.041 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -73.13 139.97 46.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.438 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.449 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 29.9 t-105 -136.67 137.72 40.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.158 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -94.97 117.32 29.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.784 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.32 146.09 38.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.886 0.374 . . . . 0.0 110.495 -177.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 395' ' ' LYS . 1.9 ttpm? . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.496 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 335' ' ' THR . 6.8 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.569 ' HB3' ' HD2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -70.84 108.48 4.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.783 0.802 . . . . 0.0 110.617 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.5 t -168.43 -167.18 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.582 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.69 113.43 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 170.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.98 144.23 56.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.658 0.742 . . . . 0.0 111.174 -171.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.93 148.33 40.15 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.13 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.731 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.81 -12.88 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.888 -173.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.469 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.5 t -98.15 -6.21 31.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.567 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.7 mmmt -75.9 -36.16 59.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.628 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -94.4 148.79 21.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 111.106 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.9 t -139.11 162.19 35.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.56 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.466 ' CZ3' ' HA ' ' A' ' 317' ' ' ALA . 93.8 m95 -67.37 111.39 4.02 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.947 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 73.3 tttt -102.52 -39.8 6.95 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.014 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.628 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 70.7 ttt180 -157.0 118.35 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.51 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.466 ' HA ' ' CZ3' ' A' ' 314' ' ' TRP . . . -67.42 161.21 66.83 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.462 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.837 ' HG3' HD11 ' A' ' 383' ' ' ILE . 74.0 Cg_exo -36.34 110.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.223 2.616 . . . . 0.0 113.251 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.538 ' O ' HG21 ' A' ' 327' ' ' VAL . 7.5 m -134.9 137.45 43.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.591 -173.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.4 131.66 13.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.162 0.505 . . . . 0.0 111.509 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 88.1 p -66.89 -23.32 65.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.77 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.05 -11.64 31.73 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -100.77 -54.13 2.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.516 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 21.9 t70 170.08 -24.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.323 1.058 . . . . 0.0 109.035 -171.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.542 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.46 -169.95 2.25 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.462 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.601 HG12 HE22 ' A' ' 394' ' ' GLN . 2.1 t -127.73 154.38 38.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.024 0.44 . . . . 0.0 111.001 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.668 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.3 m -135.22 156.61 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.76 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.573 ' SD ' HG22 ' A' ' 330' ' ' VAL . 2.0 ppp? -135.65 154.63 51.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.947 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 9.7 tt0 -126.44 123.13 37.17 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.116 0.484 . . . . 0.0 110.601 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.573 HG21 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -123.7 148.83 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.51 -177.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.23 139.35 15.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.78 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.445 ' H ' ' HD1' ' A' ' 332' ' ' PHE . 0.8 OUTLIER -91.13 179.27 5.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.345 0.573 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.7 p -135.55 -17.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.118 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.99 -47.28 0.06 OUTLIER Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.339 -1.41 . . . . 0.0 114.213 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.663 HG23 HG21 ' A' ' 303' ' ' THR . 26.3 m -56.27 125.27 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.213 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.569 ' HD2' ' HB3' ' A' ' 304' ' ' TYR . 0.0 OUTLIER -69.44 163.22 60.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 118.14 -0.933 . . . . 0.0 108.891 176.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.752 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.48 97.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.148 3.232 . . . . 0.0 114.688 -169.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 363' ' ' THR . 6.8 p -114.07 150.89 33.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.969 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -75.4 108.06 7.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.729 HG22 ' HG3' ' A' ' 364' ' ' MET . 28.8 pt -91.48 128.58 46.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.106 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.33 89.57 1.18 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.099 2.533 . . . . 0.0 112.881 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 372' ' ' ILE . 19.1 m -101.05 124.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.415 0.626 . . . . 0.0 110.938 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -132.78 -175.62 3.83 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.21 137.46 18.44 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.59 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 382' ' ' ILE . 10.7 m -115.23 166.82 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.54 117.74 34.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.535 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.5 t60 59.7 40.08 20.27 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.395 0.434 . . . . 0.0 110.519 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 69.1 6.96 55.77 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.231 -176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.1 113.09 62.75 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.897 0.349 . . . . 0.0 111.051 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.46 55.87 4.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.929 2.42 . . . . 0.0 111.88 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.32 -53.49 4.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.029 0.919 . . . . 0.0 108.621 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.6 120.89 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.787 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -54.37 107.99 0.33 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.663 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 376' ' ' LEU . 2.6 m -87.9 -8.65 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.85 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.462 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -60.02 96.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.471 0.653 . . . . 0.0 112.222 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.64 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 67.4 mtm -108.18 85.38 2.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 45.4 mt -73.41 124.37 25.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.377 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.609 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.8 mm -69.62 -20.53 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.3 m -145.74 97.13 4.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.999 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -92.47 37.91 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.483 2.788 . . . . 0.0 113.288 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -144.53 63.04 10.42 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.883 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.657 ' HB3' HG21 ' A' ' 372' ' ' ILE . 88.4 Cg_endo -86.1 131.45 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.564 2.176 . . . . 0.0 113.016 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -130.4 142.16 50.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.399 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.752 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 59.0 mtm -95.24 117.08 29.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.722 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 38.5 mt-10 -100.12 -165.47 1.22 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.898 1.374 . . . . 0.0 109.886 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.602 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -62.8 -15.0 52.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 0.0 111.314 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.602 ' N ' HD21 ' A' ' 366' ' ' ASN . 87.1 m-20 -96.7 6.44 48.69 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.184 0.516 . . . . 0.0 109.678 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 83.48 -155.19 32.1 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.573 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -68.43 -16.43 69.4 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.826 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.499 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 71.45 -87.18 0.42 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.705 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.02 143.32 15.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.099 0.476 . . . . 0.0 109.871 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.805 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 1.8 mt -119.57 157.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.668 ' HG2' HG12 ' A' ' 327' ' ' VAL . 37.0 mt-10 -126.34 130.94 51.78 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.806 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.805 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -155.26 160.56 40.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.928 -173.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.857 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -163.71 148.19 10.54 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 167.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -132.22 163.59 49.27 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -169.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 378' ' ' PRO . 3.5 Cg_endo -48.16 126.67 13.87 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.625 2.217 . . . . 0.0 112.147 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.5 Cg_exo -38.81 128.62 1.26 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.69 3.594 . . . . 0.0 113.711 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 134.32 -172.57 21.76 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.362 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.817 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.4 m-20 -71.21 101.44 2.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.931 0.365 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.523 ' HB2' HD22 ' A' ' 376' ' ' LEU . 31.9 m-80 -118.04 163.39 16.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.031 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -146.24 144.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.631 -173.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.837 HD11 ' HG3' ' A' ' 318' ' ' PRO . 21.5 mt -100.97 132.96 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.094 0.473 . . . . 0.0 110.339 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -103.84 97.15 7.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.24 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.1 t -86.5 84.68 2.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.32 -85.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.332 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 7.8 t70 -113.09 -16.23 12.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.4 mp -66.14 148.76 51.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.058 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.1 p30 -163.45 126.92 2.73 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.967 0.413 . . . . 0.0 111.494 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -153.75 119.81 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.25 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.031 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 41.5 tt0 -87.39 142.38 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.424 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.476 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 0.6 OUTLIER -153.33 141.02 19.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.817 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 7.7 p90 -74.55 107.08 6.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.288 0.566 . . . . 0.0 110.661 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.651 ' HG3' HD22 ' A' ' 376' ' ' LEU . 1.7 mm100 -85.1 145.07 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 tptm . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.819 172.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 335' ' ' THR . 7.7 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.751 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.3 p90 -58.97 130.94 49.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 110.181 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.7 t -177.58 -165.45 0.11 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 306' ' ' VAL . 6.0 p -69.02 107.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.549 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.5 OUTLIER -68.4 136.24 53.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.818 0.818 . . . . 0.0 110.877 -174.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.535 ' OD1' HG21 ' A' ' 310' ' ' THR . 8.7 t70 -65.92 147.75 52.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.924 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.776 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -61.56 -13.37 21.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.248 -177.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.535 HG21 ' OD1' ' A' ' 308' ' ' ASP . 15.3 t -104.29 6.19 35.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 41.4 mtpt -106.36 17.42 23.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.776 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.5 OUTLIER -132.74 158.32 42.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.2 t -138.71 154.08 48.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.503 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.514 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.5 m-90 -63.8 98.49 0.2 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.367 0.604 . . . . 0.0 110.885 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -83.51 -32.42 25.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 37.6 ttm180 -165.24 116.12 1.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.255 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.507 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -64.42 163.6 24.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.344 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 4.0 Cg_exo -41.7 117.91 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.638 2.226 . . . . 0.0 112.107 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.586 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.7 m -135.49 144.52 46.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.345 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.82 130.3 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 327' ' ' VAL . 80.6 p -71.15 -18.64 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.93 -2.59 72.53 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 9.1 t60 -109.09 -52.88 2.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 19.0 t70 169.19 -25.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.311 1.053 . . . . 0.0 108.915 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.455 ' CB ' HG13 ' A' ' 358' ' ' ILE . 9.4 p -92.83 -168.28 1.92 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.004 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.68 150.92 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.684 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -131.85 163.7 36.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.979 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.4 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -142.39 163.99 31.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 4.0 tt0 -132.06 126.68 34.42 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.656 0.597 . . . . 0.0 110.1 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.91 153.9 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.723 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.38 152.27 16.84 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.999 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.565 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -89.93 165.86 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.227 0.514 . . . . 0.0 111.798 -174.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 35.3 m -115.6 8.03 14.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.338 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 147.61 13.11 0.15 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.458 -1.354 . . . . 0.0 115.2 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.549 ' HB ' ' SG ' ' A' ' 307' ' ' CYS . 98.4 m -114.29 132.71 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.292 1.046 . . . . 0.0 110.586 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.751 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 28.0 ptt180 -75.94 173.11 7.72 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.027 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.713 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.62 93.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 124.051 3.167 . . . . 0.0 115.166 -168.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 1.8 p -110.8 150.78 28.63 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.035 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.28 108.75 3.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.578 ' HB ' ' HG3' ' A' ' 364' ' ' MET . 15.6 tt -92.4 119.24 68.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 121.013 0.435 . . . . 0.0 110.24 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.47 82.23 2.13 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.987 2.458 . . . . 0.0 112.535 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.665 HG13 HG11 ' A' ' 385' ' ' VAL . 29.8 m -98.93 128.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.384 0.611 . . . . 0.0 111.477 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 32.0 ptt180 -135.17 -176.13 4.15 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.558 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.68 141.58 22.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.255 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 14.6 m -120.47 168.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.44 34.11 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.049 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.55 ' HA ' ' OD2' ' A' ' 380' ' ' ASP . 5.4 t60 56.91 46.54 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.514 0.509 . . . . 0.0 111.381 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 61.79 14.44 44.24 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.642 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 347' ' ' HIS . 38.7 t -115.78 115.86 41.13 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.155 0.478 . . . . 0.0 111.216 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.16 51.29 3.8 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.231 2.62 . . . . 0.0 112.228 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.61 ' HG3' HG11 ' A' ' 352' ' ' VAL . 8.8 pt-20 -85.07 -41.4 15.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.739 0.781 . . . . 0.0 109.222 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.61 HG11 ' HG3' ' A' ' 351' ' ' GLU . 4.4 p -144.11 118.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.602 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -55.78 108.09 0.41 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.932 ' HA ' HD21 ' A' ' 376' ' ' LEU . 28.2 m -84.99 0.18 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.124 0.487 . . . . 0.0 110.293 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.558 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.36 82.97 3.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.216 0.532 . . . . 0.0 110.835 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.742 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 8.5 tpt -97.59 91.96 5.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 166.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 39.3 mt -74.49 120.37 19.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.454 -165.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.662 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.6 mm -70.32 -19.01 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 61.7 m -128.25 81.89 69.61 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.252 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -86.18 43.92 1.18 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.14 2.56 . . . . 0.0 113.811 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.14 67.62 0.41 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.447 ' O ' HG21 ' A' ' 340' ' ' ILE . 68.9 Cg_endo -91.49 134.91 1.65 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.816 2.344 . . . . 0.0 114.01 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 2.8 p -116.65 155.94 27.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.93 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.907 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 76.7 mtp -95.43 103.72 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.981 0.42 . . . . 0.0 109.868 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -79.72 -165.56 0.83 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.732 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.52 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -46.85 -30.86 2.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -122.69 25.72 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.757 -0.59 . . . . 0.0 111.289 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.723 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.09 -177.6 20.37 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.008 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.907 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.12 -25.09 53.35 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.395 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.09 -110.98 3.71 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.642 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -108.1 131.9 54.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.152 0.501 . . . . 0.0 111.721 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.622 HD11 HG11 ' A' ' 342' ' ' VAL . 1.2 mt -134.98 141.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.684 ' HG2' HG12 ' A' ' 327' ' ' VAL . 30.9 mt-10 -114.46 137.09 52.28 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.492 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.481 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -144.46 156.08 44.03 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.742 ' O ' ' HB3' ' A' ' 356' ' ' MET . 24.1 tp60 -175.65 144.92 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.709 0.29 . . . . 0.0 110.96 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.028 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.2 tp -147.15 160.07 40.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 164.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 1.028 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 38.7 Cg_exo -29.47 133.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.147 3.231 . . . . 0.0 114.579 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.581 ' HA ' HE22 ' A' ' 394' ' ' GLN . 73.0 Cg_exo -35.37 135.69 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.016 1 C-N-CA 125.441 4.094 . . . . 0.0 115.562 -176.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.61 -135.71 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.55 ' OD2' ' HA ' ' A' ' 347' ' ' HIS . 4.7 p-10 -131.17 107.47 9.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.162 0.982 . . . . 0.0 109.977 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.502 ' N ' HD21 ' A' ' 381' ' ' ASN . 0.8 OUTLIER -102.26 128.65 48.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.632 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.993 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -119.63 135.73 59.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.481 HD12 ' HG2' ' A' ' 374' ' ' MET . 42.2 mt -91.07 129.48 41.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.873 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.459 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -108.93 91.84 3.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.971 176.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.665 HG11 HG13 ' A' ' 342' ' ' VAL . 9.3 t -83.6 85.6 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.24 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.359 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 3.1 t0 -112.1 -22.64 10.89 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.514 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -64.13 140.08 58.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.226 177.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.445 ' H ' ' HZ2' ' A' ' 314' ' ' TRP . 25.7 p-10 -151.74 139.43 19.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.39 116.98 1.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.993 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 26.9 tt0 -67.38 141.57 57.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.763 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.42 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 27.9 t-105 -139.79 122.11 16.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.121 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 11.8 p90 -79.76 109.07 13.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.077 0.465 . . . . 0.0 109.908 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.581 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -104.11 133.16 49.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.048 0.452 . . . . 0.0 110.511 -178.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.61 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 335' ' ' THR . 6.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.185 0.516 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -57.99 131.15 49.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.792 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.9 t -176.39 -167.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.0 t -68.13 116.65 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 137.22 56.08 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.805 0.812 . . . . 0.0 111.446 -170.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.644 ' OD1' HG21 ' A' ' 310' ' ' THR . 13.4 t0 -60.69 143.33 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.545 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.1 -171.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.644 HG21 ' OD1' ' A' ' 308' ' ' ASP . 2.2 t -108.58 3.96 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.508 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 37.3 mttp -80.19 -21.53 42.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.676 ' HB3' ' HE3' ' A' ' 364' ' ' MET . 0.1 OUTLIER -95.97 154.02 17.46 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.347 0.594 . . . . 0.0 110.958 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.8 t -136.95 156.44 48.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.226 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -59.98 99.9 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.762 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.525 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 27.6 tptp -89.34 -46.42 8.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.428 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 28.5 ttm180 -154.92 122.43 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.792 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.46 157.19 86.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.33 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.407 ' HB2' ' CD2' ' A' ' 392' ' ' TRP . 2.4 Cg_endo -42.24 112.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.111 2.541 . . . . 0.0 112.689 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.534 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.9 m -127.61 144.64 51.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.02 -174.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.75 128.02 6.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 327' ' ' VAL . 93.4 p -64.96 -23.1 67.12 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.521 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.86 -12.4 20.36 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.753 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.0 -40.92 1.98 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -178.0 -28.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.384 0.611 . . . . 0.0 111.667 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.451 ' HB ' HG13 ' A' ' 358' ' ' ILE . 16.7 p -93.31 -170.88 2.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.035 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.835 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.0 OUTLIER -127.62 144.72 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 -177.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.828 HG12 ' HG2' ' A' ' 373' ' ' GLU . 21.9 m -129.23 142.73 43.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.518 ' CE ' HG11 ' A' ' 330' ' ' VAL . 6.7 ptm -125.91 166.88 16.08 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.525 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 15.6 tt0 -136.7 140.54 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.528 HG21 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -139.52 158.89 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.67 0.271 . . . . 0.0 111.335 -178.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -124.86 135.85 9.64 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.629 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.576 ' HD2' ' HA2' ' A' ' 368' ' ' GLY . 2.3 p90 -90.74 178.45 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.192 0.496 . . . . 0.0 109.941 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.0 m -152.45 19.1 0.63 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -160.82 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.486 -1.34 . . . . 0.0 114.11 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 336' ' ' ARG . 67.9 m -70.49 139.98 51.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.683 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 4.8 ptt180 -67.34 175.84 1.42 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 117.611 -1.185 . . . . 0.0 109.013 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.783 ' HA ' ' O ' ' A' ' 364' ' ' MET . 3.7 Cg_exo -26.02 92.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 124.002 3.134 . . . . 0.0 114.247 -174.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 1.6 p -113.34 151.85 30.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.152 -171.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 9.1 mpt_? -69.24 109.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.601 HD13 ' HE1' ' A' ' 364' ' ' MET . 11.3 tt -89.22 118.7 69.4 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 120.946 0.403 . . . . 0.0 110.459 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.8 84.12 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.085 2.523 . . . . 0.0 112.798 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 372' ' ' ILE . 29.8 m -100.7 130.63 49.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 41.0 ptt180 -138.29 -170.26 2.77 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.531 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -155.52 140.89 17.68 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.348 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.83 167.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.44 113.05 26.26 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.886 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 56.68 49.39 14.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.466 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 68.75 2.15 27.78 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.252 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 25.9 t -110.37 113.05 56.58 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 117.73 0.765 . . . . 0.0 111.484 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.33 63.17 8.69 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.485 2.79 . . . . 0.0 112.906 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.73 -46.01 6.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.622 0.725 . . . . 0.0 109.369 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.92 124.52 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.074 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.5 t30 -63.02 107.98 1.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.58 HG22 ' HB3' ' A' ' 381' ' ' ASN . 34.3 m -90.94 11.56 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.549 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.531 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -83.3 83.19 7.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.548 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 36.7 ttm -96.92 87.26 4.21 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.6 mt -72.48 119.78 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.659 -165.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.711 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -69.79 -14.42 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -142.49 85.93 10.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.552 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 357' ' ' LEU . 96.9 Cg_endo -87.46 46.03 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.328 2.686 . . . . 0.0 113.944 -171.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -163.13 62.68 1.2 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.027 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.471 ' O ' HG22 ' A' ' 340' ' ' ILE . 86.1 Cg_endo -86.02 129.44 3.39 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.167 1.912 . . . . 0.0 113.405 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -116.96 150.56 38.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.502 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.783 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 0.5 OUTLIER -99.81 118.78 37.01 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.974 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.94 -165.32 1.24 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 124.929 1.393 . . . . 0.0 110.697 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -21.67 21.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.24 -0.43 38.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.313 0.577 . . . . 0.0 110.437 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.617 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.91 -160.14 13.58 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -65.6 -2.7 11.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 117.606 0.703 . . . . 0.0 112.505 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 56.21 -130.12 48.96 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -172.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 328' ' ' MET . 38.3 p90 -112.36 150.11 31.52 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.997 0.427 . . . . 0.0 110.432 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 2.2 mt -134.0 143.68 37.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.418 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.828 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.0 mt-10 -112.4 139.71 47.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.541 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.531 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.6 ppp? -156.86 162.89 39.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.171 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.835 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.89 169.63 6.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.064 0.459 . . . . 0.0 111.829 172.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.771 HD23 ' HD2' ' A' ' 377' ' ' PRO . 1.7 tm? -166.12 141.03 3.8 Favored Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.771 ' HD2' HD23 ' A' ' 376' ' ' LEU . 22.4 Cg_exo -31.36 132.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.849 3.033 . . . . 0.0 114.12 175.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.534 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 6.0 Cg_exo -37.17 130.93 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.154 1 C-N-CA 125.783 4.322 . . . . 0.0 115.016 -170.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.99 -173.32 37.43 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.7 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.8 m-20 -90.1 101.53 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.037 0.419 . . . . 0.0 110.066 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.58 ' HB3' HG22 ' A' ' 354' ' ' VAL . 16.8 m-80 -111.89 -179.64 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.506 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.061 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.77 139.3 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 O-C-N 122.268 -0.27 . . . . 0.0 110.322 178.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.62 ' HB ' ' CE1' ' A' ' 390' ' ' HIS . 29.9 mt -91.04 133.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 389' ' ' ASN . 1.8 t80 -112.95 104.25 12.21 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.651 HG11 HG13 ' A' ' 342' ' ' VAL . 6.2 t -97.01 83.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.86 -88.74 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.516 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.41 -31.18 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.2 mp -63.62 140.92 58.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 5.0 p-10 -140.25 140.62 35.81 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.829 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.62 ' CE1' ' HB ' ' A' ' 383' ' ' ILE . 0.8 OUTLIER -162.86 102.23 1.01 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.597 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.061 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.4 tt0 -81.41 152.23 27.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.404 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.742 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.2 OUTLIER -159.53 150.37 19.47 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 35.5 p90 -94.14 128.94 40.85 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.371 -0.83 . . . . 0.0 109.665 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.784 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -109.39 145.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.022 0.439 . . . . 0.0 110.474 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.47 ' HD3' ' C ' ' A' ' 395' ' ' LYS . 7.2 tmtt? . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.466 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 335' ' ' THR . 8.7 t . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.365 0.602 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.71 113.78 5.11 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.685 0.755 . . . . 0.0 110.098 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.1 t -173.81 -166.45 0.31 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.91 104.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.701 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.6 OUTLIER -74.47 167.23 22.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD2' HG21 ' A' ' 310' ' ' THR . 14.9 t70 -71.89 150.3 44.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.613 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 24.6 pttt -74.5 -19.82 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.613 -167.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.553 HG21 ' OD2' ' A' ' 308' ' ' ASP . 15.3 t -107.69 22.65 15.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.077 0.465 . . . . 0.0 111.625 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -95.64 18.55 12.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -134.23 173.67 11.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.388 0.614 . . . . 0.0 111.187 -178.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 140.81 33.01 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.299 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -54.01 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.518 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.97 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 76.3 tttt -85.89 -43.64 13.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.549 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 24.9 ttm180 -148.84 126.77 11.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.226 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 390' ' ' HIS . . . -70.9 160.64 81.61 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.75 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -42.35 115.39 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.292 1.995 . . . . 0.0 111.467 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.57 ' O ' HG21 ' A' ' 327' ' ' VAL . 5.0 m -134.34 144.61 48.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.732 -172.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -46.3 128.15 9.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 0.0 111.239 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.62 ' HB3' HG11 ' A' ' 327' ' ' VAL . 79.8 p -74.98 -22.05 58.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.451 -173.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.25 84.55 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -169.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -124.81 32.51 5.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.394 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.3 t70 68.9 19.39 8.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.309 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.45 ' HB ' HG13 ' A' ' 358' ' ' ILE . 13.8 p -136.76 -168.26 2.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.51 151.36 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.986 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.9 m -139.44 147.62 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.193 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 383' ' ' ILE . 11.9 ptm -126.7 163.02 24.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.555 171.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.97 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 11.5 tt0 -128.14 127.47 43.06 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.87 138.23 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.062 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -108.6 139.98 15.38 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.82 -179.87 4.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.249 1.025 . . . . 0.0 111.715 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.2 p -129.99 -24.47 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.656 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -144.54 -68.02 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.375 -1.393 . . . . 0.0 115.0 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.701 HG22 ' HB3' ' A' ' 307' ' ' CYS . 7.1 m -56.24 122.19 11.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.811 0.306 . . . . 0.0 111.619 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.446 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.8 ptm180 -74.21 171.82 10.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 117.68 -1.152 . . . . 0.0 108.589 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.98 96.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.955 3.103 . . . . 0.0 114.929 -170.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.734 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.7 p -118.09 165.57 13.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.257 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.47 100.61 12.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.704 HD13 ' HB2' ' A' ' 362' ' ' PRO . 18.9 pt -74.6 128.65 85.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.79 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.24 82.09 1.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.669 2.246 . . . . 0.0 112.089 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.625 HG11 HD11 ' A' ' 372' ' ' ILE . 20.5 m -97.63 133.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.536 0.684 . . . . 0.0 111.131 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -145.45 -177.73 5.72 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.605 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.15 137.18 18.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.811 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.1 m -113.66 172.76 3.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -100.96 115.9 31.55 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 6.1 p-80 41.38 59.82 2.27 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.887 0.742 . . . . 0.0 112.831 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.813 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 67.97 5.02 37.76 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.898 -0.592 . . . . 0.0 114.226 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 25.3 t -114.52 116.98 43.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 117.386 0.593 . . . . 0.0 111.026 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -74.63 54.44 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.196 2.598 . . . . 0.0 111.471 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.571 ' HG3' HG11 ' A' ' 352' ' ' VAL . 7.8 pt-20 -86.22 -38.96 17.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.776 0.798 . . . . 0.0 108.951 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.571 HG11 ' HG3' ' A' ' 351' ' ' GLU . 5.2 p -151.68 123.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.843 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -56.19 108.05 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.883 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.99 3.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.21 0.529 . . . . 0.0 110.2 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.605 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.93 82.66 5.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.318 -177.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -96.15 91.27 5.84 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 20.9 mt -70.8 120.41 16.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.658 -167.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.7 mm -68.52 -21.03 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.287 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 10.3 m -136.98 92.38 14.24 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.845 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.4 43.65 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.218 2.612 . . . . 0.0 112.895 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -150.37 58.65 3.17 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.704 ' HB2' HD13 ' A' ' 340' ' ' ILE . 92.5 Cg_endo -86.86 113.03 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.412 2.074 . . . . 0.0 113.244 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.2 p -114.06 140.09 48.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.913 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.734 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 24.6 ptt? -102.84 126.3 49.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.737 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.03 -166.24 1.18 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.307 -172.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -61.23 -12.88 14.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.2 p30 -101.26 -4.34 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.51 -165.47 12.71 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -78.52 -7.11 88.15 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.145 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 66.59 -120.66 15.35 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.688 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -116.04 140.22 49.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.217 0.532 . . . . 0.0 111.204 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.625 HD11 HG11 ' A' ' 342' ' ' VAL . 1.4 mt -124.42 126.6 72.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.1 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.986 ' HG2' HG12 ' A' ' 327' ' ' VAL . 38.1 mt-10 -104.75 132.58 50.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.217 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.492 ' HE3' ' HB2' ' A' ' 381' ' ' ASN . 0.0 OUTLIER -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.3 tp60 -174.32 145.08 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.097 0.248 . . . . 0.0 110.592 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.101 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.0 tp -143.59 162.74 40.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 1.101 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 34.5 Cg_exo -36.48 141.8 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.269 2.646 . . . . 0.0 113.492 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.551 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.7 Cg_exo -37.53 134.64 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 125.325 4.017 . . . . 0.0 114.77 -173.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.37 -146.75 13.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.348 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 14.8 m-20 -112.55 101.36 9.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.481 0.641 . . . . 0.0 110.213 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.492 ' HB2' ' HE3' ' A' ' 374' ' ' MET . 6.6 m120 -100.05 118.81 37.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.609 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.054 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.88 133.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 328' ' ' MET . 30.7 mt -93.13 134.02 32.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.461 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.8 OUTLIER -109.74 92.76 4.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.342 174.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.513 HG11 HG13 ' A' ' 342' ' ' VAL . 5.5 t -81.28 77.99 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.69 -91.68 0.27 Allowed Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.971 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.613 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -106.61 -18.0 14.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.342 0.592 . . . . 0.0 109.643 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.9 OUTLIER -74.37 128.26 35.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.534 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.99 143.68 48.29 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.534 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 0.1 OUTLIER -166.16 120.17 1.14 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.817 0.341 . . . . 0.0 110.806 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.054 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 47.1 tt0 -82.36 146.73 29.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.935 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -141.97 132.97 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.76 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.87 119.48 29.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.551 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -114.3 146.09 40.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.002 0.43 . . . . 0.0 110.343 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 pttt . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.847 -178.366 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.052 0.453 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.529 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 14.6 p90 -60.74 128.81 38.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -176.29 -172.42 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.04 110.44 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.499 ' HB2' ' HE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -68.67 134.73 50.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.684 0.754 . . . . 0.0 112.112 -172.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.621 ' OD1' HG21 ' A' ' 310' ' ' THR . 32.7 t70 -63.51 146.18 54.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.274 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.627 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.83 -14.66 62.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.321 -1.309 . . . . 0.0 114.309 -167.507 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.621 HG21 ' OD1' ' A' ' 308' ' ' ASP . 9.1 t -106.3 5.38 29.65 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.683 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -89.73 -21.16 22.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.08 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.716 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -95.87 147.45 23.65 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.21 0.529 . . . . 0.0 110.17 172.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 4.3 t -133.25 153.3 51.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.49 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.602 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.9 m-90 -61.98 99.12 0.12 Allowed 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 123.57 0.544 . . . . 0.0 111.232 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.619 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -84.44 -42.59 15.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -156.03 125.58 6.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.894 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.632 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -66.58 167.23 13.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.258 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.55 122.28 1.32 Allowed 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.925 2.417 . . . . 0.0 112.138 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.576 ' O ' HG21 ' A' ' 327' ' ' VAL . 28.8 m -135.35 136.77 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.637 -172.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -46.0 124.65 5.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 111.131 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -36.49 83.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.749 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 130.58 -10.71 5.78 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -114.84 -78.07 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.774 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.26 0.33 0.6 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.086 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.435 ' HB ' HG13 ' A' ' 358' ' ' ILE . 20.9 p -119.9 -174.28 2.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.142 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.4 153.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.884 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.788 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.6 m -133.44 163.99 36.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.557 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.712 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -147.71 153.71 39.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.649 -178.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.619 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 26.4 tt0 -129.6 118.07 21.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.597 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.712 HG13 ' SD ' ' A' ' 328' ' ' MET . 2.3 m -122.63 150.56 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.542 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.69 136.37 12.94 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.783 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.538 ' HB3' ' HE3' ' A' ' 364' ' ' MET . 0.4 OUTLIER -90.93 -179.44 5.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.594 0.712 . . . . 0.0 111.241 -176.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.9 m -119.64 -25.78 5.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.993 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.21 -19.53 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.357 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 5.5 m -75.3 134.75 40.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.021 0.91 . . . . 0.0 112.446 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.628 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.1 OUTLIER -78.3 173.7 7.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.611 171.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -25.46 95.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 124.021 3.147 . . . . 0.0 114.745 -173.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 305' ' ' THR . 21.8 p -110.67 166.87 10.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.336 -174.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.7 mpt_? -93.75 104.6 16.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.65 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 362' ' ' PRO . 5.7 mt -75.79 123.82 88.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 81.42 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.311 2.007 . . . . 0.0 111.686 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.628 HG11 HD11 ' A' ' 372' ' ' ILE . 14.5 m -100.58 133.62 43.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.416 0.627 . . . . 0.0 111.586 -177.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -143.24 -175.53 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.453 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -156.92 143.21 18.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.249 0.547 . . . . 0.0 111.459 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.4 m -115.17 172.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.5 115.67 31.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 2.6 p-80 37.86 64.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.665 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.44 6.34 33.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.419 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 38.9 t -115.69 113.66 42.45 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 117.616 0.708 . . . . 0.0 111.467 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.72 69.07 5.4 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.08 2.52 . . . . 0.0 111.364 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -95.19 -49.02 5.68 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.13 131.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.391 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 42.8 t30 -60.1 107.91 0.7 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.023 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.903 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.3 m -85.26 1.62 4.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 110.65 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.453 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.23 82.93 6.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.073 0.463 . . . . 0.0 110.479 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.04 92.24 5.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 28.5 mt -70.25 124.85 25.16 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.773 -165.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.686 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.0 mm -69.75 -21.53 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.702 -1.135 . . . . 0.0 107.994 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.8 m -137.33 94.82 11.97 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.7 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -86.01 41.22 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.396 2.731 . . . . 0.0 113.256 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.31 70.62 2.97 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.393 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.895 ' HB2' HD13 ' A' ' 340' ' ' ILE . 95.6 Cg_endo -82.19 133.6 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.492 2.128 . . . . 0.0 112.434 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.0 p -129.12 141.28 51.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.208 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.687 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 74.1 mtp -96.0 130.51 42.98 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.5 -168.72 1.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.271 0.982 . . . . 0.0 111.837 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.439 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -70.08 -5.62 28.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.435 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 366' ' ' ASN . 65.4 m-80 -113.52 9.12 17.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.4 0.619 . . . . 0.0 109.871 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.58 -165.75 16.77 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.246 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.687 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.53 -12.86 70.56 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.035 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.47 -119.25 10.03 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.6 m-85 -121.87 131.51 54.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.688 0.756 . . . . 0.0 111.606 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.834 ' HB ' ' HE2' ' A' ' 374' ' ' MET . 1.9 mt -106.17 157.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.788 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.2 mt-10 -126.87 129.15 47.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.867 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.834 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 0.4 OUTLIER -147.99 156.41 42.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.531 -172.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.561 HE21 ' H ' ' A' ' 376' ' ' LEU . 26.6 tp60 -177.65 146.73 0.46 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.645 0.259 . . . . 0.0 110.873 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.943 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.9 tp -145.26 154.46 53.77 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.943 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 41.5 Cg_exo -26.87 133.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 124.476 3.451 . . . . 0.0 115.134 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.679 ' HA ' HE22 ' A' ' 394' ' ' GLN . 54.6 Cg_exo -35.58 128.73 0.32 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 125.134 3.889 . . . . 0.0 115.114 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 167.68 -135.25 3.56 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.984 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.437 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 23.2 m-20 -119.72 101.03 7.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.156 0.478 . . . . 0.0 110.226 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.81 125.36 48.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.102 0.477 . . . . 0.0 109.893 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.079 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -124.15 129.13 74.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 16.9 mt -91.77 130.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.921 0.391 . . . . 0.0 110.66 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.615 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.8 m-85 -99.35 92.46 5.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.88 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.433 HG11 HG13 ' A' ' 342' ' ' VAL . 14.6 t -79.92 84.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.96 -86.62 0.13 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.479 -171.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.618 ' CB ' ' HD3' ' A' ' 309' ' ' LYS . 31.0 t0 -116.71 -19.77 9.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.324 0.583 . . . . 0.0 109.479 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.8 OUTLIER -59.34 142.83 51.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.164 174.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.3 p30 -152.32 138.78 18.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.804 0.335 . . . . 0.0 110.755 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -165.17 126.39 2.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.12 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.079 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.0 tt0 -79.04 152.01 31.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.448 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 19.9 t-105 -147.61 120.69 8.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.887 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -73.98 114.26 12.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.679 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.27 144.06 42.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.699 -177.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.246 0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.414 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 335' ' ' THR . 4.8 t . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.79 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 16.4 p90 -61.56 123.47 17.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.141 0.496 . . . . 0.0 110.958 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 11.6 t -171.93 -167.61 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.21 115.37 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.09 156.09 38.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.874 0.845 . . . . 0.0 111.665 -172.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 311' ' ' LYS . 12.8 t70 -90.77 147.19 23.38 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.749 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.75 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.49 -13.56 14.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.063 -175.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 4.8 t -101.0 5.44 43.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 111.14 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.787 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 29.5 mttt -105.33 13.04 31.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.75 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -128.19 143.83 51.07 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 168.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -128.82 154.18 46.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.62 113.98 3.02 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.82 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.908 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 63.3 tttt -112.29 -53.91 2.67 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -140.71 117.89 11.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -63.22 161.37 32.76 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.09 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 2.1 Cg_endo -44.69 119.59 2.36 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.643 2.229 . . . . 0.0 111.949 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.606 ' O ' HG21 ' A' ' 327' ' ' VAL . 21.7 m -131.0 139.13 49.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.367 -174.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.58 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 111.445 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 96.5 p -67.27 -21.8 65.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.487 -174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.36 -18.73 30.07 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.482 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -105.72 -54.23 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.058 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.59 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.739 0.781 . . . . 0.0 110.687 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.851 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 32.8 p -103.76 -168.19 1.47 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.689 -174.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.894 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.1 t -125.5 151.53 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.699 HG12 ' HG3' ' A' ' 373' ' ' GLU . 18.4 m -136.32 144.89 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 123.31 0.644 . . . . 0.0 110.004 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.471 ' CE ' HG11 ' A' ' 330' ' ' VAL . 6.5 ptm -131.66 169.55 16.01 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.359 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.908 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 4.6 tt0 -136.39 133.04 36.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.144 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.471 HG11 ' CE ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -131.42 154.53 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.203 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.36 138.79 14.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.902 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.787 ' HA ' ' O ' ' A' ' 311' ' ' LYS . 1.2 p90 -99.69 177.47 5.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.731 0.765 . . . . 0.0 110.815 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t -164.69 45.71 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.044 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.487 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -176.85 -63.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.905 172.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.497 ' CG2' ' HB3' ' A' ' 338' ' ' CYS . 27.6 m -86.98 129.1 35.03 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.79 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 6.1 ptm180 -64.78 169.1 5.75 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.166 171.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.72 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.53 94.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.056 3.17 . . . . 0.0 114.383 -168.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 4.7 p -111.79 151.81 28.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.844 -173.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.3 mpt_? -73.39 108.39 6.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.525 HG12 HG12 ' A' ' 342' ' ' VAL . 14.4 tt -85.19 126.98 65.95 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.64 -175.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.62 82.17 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.557 2.171 . . . . 0.0 112.092 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.631 HG11 HD11 ' A' ' 372' ' ' ILE . 16.5 m -103.21 122.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 111.271 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 17.8 ptt-85 -129.85 -173.98 3.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.559 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -155.59 139.49 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.399 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 382' ' ' ILE . 10.4 m -113.04 171.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.43 28.51 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.495 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 34.4 t-80 51.24 55.41 9.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.004 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.618 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 63.7 8.6 28.06 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.634 0.614 . . . . 0.0 114.634 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.46 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 52.4 t -110.2 111.53 57.91 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 117.821 0.81 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.3 Cg_exo -77.89 46.29 2.02 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.475 2.783 . . . . 0.0 112.912 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -92.21 -53.46 4.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.487 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.03 111.4 35.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.203 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 40.2 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.773 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.706 ' HA ' HD23 ' A' ' 376' ' ' LEU . 35.6 m -90.17 6.5 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.675 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.559 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -78.61 83.33 4.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.384 0.612 . . . . 0.0 110.35 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.677 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.8 ttp -102.8 87.9 3.07 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.9 mt -72.3 122.82 21.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.093 -165.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -67.96 -22.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 52.9 m -128.97 85.98 58.63 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.154 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.21 40.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.948 2.432 . . . . 0.0 113.925 -170.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -170.56 69.77 0.55 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.13 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.502 ' O ' HG22 ' A' ' 340' ' ' ILE . 70.0 Cg_endo -85.09 137.87 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.299 1.999 . . . . 0.0 112.84 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.4 p -119.54 145.93 45.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.654 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 74.4 mtp -95.82 107.55 19.81 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.855 0.36 . . . . 0.0 110.193 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 46.1 mt-10 -88.02 -167.32 1.84 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.079 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.633 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -63.73 -14.33 51.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 366' ' ' ASN . 84.5 m-20 -101.29 12.97 36.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.5 0.667 . . . . 0.0 109.885 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.56 -162.27 27.87 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -67.45 -16.48 67.42 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.41 -124.45 18.94 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 328' ' ' MET . 2.7 p90 -116.83 135.53 53.67 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 2.7 mt -122.14 134.6 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.759 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.734 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.6 mp0 -103.05 133.01 48.89 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.191 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.579 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.8 ppp? -148.72 160.04 43.55 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.894 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -176.84 166.75 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.7 172.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.855 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.4 tp -164.9 151.34 9.22 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.855 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.3 Cg_exo -36.08 143.25 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.24 2.627 . . . . 0.0 113.595 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.673 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.7 Cg_exo -37.04 135.69 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.768 1 C-N-CA 125.52 4.147 . . . . 0.0 115.032 -170.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.47 -151.27 21.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.391 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.3 m-20 -109.93 101.24 10.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.212 0.506 . . . . 0.0 110.435 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.563 ' HB3' ' HE1' ' A' ' 374' ' ' MET . 8.6 m120 -101.36 122.96 44.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.965 0.412 . . . . 0.0 109.945 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.069 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.4 130.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.579 HD12 ' HG2' ' A' ' 374' ' ' MET . 37.9 mt -89.01 126.93 42.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.075 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.494 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.02 92.49 4.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.814 174.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.605 HG11 HG13 ' A' ' 342' ' ' VAL . 23.0 t -83.47 90.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.45 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.084 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -106.87 -22.7 12.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.161 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.542 HD23 ' HE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -66.14 141.11 58.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.617 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -135.66 142.42 45.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.542 ' HE1' HD23 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -163.05 102.76 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.069 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 16.9 tt0 -76.75 149.25 36.34 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -144.94 142.39 29.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.429 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -99.16 111.06 23.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.673 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -96.79 129.16 44.26 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.651 -175.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.582 ' HD3' ' HB3' ' A' ' 378' ' ' PRO . 47.5 tttm . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.938 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.448 HG21 HG23 ' A' ' 335' ' ' THR . 5.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.087 0.47 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.435 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 11.5 p90 -62.57 118.57 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t -179.57 -170.31 0.16 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.76 106.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.7 146.94 52.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.531 0.681 . . . . 0.0 112.452 -168.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.496 ' OD1' HG21 ' A' ' 310' ' ' THR . 13.1 t70 -62.34 137.87 58.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.368 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.644 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.74 -23.21 67.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.256 -170.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.496 HG21 ' OD1' ' A' ' 308' ' ' ASP . 2.7 t -94.75 -4.91 46.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 111.363 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 24.4 mtpp -88.57 49.4 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 0.0 111.366 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.476 ' HZ ' HD12 ' A' ' 340' ' ' ILE . 1.8 m-85 -139.46 169.13 18.32 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.253 -177.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -157.93 138.46 12.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.536 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.95 107.78 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.576 0.703 . . . . 0.0 111.527 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 315' ' ' LYS . 46.7 tptt -83.98 -36.81 22.93 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.438 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 9.2 ttm180 -160.04 109.18 1.76 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.833 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.43 156.41 52.38 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.185 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 392' ' ' TRP . 6.5 Cg_exo -32.72 118.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.931 3.087 . . . . 0.0 113.605 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.586 ' O ' HG21 ' A' ' 327' ' ' VAL . 15.2 m -143.52 144.38 31.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.887 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -44.44 136.55 4.11 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 111.478 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.586 ' HB3' HG11 ' A' ' 327' ' ' VAL . 67.2 p -69.43 -23.52 63.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.968 -173.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.92 -1.42 88.8 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -171.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -107.27 -54.76 2.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.12 -32.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.002 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.498 ' CB ' HG13 ' A' ' 358' ' ' ILE . 1.1 p -95.81 -166.88 1.51 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.845 -175.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.521 HG12 ' NE1' ' A' ' 392' ' ' TRP . 0.9 OUTLIER -109.48 155.99 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.876 176.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.801 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -139.42 174.25 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.115 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.729 ' HE2' HG21 ' A' ' 385' ' ' VAL . 21.5 ptt? -151.71 158.87 43.97 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 25.8 tt0 -120.27 125.82 49.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 312' ' ' PHE . 13.5 m -130.02 137.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.061 0.457 . . . . 0.0 112.03 -173.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.25 13.91 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.548 ' HD1' ' H ' ' A' ' 335' ' ' THR . 0.2 OUTLIER -118.23 179.99 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.451 0.626 . . . . 0.0 111.47 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.9 p -130.47 11.19 5.31 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.86 31.3 0.13 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 119.477 -1.344 . . . . 0.0 115.479 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.834 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 31.0 m -112.67 122.56 48.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.514 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 20.6 ptt180 -76.95 167.02 40.26 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.052 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.13 98.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 124.225 3.283 . . . . 0.0 114.855 -165.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.856 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 13.2 p -109.64 173.13 6.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.552 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -95.45 102.91 14.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.788 HG23 HG12 ' A' ' 342' ' ' VAL . 48.8 mt -75.89 124.88 88.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.747 0.308 . . . . 0.0 111.575 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.33 82.01 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.884 2.389 . . . . 0.0 111.972 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.788 HG12 HG23 ' A' ' 340' ' ' ILE . 6.1 m -103.23 129.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.572 0.701 . . . . 0.0 111.325 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -142.49 -174.57 4.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.581 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -153.04 138.78 17.91 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.898 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.34 175.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -109.03 114.08 27.52 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.554 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 50.68 47.98 23.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.598 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 67.34 16.7 67.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.484 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.86 109.85 46.98 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 110.861 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 61.76 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.48 2.786 . . . . 0.0 112.274 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -97.48 -47.2 5.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.842 0.829 . . . . 0.0 109.011 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -137.21 124.05 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.563 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.6 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.908 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.905 ' HA ' HD23 ' A' ' 376' ' ' LEU . 31.1 m -89.5 5.77 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.0 110.753 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.581 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.63 84.26 6.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.455 ' HB2' HD12 ' A' ' 376' ' ' LEU . 0.0 OUTLIER -97.5 87.02 3.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 170.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 38.1 mt -68.82 126.53 30.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.582 -167.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.657 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.1 mm -71.22 -20.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 48.6 m -136.45 87.48 21.78 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.933 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -88.4 50.95 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.332 2.688 . . . . 0.0 113.272 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.515 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.0 p-10 -160.49 58.9 1.12 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 1.2 Cg_endo -82.09 139.28 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.582 2.188 . . . . 0.0 112.592 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 338' ' ' CYS . 14.6 p -134.39 142.39 47.16 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.363 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.856 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 17.0 ptp -94.64 130.41 41.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.72 -165.32 1.19 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 124.925 1.391 . . . . 0.0 109.031 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.638 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -55.61 -20.57 14.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.638 ' N ' HD21 ' A' ' 366' ' ' ASN . 12.4 m-20 -108.55 13.12 25.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 0.0 110.696 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.21 -161.18 31.32 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.49 -25.35 74.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.84 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.08 -123.94 7.13 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.92 138.31 47.47 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.656 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 0.8 OUTLIER -129.94 166.14 28.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.801 ' HG2' HG12 ' A' ' 327' ' ' VAL . 46.0 mt-10 -129.49 138.23 51.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.739 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.656 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -152.67 151.82 31.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.073 -174.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.964 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.58 165.91 2.64 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.161 0.288 . . . . 0.0 110.864 173.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.972 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 12.2 tp -164.8 163.94 13.71 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.972 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 63.0 Cg_exo -29.11 131.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.826 3.017 . . . . 0.0 114.343 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.661 ' HB3' ' HD2' ' A' ' 395' ' ' LYS . 6.0 Cg_exo -38.28 139.36 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.825 1 C-N-CA 125.633 4.222 . . . . 0.0 114.938 -175.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.09 -153.08 24.53 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -103.35 109.91 21.71 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.264 0.225 . . . . 0.0 110.691 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -112.22 172.69 6.76 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.202 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.012 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -165.16 133.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.9 mt -93.8 133.02 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.385 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -107.64 96.97 6.77 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.322 175.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.729 HG21 ' HE2' ' A' ' 328' ' ' MET . 2.8 t -84.92 67.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.86 -84.05 0.58 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.489 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.644 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 15.1 t70 -100.44 -34.99 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.1 mp -61.03 143.34 55.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.8 p30 -159.67 138.47 10.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 126.52 1.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.154 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.012 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 23.7 mt-30 -70.13 153.23 43.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.521 ' NE1' HG12 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -153.94 150.53 28.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.474 171.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.47 136.0 40.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.534 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -132.31 147.37 52.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.772 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.661 ' HD2' ' HB3' ' A' ' 378' ' ' PRO . 23.5 tptm . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.683 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.595 ' HD2' ' HD3' ' A' ' 336' ' ' ARG . 21.5 p90 -53.57 125.83 19.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 111.298 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.7 t -175.9 -175.9 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.172 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.41 105.57 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.535 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.5 OUTLIER -72.35 153.35 41.52 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.501 ' OD1' HG21 ' A' ' 310' ' ' THR . 16.6 t70 -72.3 154.67 40.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.468 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.657 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -70.97 -12.52 61.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.453 -172.279 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.501 HG21 ' OD1' ' A' ' 308' ' ' ASP . 11.5 t -100.05 7.03 44.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.911 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.658 ' HE3' ' CB ' ' A' ' 335' ' ' THR . 3.9 mtpm? -85.31 -27.45 25.94 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.915 -0.491 . . . . 0.0 112.303 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.746 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.7 OUTLIER -102.62 160.12 14.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.646 0.736 . . . . 0.0 111.936 -175.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.0 t -140.37 155.42 46.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.789 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.459 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.5 m-90 -65.33 96.48 0.23 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.254 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.709 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.0 tttt -86.46 -46.76 9.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.738 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 37.0 ttm180 -147.34 98.93 3.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.663 171.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.512 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -55.04 159.17 4.09 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.947 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 7.1 Cg_exo -34.25 115.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.581 2.854 . . . . 0.0 113.596 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.5 m -129.49 134.06 47.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.806 -173.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -47.8 125.1 8.19 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.4 p -67.83 -35.27 78.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.577 -172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.72 -11.88 18.26 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.724 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -98.51 -71.48 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -171.61 18.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 358' ' ' ILE . 18.1 p -131.74 -167.91 1.94 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.397 -171.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.863 HG22 ' HZ2' ' A' ' 392' ' ' TRP . 1.9 t -130.04 149.78 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.272 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.982 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -135.83 140.96 43.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.394 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 11.1 ptm -130.03 150.84 51.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.958 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.738 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.9 tt0 -116.14 122.56 45.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.754 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 14.5 m -126.28 139.85 50.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.661 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.16 141.49 15.28 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.918 -176.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -90.61 178.68 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.22 0.51 . . . . 0.0 110.561 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.5 t -122.8 -62.78 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.78 -59.66 0.19 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.771 -176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.658 ' CB ' ' HE3' ' A' ' 311' ' ' LYS . 52.1 m -56.72 134.26 54.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.813 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.9 ptm180 -66.8 179.67 0.5 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.755 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.813 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.16 96.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 124.01 3.14 . . . . 0.0 114.573 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 305' ' ' THR . 31.4 p -113.93 160.08 19.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.428 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.02 104.25 9.53 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 362' ' ' PRO . 16.8 tt -87.72 127.47 58.06 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.326 0.584 . . . . 0.0 111.342 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.57 92.44 0.86 Allowed 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.857 2.371 . . . . 0.0 112.504 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.717 HG13 HG11 ' A' ' 385' ' ' VAL . 31.4 m -110.13 135.5 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.897 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 23.7 ptt180 -149.8 -174.2 4.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -156.72 143.21 18.35 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.412 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.48 169.49 10.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.51 114.4 27.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.443 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 27.1 p-80 35.29 61.76 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.684 0.794 . . . . 0.0 112.851 -175.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 76.06 0.09 64.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.402 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.23 114.32 55.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.516 0.658 . . . . 0.0 111.616 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -78.72 58.49 6.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.62 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.602 ' HG2' HG11 ' A' ' 352' ' ' VAL . 9.4 tt0 -83.22 -37.0 24.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.061 0.934 . . . . 0.0 108.823 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.602 HG11 ' HG2' ' A' ' 351' ' ' GLU . 2.1 p -161.06 122.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.49 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -51.82 107.82 0.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.268 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.55 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.7 m -90.4 6.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.688 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.513 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.91 83.39 3.46 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.342 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 16.7 mmt -95.15 85.22 4.25 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.0 mt -68.2 126.23 28.9 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.398 -167.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.676 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -71.61 -17.59 19.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.2 m -139.56 91.89 10.56 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.897 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.16 35.33 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.254 2.636 . . . . 0.0 113.511 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -149.52 64.12 6.97 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.102 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.503 ' O ' HG23 ' A' ' 340' ' ' ILE . 69.8 Cg_endo -88.13 128.09 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.583 2.189 . . . . 0.0 113.443 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 12.1 p -122.98 149.45 44.27 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.535 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.7 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 72.4 mtm -95.94 106.32 18.46 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.268 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.625 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 55.4 mm-40 -80.9 -167.64 1.48 Allowed 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.956 1.41 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -65.63 -7.19 13.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 366' ' ' ASN . 9.0 p30 -110.48 -4.84 15.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.444 0.64 . . . . 0.0 109.513 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.18 -166.75 12.71 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.97 -9.6 60.13 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.118 -175.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.78 -114.38 6.38 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.93 117.81 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.185 0.517 . . . . 0.0 111.288 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.821 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 1.6 mt -93.11 143.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.982 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -121.59 132.0 54.43 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.084 -174.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.821 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.9 OUTLIER -153.63 157.29 39.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.59 -171.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.949 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -174.6 168.67 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.224 172.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.836 HD23 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -164.64 143.92 5.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.836 ' HD2' HD23 ' A' ' 376' ' ' LEU . 23.3 Cg_exo -28.82 124.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.805 3.003 . . . . 0.0 114.281 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.635 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.4 Cg_exo -37.39 131.82 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.158 1 C-N-CA 125.475 4.116 . . . . 0.0 114.805 -171.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.68 -161.09 33.45 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.791 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -99.37 101.33 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.925 0.362 . . . . 0.0 111.025 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.481 ' OD1' HG13 ' A' ' 354' ' ' VAL . 31.6 m-80 -121.04 -179.64 4.09 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.075 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.014 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.62 141.88 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.543 HD13 ' HE3' ' A' ' 374' ' ' MET . 11.8 mt -96.22 133.55 37.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.626 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -111.9 92.17 3.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.353 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.717 HG11 HG13 ' A' ' 342' ' ' VAL . 11.9 t -86.42 90.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.41 -91.87 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.063 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -116.31 -4.7 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.577 HD12 ' HD1' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -78.06 142.38 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 23.9 p-10 -153.81 141.49 19.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.773 0.32 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.507 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.1 t-80 -162.08 116.25 1.86 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.771 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.014 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -78.26 143.19 37.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.544 177.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.863 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.8 OUTLIER -154.32 148.01 25.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -85.42 123.46 30.9 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.635 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -105.73 144.86 31.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.017 0.437 . . . . 0.0 110.806 -176.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.219 -175.454 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.68 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 23.5 p90 -68.52 112.29 5.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.933 0.873 . . . . 0.0 110.6 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 15.3 t -159.21 -165.97 1.71 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.451 -172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.0 113.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 143.89 55.15 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.8 0.81 . . . . 0.0 111.06 -174.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 8.9 t70 -75.44 147.35 39.98 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.325 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.75 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.58 -12.82 11.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.964 -173.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.452 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.2 t -103.66 9.35 37.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.674 0.273 . . . . 0.0 111.399 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 9.5 mtpp -96.39 -23.98 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.75 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -101.31 158.5 16.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 111.227 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 154.77 46.54 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.11 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.514 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 22.6 m-90 -60.36 96.34 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.7 tttm -80.52 -37.94 30.64 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.863 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 67.3 ttt180 -157.81 111.37 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.752 174.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -59.4 155.79 34.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.979 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.772 ' HG3' HD11 ' A' ' 383' ' ' ILE . 30.7 Cg_exo -34.27 115.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 123.294 2.663 . . . . 0.0 113.68 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.548 ' O ' HG21 ' A' ' 327' ' ' VAL . 7.2 m -141.75 138.35 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.707 -171.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.66 131.74 8.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.061 0.458 . . . . 0.0 112.074 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.59 ' HB3' HG11 ' A' ' 327' ' ' VAL . 86.5 p -73.9 -25.28 59.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -176.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.58 -5.35 73.71 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.362 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -119.44 39.22 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 69.97 4.84 4.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.512 0.725 . . . . 0.0 111.977 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 2.7 p -121.54 -170.26 2.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.788 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.4 OUTLIER -127.95 153.63 37.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.985 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.957 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -135.53 157.41 39.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.437 ' HE2' HG11 ' A' ' 330' ' ' VAL . 8.2 ptm -138.19 158.4 44.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 168.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.863 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.1 mt-10 -122.24 135.49 54.76 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.616 HG21 ' HA3' ' A' ' 369' ' ' GLY . 0.2 OUTLIER -132.34 152.27 36.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 177.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.89 149.68 18.15 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.922 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.415 ' H ' ' HD1' ' A' ' 332' ' ' PHE . 1.4 p90 -94.08 178.94 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.291 0.567 . . . . 0.0 110.853 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.4 p -131.68 -17.62 2.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.102 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -170.03 -51.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.306 -1.426 . . . . 0.0 114.119 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 336' ' ' ARG . 24.6 m -57.17 129.66 42.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.68 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 11.7 ptm180 -69.79 167.32 24.52 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 117.982 -1.008 . . . . 0.0 108.514 171.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.79 96.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 123.894 3.062 . . . . 0.0 115.235 -167.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 5.9 p -108.8 147.24 32.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.131 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.39 108.24 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.503 HD13 HG13 ' A' ' 385' ' ' VAL . 12.5 tt -89.49 123.82 65.82 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.559 -176.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.69 92.22 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.902 2.401 . . . . 0.0 112.669 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.665 HG11 HD11 ' A' ' 372' ' ' ILE . 30.1 m -108.78 125.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.676 0.751 . . . . 0.0 111.451 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -134.19 -177.42 4.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -148.86 135.07 19.28 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.972 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 382' ' ' ILE . 11.4 m -107.88 173.23 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -112.69 115.12 28.06 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.616 -174.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 33.4 t60 57.93 45.82 17.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.381 0.61 . . . . 0.0 110.227 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 68.02 6.57 46.19 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.001 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.16 111.42 60.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 117.361 0.58 . . . . 0.0 111.158 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -76.55 47.85 2.22 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.602 2.868 . . . . 0.0 113.032 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.35 -53.36 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.28 113.73 44.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.031 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 28.3 t30 -70.23 108.71 4.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.749 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.674 HG12 HD21 ' A' ' 376' ' ' LEU . 33.3 m -90.94 10.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.127 -175.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.487 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.23 84.37 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.116 0.484 . . . . 0.0 111.436 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.718 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 71.2 mtp -98.85 88.97 4.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 47.5 mt -76.66 120.76 22.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.157 -167.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -68.75 -16.9 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 91.5 m -135.19 87.73 27.75 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.906 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.57 40.36 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.127 2.551 . . . . 0.0 114.307 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.09 68.57 1.83 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.172 0.511 . . . . 0.0 111.389 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.475 ' HG3' HG22 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -85.48 135.59 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.444 2.096 . . . . 0.0 113.081 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.0 OUTLIER -129.72 146.85 51.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.679 174.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 29.0 mtm -94.61 104.98 16.92 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.315 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.6 -166.36 1.37 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.284 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.563 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -67.14 -10.59 51.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.147 0.499 . . . . 0.0 110.629 171.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.563 ' N ' HD21 ' A' ' 366' ' ' ASN . 47.0 m-20 -86.89 -7.03 58.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.412 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 90.27 -161.04 28.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -166.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.616 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -62.94 -19.77 61.55 Favored Glycine 0 C--N 1.322 -0.223 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.778 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 73.8 -124.68 8.71 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -112.06 127.0 55.77 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.665 HD11 HG11 ' A' ' 342' ' ' VAL . 1.0 OUTLIER -114.91 125.55 72.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.957 ' HG2' HG12 ' A' ' 327' ' ' VAL . 36.2 mt-10 -101.79 134.18 45.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.97 ' HE2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -153.19 160.51 42.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.934 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 178.87 170.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.367 0.417 . . . . 0.0 110.725 177.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.871 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 7.8 tp -161.88 157.35 20.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.871 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 53.4 Cg_exo -39.25 131.74 1.46 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.342 2.028 . . . . 0.0 112.304 169.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.866 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.3 Cg_exo -38.05 129.49 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 125.297 3.998 . . . . 0.0 114.946 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 174.41 -133.57 2.55 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.589 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.67 101.59 7.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.289 0.236 . . . . 0.0 110.561 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -112.35 161.89 16.15 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.01 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.095 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.02 138.71 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.97 HD12 ' HE2' ' A' ' 374' ' ' MET . 27.8 mt -94.65 132.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.376 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -109.03 91.71 3.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.2 t -83.88 84.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.34 -88.54 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.055 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.42 -14.17 13.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.226 0.536 . . . . 0.0 109.723 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.0 OUTLIER -68.33 147.19 52.48 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.602 175.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 24.9 p-10 -156.76 140.31 15.87 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.669 0.271 . . . . 0.0 110.66 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.589 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.3 t60 -165.88 115.2 0.99 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.546 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.095 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 44.5 tt0 -85.05 146.54 27.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.048 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.466 ' NE1' ' HB3' ' A' ' 394' ' ' GLN . 0.7 OUTLIER -147.97 150.03 33.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.35 132.78 36.46 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.952 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.466 ' HB3' ' NE1' ' A' ' 392' ' ' TRP . 0.0 OUTLIER -126.73 142.7 51.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 -177.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 12.3 ptmm? . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.656 -0.688 . . . . 0.0 110.773 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.889 0.376 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.808 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.1 p90 -64.43 130.44 43.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.499 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.7 t 178.73 -166.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.83 114.65 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 143.0 56.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.702 0.763 . . . . 0.0 110.757 -173.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.565 ' OD1' ' HG2' ' A' ' 309' ' ' LYS . 5.8 t70 -86.48 150.57 24.18 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.693 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.672 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 23.4 pttm -52.03 -23.2 4.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.521 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 9.0 t -100.92 10.42 41.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.55 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.481 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 26.7 mmmt -92.5 -25.09 18.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.688 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.4 OUTLIER -112.44 157.9 20.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.323 0.582 . . . . 0.0 112.153 -176.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -133.92 158.18 44.11 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.717 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.447 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.7 m-90 -62.28 111.81 2.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.373 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -104.12 -40.3 6.21 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.212 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.771 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 32.5 ttm180 -158.74 129.94 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.419 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.43 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -74.28 163.11 70.58 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.234 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 3.0 Cg_exo -37.03 120.41 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.427 ' O ' HG21 ' A' ' 327' ' ' VAL . 23.3 m -136.24 134.8 38.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.526 -173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -48.14 124.12 7.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.107 0.48 . . . . 0.0 110.946 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.1 p -65.17 -22.88 66.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.189 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.65 34.12 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -99.61 -71.89 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -175.06 21.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.912 0.863 . . . . 0.0 108.952 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.7 p -137.69 -169.18 2.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.418 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.602 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -127.54 151.37 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.234 0.54 . . . . 0.0 111.633 -177.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.4 m -136.6 142.42 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.608 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 9.8 ptm -128.18 164.33 22.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.015 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.771 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.5 tt0 -126.46 126.07 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.048 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.42 153.07 32.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.397 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -126.28 144.0 14.78 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.431 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -91.07 179.18 5.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.252 0.549 . . . . 0.0 111.286 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.4 p -143.24 -7.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.868 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 179.14 -3.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 118.648 -1.739 . . . . 0.0 116.068 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.481 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 26.5 m -107.62 124.65 50.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.258 1.029 . . . . 0.0 110.57 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.808 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 9.3 ptm180 -70.73 168.79 17.49 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.399 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.774 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.3 OUTLIER -25.36 94.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 124.259 3.306 . . . . 0.0 114.712 -169.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 363' ' ' THR . 7.0 p -112.77 152.16 29.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.936 -174.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -74.48 106.27 6.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 362' ' ' PRO . 14.1 tt -81.89 129.24 65.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.444 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.37 81.58 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.781 HG13 HD11 ' A' ' 372' ' ' ILE . 15.6 m -102.28 119.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.691 0.758 . . . . 0.0 111.216 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -132.46 -178.68 5.03 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.557 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.36 139.14 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.891 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 11.0 m -111.22 168.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.55 114.52 28.73 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.119 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 50.7 t60 52.9 54.87 9.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.801 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.626 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 62.79 15.84 55.44 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.988 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 46.2 t -118.37 109.64 40.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 117.438 0.619 . . . . 0.0 111.222 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.15 50.27 2.18 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.229 2.619 . . . . 0.0 112.658 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.78 -53.87 3.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.71 115.3 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.298 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -63.26 108.78 1.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.9 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 376' ' ' LEU . 34.6 m -93.93 7.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.034 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.557 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.41 83.27 6.26 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.427 0.632 . . . . 0.0 110.652 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.72 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 46.1 ttp -99.35 90.97 4.73 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.5 mt -71.66 125.1 26.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.532 -167.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 5.1 mm -68.46 -24.06 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.7 m -132.25 91.75 30.71 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.995 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.61 44.16 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.226 2.617 . . . . 0.0 114.057 -169.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.0 67.86 0.8 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.228 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.468 ' HB3' HG21 ' A' ' 372' ' ' ILE . 73.1 Cg_endo -82.74 133.63 7.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.229 1.952 . . . . 0.0 113.032 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -120.82 144.21 48.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.168 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.724 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 39.3 mtm -95.59 119.92 34.93 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.73 -167.01 1.53 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 124.41 1.069 . . . . 0.0 110.906 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.57 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -66.27 -11.72 52.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.892 176.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 366' ' ' ASN . 82.6 m-20 -99.23 0.23 42.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 109.506 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.24 -162.38 19.95 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -73.73 -16.71 79.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.276 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 67.15 -120.27 13.31 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.4 p90 -120.29 141.2 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.48 0.657 . . . . 0.0 110.902 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.8 ' HB ' ' HE2' ' A' ' 374' ' ' MET . 4.0 mt -115.3 154.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.839 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 41.9 mt-10 -120.36 128.43 53.23 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.819 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.8 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -147.56 162.62 38.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.633 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.767 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 175.74 158.92 0.25 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.004 0.366 . . . . 0.0 110.983 172.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.797 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.0 tp -154.4 149.67 20.74 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 166.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.797 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 33.5 Cg_exo -27.06 125.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.918 3.078 . . . . 0.0 113.522 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -37.53 133.04 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.66 3.573 . . . . 0.0 114.493 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.72 -128.66 1.66 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.268 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.91 100.87 7.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 110.848 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -112.56 125.25 54.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 0.0 109.684 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.077 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.05 131.76 72.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.8 mt -92.32 128.92 43.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.189 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 91.95 3.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.007 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.4 t -83.56 78.28 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.41 -82.63 0.08 OUTLIER Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.423 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 22.3 t70 -106.35 -28.95 10.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.7 mp -63.67 149.43 46.6 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.525 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.7 p30 -163.12 143.12 8.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.245 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -164.95 118.44 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.077 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.2 tm0? -81.54 140.48 34.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.57 -178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.586 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 3.5 t-105 -149.54 147.47 28.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.736 172.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -95.04 119.16 33.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.602 HE22 HG13 ' A' ' 326' ' ' VAL . 4.3 mm100 -85.12 114.44 22.25 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.329 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.271 0.558 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.408 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 42.6 p90 -62.43 121.52 13.46 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.339 0.59 . . . . 0.0 110.128 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.1 t -176.37 -172.11 0.45 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.56 105.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.35 155.08 41.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.621 -168.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.32 141.12 47.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.94 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.719 ' HD2' ' HB2' ' A' ' 387' ' ' ASP . 24.3 pttt -50.95 -27.54 7.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.502 -1.681 . . . . 0.0 114.406 -172.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 6.9 t -105.21 7.25 33.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.424 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 27.2 mtpp -84.42 -22.65 30.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.443 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -82.63 157.0 23.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.992 0.425 . . . . 0.0 109.894 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -123.29 134.38 54.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.995 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.554 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 31.5 m-90 -50.99 96.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.595 168.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -96.39 -30.2 13.52 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.405 ' HD2' ' OE1' ' A' ' 329' ' ' GLU . 14.8 ttt180 -164.43 113.64 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.107 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.539 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -64.09 164.48 17.72 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 4.2 Cg_exo -39.41 118.35 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.634 2.222 . . . . 0.0 111.86 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.494 ' O ' HG21 ' A' ' 327' ' ' VAL . 22.5 m -130.8 135.14 47.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.21 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.53 127.0 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.9 p -69.2 -16.13 63.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.16 72.87 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 69.5 t60 -108.14 -52.98 2.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.307 -178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 29.6 t70 166.18 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.467 1.127 . . . . 0.0 108.111 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.9 p -93.92 -170.94 2.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.661 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.95 151.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.689 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.0 m -136.04 144.48 33.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.249 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.709 ' SD ' HG11 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -127.58 150.62 49.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 2.6 tt0 -122.13 124.95 45.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.992 0.425 . . . . 0.0 110.514 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.709 HG11 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -122.45 150.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.363 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.568 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.52 160.43 15.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 172.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -106.52 178.16 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.078 0.939 . . . . 0.0 110.38 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -133.46 -13.15 2.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.16 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.95 -26.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.201 -1.476 . . . . 0.0 114.695 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.718 ' HB ' ' HE1' ' A' ' 364' ' ' MET . 19.8 m -82.7 135.81 34.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.632 0.716 . . . . 0.0 111.566 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 335' ' ' THR . 9.1 ptt180 -78.71 177.73 2.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -27.38 97.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.775 2.983 . . . . 0.0 114.807 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.837 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 18.1 p -110.24 166.74 10.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.719 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.77 99.3 12.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.579 HG21 HG12 ' A' ' 342' ' ' VAL . 46.1 mt -74.67 120.82 83.41 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.229 -172.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.33 80.27 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.227 1.952 . . . . 0.0 111.661 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 372' ' ' ILE . 9.5 m -99.57 133.26 43.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.088 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.99 -178.07 5.52 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.56 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -155.24 135.29 12.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.77 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.8 m -111.13 163.24 8.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.515 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -102.75 114.53 28.86 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.493 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 10.9 t-80 53.9 52.16 13.46 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.486 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 65.8 5.7 26.36 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.888 -0.596 . . . . 0.0 114.188 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 110.6 61.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.391 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.65 54.58 4.84 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.079 2.519 . . . . 0.0 112.091 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.3 -47.72 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.49 0.662 . . . . 0.0 109.55 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.24 119.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.35 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -62.58 109.44 1.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.129 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.653 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 14.1 m -91.58 12.85 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.56 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -84.69 81.82 8.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.71 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 13.1 tpt -101.15 86.33 3.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 170.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 36.9 mt -70.82 126.26 29.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.615 -167.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -71.67 -17.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 15.6 m -140.08 91.46 10.12 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.505 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.44 41.35 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.091 2.527 . . . . 0.0 112.946 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -155.68 61.01 2.67 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' A' ' 342' ' ' VAL . 93.9 Cg_endo -81.34 135.31 9.41 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.271 1.981 . . . . 0.0 112.935 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 25.2 p -131.3 133.65 45.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.717 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.837 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 25.7 ptt? -95.68 131.33 42.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.624 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 29.7 mt-10 -114.52 -165.1 0.98 Allowed 'General case' 0 C--N 1.321 -0.666 0 O-C-N 124.874 1.359 . . . . 0.0 110.318 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.55 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -62.01 -7.82 4.42 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.009 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 366' ' ' ASN . 6.8 p30 -105.81 -3.99 21.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.577 0.703 . . . . 0.0 109.547 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 -166.22 17.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.803 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.15 -9.68 64.12 Favored Glycine 0 CA--C 1.51 -0.266 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.246 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.3 -126.35 30.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 111.361 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 342' ' ' VAL . 2.8 mt -111.71 131.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.062 173.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.689 ' HG2' HG12 ' A' ' 327' ' ' VAL . 45.5 mt-10 -104.16 132.08 50.78 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.135 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.63 ' HE1' ' HB3' ' A' ' 381' ' ' ASN . 4.8 ppp? -148.52 161.99 40.53 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.86 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.35 159.03 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.69 0.281 . . . . 0.0 110.953 173.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.653 ' HG ' ' HA ' ' A' ' 354' ' ' VAL . 0.5 OUTLIER -164.98 143.92 5.52 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.642 ' HD2' HD12 ' A' ' 376' ' ' LEU . 22.2 Cg_exo -24.02 129.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.638 3.559 . . . . 0.0 114.689 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.514 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.6 Cg_exo -36.97 128.61 0.52 Allowed 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 125.583 4.189 . . . . 0.0 114.942 -171.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.09 -152.63 21.95 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.7 m-20 -98.45 101.23 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.974 0.887 . . . . 0.0 110.677 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.63 ' HB3' ' HE1' ' A' ' 374' ' ' MET . 8.2 m120 -96.75 123.81 40.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.946 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -118.54 129.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 374' ' ' MET . 30.5 mt -92.71 133.62 33.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.46 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -107.16 91.82 3.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.358 176.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.5 t -79.36 77.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.82 -83.6 0.48 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.719 ' HB2' ' HD2' ' A' ' 309' ' ' LYS . 20.3 t70 -116.26 -19.96 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.343 0.592 . . . . 0.0 109.55 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.557 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.5 OUTLIER -60.28 145.35 47.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.229 173.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.5 p30 -155.41 143.79 20.27 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.591 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.445 ' H ' HG12 ' A' ' 382' ' ' ILE . 2.3 t60 -173.31 123.75 0.39 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.285 0.366 . . . . 0.0 111.271 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.946 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.5 mt-30 -71.58 153.21 42.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.446 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 22.6 t-105 -151.36 119.84 6.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.859 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -74.65 113.25 11.7 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.37 147.54 36.18 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.468 -175.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.286 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 335' ' ' THR . 4.2 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.4 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.7 p90 -57.43 128.53 37.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.202 0.525 . . . . 0.0 110.998 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.0 t -177.42 -171.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.8 105.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.9 OUTLIER -79.06 161.7 26.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.818 0.818 . . . . 0.0 112.766 -171.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.517 ' OD2' HG21 ' A' ' 310' ' ' THR . 13.0 t70 -78.39 155.73 29.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.935 -178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.724 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -76.83 -14.64 59.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.904 -172.12 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.555 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.4 t -91.19 2.74 56.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.137 0.494 . . . . 0.0 111.192 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 307' ' ' CYS . 5.5 mtpm? -81.3 -44.43 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.981 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.724 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -84.88 159.37 20.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.466 0.651 . . . . 0.0 111.853 -172.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 t -140.04 147.84 40.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.541 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.2 m-90 -52.7 101.59 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.493 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.666 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.1 tttp -90.01 -45.5 9.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.717 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 77.9 ttt180 -152.75 118.97 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.692 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.415 ' HB2' ' HD2' ' A' ' 318' ' ' PRO . . . -66.83 162.82 49.0 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.39 -175.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.673 ' HG2' ' O ' ' A' ' 390' ' ' HIS . 53.4 Cg_exo -30.79 116.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.703 2.935 . . . . 0.0 113.558 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.432 ' O ' HG11 ' A' ' 326' ' ' VAL . 52.9 m -127.9 124.84 38.4 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.98 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.27 127.02 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.212 0.53 . . . . 0.0 109.88 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.5 p -68.41 -21.55 64.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 -174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.69 -0.19 86.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.514 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -112.38 28.82 8.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 11.7 t70 64.09 24.83 13.61 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.84 0.829 . . . . 0.0 110.05 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.422 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.5 p -140.1 -171.72 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.203 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.946 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -129.71 155.66 41.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 118.201 0.455 . . . . 0.0 111.665 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.8 m -141.2 144.98 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.354 175.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.414 ' HE2' HG11 ' A' ' 330' ' ' VAL . 13.1 ptm -136.62 167.0 22.23 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.465 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.717 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 26.8 tt0 -133.34 128.33 35.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.282 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.414 HG11 ' HE2' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.07 157.58 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.937 0.399 . . . . 0.0 111.842 -178.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.92 153.02 17.57 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -95.01 178.78 5.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.342 0.571 . . . . 0.0 110.697 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.1 t -162.86 35.8 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.28 -92.46 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.241 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.66 ' HB ' ' HE3' ' A' ' 311' ' ' LYS . 21.5 m -54.67 134.42 47.13 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.182 0.593 . . . . 0.0 111.966 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.786 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.6 ptt180 -72.14 -177.58 0.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.125 172.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.64 94.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.852 3.035 . . . . 0.0 114.588 -173.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.8 p -116.05 158.06 23.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.788 -172.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -74.84 97.14 3.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.807 HD12 ' HE3' ' A' ' 364' ' ' MET . 10.5 tt -77.34 122.85 86.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -173.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 82.66 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.772 2.314 . . . . 0.0 112.466 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 385' ' ' VAL . 13.1 m -105.76 120.14 56.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.319 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 19.1 ptt180 -129.32 -175.29 3.53 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.53 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -157.16 147.56 21.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.586 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 382' ' ' ILE . 4.9 m -123.32 170.98 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.49 39.27 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.226 -173.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 32.8 t60 56.46 42.4 27.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.261 0.553 . . . . 0.0 110.47 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 67.07 9.94 55.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.423 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.78 107.84 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.115 0.458 . . . . 0.0 110.724 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.3 52.98 2.46 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.431 2.754 . . . . 0.0 112.644 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -97.59 -53.52 3.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.73 115.16 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.237 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.5 t30 -60.0 108.4 0.76 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.033 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.87 ' HA ' HD22 ' A' ' 376' ' ' LEU . 33.7 m -93.01 9.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.53 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -82.57 82.2 8.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.681 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.0 ttp -103.57 93.27 4.84 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 44.1 mt -76.33 125.94 30.09 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.66 -163.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -68.13 -23.62 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 11.9 m -126.4 90.21 50.47 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.82 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 89.2 Cg_endo -85.77 33.57 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.28 2.653 . . . . 0.0 114.317 -167.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -167.6 63.04 0.63 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.317 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.472 ' O ' HG22 ' A' ' 340' ' ' ILE . 61.4 Cg_endo -81.55 139.64 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.31 2.007 . . . . 0.0 113.049 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 20.4 p -124.15 133.01 53.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.73 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.807 ' HE3' HD12 ' A' ' 340' ' ' ILE . 6.5 ptp -95.18 125.1 39.59 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.501 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 25.9 mt-10 -81.28 -169.48 2.29 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.471 1.107 . . . . 0.0 111.21 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.479 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -73.93 -4.56 35.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.047 175.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 366' ' ' ASN . 15.6 m120 -100.95 -14.61 17.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.355 0.598 . . . . 0.0 109.659 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.0 -169.85 16.15 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.465 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -77.68 -22.53 69.36 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.545 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.64 -118.45 11.66 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -114.77 143.39 45.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.211 0.529 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.755 ' HB ' ' HE3' ' A' ' 374' ' ' MET . 3.1 mt -123.9 159.29 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.682 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 45.4 mt-10 -126.99 134.74 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.732 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.755 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.2 OUTLIER -149.57 169.81 20.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.977 -175.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.824 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 172.63 155.39 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.159 0.504 . . . . 0.0 111.679 170.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.007 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -160.43 153.53 18.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 165.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 1.007 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 46.9 Cg_exo -16.52 125.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 1 C-N-CA 125.468 4.112 . . . . 0.0 115.843 -175.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 395' ' ' LYS . 60.7 Cg_exo -40.17 139.84 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.692 3.595 . . . . 0.0 114.092 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 393' ' ' PHE . . . 138.93 -163.4 25.91 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -76.4 100.04 5.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.347 0.573 . . . . 0.0 111.239 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -112.75 129.62 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.095 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.99 135.25 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 -179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.609 HD11 ' HG3' ' A' ' 318' ' ' PRO . 25.4 mt -96.1 133.65 36.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.926 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -109.77 91.39 3.63 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.887 175.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -81.84 87.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.97 -95.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.352 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.02 0.84 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.101 0.477 . . . . 0.0 110.549 175.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -75.41 148.28 39.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.1 p30 -159.63 149.12 18.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.568 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.673 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 4.2 t60 -170.81 119.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.849 173.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.095 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.7 tt0 -82.64 134.16 35.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.738 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.531 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.1 t-105 -140.01 143.75 36.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.462 175.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.433 ' CE2' ' HA2' ' A' ' 379' ' ' GLY . 55.8 t80 -87.82 108.24 19.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.946 HE22 HG13 ' A' ' 326' ' ' VAL . 5.6 mm100 -72.82 144.35 47.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.863 ' HZ2' ' HA ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.494 -173.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.636 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 21.8 p90 -60.67 129.6 42.36 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.0 t 178.55 -169.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 59.5 t -60.5 110.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 168.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 142.77 56.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.795 0.807 . . . . 0.0 111.108 -170.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.81 148.6 36.49 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.111 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.747 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.27 -13.23 17.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.935 -172.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.8 t -101.14 -0.61 35.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.5 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 28.5 mmmt -78.4 -36.45 45.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.837 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -89.93 157.57 17.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.266 0.555 . . . . 0.0 111.606 -177.47 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.1 t -142.48 147.5 36.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.02 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -60.28 110.73 1.31 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.395 0.617 . . . . 0.0 112.159 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.53 ' HE3' ' OE1' ' A' ' 329' ' ' GLU . 65.3 tttp -93.54 -34.42 13.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.492 170.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.964 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 64.8 ttt180 -164.33 119.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.91 157.38 75.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.991 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -40.36 117.54 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.395 2.73 . . . . 0.0 112.587 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.524 ' O ' HG21 ' A' ' 327' ' ' VAL . 18.1 m -134.18 132.46 39.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.922 -177.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.53 124.83 13.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 111.096 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.45 ' HB3' HG11 ' A' ' 327' ' ' VAL . 87.6 p -57.79 -30.45 65.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.974 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.86 -2.57 41.53 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -105.4 -73.26 0.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -165.87 15.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.607 0.717 . . . . 0.0 109.665 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.679 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 12.3 p -137.69 -166.79 2.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.541 -172.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -126.62 153.17 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.517 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 17.3 m -135.91 145.66 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.717 ' HE3' HG21 ' A' ' 385' ' ' VAL . 17.4 ptt? -135.43 169.59 17.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.964 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 14.0 mt-10 -138.04 136.4 36.8 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.345 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.67 151.07 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.3 155.12 16.33 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.787 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.449 ' HB3' ' HB3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -101.97 -179.84 4.12 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 110.974 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.4 p -137.49 -41.13 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.635 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -156.07 4.58 0.2 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.158 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.5 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 33.1 m -113.12 127.03 56.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 117.425 0.612 . . . . 0.0 110.13 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.685 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 14.2 ptm180 -73.38 171.2 11.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.048 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.78 95.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.202 3.268 . . . . 0.0 114.608 -170.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . . . . . . . . . 6.0 p -112.14 154.34 25.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.969 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.412 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.4 mmt180 -74.57 107.83 6.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.652 HG21 HG12 ' A' ' 342' ' ' VAL . 38.8 mm -82.82 119.89 75.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.4 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.63 82.5 2.1 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.67 2.246 . . . . 0.0 112.088 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.652 HG12 HG21 ' A' ' 340' ' ' ILE . 13.9 m -101.5 124.94 55.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.575 0.702 . . . . 0.0 110.879 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.78 -175.38 4.01 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.478 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -153.41 144.62 23.03 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.323 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.65 164.56 15.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -96.83 114.34 25.97 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.126 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 39.25 63.88 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.633 0.773 . . . . 0.0 112.651 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.45 7.99 42.97 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.644 -0.707 . . . . 0.0 114.669 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.66 113.06 47.9 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 117.864 0.832 . . . . 0.0 111.557 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.15 62.19 5.93 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.198 2.599 . . . . 0.0 111.785 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.598 ' HG2' HG11 ' A' ' 352' ' ' VAL . 15.2 tt0 -86.65 -43.56 12.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.158 0.98 . . . . 0.0 108.939 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.598 HG11 ' HG2' ' A' ' 351' ' ' GLU . 1.5 p -158.17 122.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.34 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -51.23 108.5 0.26 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.331 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 1.018 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.44 7.98 4.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.825 -176.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.478 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -82.66 84.18 7.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.182 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.97 84.9 2.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 40.2 mt -68.05 129.55 40.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.166 -165.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.657 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.5 mm -72.62 -23.96 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.2 m -131.52 88.26 43.89 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.715 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.66 53.13 3.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.16 2.573 . . . . 0.0 113.336 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -168.02 69.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.882 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.495 ' HB3' HG21 ' A' ' 372' ' ' ILE . 45.7 Cg_endo -91.1 136.29 1.98 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.552 2.168 . . . . 0.0 112.65 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.1 p -132.42 144.95 50.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.452 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.617 ' HG3' HD12 ' A' ' 340' ' ' ILE . 56.2 mtm -95.95 116.62 29.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.507 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 31.9 mt-10 -104.15 -165.68 1.17 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.386 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -59.11 -13.08 5.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.886 0.375 . . . . 0.0 111.769 175.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.2 p30 -103.83 -2.07 26.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.366 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.6 -160.71 22.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.529 ' CA ' ' HG2' ' A' ' 364' ' ' MET . . . -77.27 -11.84 85.15 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.823 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.535 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 65.61 -124.03 26.03 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -125.87 147.47 49.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.869 0.366 . . . . 0.0 110.092 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.696 ' HB ' ' HE3' ' A' ' 374' ' ' MET . 1.0 OUTLIER -128.5 160.46 38.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.657 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 61.4 mt-10 -123.4 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.674 0.273 . . . . 0.0 110.284 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.696 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -153.29 154.6 34.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.913 -174.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.887 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -173.03 167.53 4.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.978 171.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.018 ' HG ' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -168.21 178.08 1.15 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.169 174.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.686 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 52.0 Cg_exo -36.1 131.24 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.748 2.299 . . . . 0.0 113.65 174.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.91 137.39 52.37 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.676 2.918 . . . . 0.0 113.16 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.06 -176.85 29.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.156 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.616 ' HB3' HE21 ' A' ' 391' ' ' GLN . 12.7 m-20 -74.33 101.15 3.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.206 0.202 . . . . 0.0 111.116 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.546 ' CG ' HD12 ' A' ' 376' ' ' LEU . 38.9 m-80 -123.39 153.54 40.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.262 0.553 . . . . 0.0 110.96 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.957 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -134.45 139.89 46.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 -176.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.536 HD13 ' HE2' ' A' ' 374' ' ' MET . 20.8 mt -94.18 132.89 36.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -109.62 92.66 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.026 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.753 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.4 t -79.99 76.35 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.69 -81.93 0.16 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.224 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 31.7 t70 -113.44 -12.27 12.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.449 0.642 . . . . 0.0 109.562 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.753 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.8 mp -78.32 148.37 33.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.216 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 4.4 p-10 -155.99 140.82 17.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.781 0.324 . . . . 0.0 111.214 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -166.28 123.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.624 171.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.957 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 43.4 tt0 -86.84 152.19 22.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.184 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.49 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.0 OUTLIER -159.45 142.94 14.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.672 175.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.3 p90 -90.77 108.06 19.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.755 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.887 ' HG3' HE22 ' A' ' 375' ' ' GLN . 0.1 OUTLIER -70.29 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.544 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 C--O 1.247 0.956 0 O-C-N 124.371 1.044 . . . . 0.0 110.51 -179.286 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -62.36 124.4 20.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.341 0.591 . . . . 0.0 111.416 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -174.32 -169.83 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.36 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.43 106.56 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.2 149.02 43.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.698 0.761 . . . . 0.0 112.191 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.49 ' OD1' HG21 ' A' ' 310' ' ' THR . 21.2 t0 -72.28 146.51 47.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.129 -178.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.729 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.35 -13.28 60.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.949 -167.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.49 HG21 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -97.0 4.1 51.66 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.981 -0.45 . . . . 0.0 112.035 -175.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.793 ' HE3' ' HA3' ' A' ' 334' ' ' GLY . 34.1 mttp -89.2 -28.56 19.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.729 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -84.57 156.47 21.6 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.808 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.3 t -141.36 145.27 35.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.554 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.603 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.1 m-90 -56.06 104.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.269 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.545 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.3 tttt -97.17 -42.88 7.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 38.9 ttt180 -152.55 123.01 7.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.605 173.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -65.74 163.94 31.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.48 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 2.8 Cg_exo -38.52 107.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.39 2.727 . . . . 0.0 112.373 176.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.8 m -115.97 128.49 55.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.296 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -49.23 125.71 11.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.378 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.0 p -70.96 -20.19 62.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -173.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.55 -2.31 70.24 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -171.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.82 27.96 8.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.458 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 64.09 21.16 12.48 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.658 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.445 ' HA ' ' OE1' ' A' ' 375' ' ' GLN . 6.6 p -129.53 -168.53 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.452 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.862 HG13 HE22 ' A' ' 394' ' ' GLN . 0.1 OUTLIER -132.21 150.22 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.339 0.59 . . . . 0.0 112.317 -175.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.73 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -138.56 138.08 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.62 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 14.2 ptm -127.55 162.8 25.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.548 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 30.2 tt0 -126.33 127.96 46.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.433 HG11 ' HE1' ' A' ' 328' ' ' MET . 0.8 OUTLIER -132.76 147.43 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.183 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -106.01 147.8 16.32 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.52 ' HB3' ' HE3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -106.31 179.03 4.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.121 0.961 . . . . 0.0 110.355 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.8 p -152.48 30.72 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.68 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.793 ' HA3' ' HE3' ' A' ' 311' ' ' LYS . . . -170.96 -83.28 0.05 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.876 -1.155 . . . . 0.0 113.764 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 303' ' ' THR . 12.9 m -69.52 128.46 36.59 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.111 0.565 . . . . 0.0 112.424 -172.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.738 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -67.1 176.1 1.27 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.147 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.738 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -24.88 93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.043 3.162 . . . . 0.0 114.538 -171.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 363' ' ' THR . 27.6 p -111.62 166.34 11.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.053 -171.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -87.43 96.81 10.51 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.478 HG22 ' HG2' ' A' ' 362' ' ' PRO . 12.4 tt -80.44 126.03 79.6 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.295 -171.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.31 93.98 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.96 2.44 . . . . 0.0 112.331 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 372' ' ' ILE . 16.7 m -115.01 120.98 66.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.699 0.761 . . . . 0.0 111.384 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 29.8 ptt180 -132.63 -174.35 3.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.53 149.38 22.22 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.723 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 382' ' ' ILE . 11.4 m -122.9 170.28 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.79 114.85 28.28 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.215 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.564 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 17.9 p80 40.04 57.07 2.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.847 . . . . 0.0 112.587 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.655 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 79.71 -10.42 38.7 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.164 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 27.5 t -101.91 114.01 65.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.307 0.554 . . . . 0.0 111.226 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -77.14 38.67 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 123.466 2.777 . . . . 0.0 113.059 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.44 -54.29 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.81 112.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.941 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 36.7 t30 -55.11 108.07 0.37 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.502 171.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.643 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 35.9 m -93.23 8.64 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.142 0.496 . . . . 0.0 111.159 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.528 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -80.83 82.81 6.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.378 0.609 . . . . 0.0 110.554 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.752 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.1 ttt -102.32 82.26 2.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 30.9 mt -64.26 130.11 42.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.862 -167.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -70.38 -26.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.3 m -131.83 95.95 21.56 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.452 172.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.477 ' HA ' HD12 ' A' ' 357' ' ' LEU . 4.1 Cg_endo -86.05 27.21 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.524 2.816 . . . . 0.0 113.523 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -147.88 64.32 8.24 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.123 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.478 ' HG2' HG22 ' A' ' 340' ' ' ILE . 90.0 Cg_endo -82.66 144.65 12.61 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.532 2.155 . . . . 0.0 112.884 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 11.4 p -128.55 142.57 51.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.068 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.826 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 56.7 mtp -95.39 110.58 22.59 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.01 -171.29 1.94 Allowed 'General case' 0 C--N 1.32 -0.704 0 O-C-N 124.403 1.065 . . . . 0.0 111.24 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.507 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -66.81 -6.61 16.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.779 174.591 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -110.84 -6.75 14.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.229 0.537 . . . . 0.0 109.972 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.64 -171.92 14.13 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.826 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -64.68 -14.97 59.06 Favored Glycine 0 N--CA 1.458 0.127 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.532 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 72.03 -106.26 1.88 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 328' ' ' MET . 20.8 m-85 -132.33 135.91 46.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.285 0.564 . . . . 0.0 110.996 175.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.711 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 4.7 mt -115.32 136.53 51.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.343 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.73 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -106.7 128.63 54.36 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.198 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -144.64 163.14 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.047 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.752 ' O ' ' HB3' ' A' ' 356' ' ' MET . 29.5 tp60 -176.05 152.08 1.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 110.036 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.805 HD21 ' HD2' ' A' ' 377' ' ' PRO . 1.0 OUTLIER -151.78 140.42 13.54 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 170.318 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.805 ' HD2' HD21 ' A' ' 376' ' ' LEU . 27.4 Cg_exo -19.97 130.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 125.144 3.896 . . . . 0.0 114.781 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -37.92 131.91 0.81 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.82 3.68 . . . . 0.0 114.38 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.85 -167.77 32.21 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.295 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 8.1 m-20 -80.57 100.12 8.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.913 0.356 . . . . 0.0 110.899 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.404 ' OD1' ' HB3' ' A' ' 376' ' ' LEU . 21.5 m-80 -111.57 138.72 47.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.986 0.422 . . . . 0.0 110.249 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.963 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -135.76 136.42 50.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.557 HD12 ' HG2' ' A' ' 374' ' ' MET . 39.5 mt -95.25 130.78 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.086 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.508 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.674 175.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.65 HG11 HG13 ' A' ' 342' ' ' VAL . 6.7 t -84.87 81.9 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.75 -91.15 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.144 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.636 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 6.3 t70 -98.55 -18.89 17.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.613 0.721 . . . . 0.0 109.395 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.618 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.3 mp -76.44 148.85 37.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -154.77 137.21 15.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.036 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -164.59 123.73 1.86 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.751 0.31 . . . . 0.0 110.484 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.963 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -90.3 141.2 28.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.519 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.523 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.2 t-105 -144.64 137.01 26.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.006 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.8 p90 -80.6 110.25 15.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.947 -0.471 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.862 HE22 HG13 ' A' ' 326' ' ' VAL . 5.8 mm100 -74.04 102.27 4.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 395' ' ' LYS . 12.1 ttpp . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.752 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 335' ' ' THR . 2.9 t . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -59.89 126.76 28.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.194 0.521 . . . . 0.0 109.871 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.8 t -179.24 -174.76 0.34 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.3 106.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.52 155.55 40.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.972 0.892 . . . . 0.0 112.608 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.621 ' OD1' HG21 ' A' ' 310' ' ' THR . 11.1 t70 -81.01 140.65 35.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.106 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -60.41 -21.72 62.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.62 -173.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.626 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.6 t -87.05 -4.56 59.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.828 0.346 . . . . 0.0 111.46 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -93.92 16.5 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.804 ' HE2' HG12 ' A' ' 385' ' ' VAL . 1.3 m-85 -102.38 170.66 7.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.675 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -165.65 131.9 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.396 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.437 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -51.68 120.33 5.11 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.398 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 21.3 tptm -110.14 -48.67 3.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.583 172.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -156.1 127.96 7.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.113 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.14 155.67 93.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.823 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.491 ' HG3' HD11 ' A' ' 383' ' ' ILE . 84.1 Cg_exo -33.08 113.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.832 3.021 . . . . 0.0 113.153 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.483 ' O ' HG21 ' A' ' 327' ' ' VAL . 20.3 m -128.95 135.06 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.055 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -44.96 124.66 4.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.612 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.5 p -71.47 -22.07 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.67 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.39 -2.62 74.56 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -121.89 33.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.88 16.68 8.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.823 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.513 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 8.5 p -124.23 -168.85 1.86 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.725 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.37 146.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.417 -177.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 14.8 m -128.51 138.83 53.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.101 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 16.4 ptt? -121.55 154.87 36.13 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 23.0 tt0 -114.28 127.66 55.98 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 385' ' ' VAL . 8.4 m -130.43 136.57 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.881 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -111.98 143.39 17.44 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.657 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.682 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.7 OUTLIER -141.44 163.03 34.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 49.4 m -153.51 65.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.507 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -165.0 -50.71 0.02 OUTLIER Glycine 0 C--O 1.226 -0.356 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.743 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.532 HG21 ' O ' ' A' ' 336' ' ' ARG . 23.3 m -98.6 142.72 29.83 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 122.85 -0.206 . . . . 0.0 110.863 -175.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.667 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 15.3 ptt180 -79.38 168.65 24.94 Favored Pre-proline 0 CA--C 1.527 0.08 0 CA-C-O 117.729 -1.129 . . . . 0.0 108.485 171.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -26.55 96.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.999 3.133 . . . . 0.0 114.449 -170.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.652 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 28.8 p -116.09 164.93 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.477 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -85.31 96.97 9.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 362' ' ' PRO . 12.1 pt -79.77 130.15 68.38 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.297 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.647 ' HD2' ' HZ ' ' A' ' 312' ' ' PHE . 63.9 Cg_endo -75.29 81.94 2.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.725 2.283 . . . . 0.0 112.021 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.705 HG13 HG11 ' A' ' 385' ' ' VAL . 10.5 m -100.22 116.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.993 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.402 ' O ' HG23 ' A' ' 383' ' ' ILE . 20.4 ptt180 -126.61 179.82 5.15 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.482 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -152.06 139.78 19.84 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.818 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.15 171.4 7.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.927 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.59 116.45 32.62 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.446 ' HA ' ' CD ' ' A' ' 391' ' ' GLN . 8.9 p-80 41.04 59.68 2.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.515 0.726 . . . . 0.0 112.703 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.711 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 66.2 6.4 32.65 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.28 116.59 44.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.591 0.695 . . . . 0.0 111.045 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.09 55.98 3.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.198 2.599 . . . . 0.0 111.753 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.59 -52.22 5.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.64 123.0 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.283 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.76 107.74 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.645 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 32.0 m -92.2 9.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.634 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.482 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -81.25 83.65 6.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.45 84.63 2.22 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.624 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.7 mt -74.02 128.32 35.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.816 -165.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.706 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.9 mm -75.94 -19.42 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.5 m -121.74 81.91 41.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.165 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 9.8 Cg_endo -87.23 32.57 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.27 2.647 . . . . 0.0 114.156 -166.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -177.01 70.78 0.23 Allowed Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.588 ' HB2' HD12 ' A' ' 340' ' ' ILE . 45.1 Cg_endo -88.19 136.75 3.55 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.503 2.136 . . . . 0.0 113.587 -176.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 40.5 p -118.1 130.59 56.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.545 175.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.652 ' HE2' ' SG ' ' A' ' 338' ' ' CYS . 0.0 OUTLIER -99.51 143.59 29.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.514 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 31.3 mt-10 -95.04 -179.35 4.79 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.626 0.579 . . . . 0.0 109.941 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -24.79 41.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.49 -3.23 18.3 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.095 -0.378 . . . . 0.0 111.592 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.682 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 144.62 177.05 19.16 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.265 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -97.53 -16.19 35.09 Favored Glycine 0 CA--C 1.507 -0.458 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.905 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 74.52 -126.17 9.01 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -174.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 328' ' ' MET . 79.6 m-85 -105.88 147.38 28.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.02 0.438 . . . . 0.0 111.154 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.4 mt -132.48 152.96 37.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.706 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 30.6 mt-10 -110.81 134.59 52.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.955 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.881 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -145.0 165.35 28.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.725 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -174.03 163.89 4.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.384 0.612 . . . . 0.0 111.449 172.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.696 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.3 tp -165.02 143.87 5.47 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 165.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.696 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 16.2 Cg_exo -31.3 135.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.998 3.132 . . . . 0.0 113.486 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -37.0 128.43 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.704 3.602 . . . . 0.0 114.471 -166.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.11 178.06 35.68 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 0.0 OUTLIER -81.02 99.73 8.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.945 0.872 . . . . 0.0 110.826 -176.209 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.645 ' OD1' ' HB ' ' A' ' 354' ' ' VAL . 18.6 m-80 -108.19 126.7 53.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.302 0.572 . . . . 0.0 110.015 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.975 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.52 137.69 57.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.145 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.881 HD12 ' HG2' ' A' ' 374' ' ' MET . 30.1 mt -99.78 127.1 52.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.792 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -95.64 102.73 14.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.932 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.804 HG12 ' HE2' ' A' ' 312' ' ' PHE . 2.1 t -92.59 78.56 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.295 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 69.56 -85.61 0.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.446 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.592 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 34.2 t70 -108.75 -25.58 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.523 0.678 . . . . 0.0 109.325 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.437 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.2 mp -65.45 151.81 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.536 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -151.94 144.35 24.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.79 109.9 0.94 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.111 0.482 . . . . 0.0 111.356 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.975 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.3 tt0 -84.25 149.09 26.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.386 -176.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 4.8 t-105 -158.77 142.27 15.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.822 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.821 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.3 p90 -92.72 114.83 27.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.583 -0.698 . . . . 0.0 110.062 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.616 ' HG2' HD21 ' A' ' 381' ' ' ASN . 5.0 mm100 -72.6 115.42 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.229 -174.826 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.615 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 14.2 p90 -70.45 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.6 t -177.14 -171.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 77.7 t -67.57 107.29 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 340' ' ' ILE . 0.1 OUTLIER -69.15 148.77 49.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.007 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.574 ' OD1' HG21 ' A' ' 310' ' ' THR . 24.2 t0 -72.48 135.76 45.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.288 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.65 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.79 -16.1 56.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.574 HG21 ' OD1' ' A' ' 308' ' ' ASP . 8.1 t -96.6 2.41 52.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.132 0.492 . . . . 0.0 111.325 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 29.0 mtpp -95.29 37.48 1.17 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.229 -0.295 . . . . 0.0 111.589 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.812 ' CE1' ' HB ' ' A' ' 330' ' ' VAL . 0.0 OUTLIER -135.9 150.74 49.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.923 0.392 . . . . 0.0 110.994 -176.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 29.2 p -135.35 139.15 44.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.185 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -54.7 105.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.974 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -92.52 -32.34 14.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.877 ' HB2' ' HB2' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -165.31 114.88 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.133 174.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.47 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.07 161.15 42.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.267 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.477 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 2.7 Cg_exo -39.22 119.6 0.5 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.83 2.354 . . . . 0.0 112.341 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.579 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.9 m -139.15 136.94 35.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.67 -173.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.7 133.76 16.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.739 0.304 . . . . 0.0 110.964 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.411 ' HB3' HG11 ' A' ' 327' ' ' VAL . 92.8 p -70.75 -12.04 61.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.785 -172.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 91.74 -7.62 79.26 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -102.19 -59.19 1.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.124 0.488 . . . . 0.0 109.929 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 12.0 t70 170.2 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.394 1.092 . . . . 0.0 108.436 -169.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.414 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.67 -168.72 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.782 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 374' ' ' MET . 2.1 t -125.21 152.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.08 0.467 . . . . 0.0 111.056 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.765 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.5 m -130.45 168.16 23.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.529 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.438 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 1.0 OUTLIER -155.01 157.85 38.25 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.877 ' HB2' ' HB2' ' A' ' 316' ' ' ARG . 4.1 mt-10 -129.01 139.95 51.85 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.452 0.47 . . . . 0.0 110.301 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.812 ' HB ' ' CE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -147.94 146.42 18.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.006 -175.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' A' ' 312' ' ' PHE . . . -117.18 137.43 13.41 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.656 ' HD2' ' H ' ' A' ' 335' ' ' THR . 0.3 OUTLIER -90.0 179.27 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.814 0.816 . . . . 0.0 112.32 -173.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 48.1 t -106.15 -41.86 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 176.73 40.5 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.273 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.656 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 4.8 m -116.07 127.54 54.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.247 0.523 . . . . 0.0 109.856 173.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.681 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -71.17 171.55 8.43 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.076 174.68 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.681 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.52 95.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.974 3.116 . . . . 0.0 114.155 -177.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.56 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 20.1 p -117.38 174.5 6.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.768 -1.56 . . . . 0.0 111.619 -171.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -96.57 101.58 13.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.536 ' CG2' HG12 ' A' ' 342' ' ' VAL . 8.2 mm -80.15 130.78 64.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.257 0.551 . . . . 0.0 112.265 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.88 81.79 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.66 2.24 . . . . 0.0 111.653 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.836 HG23 ' HG2' ' A' ' 362' ' ' PRO . 0.0 OUTLIER -96.84 130.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.423 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -145.35 179.64 7.26 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.52 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -152.2 143.83 23.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.392 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.8 m -113.98 172.06 3.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -108.44 115.51 30.24 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.717 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 57.1 47.42 17.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.623 0.577 . . . . 0.0 110.583 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.527 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 68.24 4.54 37.12 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.75 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 40.8 t -107.37 108.19 61.43 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 117.088 0.444 . . . . 0.0 111.2 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -74.2 59.51 4.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.365 2.71 . . . . 0.0 112.419 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.03 -45.81 6.12 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.5 123.62 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.1 t30 -60.34 108.34 0.79 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.694 175.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.592 ' HA ' HD21 ' A' ' 376' ' ' LEU . 27.1 m -90.5 3.9 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.52 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.97 83.98 3.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.651 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.672 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.5 ttm -100.07 88.0 3.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.896 HD22 ' HE3' ' A' ' 374' ' ' MET . 27.5 mt -66.32 126.52 29.03 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.985 -1.462 . . . . 0.0 111.664 -165.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.7 mm -73.37 -23.78 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.5 m -134.33 98.74 13.72 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.997 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.88 54.2 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.244 2.629 . . . . 0.0 113.379 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.582 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 63.6 t30 -157.96 58.73 1.47 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 172.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.836 ' HG2' HG23 ' A' ' 342' ' ' VAL . 15.0 Cg_exo -72.07 104.39 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.255 1.97 . . . . 0.0 112.155 175.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.1 p -110.34 149.16 30.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.669 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 49.0 mtm -95.7 120.76 36.53 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.12 -165.47 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.903 1.377 . . . . 0.0 109.928 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.554 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -52.3 -25.19 8.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.335 174.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -105.58 10.14 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 110.689 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.9 -156.78 23.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 110.986 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.06 -14.61 59.34 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 66.21 -118.5 11.18 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.045 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -116.47 122.96 46.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.7 OUTLIER -113.24 161.47 12.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.082 177.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.7 mt-10 -132.87 130.92 40.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.896 ' HE3' HD22 ' A' ' 357' ' ' LEU . 4.0 ptp -159.77 151.6 20.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.12 -173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.864 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.43 169.64 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.683 0.278 . . . . 0.0 111.039 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.954 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.0 tp -163.35 159.31 18.05 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.954 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 48.8 Cg_exo -29.97 130.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 113.978 173.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.0 Cg_exo -37.5 129.65 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.182 3.921 . . . . 0.0 114.516 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.19 -129.5 1.83 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.527 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.466 ' HB3' ' OE1' ' A' ' 391' ' ' GLN . 19.7 m-20 -127.49 107.33 9.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.502 0.191 . . . . 0.0 110.647 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.27 127.7 55.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.065 0.46 . . . . 0.0 110.01 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.042 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.64 130.72 74.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.639 HD13 ' SD ' ' A' ' 374' ' ' MET . 9.6 mt -92.11 131.62 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.336 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -102.64 92.0 4.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.267 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.66 76.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.42 -91.28 0.74 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.162 -171.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.65 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 19.6 t70 -110.25 -20.88 12.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.258 0.552 . . . . 0.0 109.96 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 2.1 tp -67.87 145.29 54.76 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.518 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.8 p30 -151.44 147.99 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.802 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -170.46 123.53 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.024 175.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.042 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -75.68 144.26 41.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 17.2 t-105 -143.32 130.4 20.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.204 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -82.53 117.34 22.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -117.54 142.66 46.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 111.085 -174.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.675 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 305' ' ' THR . 7.2 t . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.918 0.39 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.469 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 39.4 p90 -60.8 116.32 4.34 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.306 0.574 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 303' ' ' THR . 14.3 t -173.48 -166.59 0.33 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.118 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 13.7 t -61.19 114.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 144.64 55.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.909 0.861 . . . . 0.0 112.201 -170.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.63 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.7 t0 -59.76 141.58 54.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.704 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.699 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.24 -11.8 44.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.735 -175.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.63 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -105.41 -1.15 25.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 46.2 mttp -83.77 -30.08 26.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.699 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -86.92 147.93 25.56 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.678 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.1 p -135.5 145.26 46.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.524 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.485 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.9 m-90 -53.49 96.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.862 0.726 . . . . 0.0 111.462 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.419 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 76.9 tttt -87.84 -35.08 17.99 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.916 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.3 ttm180 -159.07 113.71 2.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.238 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.05 80.04 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 119.188 -0.434 . . . . 0.0 109.957 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -41.83 119.1 1.05 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.706 2.271 . . . . 0.0 112.461 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.3 m -139.61 142.41 37.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.322 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -40.66 130.77 2.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.863 0.465 . . . . 0.0 111.02 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.458 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -65.82 -23.75 66.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.61 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.37 -0.57 27.99 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.438 -174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -126.89 -56.46 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.348 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.31 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.548 0.689 . . . . 0.0 110.498 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.744 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 11.1 p -92.0 -172.04 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.953 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.7 148.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.387 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -130.55 158.15 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 122.743 0.417 . . . . 0.0 110.978 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.515 ' HB3' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -136.79 163.47 30.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 2.5 mt-10 -130.3 135.1 47.73 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.913 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.84 146.21 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.982 0.42 . . . . 0.0 111.367 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.11 145.8 18.55 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.547 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -89.78 178.34 6.27 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.569 0.7 . . . . 0.0 111.326 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.3 m -149.32 28.5 0.81 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.367 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 165.56 -70.52 0.19 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 119.663 -1.256 . . . . 0.0 113.946 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 336' ' ' ARG . 41.1 m -58.65 136.43 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.956 0.503 . . . . 0.0 112.15 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 335' ' ' THR . 12.3 ptm180 -70.19 170.4 10.36 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.442 171.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.703 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.9 97.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.975 3.117 . . . . 0.0 114.759 -171.066 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.542 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 6.3 p -113.47 152.76 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.297 -172.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 306' ' ' VAL . 9.2 mpt_? -82.41 105.41 13.45 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.3 pt -87.31 131.43 44.29 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.602 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.39 84.34 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.053 2.502 . . . . 0.0 112.364 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.631 HG11 HD13 ' A' ' 372' ' ' ILE . 19.3 m -96.72 129.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.796 0.807 . . . . 0.0 111.253 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 35.6 ptt180 -140.21 -172.44 3.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -159.37 143.41 15.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.286 0.565 . . . . 0.0 111.416 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 382' ' ' ILE . 16.0 m -119.69 171.31 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -103.06 116.38 32.41 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 3.7 p-80 40.14 60.11 1.84 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.928 0.768 . . . . 0.0 112.459 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.9 3.92 24.65 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.609 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.25 118.88 45.06 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.546 0.673 . . . . 0.0 111.164 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.71 55.33 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.067 2.511 . . . . 0.0 111.445 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -86.07 -35.78 20.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.868 0.842 . . . . 0.0 108.895 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.581 HG12 ' HG3' ' A' ' 351' ' ' GLU . 6.7 p -155.66 122.93 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.745 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.2 107.77 0.27 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.185 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 376' ' ' LEU . 31.4 m -88.65 5.2 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.394 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -79.84 82.7 5.89 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.349 0.595 . . . . 0.0 110.645 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 36.8 mtm -97.61 90.37 4.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.7 mt -75.93 117.01 17.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.473 -165.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.3 mm -68.95 -22.13 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -131.38 85.42 53.32 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.776 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -87.28 41.68 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.376 2.718 . . . . 0.0 114.035 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -165.61 73.55 1.34 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.221 0.534 . . . . 0.0 110.557 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.589 ' HB2' HD11 ' A' ' 340' ' ' ILE . 91.7 Cg_endo -87.67 120.2 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.411 2.074 . . . . 0.0 112.586 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.8 p -115.21 140.72 48.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.952 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.703 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 54.9 mtm -95.04 113.63 25.35 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.355 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 39.5 mt-10 -104.24 -165.8 1.18 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.506 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -55.2 -17.74 4.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -105.06 2.52 29.56 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.5 0.667 . . . . 0.0 110.368 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 98.02 -158.63 20.7 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.88 -1.84 74.53 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.953 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.0 -129.62 32.49 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -115.63 142.03 47.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.296 0.57 . . . . 0.0 110.801 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.631 HD13 HG11 ' A' ' 342' ' ' VAL . 2.0 mt -120.12 130.9 73.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.573 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.938 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.1 mt-10 -103.92 135.97 44.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 110.451 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.476 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 4.4 ppp? -147.46 159.33 43.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.512 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.744 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.1 OUTLIER -172.89 167.12 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.557 . . . . 0.0 112.269 174.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.965 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.1 tp -164.82 156.85 13.75 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 172.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.965 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 47.2 Cg_exo -37.08 138.2 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.766 2.31 . . . . 0.0 112.798 172.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.468 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 89.1 Cg_exo -34.92 136.45 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 125.08 3.853 . . . . 0.0 114.985 -174.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.21 -150.94 22.24 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.463 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 8.3 m-20 -108.08 105.64 15.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.146 0.473 . . . . 0.0 110.484 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 76.8 m-20 -105.0 125.1 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.031 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.093 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.44 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.306 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 328' ' ' MET . 22.4 mt -91.54 135.67 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -115.46 91.91 3.75 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.135 178.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 342' ' ' VAL . 6.3 t -83.79 92.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.64 0.12 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.867 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -110.57 -15.66 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.067 0.461 . . . . 0.0 110.108 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.564 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -63.29 139.96 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.8 p30 -149.41 148.1 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.587 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.8 OUTLIER -171.77 122.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 173.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.093 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 11.2 tt0 -76.82 148.89 36.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -143.54 129.52 19.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.484 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -86.34 112.18 21.18 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.5 pp0? -102.19 126.47 49.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 395' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.428 -169.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.705 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 35.4 p90 -65.46 117.08 7.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.65 0.738 . . . . 0.0 110.332 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t -168.63 -171.25 1.37 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 53.6 t -62.65 109.29 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 140.05 56.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.469 0.652 . . . . 0.0 111.551 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.8 t70 -64.84 143.95 57.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.645 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.683 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -64.34 -11.93 37.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.176 -1.375 . . . . 0.0 113.484 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 308' ' ' ASP . 3.7 t -104.92 12.22 32.7 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.059 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.453 ' HE2' ' HA3' ' A' ' 334' ' ' GLY . 25.7 mtpp -101.63 1.36 37.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.866 ' HD1' HD13 ' A' ' 388' ' ' LEU . 2.4 p90 -125.53 169.38 12.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.3 t -149.2 162.37 40.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.951 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.542 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.3 m-90 -69.74 111.04 5.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 60.1 tptt -86.21 -36.26 19.55 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.544 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 11.3 ttm180 -164.6 120.99 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.138 175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.25 161.12 59.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.522 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.82 116.08 0.39 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.769 2.313 . . . . 0.0 112.013 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -131.9 134.34 45.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.173 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.45 127.4 24.9 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.412 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.3 p -66.8 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.7 -4.34 42.77 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -139.71 59.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.548 0.213 . . . . 0.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 74.13 -24.73 0.2 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 21.4 p -101.33 -171.39 1.98 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.301 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.74 153.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.402 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.986 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -134.8 154.48 36.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.877 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.669 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -137.69 161.86 35.39 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 16.2 tt0 -134.15 131.26 38.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.508 ' CG2' HD11 ' A' ' 372' ' ' ILE . 1.2 m -135.96 145.46 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.623 0.249 . . . . 0.0 111.3 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.91 135.19 11.53 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.302 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.594 ' CE1' ' HD2' ' A' ' 312' ' ' PHE . 1.3 m-85 -122.08 172.75 8.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 70.8 m -157.25 52.84 0.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.453 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -163.86 -74.69 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.35 -1.405 . . . . 0.0 113.766 170.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.665 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 3.8 m -57.53 144.23 37.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.437 0.695 . . . . 0.0 111.919 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.705 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 13.9 ptm180 -76.69 168.9 24.08 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.555 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 364' ' ' MET . 1.0 OUTLIER -27.26 98.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.008 3.139 . . . . 0.0 114.373 -173.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.796 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 26.9 p -110.58 173.49 6.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.784 -169.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 24.2 mmm180 -90.37 102.32 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.909 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.871 HD11 ' HB3' ' A' ' 364' ' ' MET . 58.6 mt -74.67 122.96 88.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.575 0.226 . . . . 0.0 111.08 -176.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.6 81.75 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.471 2.114 . . . . 0.0 112.4 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 340' ' ' ILE . 6.4 m -102.9 126.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 111.504 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 21.0 ptt180 -139.07 -178.24 5.25 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.93 135.96 11.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.629 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.16 174.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -104.67 115.89 31.1 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 15.8 p80 42.98 55.45 4.44 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.913 0.758 . . . . 0.0 112.575 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.862 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.68 11.09 56.6 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.881 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.91 118.02 30.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.468 -0.43 . . . . 0.0 110.679 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.17 61.91 5.0 Favored 'Trans proline' 0 N--CA 1.463 -0.324 0 C-N-CA 123.024 2.483 . . . . 0.0 111.268 172.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.86 -38.68 12.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.8 p -151.45 126.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.296 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -60.75 106.37 0.56 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.802 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.8 m -88.01 3.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.36 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.421 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.68 82.0 4.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.56 0.695 . . . . 0.0 110.747 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.817 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 2.5 tpt -98.91 83.5 2.93 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.3 mt -68.05 125.92 27.85 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.118 -169.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.581 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 6.2 mm -70.03 -23.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.399 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 13.0 m -138.63 92.95 11.21 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.057 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -91.75 41.04 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.386 2.724 . . . . 0.0 113.624 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.94 65.84 5.85 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.264 0.554 . . . . 0.0 110.098 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.702 ' HB3' HG23 ' A' ' 372' ' ' ILE . 97.2 Cg_endo -87.95 118.0 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.414 2.076 . . . . 0.0 113.168 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.4 p -110.0 134.5 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.412 171.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.871 ' HB3' HD11 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -107.14 149.94 27.12 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.542 -176.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -111.03 -168.53 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.827 1.329 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -64.91 -16.04 62.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -86.47 -11.44 51.78 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.306 0.574 . . . . 0.0 110.171 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.534 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 113.2 -167.67 12.38 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.707 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 364' ' ' MET . . . -81.49 -15.18 76.79 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.986 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.4 -127.62 23.8 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.128 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.95 133.31 50.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.072 0.463 . . . . 0.0 111.184 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -125.12 165.14 22.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.986 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.1 mt-10 -134.43 137.28 43.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.216 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.605 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.77 159.74 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -175.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.817 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.2 tp60 -179.0 160.12 1.05 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 123.022 0.201 . . . . 0.0 110.579 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.802 HD22 ' HA ' ' A' ' 354' ' ' VAL . 13.8 tp -158.94 150.67 17.0 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.802 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.6 Cg_exo -32.93 136.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.49 2.793 . . . . 0.0 113.604 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.79 128.75 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.851 1 C-N-CA 125.725 4.283 . . . . 0.0 114.951 -169.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.5 -134.41 2.89 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.406 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 14.7 m-20 -127.12 102.0 6.77 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.506 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.8 m120 -102.88 123.0 45.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.102 0.477 . . . . 0.0 109.987 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.042 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.79 129.75 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' A' ' 374' ' ' MET . 29.7 mt -91.65 131.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.414 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.4 OUTLIER -108.03 91.47 3.66 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.039 174.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 342' ' ' VAL . 7.6 t -83.86 94.6 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.61 -97.49 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.952 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 28.0 t70 -104.73 -19.89 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.173 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.866 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.1 tp -64.31 146.43 54.41 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.4 p30 -158.84 143.22 15.66 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.492 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -166.18 124.69 1.51 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.421 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.042 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.5 tm0? -78.35 143.2 37.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.906 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 394' ' ' GLN . 26.8 t-105 -145.37 114.54 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.366 174.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 27.3 p90 -74.38 125.8 29.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.409 ' HB3' ' NE1' ' A' ' 392' ' ' TRP . 1.3 pp0? -120.08 140.53 50.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.67 0.748 . . . . 0.0 112.731 -171.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.314 168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.421 0.629 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -69.53 120.36 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.676 -0.64 . . . . 0.0 110.124 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.3 t -171.29 -167.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.719 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.45 113.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 143.78 55.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.791 0.805 . . . . 0.0 110.812 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.57 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.0 t70 -80.29 150.65 29.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.273 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 10.8 ptmt -58.51 -18.58 30.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.017 -173.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.57 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.0 t -100.19 -0.22 39.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.3 mmmt -80.86 -33.79 34.2 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -93.84 154.55 17.67 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.154 0.502 . . . . 0.0 111.535 -178.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.443 ' HA ' HD11 ' A' ' 388' ' ' LEU . 8.9 t -144.38 150.62 38.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.283 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -64.98 112.76 3.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.225 0.536 . . . . 0.0 111.999 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.484 ' HG2' ' OE2' ' A' ' 329' ' ' GLU . 38.2 tttm -94.99 -28.54 15.09 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 72.1 ttt180 -168.89 110.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.628 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.2 160.47 39.94 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.43 -175.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.765 ' HG3' HD12 ' A' ' 383' ' ' ILE . 69.6 Cg_exo -30.78 118.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.922 3.081 . . . . 0.0 113.498 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -137.21 134.55 36.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.738 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.564 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 14.3 t70 -52.16 130.17 29.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.945 0.402 . . . . 0.0 110.497 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 99.9 p -69.75 -24.14 63.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.354 -173.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 102.49 -12.68 56.82 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -125.11 57.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 4.9 p-10 47.41 23.08 0.32 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.131 0.972 . . . . 0.0 113.529 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.591 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -127.43 -172.7 2.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.7 OUTLIER -128.92 152.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.882 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 373' ' ' GLU . 25.8 m -137.6 153.26 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.687 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.59 ' CE ' HD12 ' A' ' 372' ' ' ILE . 18.0 ptt? -136.52 158.15 45.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.715 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.4 tt0 -121.29 118.82 30.49 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.263 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.82 148.86 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -120.49 157.07 15.88 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.87 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.443 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -95.75 178.74 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.825 -177.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 311' ' ' LYS . 37.6 p -136.2 -3.04 2.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.0 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 161.06 11.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 119.207 -1.473 . . . . 0.0 115.782 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 39.8 m -113.08 127.48 56.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.138 0.969 . . . . 0.0 109.903 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.591 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.6 ptt180 -75.03 171.48 11.6 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.033 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.9 OUTLIER -25.51 92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.986 3.124 . . . . 0.0 114.8 -166.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 363' ' ' THR . 9.2 p -110.54 144.72 38.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.709 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 6.1 mpt_? -73.47 103.95 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.713 HG21 ' HG3' ' A' ' 364' ' ' MET . 21.1 pt -88.28 128.71 52.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.252 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 312' ' ' PHE . 58.4 Cg_endo -74.5 82.53 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.73 2.287 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 385' ' ' VAL . 13.5 m -98.57 113.7 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.694 0.759 . . . . 0.0 111.31 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 383' ' ' ILE . 18.2 ptt180 -123.09 -178.74 4.05 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -154.6 142.27 19.88 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.195 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -114.38 169.65 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.544 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -112.44 116.79 30.86 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.974 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 380' ' ' ASP . 19.6 t60 63.95 39.07 8.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.6 0.562 . . . . 0.0 109.902 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 70.2 5.76 54.98 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.427 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 47.5 t -111.65 115.37 51.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 117.201 0.501 . . . . 0.0 111.348 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.8 Cg_exo -77.91 52.62 4.08 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.293 2.662 . . . . 0.0 112.298 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.63 -53.38 4.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.661 0.743 . . . . 0.0 109.108 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.33 117.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.603 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.8 t30 -53.29 108.67 0.35 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.244 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.876 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.9 m -87.13 8.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -81.69 80.89 7.91 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.515 0.674 . . . . 0.0 110.718 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 37.9 mtt -102.39 81.05 2.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.2 mt -63.68 125.25 23.68 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.271 -169.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 375' ' ' GLN . 4.6 mm -65.47 -20.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.4 m -136.61 92.27 15.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.489 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 357' ' ' LEU . 80.0 Cg_endo -92.07 48.93 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.6 2.867 . . . . 0.0 114.739 -168.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -170.47 70.11 0.56 Allowed Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 109.918 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.486 ' HB3' HG23 ' A' ' 372' ' ' ILE . 86.2 Cg_endo -90.91 138.32 2.4 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.949 2.433 . . . . 0.0 113.822 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 17.2 p -123.98 143.09 50.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.651 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.713 ' HG3' HG21 ' A' ' 340' ' ' ILE . 53.7 mtm -95.86 128.82 43.08 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.121 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 mm-40 -93.2 -172.22 2.89 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.348 1.03 . . . . 0.0 112.245 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -66.25 -6.23 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.838 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.87 -2.1 14.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.31 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 105.31 -175.34 21.87 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.0 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -75.29 -37.72 41.22 Favored Glycine 0 CA--C 1.509 -0.306 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.494 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.76 -124.11 6.46 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.431 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.2 134.94 45.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.106 0.479 . . . . 0.0 111.559 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.59 HD12 ' CE ' ' A' ' 328' ' ' MET . 0.9 OUTLIER -128.7 155.33 40.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.767 ' HG2' HG12 ' A' ' 327' ' ' VAL . 33.8 mt-10 -125.09 138.34 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.875 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -153.59 157.18 39.3 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.908 0.483 . . . . 0.0 110.709 -174.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.718 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -170.07 163.72 9.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 173.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.9 tp -165.51 163.41 12.97 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 72.1 Cg_exo -27.83 133.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.103 3.202 . . . . 0.0 114.348 168.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.839 ' HB3' ' HB2' ' A' ' 395' ' ' LYS . 5.2 Cg_exo -37.09 138.46 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.857 4.371 . . . . 0.0 115.362 -175.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 147.05 -179.76 23.73 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.063 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.5 m-20 -69.02 104.26 2.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 117.791 0.796 . . . . 0.0 110.561 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -94.34 112.54 24.33 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.011 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -114.78 127.56 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.863 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.765 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.8 mt -92.74 132.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.992 -175.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.676 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.6 OUTLIER -104.58 92.57 4.35 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.062 174.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.3 t -81.23 86.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.98 -91.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.533 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.542 ' HB2' ' HE3' ' A' ' 309' ' ' LYS . 10.5 t70 -108.75 -15.01 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 109.809 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -64.35 147.93 51.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.8 p-10 -158.34 140.87 14.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.585 0.231 . . . . 0.0 111.127 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.621 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -167.88 121.7 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.24 174.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.011 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 70.6 mt-30 -70.83 150.96 45.29 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.564 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 12.1 t-105 -151.04 110.7 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.985 169.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.9 p90 -74.39 111.36 9.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.652 0.739 . . . . 0.0 109.8 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 395' ' ' LYS . 1.7 pp0? -99.11 146.27 26.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.139 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' A' ' 378' ' ' PRO . 71.7 mmtt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.197 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.526 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 25.1 p90 -64.74 129.82 41.23 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.92 -0.488 . . . . 0.0 110.062 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.4 t 176.78 -173.61 0.1 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 17.3 t -69.56 106.09 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.482 ' SG ' HG22 ' A' ' 340' ' ' ILE . 0.3 OUTLIER -68.86 156.68 38.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.682 0.754 . . . . 0.0 112.393 -167.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.677 ' OD2' HG22 ' A' ' 310' ' ' THR . 18.4 t70 -67.8 143.16 55.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -66.11 -22.39 66.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.494 -170.022 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.677 HG22 ' OD2' ' A' ' 308' ' ' ASP . 2.6 t -100.0 -6.23 26.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.635 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 29.3 mtpp -83.02 38.19 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -175.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -123.93 173.69 8.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.261 0.553 . . . . 0.0 111.497 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 10.0 t -157.13 135.43 11.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.478 170.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -55.16 110.87 0.74 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.839 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.714 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 1.1 tpmt? -92.36 -41.68 10.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 69.9 ttt180 -161.16 126.16 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.2 162.57 71.84 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.648 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 4.9 Cg_exo -40.37 122.69 1.32 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.609 2.206 . . . . 0.0 111.718 175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 12.3 m -142.85 142.17 31.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.259 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.12 125.58 6.66 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.176 0.298 . . . . 0.0 110.487 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.576 ' HB3' HG13 ' A' ' 327' ' ' VAL . 94.9 p -66.79 -20.15 65.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.902 -174.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.89 -2.19 79.29 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -140.01 55.33 1.64 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 110.97 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 72.96 12.92 5.02 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.716 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.68 ' HA ' HE21 ' A' ' 375' ' ' GLN . 5.1 p -144.62 -166.78 2.47 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.481 -0.137 . . . . 0.0 110.699 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.96 155.19 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.86 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.696 HG12 ' HG3' ' A' ' 373' ' ' GLU . 17.9 m -137.5 160.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.655 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.441 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 10.5 ptm -141.39 165.1 28.43 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.5 tt0 -130.19 124.68 33.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 385' ' ' VAL . 14.1 m -128.78 141.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.169 0.509 . . . . 0.0 111.599 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.03 161.04 14.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.0 OUTLIER -108.5 179.9 4.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.907 0.86 . . . . 0.0 112.833 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.2 t -98.8 -42.79 7.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.363 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.8 41.11 0.04 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.245 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.7 m -114.32 119.9 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.118 0.459 . . . . 0.0 110.33 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.575 ' HE ' ' HD2' ' A' ' 337' ' ' PRO . 2.6 ptm180 -69.87 171.22 7.73 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.253 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HD2' ' HE ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.05 92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 124.184 3.256 . . . . 0.0 114.532 -169.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 363' ' ' THR . 20.8 p -114.34 164.1 14.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.274 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 20.8 mmt180 -86.59 99.03 11.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.815 HG13 HG22 ' A' ' 342' ' ' VAL . 16.7 pt -81.0 130.03 64.97 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.548 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.94 78.97 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.173 1.915 . . . . 0.0 112.354 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -98.25 121.62 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.832 0.825 . . . . 0.0 112.411 175.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -126.67 -176.69 3.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.326 171.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.47 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.9 134.47 15.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.348 0.594 . . . . 0.0 110.647 176.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 18.3 m -110.74 167.63 4.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.37 114.41 28.66 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.349 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 57.35 46.79 17.78 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 123.721 0.638 . . . . 0.0 110.621 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.587 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 64.75 13.84 57.02 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.837 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 351' ' ' GLU . 46.9 t -114.66 112.95 45.2 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.51 0.655 . . . . 0.0 111.301 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.64 52.56 2.51 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.627 2.885 . . . . 0.0 112.134 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.475 ' HB2' HG12 ' A' ' 349' ' ' VAL . 10.5 tp10 -90.93 -51.59 5.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.945 0.879 . . . . 0.0 108.828 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.8 118.51 29.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.115 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -61.03 107.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.719 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.747 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 27.0 m -89.53 6.58 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.47 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.95 83.37 6.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.466 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -99.82 91.98 5.09 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 29.6 mt -73.24 118.7 16.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.208 -167.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -66.66 -22.95 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.361 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -131.12 93.43 30.36 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.951 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.71 43.3 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.035 2.49 . . . . 0.0 113.035 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 66.6 t30 -150.54 61.03 4.48 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.543 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.648 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.9 Cg_endo -88.53 118.96 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.528 2.152 . . . . 0.0 112.789 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 53.2 p -124.42 149.63 46.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.377 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.993 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 71.3 mtm -94.61 133.8 37.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.46 -168.72 1.37 Allowed 'General case' 0 C--N 1.318 -0.795 0 O-C-N 124.551 1.157 . . . . 0.0 111.891 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.51 -23.73 6.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -109.43 -7.93 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.077 -0.389 . . . . 0.0 111.156 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 127.75 -178.14 17.18 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.993 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -63.12 -29.66 75.09 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.63 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.9 -123.42 6.58 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.347 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -103.55 147.28 27.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.191 0.519 . . . . 0.0 111.644 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.648 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -136.54 137.67 47.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.962 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.7 mp0 -107.29 135.52 48.66 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.292 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.748 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -152.45 158.09 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.68 HE21 ' HA ' ' A' ' 325' ' ' THR . 6.4 tp-100 -176.04 145.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.725 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.788 HD22 ' HD2' ' A' ' 377' ' ' PRO . 0.8 OUTLIER -146.25 142.48 17.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 167.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.788 ' HD2' HD22 ' A' ' 376' ' ' LEU . 28.2 Cg_exo -23.94 136.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.844 3.696 . . . . 0.0 115.004 177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.547 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 6.3 Cg_exo -37.11 134.2 0.41 Allowed 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 125.79 4.327 . . . . 0.0 114.97 -171.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 161.51 -124.6 1.33 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.995 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -132.29 101.78 5.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.418 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.9 m120 -104.57 124.75 49.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.55 134.28 66.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 374' ' ' MET . 41.9 mt -95.27 134.1 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.176 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.23 94.24 4.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.133 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 342' ' ' VAL . 2.8 t -84.82 72.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.64 -80.66 0.77 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.504 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.506 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 1.9 t70 -110.54 -30.08 7.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.51 141.77 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.537 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.4 p30 -150.73 154.27 37.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -170.08 116.07 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 175.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.0 OUTLIER -73.13 139.97 46.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.438 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 29.9 t-105 -136.67 137.72 40.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.158 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -94.97 117.32 29.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -112.32 146.09 38.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.886 0.374 . . . . 0.0 110.495 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 395' ' ' LYS . 1.9 ttpm? . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.496 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 335' ' ' THR . 6.8 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HD1' ' H ' ' A' ' 304' ' ' TYR . 0.4 OUTLIER -70.84 108.48 4.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.783 0.802 . . . . 0.0 110.617 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.5 t -168.43 -167.18 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.582 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.69 113.43 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 170.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.98 144.23 56.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.658 0.742 . . . . 0.0 111.174 -171.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.93 148.33 40.15 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.13 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.81 -12.88 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.888 -173.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.477 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.5 t -98.15 -6.21 31.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.568 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.7 mmmt -75.9 -36.16 59.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.628 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -94.4 148.79 21.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 111.106 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.9 t -139.11 162.19 35.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.56 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.466 ' CZ3' ' HA ' ' A' ' 317' ' ' ALA . 93.8 m95 -67.37 111.39 4.02 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.958 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 73.3 tttt -102.52 -39.8 6.95 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.014 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.644 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 70.7 ttt180 -157.0 118.35 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.51 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.466 ' HA ' ' CZ3' ' A' ' 314' ' ' TRP . . . -67.42 161.21 66.83 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.462 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.866 ' HG3' HD12 ' A' ' 383' ' ' ILE . 74.0 Cg_exo -36.34 110.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.223 2.616 . . . . 0.0 113.251 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.5 m -134.9 137.45 43.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.591 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.4 131.66 13.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.162 0.505 . . . . 0.0 111.509 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.457 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.1 p -66.89 -23.32 65.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.77 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.05 -11.64 31.73 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -100.77 -54.13 2.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.516 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 21.9 t70 170.08 -24.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.323 1.058 . . . . 0.0 109.035 -171.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.563 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.46 -169.95 2.25 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.462 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.73 154.38 38.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.024 0.44 . . . . 0.0 111.001 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.3 m -135.22 156.61 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.76 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.568 ' SD ' HG22 ' A' ' 330' ' ' VAL . 2.0 ppp? -135.65 154.63 51.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.958 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 9.7 tt0 -126.44 123.13 37.17 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.116 0.484 . . . . 0.0 110.601 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -123.7 148.83 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.51 -177.167 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.23 139.35 15.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.78 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.521 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.8 OUTLIER -91.13 179.27 5.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.345 0.573 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.7 p -135.55 -17.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.118 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.99 -47.28 0.06 OUTLIER Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.339 -1.41 . . . . 0.0 114.213 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 303' ' ' THR . 26.3 m -56.27 125.27 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.213 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.584 ' HD2' ' HB3' ' A' ' 304' ' ' TYR . 0.0 OUTLIER -69.44 163.22 60.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 118.14 -0.933 . . . . 0.0 108.891 176.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.48 97.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.148 3.232 . . . . 0.0 114.688 -169.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 363' ' ' THR . 6.8 p -114.07 150.89 33.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.969 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -75.4 108.06 7.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.736 HG21 ' HG3' ' A' ' 364' ' ' MET . 28.8 pt -91.48 128.58 46.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.106 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.33 89.57 1.18 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.099 2.533 . . . . 0.0 112.881 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 372' ' ' ILE . 19.1 m -101.05 124.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.415 0.626 . . . . 0.0 110.938 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -132.78 -175.62 3.83 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.454 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 137.46 18.44 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.59 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 382' ' ' ILE . 10.7 m -115.23 166.82 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.54 117.74 34.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.535 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.5 t60 59.7 40.08 20.27 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.395 0.434 . . . . 0.0 110.519 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.432 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 69.1 6.96 55.77 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.231 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.1 113.09 62.75 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.897 0.349 . . . . 0.0 111.051 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.46 55.87 4.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.929 2.42 . . . . 0.0 111.88 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.32 -53.49 4.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.029 0.919 . . . . 0.0 108.621 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.6 120.89 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.787 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -54.37 107.99 0.33 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.663 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 1.049 ' HB ' ' HB3' ' A' ' 376' ' ' LEU . 2.6 m -87.9 -8.65 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.85 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.454 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -60.02 96.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.471 0.653 . . . . 0.0 112.222 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.637 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 67.4 mtm -108.18 85.38 2.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 45.4 mt -73.41 124.37 25.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.377 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.8 mm -69.62 -20.53 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.3 m -145.74 97.13 4.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.999 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -92.47 37.91 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.483 2.788 . . . . 0.0 113.288 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -144.53 63.04 10.42 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.883 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.741 ' HB3' HG23 ' A' ' 372' ' ' ILE . 88.4 Cg_endo -86.1 131.45 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.564 2.176 . . . . 0.0 113.016 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -130.4 142.16 50.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.399 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 59.0 mtm -95.24 117.08 29.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.722 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 38.5 mt-10 -100.12 -165.47 1.22 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.898 1.374 . . . . 0.0 109.886 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -62.8 -15.0 52.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 0.0 111.314 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.7 6.44 48.69 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.184 0.516 . . . . 0.0 109.678 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 83.48 -155.19 32.1 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -68.43 -16.43 69.4 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.826 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 71.45 -87.18 0.42 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.705 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.02 143.32 15.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.099 0.476 . . . . 0.0 109.871 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.8 mt -119.57 157.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.671 ' HG2' HG12 ' A' ' 327' ' ' VAL . 37.0 mt-10 -126.34 130.94 51.78 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.806 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.646 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -155.26 160.56 40.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.928 -173.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.637 ' O ' ' HB2' ' A' ' 356' ' ' MET . 4.7 tp60 -163.71 148.19 10.54 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 167.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.049 ' HB3' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -132.22 163.59 49.27 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -169.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 378' ' ' PRO . 3.5 Cg_endo -48.16 126.67 13.87 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.625 2.217 . . . . 0.0 112.147 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.5 Cg_exo -38.81 128.62 1.26 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.69 3.594 . . . . 0.0 113.711 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 134.32 -172.57 21.76 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.362 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.4 m-20 -71.21 101.44 2.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.931 0.365 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.546 ' HB2' HD23 ' A' ' 376' ' ' LEU . 31.9 m-80 -118.04 163.39 16.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.055 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -146.24 144.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.631 -173.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.5 mt -100.97 132.96 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.094 0.473 . . . . 0.0 110.339 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -103.84 97.15 7.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.24 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.1 t -86.5 84.68 2.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.32 -85.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.332 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.765 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 7.8 t70 -113.09 -16.23 12.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.681 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.4 mp -66.14 148.76 51.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.058 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.1 p30 -163.45 126.92 2.73 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.967 0.413 . . . . 0.0 111.494 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -153.75 119.81 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.25 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.055 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 9.7 tt0 -87.39 142.38 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.424 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.473 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 0.6 OUTLIER -153.33 141.02 19.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.83 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 7.7 p90 -74.55 107.08 6.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.288 0.566 . . . . 0.0 110.661 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.695 ' HG3' HD23 ' A' ' 376' ' ' LEU . 8.0 mm-40 -85.1 145.07 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 tptm . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.819 172.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 335' ' ' THR . 7.7 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.789 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.3 p90 -58.97 130.94 49.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 110.181 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.7 t -177.58 -165.45 0.11 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.02 107.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.538 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.5 OUTLIER -68.4 136.24 53.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.818 0.818 . . . . 0.0 110.877 -174.096 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.544 ' OD1' HG22 ' A' ' 310' ' ' THR . 8.7 t70 -65.92 147.75 52.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.924 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.792 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -61.56 -13.37 21.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.248 -177.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.544 HG22 ' OD1' ' A' ' 308' ' ' ASP . 15.3 t -104.29 6.19 35.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 41.4 mtpt -106.36 17.42 23.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.792 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.5 OUTLIER -132.74 158.32 42.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.2 t -138.71 154.08 48.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.503 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.524 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.5 m-90 -63.8 98.49 0.2 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.367 0.604 . . . . 0.0 110.885 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -83.51 -32.42 25.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 37.6 ttm180 -165.24 116.12 1.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.255 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.42 163.6 24.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.344 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.0 Cg_exo -41.7 117.91 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.638 2.226 . . . . 0.0 112.107 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.7 m -135.49 144.52 46.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.345 -172.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.82 130.3 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.529 ' HB3' HG13 ' A' ' 327' ' ' VAL . 80.6 p -71.15 -18.64 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.93 -2.59 72.53 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 9.1 t60 -109.09 -52.88 2.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 19.0 t70 169.19 -25.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.311 1.053 . . . . 0.0 108.915 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.456 ' CB ' HG13 ' A' ' 358' ' ' ILE . 9.4 p -92.83 -168.28 1.92 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.004 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.68 150.92 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -131.85 163.7 36.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.979 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.39 163.99 31.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 4.0 tt0 -132.06 126.68 34.42 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.656 0.597 . . . . 0.0 110.1 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.91 153.9 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.38 152.27 16.84 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.999 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.644 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -89.93 165.86 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.227 0.514 . . . . 0.0 111.798 -174.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 35.3 m -115.6 8.03 14.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.338 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 147.61 13.11 0.15 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.458 -1.354 . . . . 0.0 115.2 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 336' ' ' ARG . 98.4 m -114.29 132.71 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.292 1.046 . . . . 0.0 110.586 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.789 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 28.0 ptt180 -75.94 173.11 7.72 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.027 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.62 93.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 124.051 3.167 . . . . 0.0 115.166 -168.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 1.8 p -110.8 150.78 28.63 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.035 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.28 108.75 3.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.599 ' HB ' ' HG3' ' A' ' 364' ' ' MET . 15.6 tt -92.4 119.24 68.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 121.013 0.435 . . . . 0.0 110.24 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.47 82.23 2.13 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.987 2.458 . . . . 0.0 112.535 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -98.93 128.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.384 0.611 . . . . 0.0 111.477 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 32.0 ptt180 -135.17 -176.13 4.15 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.68 141.58 22.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.255 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 14.6 m -120.47 168.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.44 34.11 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.049 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.538 ' HA ' ' OD2' ' A' ' 380' ' ' ASP . 5.4 t60 56.91 46.54 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.514 0.509 . . . . 0.0 111.381 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.431 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 61.79 14.44 44.24 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.642 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 347' ' ' HIS . 38.7 t -115.78 115.86 41.13 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.155 0.478 . . . . 0.0 111.216 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.9 Cg_exo -79.16 51.29 3.8 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.231 2.62 . . . . 0.0 112.228 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -85.07 -41.4 15.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.739 0.781 . . . . 0.0 109.222 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 351' ' ' GLU . 4.4 p -144.11 118.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.602 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -55.78 108.09 0.41 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.948 ' HA ' HD22 ' A' ' 376' ' ' LEU . 28.2 m -84.99 0.18 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.124 0.487 . . . . 0.0 110.293 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.455 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.36 82.97 3.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.216 0.532 . . . . 0.0 110.835 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.744 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 8.5 tpt -97.59 91.96 5.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 166.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 39.3 mt -74.49 120.37 19.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.454 -165.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -70.32 -19.01 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 61.7 m -128.25 81.89 69.61 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.252 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -86.18 43.92 1.18 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.14 2.56 . . . . 0.0 113.811 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.14 67.62 0.41 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.473 ' HB3' HG23 ' A' ' 372' ' ' ILE . 68.9 Cg_endo -91.49 134.91 1.65 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.816 2.344 . . . . 0.0 114.01 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 2.8 p -116.65 155.94 27.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.93 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.933 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 76.7 mtp -95.43 103.72 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.981 0.42 . . . . 0.0 109.868 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -79.72 -165.56 0.83 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.732 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -46.85 -30.86 2.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -122.69 25.72 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.757 -0.59 . . . . 0.0 111.289 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.09 -177.6 20.37 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.008 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.933 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.12 -25.09 53.35 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.395 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.09 -110.98 3.71 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.642 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -108.1 131.9 54.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.152 0.501 . . . . 0.0 111.721 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.2 mt -134.98 141.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.857 ' HG2' HG12 ' A' ' 327' ' ' VAL . 30.9 mt-10 -114.46 137.09 52.28 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.492 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.524 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -144.46 156.08 44.03 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.744 ' O ' ' HB3' ' A' ' 356' ' ' MET . 24.1 tp60 -175.65 144.92 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.709 0.29 . . . . 0.0 110.96 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.017 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.2 tp -147.15 160.07 40.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 164.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 1.017 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 38.7 Cg_exo -29.47 133.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.147 3.231 . . . . 0.0 114.579 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.439 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 73.0 Cg_exo -35.37 135.69 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.016 1 C-N-CA 125.441 4.094 . . . . 0.0 115.562 -176.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.61 -135.71 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.7 p-10 -131.17 107.47 9.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.162 0.982 . . . . 0.0 109.977 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 354' ' ' VAL . 6.1 m-20 -102.26 128.65 48.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.632 -177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.968 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -119.63 135.73 59.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.524 HD11 ' HG2' ' A' ' 374' ' ' MET . 42.2 mt -91.07 129.48 41.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.873 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -108.93 91.84 3.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.971 176.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 342' ' ' VAL . 9.3 t -83.6 85.6 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.24 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.359 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 3.1 t0 -112.1 -22.64 10.89 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.643 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -64.13 140.08 58.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.226 177.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.489 ' H ' ' HZ2' ' A' ' 314' ' ' TRP . 25.7 p-10 -151.74 139.43 19.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.39 116.98 1.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.968 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 26.9 tt0 -67.38 141.57 57.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.763 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 27.9 t-105 -139.79 122.11 16.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.121 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 11.8 p90 -79.76 109.07 13.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.077 0.465 . . . . 0.0 109.908 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 3.2 pp0? -104.11 133.16 49.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.048 0.452 . . . . 0.0 110.511 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.61 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 335' ' ' THR . 6.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.185 0.516 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -57.99 131.15 49.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.792 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.9 t -176.39 -167.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.0 t -68.13 116.65 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 137.22 56.08 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.805 0.812 . . . . 0.0 111.446 -170.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.65 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.4 t0 -60.69 143.33 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.545 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.646 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.1 -171.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.65 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.2 t -108.58 3.96 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.508 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 37.3 mttp -80.19 -21.53 42.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -95.97 154.02 17.46 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.347 0.594 . . . . 0.0 110.958 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.8 t -136.95 156.44 48.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.226 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -59.98 99.9 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.762 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.536 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 27.6 tptp -89.34 -46.42 8.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.445 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 28.5 ttm180 -154.92 122.43 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.792 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.46 157.19 86.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.33 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 392' ' ' TRP . 2.4 Cg_endo -42.24 112.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.111 2.541 . . . . 0.0 112.689 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -127.61 144.64 51.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.02 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.75 128.02 6.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 93.4 p -64.96 -23.1 67.12 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.521 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.86 -12.4 20.36 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.753 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.0 -40.92 1.98 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -178.0 -28.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.384 0.611 . . . . 0.0 111.667 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.467 ' HB ' HG13 ' A' ' 358' ' ' ILE . 16.7 p -93.31 -170.88 2.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.035 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.0 OUTLIER -127.62 144.72 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 -177.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.915 HG12 ' HG2' ' A' ' 373' ' ' GLU . 21.9 m -129.23 142.73 43.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.603 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.7 ptm -125.91 166.88 16.08 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.536 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 15.6 tt0 -136.7 140.54 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.603 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -139.52 158.89 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.67 0.271 . . . . 0.0 111.335 -178.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.652 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.86 135.85 9.64 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.629 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD2' ' HA2' ' A' ' 368' ' ' GLY . 2.3 p90 -90.74 178.45 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.192 0.496 . . . . 0.0 109.941 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.0 m -152.45 19.1 0.63 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -160.82 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.486 -1.34 . . . . 0.0 114.11 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 336' ' ' ARG . 67.9 m -70.49 139.98 51.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 4.8 ptt180 -67.34 175.84 1.42 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 117.611 -1.185 . . . . 0.0 109.013 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 364' ' ' MET . 3.7 Cg_exo -26.02 92.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 124.002 3.134 . . . . 0.0 114.247 -174.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 1.6 p -113.34 151.85 30.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.152 -171.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 9.1 mpt_? -69.24 109.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.579 HD11 HG11 ' A' ' 385' ' ' VAL . 11.3 tt -89.22 118.7 69.4 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 120.946 0.403 . . . . 0.0 110.459 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.8 84.12 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.085 2.523 . . . . 0.0 112.798 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -100.7 130.63 49.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 41.0 ptt180 -138.29 -170.26 2.77 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' A' ' 355' ' ' ALA . . . -155.52 140.89 17.68 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.348 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.83 167.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.44 113.05 26.26 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.886 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 56.68 49.39 14.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.75 2.15 27.78 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.252 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 25.9 t -110.37 113.05 56.58 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 117.73 0.765 . . . . 0.0 111.484 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 3.0 Cg_exo -79.33 63.17 8.69 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.485 2.79 . . . . 0.0 112.906 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.73 -46.01 6.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.622 0.725 . . . . 0.0 109.369 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.92 124.52 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.074 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.5 t30 -63.02 107.98 1.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.62 HG11 HD21 ' A' ' 381' ' ' ASN . 34.3 m -90.94 11.56 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.549 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -83.3 83.19 7.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.548 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 36.7 ttm -96.92 87.26 4.21 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.6 mt -72.48 119.78 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.659 -165.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -69.79 -14.42 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -142.49 85.93 10.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.552 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 357' ' ' LEU . 96.9 Cg_endo -87.46 46.03 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.328 2.686 . . . . 0.0 113.944 -171.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -163.13 62.68 1.2 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.027 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.483 ' O ' HG22 ' A' ' 340' ' ' ILE . 86.1 Cg_endo -86.02 129.44 3.39 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.167 1.912 . . . . 0.0 113.405 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -116.96 150.56 38.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.502 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.839 ' HE1' ' HB3' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -99.81 118.78 37.01 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.974 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.94 -165.32 1.24 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 124.929 1.393 . . . . 0.0 110.697 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -55.89 -21.67 21.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -100.24 -0.43 38.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.313 0.577 . . . . 0.0 110.437 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.652 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.91 -160.14 13.58 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -65.6 -2.7 11.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 117.606 0.703 . . . . 0.0 112.505 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 56.21 -130.12 48.96 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -172.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 328' ' ' MET . 38.3 p90 -112.36 150.11 31.52 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.997 0.427 . . . . 0.0 110.432 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 342' ' ' VAL . 2.2 mt -134.0 143.68 37.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.418 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.915 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.0 mt-10 -112.4 139.71 47.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.541 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.6 ppp? -156.86 162.89 39.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.171 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.864 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.89 169.63 6.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.064 0.459 . . . . 0.0 111.829 172.388 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.7 tm? -166.12 141.03 3.8 Favored Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.809 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.4 Cg_exo -31.36 132.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.849 3.033 . . . . 0.0 114.12 175.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.541 ' CA ' HE22 ' A' ' 394' ' ' GLN . 6.0 Cg_exo -37.17 130.93 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.154 1 C-N-CA 125.783 4.322 . . . . 0.0 115.016 -170.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.99 -173.32 37.43 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.7 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.8 m-20 -90.1 101.53 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.037 0.419 . . . . 0.0 110.066 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.62 HD21 HG11 ' A' ' 354' ' ' VAL . 11.1 m120 -111.89 -179.64 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.506 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.77 139.3 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 O-C-N 122.268 -0.27 . . . . 0.0 110.322 178.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.628 ' HB ' ' CE1' ' A' ' 390' ' ' HIS . 29.9 mt -91.04 133.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 389' ' ' ASN . 1.8 t80 -112.95 104.25 12.21 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 342' ' ' VAL . 6.2 t -97.01 83.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.86 -88.74 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.516 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.41 -31.18 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.2 mp -63.62 140.92 58.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 5.0 p-10 -140.25 140.62 35.81 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.829 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.628 ' CE1' ' HB ' ' A' ' 383' ' ' ILE . 0.8 OUTLIER -162.86 102.23 1.01 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.597 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.4 tt0 -81.41 152.23 27.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.404 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.739 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.2 OUTLIER -159.53 150.37 19.47 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 35.5 p90 -94.14 128.94 40.85 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.371 -0.83 . . . . 0.0 109.665 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.541 HE22 ' CA ' ' A' ' 378' ' ' PRO . 3.6 pp0? -109.39 145.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.022 0.439 . . . . 0.0 110.474 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 395' ' ' LYS . 7.2 tmtt? . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.466 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.595 HG23 HG23 ' A' ' 335' ' ' THR . 8.7 t . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.365 0.602 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.71 113.78 5.11 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.685 0.755 . . . . 0.0 110.098 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.1 t -173.81 -166.45 0.31 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.91 104.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.729 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.6 OUTLIER -74.47 167.23 22.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.9 t70 -71.89 150.3 44.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.62 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 24.6 pttt -74.5 -19.82 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.613 -167.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 308' ' ' ASP . 15.3 t -107.69 22.65 15.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.077 0.465 . . . . 0.0 111.625 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -95.64 18.55 12.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -134.23 173.67 11.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.388 0.614 . . . . 0.0 111.187 -178.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 140.81 33.01 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.299 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -54.01 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.518 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.98 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 76.3 tttt -85.89 -43.64 13.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 24.9 ttm180 -148.84 126.77 11.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.226 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' A' ' 390' ' ' HIS . . . -70.9 160.64 81.61 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.75 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -42.35 115.39 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.292 1.995 . . . . 0.0 111.467 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 5.0 m -134.34 144.61 48.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.732 -172.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -46.3 128.15 9.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 0.0 111.239 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -74.98 -22.05 58.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.451 -173.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.25 84.55 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -169.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -124.81 32.51 5.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.394 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.3 t70 68.9 19.39 8.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.309 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.764 ' HA ' HE21 ' A' ' 375' ' ' GLN . 13.8 p -136.76 -168.26 2.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.51 151.36 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.982 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.9 m -139.44 147.62 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.193 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.57 ' HB3' HD12 ' A' ' 383' ' ' ILE . 11.9 ptm -126.7 163.02 24.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.555 171.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.98 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 11.5 tt0 -128.14 127.47 43.06 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.87 138.23 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.062 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -108.6 139.98 15.38 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.82 -179.87 4.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.249 1.025 . . . . 0.0 111.715 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.2 p -129.99 -24.47 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.656 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -144.54 -68.02 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.375 -1.393 . . . . 0.0 115.0 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 307' ' ' CYS . 7.1 m -56.24 122.19 11.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.811 0.306 . . . . 0.0 111.619 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.459 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.8 ptm180 -74.21 171.82 10.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 117.68 -1.152 . . . . 0.0 108.589 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.98 96.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.955 3.103 . . . . 0.0 114.929 -170.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.746 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.7 p -118.09 165.57 13.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.257 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.47 100.61 12.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 362' ' ' PRO . 18.9 pt -74.6 128.65 85.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.79 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.24 82.09 1.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.669 2.246 . . . . 0.0 112.089 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 20.5 m -97.63 133.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.536 0.684 . . . . 0.0 111.131 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -145.45 -177.73 5.72 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.516 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.15 137.18 18.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.811 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.1 m -113.66 172.76 3.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -100.96 115.9 31.55 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 6.1 p-80 41.38 59.82 2.27 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.887 0.742 . . . . 0.0 112.831 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.867 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.97 5.02 37.76 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.898 -0.592 . . . . 0.0 114.226 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 25.3 t -114.52 116.98 43.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 117.386 0.593 . . . . 0.0 111.026 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 9.6 Cg_exo -74.63 54.44 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.196 2.598 . . . . 0.0 111.471 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.561 ' HG3' HG12 ' A' ' 352' ' ' VAL . 7.8 pt-20 -86.22 -38.96 17.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.776 0.798 . . . . 0.0 108.951 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 351' ' ' GLU . 5.2 p -151.68 123.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.843 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -56.19 108.05 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.894 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.99 3.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.21 0.529 . . . . 0.0 110.2 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.93 82.66 5.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.318 -177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -96.15 91.27 5.84 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 373' ' ' GLU . 20.9 mt -70.8 120.41 16.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.658 -167.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.7 mm -68.52 -21.03 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.287 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 10.3 m -136.98 92.38 14.24 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.845 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.4 43.65 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.218 2.612 . . . . 0.0 112.895 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.4 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.1 p-10 -150.37 58.65 3.17 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.722 ' HB2' HD11 ' A' ' 340' ' ' ILE . 92.5 Cg_endo -86.86 113.03 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.412 2.074 . . . . 0.0 113.244 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.2 p -114.06 140.09 48.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.913 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.746 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 24.6 ptt? -102.84 126.3 49.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.737 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.03 -166.24 1.18 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.307 -172.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -61.23 -12.88 14.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.26 -4.34 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.335 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.51 -165.47 12.71 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -78.52 -7.11 88.15 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.145 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 66.59 -120.66 15.35 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.688 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -116.04 140.22 49.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.217 0.532 . . . . 0.0 111.204 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.4 mt -124.42 126.6 72.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.1 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.982 ' HG2' HG12 ' A' ' 327' ' ' VAL . 38.1 mt-10 -104.75 132.58 50.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.217 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.464 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.764 HE21 ' HA ' ' A' ' 325' ' ' THR . 6.4 tp-100 -174.32 145.08 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.097 0.248 . . . . 0.0 110.592 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.0 tp -143.59 162.74 40.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 34.5 Cg_exo -36.48 141.8 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.269 2.646 . . . . 0.0 113.492 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.434 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 5.7 Cg_exo -37.53 134.64 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 125.325 4.017 . . . . 0.0 114.77 -173.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.37 -146.75 13.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.348 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 14.8 m-20 -112.55 101.36 9.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.481 0.641 . . . . 0.0 110.213 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 354' ' ' VAL . 6.6 m120 -100.05 118.81 37.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.609 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.016 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.88 133.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 328' ' ' MET . 30.7 mt -93.13 134.02 32.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.461 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.8 OUTLIER -109.74 92.76 4.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.342 174.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 342' ' ' VAL . 5.5 t -81.28 77.99 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.69 -91.68 0.27 Allowed Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.971 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.62 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -106.61 -18.0 14.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.342 0.592 . . . . 0.0 109.643 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.9 OUTLIER -74.37 128.26 35.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.534 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.99 143.68 48.29 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.534 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 0.1 OUTLIER -166.16 120.17 1.14 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.817 0.341 . . . . 0.0 110.806 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.016 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 47.1 tt0 -82.36 146.73 29.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.935 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 19.7 t-105 -141.97 132.97 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.76 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.87 119.48 29.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.434 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 3.2 pp0? -114.3 146.09 40.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.002 0.43 . . . . 0.0 110.343 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 pttt . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.847 -178.366 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.052 0.453 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.594 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 14.6 p90 -60.74 128.81 38.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -176.29 -172.42 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.04 110.44 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.494 ' HB2' ' HE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -68.67 134.73 50.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.684 0.754 . . . . 0.0 112.112 -172.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.632 ' OD1' HG22 ' A' ' 310' ' ' THR . 32.7 t70 -63.51 146.18 54.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.274 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.659 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.83 -14.66 62.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.321 -1.309 . . . . 0.0 114.309 -167.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.632 HG22 ' OD1' ' A' ' 308' ' ' ASP . 9.1 t -106.3 5.38 29.65 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.683 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -89.73 -21.16 22.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.08 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.72 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -95.87 147.45 23.65 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.21 0.529 . . . . 0.0 110.17 172.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 4.3 t -133.25 153.3 51.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.49 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.9 m-90 -61.98 99.12 0.12 Allowed 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 123.57 0.544 . . . . 0.0 111.232 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.629 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -84.44 -42.59 15.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 53.7 ttt180 -156.03 125.58 6.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.894 170.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.58 167.23 13.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.258 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.55 122.28 1.32 Allowed 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.925 2.417 . . . . 0.0 112.138 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -135.35 136.77 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.637 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -46.0 124.65 5.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 111.131 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -36.49 83.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.749 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 130.58 -10.71 5.78 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -114.84 -78.07 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.774 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.26 0.33 0.6 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.086 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.872 ' HA ' HE21 ' A' ' 375' ' ' GLN . 20.9 p -119.9 -174.28 2.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.142 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.4 153.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.884 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.816 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.6 m -133.44 163.99 36.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.557 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -147.71 153.71 39.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.649 -178.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.629 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 26.4 tt0 -129.6 118.07 21.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.597 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.721 HG13 ' SD ' ' A' ' 328' ' ' MET . 2.3 m -122.63 150.56 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.542 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.69 136.37 12.94 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.783 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.4 OUTLIER -90.93 -179.44 5.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.594 0.712 . . . . 0.0 111.241 -176.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.9 m -119.64 -25.78 5.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.993 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.21 -19.53 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.357 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 336' ' ' ARG . 5.5 m -75.3 134.75 40.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.021 0.91 . . . . 0.0 112.446 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.642 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.1 OUTLIER -78.3 173.7 7.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.611 171.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -25.46 95.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 124.021 3.147 . . . . 0.0 114.745 -173.299 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 305' ' ' THR . 21.8 p -110.67 166.87 10.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.336 -174.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.7 mpt_? -93.75 104.6 16.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.65 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.896 HD12 ' HB2' ' A' ' 362' ' ' PRO . 5.7 mt -75.79 123.82 88.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 81.42 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.311 2.007 . . . . 0.0 111.686 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 372' ' ' ILE . 14.5 m -100.58 133.62 43.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.416 0.627 . . . . 0.0 111.586 -177.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -143.24 -175.53 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.92 143.21 18.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.249 0.547 . . . . 0.0 111.459 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.4 m -115.17 172.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -102.5 115.67 31.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 2.6 p-80 37.86 64.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.728 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.44 6.34 33.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 38.9 t -115.69 113.66 42.45 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 117.616 0.708 . . . . 0.0 111.467 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.72 69.07 5.4 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.08 2.52 . . . . 0.0 111.364 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -95.19 -49.02 5.68 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.13 131.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.391 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 42.8 t30 -60.1 107.91 0.7 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.023 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.921 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.3 m -85.26 1.62 4.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 110.65 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.23 82.93 6.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.073 0.463 . . . . 0.0 110.479 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.04 92.24 5.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 28.5 mt -70.25 124.85 25.16 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.773 -165.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.0 mm -69.75 -21.53 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.702 -1.135 . . . . 0.0 107.994 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.8 m -137.33 94.82 11.97 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.7 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -86.01 41.22 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.396 2.731 . . . . 0.0 113.256 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -160.31 70.62 2.97 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.393 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.896 ' HB2' HD12 ' A' ' 340' ' ' ILE . 95.6 Cg_endo -82.19 133.6 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.492 2.128 . . . . 0.0 112.434 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.0 p -129.12 141.28 51.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.208 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.716 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 74.1 mtp -96.0 130.51 42.98 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.5 -168.72 1.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.271 0.982 . . . . 0.0 111.837 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . 12.3 p30 -70.08 -5.62 28.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.435 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -113.52 9.12 17.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.4 0.619 . . . . 0.0 109.871 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.58 -165.75 16.77 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.246 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.716 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.53 -12.86 70.56 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.035 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.47 -119.25 10.03 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.6 m-85 -121.87 131.51 54.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.688 0.756 . . . . 0.0 111.606 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -106.17 157.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.816 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.2 mt-10 -126.87 129.15 47.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.867 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.4 OUTLIER -147.99 156.41 42.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.531 -172.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.872 HE21 ' HA ' ' A' ' 325' ' ' THR . 6.8 tp-100 -177.65 146.73 0.46 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.645 0.259 . . . . 0.0 110.873 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.954 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.9 tp -145.26 154.46 53.77 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.954 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 41.5 Cg_exo -26.87 133.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 124.476 3.451 . . . . 0.0 115.134 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.527 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 54.6 Cg_exo -35.58 128.73 0.32 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 125.134 3.889 . . . . 0.0 115.114 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 167.68 -135.25 3.56 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.984 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.434 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 23.2 m-20 -119.72 101.03 7.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.156 0.478 . . . . 0.0 110.226 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.81 125.36 48.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.102 0.477 . . . . 0.0 109.893 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -124.15 129.13 74.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 16.9 mt -91.77 130.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.921 0.391 . . . . 0.0 110.66 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.8 m-85 -99.35 92.46 5.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.88 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.461 HG13 HG12 ' A' ' 342' ' ' VAL . 14.6 t -79.92 84.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.96 -86.62 0.13 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.479 -171.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.62 ' CB ' ' HD3' ' A' ' 309' ' ' LYS . 31.0 t0 -116.71 -19.77 9.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.324 0.583 . . . . 0.0 109.479 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.613 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 0.8 OUTLIER -59.34 142.83 51.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.164 174.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.3 p30 -152.32 138.78 18.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.804 0.335 . . . . 0.0 110.755 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.414 ' C ' HG12 ' A' ' 382' ' ' ILE . 33.7 t-80 -165.17 126.39 2.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.12 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.0 tt0 -79.04 152.01 31.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 19.9 t-105 -147.61 120.69 8.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.887 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -73.98 114.26 12.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.527 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.3 pp0? -112.27 144.06 42.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.699 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.246 0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.414 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 335' ' ' THR . 4.8 t . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 16.4 p90 -61.56 123.47 17.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.141 0.496 . . . . 0.0 110.958 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 11.6 t -171.93 -167.61 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.21 115.37 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.09 156.09 38.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.874 0.845 . . . . 0.0 111.665 -172.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.584 ' HB3' ' HD2' ' A' ' 311' ' ' LYS . 12.8 t70 -90.77 147.19 23.38 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.749 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.775 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.49 -13.56 14.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.063 -175.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.405 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 4.8 t -101.0 5.44 43.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 29.5 mttt -105.33 13.04 31.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.775 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -128.19 143.83 51.07 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 168.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -128.82 154.18 46.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.62 113.98 3.02 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.82 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 63.3 tttt -112.29 -53.91 2.67 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -140.71 117.89 11.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.22 161.37 32.76 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.09 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -44.69 119.59 2.36 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.643 2.229 . . . . 0.0 111.949 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -131.0 139.13 49.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.367 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.58 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 111.445 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 96.5 p -67.27 -21.8 65.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.487 -174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.36 -18.73 30.07 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.482 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -105.72 -54.23 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.058 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.59 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.739 0.781 . . . . 0.0 110.687 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.879 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 32.8 p -103.76 -168.19 1.47 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.689 -174.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.949 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.1 t -125.5 151.53 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 373' ' ' GLU . 18.4 m -136.32 144.89 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 123.31 0.644 . . . . 0.0 110.004 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.6 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.5 ptm -131.66 169.55 16.01 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.359 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.924 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 4.6 tt0 -136.39 133.04 36.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.144 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.6 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -131.42 154.53 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.203 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.36 138.79 14.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.902 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.798 ' HA ' ' O ' ' A' ' 311' ' ' LYS . 1.2 p90 -99.69 177.47 5.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.731 0.765 . . . . 0.0 110.815 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t -164.69 45.71 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.044 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.508 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -176.85 -63.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.905 172.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 338' ' ' CYS . 27.6 m -86.98 129.1 35.03 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.807 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 6.1 ptm180 -64.78 169.1 5.75 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.166 171.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.53 94.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.056 3.17 . . . . 0.0 114.383 -168.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 4.7 p -111.79 151.81 28.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.844 -173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.3 mpt_? -73.39 108.39 6.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.514 HD11 HG11 ' A' ' 385' ' ' VAL . 14.4 tt -85.19 126.98 65.95 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.64 -175.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.62 82.17 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.557 2.171 . . . . 0.0 112.092 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 372' ' ' ILE . 16.5 m -103.21 122.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 111.271 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 17.8 ptt-85 -129.85 -173.98 3.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -155.59 139.49 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.399 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -113.04 171.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.43 28.51 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.495 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 34.4 t-80 51.24 55.41 9.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.004 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.664 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 63.7 8.6 28.06 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.634 0.614 . . . . 0.0 114.634 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 52.4 t -110.2 111.53 57.91 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 117.821 0.81 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.3 Cg_exo -77.89 46.29 2.02 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.475 2.783 . . . . 0.0 112.912 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -92.21 -53.46 4.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.487 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.03 111.4 35.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.203 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 40.2 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.773 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.723 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.17 6.5 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.675 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.61 83.33 4.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.384 0.612 . . . . 0.0 110.35 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.8 ttp -102.8 87.9 3.07 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.9 mt -72.3 122.82 21.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.093 -165.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -67.96 -22.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 52.9 m -128.97 85.98 58.63 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.154 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.21 40.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.948 2.432 . . . . 0.0 113.925 -170.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -170.56 69.77 0.55 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.13 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 340' ' ' ILE . 70.0 Cg_endo -85.09 137.87 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.299 1.999 . . . . 0.0 112.84 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.4 p -119.54 145.93 45.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.681 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 74.4 mtp -95.82 107.55 19.81 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.855 0.36 . . . . 0.0 110.193 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.02 -167.32 1.84 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.079 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -63.73 -14.33 51.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -101.29 12.97 36.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.5 0.667 . . . . 0.0 109.885 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.56 -162.27 27.87 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -67.45 -16.48 67.42 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.41 -124.45 18.94 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 328' ' ' MET . 2.7 p90 -116.83 135.53 53.67 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 342' ' ' VAL . 2.7 mt -122.14 134.6 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.759 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.6 mp0 -103.05 133.01 48.89 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.191 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.8 ppp? -148.72 160.04 43.55 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -176.84 166.75 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.7 172.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.864 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.4 tp -164.9 151.34 9.22 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.864 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.3 Cg_exo -36.08 143.25 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.24 2.627 . . . . 0.0 113.595 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.628 ' HB3' ' HD3' ' A' ' 395' ' ' LYS . 3.7 Cg_exo -37.04 135.69 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.768 1 C-N-CA 125.52 4.147 . . . . 0.0 115.032 -170.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.47 -151.27 21.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.391 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.3 m-20 -109.93 101.24 10.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.212 0.506 . . . . 0.0 110.435 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.438 ' HA ' HG21 ' A' ' 354' ' ' VAL . 8.6 m120 -101.36 122.96 44.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.965 0.412 . . . . 0.0 109.945 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.102 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.4 130.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.241 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.9 mt -89.01 126.93 42.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.075 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.512 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.02 92.49 4.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.814 174.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.565 HG13 HG12 ' A' ' 342' ' ' VAL . 23.0 t -83.47 90.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.45 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.084 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -106.87 -22.7 12.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.161 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.536 HD23 ' CE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -66.14 141.11 58.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.617 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -135.66 142.42 45.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.536 ' CE1' HD23 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -163.05 102.76 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.102 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 16.9 tt0 -76.75 149.25 36.34 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -144.94 142.39 29.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.429 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -99.16 111.06 23.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.467 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.0 pp0? -96.79 129.16 44.26 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.651 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 378' ' ' PRO . 47.5 tttm . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.938 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 305' ' ' THR . 5.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.087 0.47 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.479 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 11.5 p90 -62.57 118.57 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t -179.57 -170.31 0.16 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.4 t -66.76 106.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.7 146.94 52.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.531 0.681 . . . . 0.0 112.452 -168.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.507 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.1 t70 -62.34 137.87 58.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.368 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.74 -23.21 67.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.256 -170.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.507 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.7 t -94.75 -4.91 46.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 111.363 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 24.4 mtpp -88.57 49.4 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 0.0 111.366 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.474 ' HZ ' HD13 ' A' ' 340' ' ' ILE . 1.8 m-85 -139.46 169.13 18.32 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.253 -177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -157.93 138.46 12.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.536 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.95 107.78 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.576 0.703 . . . . 0.0 111.527 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 315' ' ' LYS . 46.7 tptt -83.98 -36.81 22.93 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 9.2 ttm180 -160.04 109.18 1.76 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.833 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.43 156.41 52.38 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.185 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 392' ' ' TRP . 6.5 Cg_exo -32.72 118.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.931 3.087 . . . . 0.0 113.605 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.2 m -143.52 144.38 31.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.887 -171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -44.44 136.55 4.11 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 111.478 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.636 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.2 p -69.43 -23.52 63.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.968 -173.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.92 -1.42 88.8 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -171.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -107.27 -54.76 2.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.12 -32.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.002 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.502 ' CB ' HG13 ' A' ' 358' ' ' ILE . 1.1 p -95.81 -166.88 1.51 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.845 -175.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 392' ' ' TRP . 0.9 OUTLIER -109.48 155.99 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.876 176.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -139.42 174.25 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.115 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.702 ' HE2' HD12 ' A' ' 372' ' ' ILE . 21.5 ptt? -151.71 158.87 43.97 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 25.8 tt0 -120.27 125.82 49.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 312' ' ' PHE . 13.5 m -130.02 137.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.061 0.457 . . . . 0.0 112.03 -173.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.25 13.91 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.574 ' HD1' ' H ' ' A' ' 335' ' ' THR . 0.2 OUTLIER -118.23 179.99 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.451 0.626 . . . . 0.0 111.47 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.9 p -130.47 11.19 5.31 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.86 31.3 0.13 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 119.477 -1.344 . . . . 0.0 115.479 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.845 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 31.0 m -112.67 122.56 48.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.537 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 20.6 ptt180 -76.95 167.02 40.26 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.052 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.13 98.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 124.225 3.283 . . . . 0.0 114.855 -165.395 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.86 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 13.2 p -109.64 173.13 6.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.552 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 19.9 mmm180 -95.45 102.91 14.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.795 HG22 HG13 ' A' ' 342' ' ' VAL . 48.8 mt -75.89 124.88 88.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.747 0.308 . . . . 0.0 111.575 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.33 82.01 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.884 2.389 . . . . 0.0 111.972 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.795 HG13 HG22 ' A' ' 340' ' ' ILE . 6.1 m -103.23 129.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.572 0.701 . . . . 0.0 111.325 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -142.49 -174.57 4.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -153.04 138.78 17.91 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.898 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 382' ' ' ILE . 16.8 m -110.34 175.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -109.03 114.08 27.52 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.554 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 50.68 47.98 23.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.688 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.34 16.7 67.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.484 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.86 109.85 46.98 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 110.861 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 61.76 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.48 2.786 . . . . 0.0 112.274 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -97.48 -47.2 5.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.842 0.829 . . . . 0.0 109.011 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -137.21 124.05 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.563 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.6 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.908 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.907 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.1 m -89.5 5.77 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.0 110.753 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.63 84.26 6.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.447 ' HB2' HD13 ' A' ' 376' ' ' LEU . 0.0 OUTLIER -97.5 87.02 3.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 170.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 38.1 mt -68.82 126.53 30.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.582 -167.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -71.22 -20.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 48.6 m -136.45 87.48 21.78 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.933 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -88.4 50.95 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.332 2.688 . . . . 0.0 113.272 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.518 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.0 p-10 -160.49 58.9 1.12 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 1.2 Cg_endo -82.09 139.28 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.582 2.188 . . . . 0.0 112.592 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 338' ' ' CYS . 14.6 p -134.39 142.39 47.16 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.363 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.86 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 17.0 ptp -94.64 130.41 41.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.72 -165.32 1.19 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 124.925 1.391 . . . . 0.0 109.031 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -55.61 -20.57 14.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -108.55 13.12 25.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.21 -161.18 31.32 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.49 -25.35 74.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.84 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.08 -123.94 7.13 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.92 138.31 47.47 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' A' ' 328' ' ' MET . 0.8 OUTLIER -129.94 166.14 28.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.848 ' HG2' HG12 ' A' ' 327' ' ' VAL . 46.0 mt-10 -129.49 138.23 51.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.739 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -152.67 151.82 31.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.073 -174.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.761 HE22 ' HB2' ' A' ' 394' ' ' GLN . 4.6 tp60 -176.58 165.91 2.64 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.161 0.288 . . . . 0.0 110.864 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 12.2 tp -164.8 163.94 13.71 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 63.0 Cg_exo -29.11 131.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.826 3.017 . . . . 0.0 114.343 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.71 ' HB3' ' HD2' ' A' ' 395' ' ' LYS . 6.0 Cg_exo -38.28 139.36 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.825 1 C-N-CA 125.633 4.222 . . . . 0.0 114.938 -175.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.09 -153.08 24.53 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -103.35 109.91 21.71 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.264 0.225 . . . . 0.0 110.691 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 27.8 m-20 -112.22 172.69 6.76 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.202 175.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.051 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -165.16 133.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.9 mt -93.8 133.02 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.385 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -107.64 96.97 6.77 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.322 175.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.92 67.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.86 -84.05 0.58 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.489 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 15.1 t70 -100.44 -34.99 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.1 mp -61.03 143.34 55.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.8 p30 -159.67 138.47 10.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 126.52 1.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.154 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.051 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 57.5 mt-30 -70.13 153.23 43.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.546 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -153.94 150.53 28.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.474 171.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.47 136.0 40.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.761 ' HB2' HE22 ' A' ' 375' ' ' GLN . 2.9 pp0? -132.31 147.37 52.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.772 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.71 ' HD2' ' HB3' ' A' ' 378' ' ' PRO . 23.5 tptm . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.683 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.607 ' HD2' ' HD3' ' A' ' 336' ' ' ARG . 21.5 p90 -53.57 125.83 19.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 111.298 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.7 t -175.9 -175.9 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.172 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.41 105.57 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.5 OUTLIER -72.35 153.35 41.52 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.6 t70 -72.3 154.67 40.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.468 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -70.97 -12.52 61.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.453 -172.279 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.5 t -100.05 7.03 44.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.911 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.665 ' HE3' ' CB ' ' A' ' 335' ' ' THR . 3.9 mtpm? -85.31 -27.45 25.94 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.915 -0.491 . . . . 0.0 112.303 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.78 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.7 OUTLIER -102.62 160.12 14.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.646 0.736 . . . . 0.0 111.936 -175.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.0 t -140.37 155.42 46.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.789 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.47 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.5 m-90 -65.33 96.48 0.23 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.254 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.0 tttt -86.46 -46.76 9.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 37.0 ttm180 -147.34 98.93 3.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.663 171.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -55.04 159.17 4.09 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.947 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 7.1 Cg_exo -34.25 115.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.581 2.854 . . . . 0.0 113.596 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -129.49 134.06 47.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.806 -173.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -47.8 125.1 8.19 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.465 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.4 p -67.83 -35.27 78.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.577 -172.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.72 -11.88 18.26 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.724 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -98.51 -71.48 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -171.61 18.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.57 ' HB ' HG13 ' A' ' 358' ' ' ILE . 18.1 p -131.74 -167.91 1.94 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.397 -171.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.904 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 1.9 t -130.04 149.78 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.272 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.991 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -135.83 140.96 43.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.394 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 11.1 ptm -130.03 150.84 51.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.958 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.791 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.9 tt0 -116.14 122.56 45.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.754 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 14.5 m -126.28 139.85 50.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.661 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.16 141.49 15.28 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.918 -176.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -90.61 178.68 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.22 0.51 . . . . 0.0 110.561 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.5 t -122.8 -62.78 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.78 -59.66 0.19 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.771 -176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.665 ' CB ' ' HE3' ' A' ' 311' ' ' LYS . 52.1 m -56.72 134.26 54.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.827 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.9 ptm180 -66.8 179.67 0.5 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.755 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.16 96.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 124.01 3.14 . . . . 0.0 114.573 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 305' ' ' THR . 31.4 p -113.93 160.08 19.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.428 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.02 104.25 9.53 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 362' ' ' PRO . 16.8 tt -87.72 127.47 58.06 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.326 0.584 . . . . 0.0 111.342 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.57 92.44 0.86 Allowed 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.857 2.371 . . . . 0.0 112.504 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.67 HG11 HD13 ' A' ' 372' ' ' ILE . 31.4 m -110.13 135.5 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.897 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 23.7 ptt180 -149.8 -174.2 4.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.41 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.72 143.21 18.35 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.412 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.48 169.49 10.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.51 114.4 27.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 27.1 p-80 35.29 61.76 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.684 0.794 . . . . 0.0 112.851 -175.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.585 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 76.06 0.09 64.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.402 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.23 114.32 55.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.516 0.658 . . . . 0.0 111.616 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -78.72 58.49 6.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.62 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 352' ' ' VAL . 9.4 tt0 -83.22 -37.0 24.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.061 0.934 . . . . 0.0 108.823 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 351' ' ' GLU . 2.1 p -161.06 122.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.49 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -51.82 107.82 0.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.268 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.742 HG21 HD21 ' A' ' 381' ' ' ASN . 27.7 m -90.4 6.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.688 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -76.91 83.39 3.46 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.342 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 16.7 mmt -95.15 85.22 4.25 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.0 mt -68.2 126.23 28.9 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.398 -167.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -71.61 -17.59 19.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.2 m -139.56 91.89 10.56 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.897 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.16 35.33 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.254 2.636 . . . . 0.0 113.511 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -149.52 64.12 6.97 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.102 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 372' ' ' ILE . 69.8 Cg_endo -88.13 128.09 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.583 2.189 . . . . 0.0 113.443 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 12.1 p -122.98 149.45 44.27 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.535 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.728 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 72.4 mtm -95.94 106.32 18.46 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.268 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.591 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 55.4 mm-40 -80.9 -167.64 1.48 Allowed 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.956 1.41 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -65.63 -7.19 13.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.48 -4.84 15.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.444 0.64 . . . . 0.0 109.513 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.18 -166.75 12.71 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.97 -9.6 60.13 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.118 -175.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.78 -114.38 6.38 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.93 117.81 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.185 0.517 . . . . 0.0 111.288 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.67 HD13 HG11 ' A' ' 342' ' ' VAL . 1.6 mt -93.11 143.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.991 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -121.59 132.0 54.43 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.084 -174.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.628 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.9 OUTLIER -153.63 157.29 39.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.59 -171.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.783 HE22 ' HB2' ' A' ' 394' ' ' GLN . 3.3 tp60 -174.6 168.67 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.224 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.871 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -164.64 143.92 5.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.871 ' HD2' HD22 ' A' ' 376' ' ' LEU . 23.3 Cg_exo -28.82 124.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.805 3.003 . . . . 0.0 114.281 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.494 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 5.4 Cg_exo -37.39 131.82 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.158 1 C-N-CA 125.475 4.116 . . . . 0.0 114.805 -171.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 379' ' ' GLY . . . . . 0.437 ' N ' ' NE2' ' A' ' 394' ' ' GLN . . . 162.68 -161.09 33.45 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.791 -175.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -99.37 101.33 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.925 0.362 . . . . 0.0 111.025 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.742 HD21 HG21 ' A' ' 354' ' ' VAL . 14.9 m120 -121.04 -179.64 4.09 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.075 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.989 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.62 141.88 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 11.8 mt -96.22 133.55 37.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.639 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -111.9 92.17 3.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.353 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 11.9 t -86.42 90.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.41 -91.87 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.063 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -116.31 -4.7 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.78 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -78.06 142.38 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 23.9 p-10 -153.81 141.49 19.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.773 0.32 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.1 t-80 -162.08 116.25 1.86 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.771 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.989 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -78.26 143.19 37.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.544 177.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.904 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.8 OUTLIER -154.32 148.01 25.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -85.42 123.46 30.9 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.783 ' HB2' HE22 ' A' ' 375' ' ' GLN . 2.5 pp0? -105.73 144.86 31.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.017 0.437 . . . . 0.0 110.806 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.219 -175.454 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.714 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 23.5 p90 -68.52 112.29 5.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.933 0.873 . . . . 0.0 110.6 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 15.3 t -159.21 -165.97 1.71 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.451 -172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.0 113.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 143.89 55.15 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.8 0.81 . . . . 0.0 111.06 -174.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 8.9 t70 -75.44 147.35 39.98 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.325 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.773 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.58 -12.82 11.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.964 -173.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.459 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.2 t -103.66 9.35 37.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.674 0.273 . . . . 0.0 111.399 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 9.5 mtpp -96.39 -23.98 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.773 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -101.31 158.5 16.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 111.227 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 154.77 46.54 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.11 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.526 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 22.6 m-90 -60.36 96.34 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.7 tttm -80.52 -37.94 30.64 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.89 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 67.3 ttt180 -157.81 111.37 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.752 174.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -59.4 155.79 34.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.979 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.742 ' HG3' HD12 ' A' ' 383' ' ' ILE . 30.7 Cg_exo -34.27 115.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 123.294 2.663 . . . . 0.0 113.68 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.2 m -141.75 138.35 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.707 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.66 131.74 8.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.061 0.458 . . . . 0.0 112.074 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.649 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.5 p -73.9 -25.28 59.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -176.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.58 -5.35 73.71 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.362 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -119.44 39.22 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 69.97 4.84 4.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.512 0.725 . . . . 0.0 111.977 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 2.7 p -121.54 -170.26 2.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.797 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.4 OUTLIER -127.95 153.63 37.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.985 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.976 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -135.53 157.41 39.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 8.2 ptm -138.19 158.4 44.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.89 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.1 mt-10 -122.24 135.49 54.76 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.587 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.2 OUTLIER -132.34 152.27 36.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 177.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.691 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.89 149.68 18.15 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.922 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.479 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.4 p90 -94.08 178.94 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.291 0.567 . . . . 0.0 110.853 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.4 p -131.68 -17.62 2.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.102 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -170.03 -51.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.306 -1.426 . . . . 0.0 114.119 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 336' ' ' ARG . 24.6 m -57.17 129.66 42.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.714 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 11.7 ptm180 -69.79 167.32 24.52 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 117.982 -1.008 . . . . 0.0 108.514 171.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.79 96.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 123.894 3.062 . . . . 0.0 115.235 -167.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 5.9 p -108.8 147.24 32.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.131 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.39 108.24 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.55 HD11 HG11 ' A' ' 385' ' ' VAL . 12.5 tt -89.49 123.82 65.82 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.559 -176.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.69 92.22 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.902 2.401 . . . . 0.0 112.669 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.68 HG11 HD13 ' A' ' 372' ' ' ILE . 30.1 m -108.78 125.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.676 0.751 . . . . 0.0 111.451 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -134.19 -177.42 4.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -148.86 135.07 19.28 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.972 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -107.88 173.23 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -112.69 115.12 28.06 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.616 -174.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 33.4 t60 57.93 45.82 17.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.381 0.61 . . . . 0.0 110.227 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.441 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.02 6.57 46.19 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.001 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.16 111.42 60.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 117.361 0.58 . . . . 0.0 111.158 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -76.55 47.85 2.22 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.602 2.868 . . . . 0.0 113.032 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.35 -53.36 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.28 113.73 44.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.031 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 28.3 t30 -70.23 108.71 4.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.749 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.657 HG12 HD22 ' A' ' 376' ' ' LEU . 33.3 m -90.94 10.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.127 -175.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.459 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.23 84.37 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.116 0.484 . . . . 0.0 111.436 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.724 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 71.2 mtp -98.85 88.97 4.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 47.5 mt -76.66 120.76 22.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.157 -167.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.729 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -68.75 -16.9 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 91.5 m -135.19 87.73 27.75 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.906 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.57 40.36 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.127 2.551 . . . . 0.0 114.307 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.09 68.57 1.83 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.172 0.511 . . . . 0.0 111.389 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.502 ' HG3' HG21 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -85.48 135.59 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.444 2.096 . . . . 0.0 113.081 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.0 OUTLIER -129.72 146.85 51.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.679 174.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.651 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 29.0 mtm -94.61 104.98 16.92 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.315 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.6 -166.36 1.37 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.284 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -67.14 -10.59 51.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.147 0.499 . . . . 0.0 110.629 171.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.89 -7.03 58.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 90.27 -161.04 28.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -166.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -62.94 -19.77 61.55 Favored Glycine 0 C--N 1.322 -0.223 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.778 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 73.8 -124.68 8.71 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -112.06 127.0 55.77 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.68 HD13 HG11 ' A' ' 342' ' ' VAL . 1.0 OUTLIER -114.91 125.55 72.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.976 ' HG2' HG12 ' A' ' 327' ' ' VAL . 36.2 mt-10 -101.79 134.18 45.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.797 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -153.19 160.51 42.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.724 ' O ' ' HB2' ' A' ' 356' ' ' MET . 4.4 tp60 178.87 170.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.367 0.417 . . . . 0.0 110.725 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.854 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 7.8 tp -161.88 157.35 20.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.854 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 53.4 Cg_exo -39.25 131.74 1.46 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.342 2.028 . . . . 0.0 112.304 169.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.866 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.3 Cg_exo -38.05 129.49 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 125.297 3.998 . . . . 0.0 114.946 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 174.41 -133.57 2.55 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.589 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.67 101.59 7.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.289 0.236 . . . . 0.0 110.561 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.405 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 7.4 m120 -112.35 161.89 16.15 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.088 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.02 138.71 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.742 HD12 ' HG3' ' A' ' 318' ' ' PRO . 27.8 mt -94.65 132.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.376 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -109.03 91.71 3.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.2 t -83.88 84.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.34 -88.54 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.055 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.42 -14.17 13.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.226 0.536 . . . . 0.0 109.723 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.702 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -68.33 147.19 52.48 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.602 175.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 24.9 p-10 -156.76 140.31 15.87 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.669 0.271 . . . . 0.0 110.66 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 61.9 t-80 -165.88 115.2 0.99 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.546 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.088 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 44.5 tt0 -85.05 146.54 27.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.048 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.589 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.7 OUTLIER -147.97 150.03 33.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.35 132.78 36.46 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.952 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.475 ' HB3' ' NE1' ' A' ' 392' ' ' TRP . 3.2 pp0? -126.73 142.7 51.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 12.3 ptmm? . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.656 -0.688 . . . . 0.0 110.773 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.889 0.376 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.1 p90 -64.43 130.44 43.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.499 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.7 t 178.73 -166.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.83 114.65 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 143.0 56.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.702 0.763 . . . . 0.0 110.757 -173.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' ' HG2' ' A' ' 309' ' ' LYS . 5.8 t70 -86.48 150.57 24.18 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.693 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.703 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 23.4 pttm -52.03 -23.2 4.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.521 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 9.0 t -100.92 10.42 41.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.55 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 26.7 mmmt -92.5 -25.09 18.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.7 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.4 OUTLIER -112.44 157.9 20.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.323 0.582 . . . . 0.0 112.153 -176.446 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -133.92 158.18 44.11 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.717 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.463 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.7 m-90 -62.28 111.81 2.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.373 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.485 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -104.12 -40.3 6.21 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.212 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.818 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 32.5 ttm180 -158.74 129.94 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.419 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.28 163.11 70.58 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.234 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 3.0 Cg_exo -37.03 120.41 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.3 m -136.24 134.8 38.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.526 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -48.14 124.12 7.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.107 0.48 . . . . 0.0 110.946 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.1 p -65.17 -22.88 66.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.189 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.65 34.12 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -99.61 -71.89 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -175.06 21.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.912 0.863 . . . . 0.0 108.952 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.7 p -137.69 -169.18 2.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.418 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 374' ' ' MET . 0.2 OUTLIER -127.54 151.37 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.234 0.54 . . . . 0.0 111.633 -177.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.4 m -136.6 142.42 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.608 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 9.8 ptm -128.18 164.33 22.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.015 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.5 tt0 -126.46 126.07 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.048 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.42 153.07 32.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.397 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -126.28 144.0 14.78 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.431 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.408 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 1.3 p90 -91.07 179.18 5.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.252 0.549 . . . . 0.0 111.286 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.4 p -143.24 -7.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.868 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 179.14 -3.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 118.648 -1.739 . . . . 0.0 116.068 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 26.5 m -107.62 124.65 50.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.258 1.029 . . . . 0.0 110.57 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.823 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 9.3 ptm180 -70.73 168.79 17.49 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.399 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.799 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.3 OUTLIER -25.36 94.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 124.259 3.306 . . . . 0.0 114.712 -169.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 363' ' ' THR . 7.0 p -112.77 152.16 29.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.936 -174.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -74.48 106.27 6.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 362' ' ' PRO . 14.1 tt -81.89 129.24 65.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.444 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.37 81.58 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.802 HG11 HD13 ' A' ' 372' ' ' ILE . 15.6 m -102.28 119.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.691 0.758 . . . . 0.0 111.216 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -132.46 -178.68 5.03 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.36 139.14 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.891 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.474 HG22 HD12 ' A' ' 382' ' ' ILE . 11.0 m -111.22 168.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.55 114.52 28.73 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.119 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 50.7 t60 52.9 54.87 9.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.801 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.727 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 62.79 15.84 55.44 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.988 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 46.2 t -118.37 109.64 40.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 117.438 0.619 . . . . 0.0 111.222 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.15 50.27 2.18 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.229 2.619 . . . . 0.0 112.658 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.78 -53.87 3.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.71 115.3 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.298 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -63.26 108.78 1.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.9 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.566 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.6 m -93.93 7.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.034 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.42 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.41 83.27 6.26 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.427 0.632 . . . . 0.0 110.652 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.726 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 46.1 ttp -99.35 90.97 4.73 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.5 mt -71.66 125.1 26.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.532 -167.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 5.1 mm -68.46 -24.06 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.7 m -132.25 91.75 30.71 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.995 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.61 44.16 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.226 2.617 . . . . 0.0 114.057 -169.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.0 67.86 0.8 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.228 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.552 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.1 Cg_endo -82.74 133.63 7.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.229 1.952 . . . . 0.0 113.032 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -120.82 144.21 48.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.168 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 39.3 mtm -95.59 119.92 34.93 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.73 -167.01 1.53 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 124.41 1.069 . . . . 0.0 110.906 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.27 -11.72 52.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.892 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -99.23 0.23 42.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 109.506 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.24 -162.38 19.95 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -73.73 -16.71 79.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.276 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 67.15 -120.27 13.31 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.4 p90 -120.29 141.2 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.48 0.657 . . . . 0.0 110.902 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.802 HD13 HG11 ' A' ' 342' ' ' VAL . 4.0 mt -115.3 154.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.839 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.759 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 41.9 mt-10 -120.36 128.43 53.23 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.819 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.56 162.62 38.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.633 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.726 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.4 tp60 175.74 158.92 0.25 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.004 0.366 . . . . 0.0 110.983 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.783 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.0 tp -154.4 149.67 20.74 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 166.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.783 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 33.5 Cg_exo -27.06 125.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.918 3.078 . . . . 0.0 113.522 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -37.53 133.04 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.66 3.573 . . . . 0.0 114.493 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.72 -128.66 1.66 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.268 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.91 100.87 7.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 110.848 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.627 ' HB2' HE21 ' A' ' 394' ' ' GLN . 8.0 m120 -112.56 125.25 54.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 0.0 109.684 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.05 131.76 72.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.361 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.8 mt -92.32 128.92 43.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.189 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 91.95 3.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.007 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.4 t -83.56 78.28 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.41 -82.63 0.08 OUTLIER Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.423 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.703 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 22.3 t70 -106.35 -28.95 10.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.7 mp -63.67 149.43 46.6 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.525 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.7 p30 -163.12 143.12 8.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.245 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -164.95 118.44 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.2 tm0? -81.54 140.48 34.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.57 -178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.738 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 3.5 t-105 -149.54 147.47 28.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.736 172.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -95.04 119.16 33.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.738 ' NE2' ' HD1' ' A' ' 392' ' ' TRP . 30.0 mm-40 -85.12 114.44 22.25 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.329 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.271 0.558 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 42.6 p90 -62.43 121.52 13.46 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.339 0.59 . . . . 0.0 110.128 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.1 t -176.37 -172.11 0.45 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.56 105.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 340' ' ' ILE . 0.5 OUTLIER -70.35 155.08 41.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.621 -168.039 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.3 t70 -73.32 141.12 47.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.94 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 387' ' ' ASP . 24.3 pttt -50.95 -27.54 7.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.502 -1.681 . . . . 0.0 114.406 -172.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.427 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.9 t -105.21 7.25 33.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -169.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 27.2 mtpp -84.42 -22.65 30.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.443 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -82.63 157.0 23.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.992 0.425 . . . . 0.0 109.894 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -123.29 134.38 54.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.995 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.569 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 31.5 m-90 -50.99 96.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.595 168.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -96.39 -30.2 13.52 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 14.8 ttt180 -164.43 113.64 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.107 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.527 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.09 164.48 17.72 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.2 Cg_exo -39.41 118.35 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.634 2.222 . . . . 0.0 111.86 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 22.5 m -130.8 135.14 47.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.21 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.53 127.0 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.9 p -69.2 -16.13 63.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.16 72.87 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 69.5 t60 -108.14 -52.98 2.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.307 -178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 29.6 t70 166.18 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.467 1.127 . . . . 0.0 108.111 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.9 p -93.92 -170.94 2.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.661 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.95 151.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.723 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.0 m -136.04 144.48 33.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.249 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.744 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -127.58 150.62 49.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 2.6 tt0 -122.13 124.95 45.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.992 0.425 . . . . 0.0 110.514 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.744 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -122.45 150.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.363 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.52 160.43 15.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 172.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.449 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.5 p90 -106.52 178.16 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.078 0.939 . . . . 0.0 110.38 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -133.46 -13.15 2.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.16 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.95 -26.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.201 -1.476 . . . . 0.0 114.695 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.638 ' HB ' ' HE2' ' A' ' 364' ' ' MET . 19.8 m -82.7 135.81 34.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.632 0.716 . . . . 0.0 111.566 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.618 ' O ' HG22 ' A' ' 335' ' ' THR . 9.1 ptt180 -78.71 177.73 2.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -27.38 97.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.775 2.983 . . . . 0.0 114.807 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.841 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 18.1 p -110.24 166.74 10.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.719 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.77 99.3 12.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.613 HG22 HG13 ' A' ' 342' ' ' VAL . 46.1 mt -74.67 120.82 83.41 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.229 -172.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.33 80.27 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.227 1.952 . . . . 0.0 111.661 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.657 HG11 HD13 ' A' ' 372' ' ' ILE . 9.5 m -99.57 133.26 43.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.088 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.99 -178.07 5.52 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -155.24 135.29 12.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.77 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 382' ' ' ILE . 15.8 m -111.13 163.24 8.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.75 114.53 28.86 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.493 -174.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 10.9 t-80 53.9 52.16 13.46 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.486 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 65.8 5.7 26.36 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.888 -0.596 . . . . 0.0 114.188 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 110.6 61.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.391 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.65 54.58 4.84 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.079 2.519 . . . . 0.0 112.091 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.3 -47.72 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.49 0.662 . . . . 0.0 109.55 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.24 119.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.35 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -62.58 109.44 1.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.129 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.659 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 14.1 m -91.58 12.85 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -84.69 81.82 8.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 13.1 tpt -101.15 86.33 3.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 170.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 36.9 mt -70.82 126.26 29.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.615 -167.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -71.67 -17.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 15.6 m -140.08 91.46 10.12 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.505 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.44 41.35 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.091 2.527 . . . . 0.0 112.946 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -155.68 61.01 2.67 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.58 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -81.34 135.31 9.41 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.271 1.981 . . . . 0.0 112.935 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 25.2 p -131.3 133.65 45.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.717 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.85 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 25.7 ptt? -95.68 131.33 42.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.624 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 29.7 mt-10 -114.52 -165.1 0.98 Allowed 'General case' 0 C--N 1.321 -0.666 0 O-C-N 124.874 1.359 . . . . 0.0 110.318 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -62.01 -7.82 4.42 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -105.81 -3.99 21.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.577 0.703 . . . . 0.0 109.547 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 -166.22 17.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.85 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.15 -9.68 64.12 Favored Glycine 0 CA--C 1.51 -0.266 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.246 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.3 -126.35 30.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 111.361 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.657 HD13 HG11 ' A' ' 342' ' ' VAL . 2.8 mt -111.71 131.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.062 173.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.723 ' HG2' HG12 ' A' ' 327' ' ' VAL . 45.5 mt-10 -104.16 132.08 50.78 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.135 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.8 ppp? -148.52 161.99 40.53 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.715 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.2 tp60 -177.35 159.03 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.69 0.281 . . . . 0.0 110.953 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 354' ' ' VAL . 0.5 OUTLIER -164.98 143.92 5.52 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.529 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.653 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.2 Cg_exo -24.02 129.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.638 3.559 . . . . 0.0 114.689 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.6 Cg_exo -36.97 128.61 0.52 Allowed 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 125.583 4.189 . . . . 0.0 114.942 -171.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.09 -152.63 21.95 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.7 m-20 -98.45 101.23 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.974 0.887 . . . . 0.0 110.677 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -96.75 123.81 40.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.975 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -118.54 129.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.5 mt -92.71 133.62 33.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.46 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -107.16 91.82 3.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.358 176.196 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.5 t -79.36 77.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.82 -83.6 0.48 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 309' ' ' LYS . 20.3 t70 -116.26 -19.96 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.343 0.592 . . . . 0.0 109.55 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.5 OUTLIER -60.28 145.35 47.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.229 173.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.463 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.5 p30 -155.41 143.79 20.27 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.591 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.532 ' H ' HG12 ' A' ' 382' ' ' ILE . 2.3 t60 -173.31 123.75 0.39 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.285 0.366 . . . . 0.0 111.271 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.975 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.5 mt-30 -71.58 153.21 42.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.446 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 22.6 t-105 -151.36 119.84 6.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.859 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -74.65 113.25 11.7 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.423 ' HB3' ' CD1' ' A' ' 392' ' ' TRP . 2.3 pp0? -112.37 147.54 36.18 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.468 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.286 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 335' ' ' THR . 4.2 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.443 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.7 p90 -57.43 128.53 37.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.202 0.525 . . . . 0.0 110.998 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.0 t -177.42 -171.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.8 105.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.749 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.9 OUTLIER -79.06 161.7 26.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.818 0.818 . . . . 0.0 112.766 -171.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.0 t70 -78.39 155.73 29.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.935 -178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.747 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -76.83 -14.64 59.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.904 -172.12 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.4 t -91.19 2.74 56.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.137 0.494 . . . . 0.0 111.192 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.749 ' HD3' ' HB2' ' A' ' 307' ' ' CYS . 5.5 mtpm? -81.3 -44.43 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.981 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.747 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -84.88 159.37 20.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.466 0.651 . . . . 0.0 111.853 -172.3 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 t -140.04 147.84 40.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.2 m-90 -52.7 101.59 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.493 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.671 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.1 tttp -90.01 -45.5 9.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 77.9 ttt180 -152.75 118.97 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.692 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.83 162.82 49.0 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.39 -175.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.675 ' HG2' ' O ' ' A' ' 390' ' ' HIS . 53.4 Cg_exo -30.79 116.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.703 2.935 . . . . 0.0 113.558 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 52.9 m -127.9 124.84 38.4 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.98 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.27 127.02 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.212 0.53 . . . . 0.0 109.88 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.416 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.5 p -68.41 -21.55 64.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 -174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.69 -0.19 86.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.514 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -112.38 28.82 8.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 11.7 t70 64.09 24.83 13.61 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.84 0.829 . . . . 0.0 110.05 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.411 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.5 p -140.1 -171.72 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.203 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.731 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.71 155.66 41.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 118.201 0.455 . . . . 0.0 111.665 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -141.2 144.98 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.354 175.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.531 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 13.1 ptm -136.62 167.0 22.23 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.465 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 26.8 tt0 -133.34 128.33 35.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.282 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.07 157.58 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.937 0.399 . . . . 0.0 111.842 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.92 153.02 17.57 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -95.01 178.78 5.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.342 0.571 . . . . 0.0 110.697 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.1 t -162.86 35.8 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.28 -92.46 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.241 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.659 ' HB ' ' HE3' ' A' ' 311' ' ' LYS . 21.5 m -54.67 134.42 47.13 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.182 0.593 . . . . 0.0 111.966 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.808 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.6 ptt180 -72.14 -177.58 0.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.125 172.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.808 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.64 94.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.852 3.035 . . . . 0.0 114.588 -173.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.8 p -116.05 158.06 23.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.788 -172.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -74.84 97.14 3.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.494 HG12 HG13 ' A' ' 342' ' ' VAL . 10.5 tt -77.34 122.85 86.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -173.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 82.66 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.772 2.314 . . . . 0.0 112.466 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.563 HG12 HG13 ' A' ' 385' ' ' VAL . 13.1 m -105.76 120.14 56.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.319 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 19.1 ptt180 -129.32 -175.29 3.53 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.16 147.56 21.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.586 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 382' ' ' ILE . 4.9 m -123.32 170.98 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.49 39.27 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.226 -173.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 32.8 t60 56.46 42.4 27.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.261 0.553 . . . . 0.0 110.47 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 67.07 9.94 55.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.423 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.78 107.84 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.115 0.458 . . . . 0.0 110.724 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.3 52.98 2.46 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.431 2.754 . . . . 0.0 112.644 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -97.59 -53.52 3.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.73 115.16 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.237 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.5 t30 -60.0 108.4 0.76 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.033 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.895 ' HA ' HD22 ' A' ' 376' ' ' LEU . 33.7 m -93.01 9.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.449 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -82.57 82.2 8.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.689 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.0 ttp -103.57 93.27 4.84 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 44.1 mt -76.33 125.94 30.09 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.66 -163.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -68.13 -23.62 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 11.9 m -126.4 90.21 50.47 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.82 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 89.2 Cg_endo -85.77 33.57 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.28 2.653 . . . . 0.0 114.317 -167.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -167.6 63.04 0.63 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.317 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.48 ' O ' HG22 ' A' ' 340' ' ' ILE . 61.4 Cg_endo -81.55 139.64 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.31 2.007 . . . . 0.0 113.049 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 20.4 p -124.15 133.01 53.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.73 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 6.5 ptp -95.18 125.1 39.59 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 25.9 mt-10 -81.28 -169.48 2.29 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.471 1.107 . . . . 0.0 111.21 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.93 -4.56 35.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.047 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.95 -14.61 17.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.355 0.598 . . . . 0.0 109.659 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.0 -169.85 16.15 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.465 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -77.68 -22.53 69.36 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.545 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.64 -118.45 11.66 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -114.77 143.39 45.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.211 0.529 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 3.1 mt -123.9 159.29 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.735 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 45.4 mt-10 -126.99 134.74 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.732 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.731 ' HG2' ' HB ' ' A' ' 326' ' ' VAL . 0.2 OUTLIER -149.57 169.81 20.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.977 -175.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 356' ' ' MET . 6.3 tp60 172.63 155.39 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.159 0.504 . . . . 0.0 111.679 170.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.029 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -160.43 153.53 18.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 165.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 1.029 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 46.9 Cg_exo -16.52 125.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 1 C-N-CA 125.468 4.112 . . . . 0.0 115.843 -175.377 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 395' ' ' LYS . 60.7 Cg_exo -40.17 139.84 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.692 3.595 . . . . 0.0 114.092 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 393' ' ' PHE . . . 138.93 -163.4 25.91 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -76.4 100.04 5.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.347 0.573 . . . . 0.0 111.239 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.583 ' HB2' HE21 ' A' ' 394' ' ' GLN . 8.0 m-80 -112.75 129.62 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.083 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.99 135.25 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 -179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.64 HD12 ' HG3' ' A' ' 318' ' ' PRO . 25.4 mt -96.1 133.65 36.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.926 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.539 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -109.77 91.39 3.63 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.887 175.669 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -81.84 87.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.97 -95.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.352 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.02 0.84 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.101 0.477 . . . . 0.0 110.549 175.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -75.41 148.28 39.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.503 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.1 p30 -159.63 149.12 18.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.568 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.675 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 4.2 t60 -170.81 119.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.849 173.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.083 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.7 tt0 -82.64 134.16 35.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.738 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.689 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.1 t-105 -140.01 143.75 36.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.462 175.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 379' ' ' GLY . 55.8 t80 -87.82 108.24 19.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.689 ' NE2' ' HD1' ' A' ' 392' ' ' TRP . 38.6 mm-40 -72.82 144.35 47.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.586 ' HA ' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.494 -173.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.677 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 21.8 p90 -60.67 129.6 42.36 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.0 t 178.55 -169.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 59.5 t -60.5 110.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 168.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 142.77 56.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.795 0.807 . . . . 0.0 111.108 -170.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.402 ' OD2' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -76.81 148.6 36.49 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.111 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.77 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.27 -13.23 17.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.935 -172.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.402 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.8 t -101.14 -0.61 35.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.503 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 28.5 mmmt -78.4 -36.45 45.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.837 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -89.93 157.57 17.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.266 0.555 . . . . 0.0 111.606 -177.47 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.1 t -142.48 147.5 36.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.02 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -60.28 110.73 1.31 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.395 0.617 . . . . 0.0 112.159 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.543 ' HE3' ' OE1' ' A' ' 329' ' ' GLU . 65.3 tttp -93.54 -34.42 13.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.492 170.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.971 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 64.8 ttt180 -164.33 119.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.91 157.38 75.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.991 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -40.36 117.54 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.395 2.73 . . . . 0.0 112.587 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.1 m -134.18 132.46 39.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.922 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.53 124.83 13.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 111.096 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.522 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.6 p -57.79 -30.45 65.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.974 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.86 -2.57 41.53 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -105.4 -73.26 0.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -165.87 15.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.607 0.717 . . . . 0.0 109.665 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.712 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 12.3 p -137.69 -166.79 2.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.541 -172.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -126.62 153.17 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.517 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 17.3 m -135.91 145.66 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.566 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 17.4 ptt? -135.43 169.59 17.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.971 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 14.0 mt-10 -138.04 136.4 36.8 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.345 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.67 151.07 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.3 155.12 16.33 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.787 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -101.97 -179.84 4.12 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 110.974 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.4 p -137.49 -41.13 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.635 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -156.07 4.58 0.2 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.158 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.503 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 33.1 m -113.12 127.03 56.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 117.425 0.612 . . . . 0.0 110.13 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.708 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 14.2 ptm180 -73.38 171.2 11.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.048 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.78 95.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.202 3.268 . . . . 0.0 114.608 -170.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 338' ' ' CYS . . . . . . . . . . . . . 6.0 p -112.14 154.34 25.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.969 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.4 mmt180 -74.57 107.83 6.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.672 HG22 HG13 ' A' ' 342' ' ' VAL . 38.8 mm -82.82 119.89 75.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.4 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.63 82.5 2.1 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.67 2.246 . . . . 0.0 112.088 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.672 HG13 HG22 ' A' ' 340' ' ' ILE . 13.9 m -101.5 124.94 55.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.575 0.702 . . . . 0.0 110.879 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.78 -175.38 4.01 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -153.41 144.62 23.03 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.323 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.65 164.56 15.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -96.83 114.34 25.97 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.126 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 39.25 63.88 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.633 0.773 . . . . 0.0 112.651 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.494 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.45 7.99 42.97 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.644 -0.707 . . . . 0.0 114.669 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.66 113.06 47.9 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 117.864 0.832 . . . . 0.0 111.557 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.15 62.19 5.93 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.198 2.599 . . . . 0.0 111.785 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.591 ' HG2' HG12 ' A' ' 352' ' ' VAL . 15.2 tt0 -86.65 -43.56 12.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.158 0.98 . . . . 0.0 108.939 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 351' ' ' GLU . 1.5 p -158.17 122.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.34 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -51.23 108.5 0.26 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.331 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 1.007 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.44 7.98 4.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.825 -176.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -82.66 84.18 7.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.182 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.97 84.9 2.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 40.2 mt -68.05 129.55 40.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.166 -165.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.678 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.5 mm -72.62 -23.96 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.2 m -131.52 88.26 43.89 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.715 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.66 53.13 3.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.16 2.573 . . . . 0.0 113.336 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -168.02 69.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.882 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' A' ' 372' ' ' ILE . 45.7 Cg_endo -91.1 136.29 1.98 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.552 2.168 . . . . 0.0 112.65 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.1 p -132.42 144.95 50.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.452 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.607 ' HG3' HD11 ' A' ' 340' ' ' ILE . 56.2 mtm -95.95 116.62 29.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.517 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 31.9 mt-10 -104.15 -165.68 1.17 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.386 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -59.11 -13.08 5.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.886 0.375 . . . . 0.0 111.769 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 365' ' ' GLU . 10.2 p30 -103.83 -2.07 26.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.366 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.6 -160.71 22.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 364' ' ' MET . . . -77.27 -11.84 85.15 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.823 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 65.61 -124.03 26.03 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -125.87 147.47 49.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.869 0.366 . . . . 0.0 110.092 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.0 OUTLIER -128.5 160.46 38.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.678 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 61.4 mt-10 -123.4 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.674 0.273 . . . . 0.0 110.284 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -153.29 154.6 34.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.913 -174.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.864 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.03 167.53 4.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.978 171.004 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.007 ' HG ' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -168.21 178.08 1.15 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.169 174.549 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.703 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 52.0 Cg_exo -36.1 131.24 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.748 2.299 . . . . 0.0 113.65 174.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.91 137.39 52.37 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.676 2.918 . . . . 0.0 113.16 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.06 -176.85 29.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.156 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 12.7 m-20 -74.33 101.15 3.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.206 0.202 . . . . 0.0 111.116 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.87 ' HB2' HE21 ' A' ' 394' ' ' GLN . 38.9 m-80 -123.39 153.54 40.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.262 0.553 . . . . 0.0 110.96 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.96 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -134.45 139.89 46.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 -176.333 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 374' ' ' MET . 20.8 mt -94.18 132.89 36.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -109.62 92.66 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.026 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.78 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.4 t -79.99 76.35 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.69 -81.93 0.16 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.224 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.77 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 31.7 t70 -113.44 -12.27 12.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.449 0.642 . . . . 0.0 109.562 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.8 mp -78.32 148.37 33.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.216 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 4.4 p-10 -155.99 140.82 17.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.781 0.324 . . . . 0.0 111.214 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.409 ' H ' HG12 ' A' ' 382' ' ' ILE . 18.3 t-80 -166.28 123.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.624 171.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.96 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 9.7 tt0 -86.84 152.19 22.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.184 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.45 142.94 14.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.672 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.3 p90 -90.77 108.06 19.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.755 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.87 HE21 ' HB2' ' A' ' 381' ' ' ASN . 0.9 OUTLIER -70.29 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.544 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 C--O 1.247 0.956 0 O-C-N 124.371 1.044 . . . . 0.0 110.51 -179.286 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -62.36 124.4 20.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.341 0.591 . . . . 0.0 111.416 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -174.32 -169.83 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.36 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.43 106.56 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.2 149.02 43.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.698 0.761 . . . . 0.0 112.191 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' A' ' 310' ' ' THR . 21.2 t0 -72.28 146.51 47.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.129 -178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.76 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.35 -13.28 60.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.949 -167.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -97.0 4.1 51.66 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.981 -0.45 . . . . 0.0 112.035 -175.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.817 ' HE3' ' HA3' ' A' ' 334' ' ' GLY . 34.1 mttp -89.2 -28.56 19.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.76 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -84.57 156.47 21.6 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.808 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.3 t -141.36 145.27 35.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.554 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.1 m-90 -56.06 104.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.269 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.554 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.3 tttt -97.17 -42.88 7.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 38.9 ttt180 -152.55 123.01 7.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.605 173.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -65.74 163.94 31.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.48 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 2.8 Cg_exo -38.52 107.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.39 2.727 . . . . 0.0 112.373 176.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.8 m -115.97 128.49 55.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.296 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -49.23 125.71 11.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.378 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.0 p -70.96 -20.19 62.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -173.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.55 -2.31 70.24 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -171.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.82 27.96 8.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.458 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 64.09 21.16 12.48 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.658 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.439 ' HA ' ' OE1' ' A' ' 375' ' ' GLN . 6.6 p -129.53 -168.53 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.452 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 374' ' ' MET . 0.1 OUTLIER -132.21 150.22 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.339 0.59 . . . . 0.0 112.317 -175.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.76 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -138.56 138.08 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.62 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 14.2 ptm -127.55 162.8 25.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.548 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 30.2 tt0 -126.33 127.96 46.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.76 147.43 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.183 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -106.01 147.8 16.32 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.31 179.03 4.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.121 0.961 . . . . 0.0 110.355 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.8 p -152.48 30.72 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.68 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.817 ' HA3' ' HE3' ' A' ' 311' ' ' LYS . . . -170.96 -83.28 0.05 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.876 -1.155 . . . . 0.0 113.764 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 303' ' ' THR . 12.9 m -69.52 128.46 36.59 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.111 0.565 . . . . 0.0 112.424 -172.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.755 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -67.1 176.1 1.27 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.147 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -24.88 93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.043 3.162 . . . . 0.0 114.538 -171.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 363' ' ' THR . 27.6 p -111.62 166.34 11.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.053 -171.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -87.43 96.81 10.51 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 362' ' ' PRO . 12.4 tt -80.44 126.03 79.6 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.295 -171.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.31 93.98 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.96 2.44 . . . . 0.0 112.331 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 372' ' ' ILE . 16.7 m -115.01 120.98 66.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.699 0.761 . . . . 0.0 111.384 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 29.8 ptt180 -132.63 -174.35 3.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.53 149.38 22.22 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.723 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -122.9 170.28 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.79 114.85 28.28 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.215 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 17.9 p80 40.04 57.07 2.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.847 . . . . 0.0 112.587 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.681 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 79.71 -10.42 38.7 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.164 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.48 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 27.5 t -101.91 114.01 65.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.307 0.554 . . . . 0.0 111.226 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.6 Cg_exo -77.14 38.67 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 123.466 2.777 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.44 -54.29 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.81 112.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.941 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 36.7 t30 -55.11 108.07 0.37 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.502 171.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.643 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 35.9 m -93.23 8.64 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.142 0.496 . . . . 0.0 111.159 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.436 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -80.83 82.81 6.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.378 0.609 . . . . 0.0 110.554 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.758 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.1 ttt -102.32 82.26 2.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 30.9 mt -64.26 130.11 42.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.862 -167.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -70.38 -26.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 360' ' ' PRO . 6.3 m -131.83 95.95 21.56 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.452 172.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 357' ' ' LEU . 4.1 Cg_endo -86.05 27.21 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.524 2.816 . . . . 0.0 113.523 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -147.88 64.32 8.24 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.123 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 340' ' ' ILE . 90.0 Cg_endo -82.66 144.65 12.61 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.532 2.155 . . . . 0.0 112.884 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 11.4 p -128.55 142.57 51.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.068 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.846 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 56.7 mtp -95.39 110.58 22.59 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.01 -171.29 1.94 Allowed 'General case' 0 C--N 1.32 -0.704 0 O-C-N 124.403 1.065 . . . . 0.0 111.24 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -66.81 -6.61 16.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.779 174.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -110.84 -6.75 14.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.229 0.537 . . . . 0.0 109.972 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.64 -171.92 14.13 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -64.68 -14.97 59.06 Favored Glycine 0 N--CA 1.458 0.127 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.532 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 72.03 -106.26 1.88 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 328' ' ' MET . 20.8 m-85 -132.33 135.91 46.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.285 0.564 . . . . 0.0 110.996 175.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.794 HD13 HG11 ' A' ' 342' ' ' VAL . 4.7 mt -115.32 136.53 51.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.343 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.76 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -106.7 128.63 54.36 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.198 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.692 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -144.64 163.14 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.047 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.761 HE21 ' H ' ' A' ' 376' ' ' LEU . 29.5 tp60 -176.05 152.08 1.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 110.036 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.828 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.0 OUTLIER -151.78 140.42 13.54 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 170.318 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.828 ' HD2' HD22 ' A' ' 376' ' ' LEU . 27.4 Cg_exo -19.97 130.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 125.144 3.896 . . . . 0.0 114.781 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -37.92 131.91 0.81 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.82 3.68 . . . . 0.0 114.38 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.85 -167.77 32.21 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.295 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 8.1 m-20 -80.57 100.12 8.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.913 0.356 . . . . 0.0 110.899 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 376' ' ' LEU . 21.5 m-80 -111.57 138.72 47.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.986 0.422 . . . . 0.0 110.249 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -135.76 136.42 50.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.612 HD11 ' HG2' ' A' ' 374' ' ' MET . 39.5 mt -95.25 130.78 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.086 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.674 175.258 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 6.7 t -84.87 81.9 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.75 -91.15 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.144 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.655 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 6.3 t70 -98.55 -18.89 17.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.613 0.721 . . . . 0.0 109.395 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.3 mp -76.44 148.85 37.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -154.77 137.21 15.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.036 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -164.59 123.73 1.86 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.751 0.31 . . . . 0.0 110.484 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.938 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -90.3 141.2 28.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.519 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.669 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.2 t-105 -144.64 137.01 26.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.006 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.8 p90 -80.6 110.25 15.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.947 -0.471 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.669 ' NE2' ' HD1' ' A' ' 392' ' ' TRP . 40.1 mm-40 -74.04 102.27 4.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 395' ' ' LYS . 12.1 ttpp . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.752 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 335' ' ' THR . 2.9 t . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -59.89 126.76 28.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.194 0.521 . . . . 0.0 109.871 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.8 t -179.24 -174.76 0.34 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.3 106.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.52 155.55 40.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.972 0.892 . . . . 0.0 112.608 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.606 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.1 t70 -81.01 140.65 35.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.106 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -60.41 -21.72 62.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.62 -173.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.637 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.6 t -87.05 -4.56 59.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.828 0.346 . . . . 0.0 111.46 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -93.92 16.5 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.814 ' HE2' HG12 ' A' ' 385' ' ' VAL . 1.3 m-85 -102.38 170.66 7.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.675 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -165.65 131.9 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.396 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.459 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -51.68 120.33 5.11 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.398 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 21.3 tptm -110.14 -48.67 3.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.583 172.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 10.6 ttm180 -156.1 127.96 7.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.113 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.14 155.67 93.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.823 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.492 ' HG3' HD12 ' A' ' 383' ' ' ILE . 84.1 Cg_exo -33.08 113.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.832 3.021 . . . . 0.0 113.153 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 20.3 m -128.95 135.06 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.055 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -44.96 124.66 4.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.612 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.5 p -71.47 -22.07 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.67 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.39 -2.62 74.56 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -121.89 33.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.88 16.68 8.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.823 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.554 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 8.5 p -124.23 -168.85 1.86 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.741 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.37 146.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.417 -177.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 14.8 m -128.51 138.83 53.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.101 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 16.4 ptt? -121.55 154.87 36.13 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 23.0 tt0 -114.28 127.66 55.98 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 385' ' ' VAL . 8.4 m -130.43 136.57 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.881 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -111.98 143.39 17.44 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.657 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.686 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.7 OUTLIER -141.44 163.03 34.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 366' ' ' ASN . 49.4 m -153.51 65.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.507 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -165.0 -50.71 0.02 OUTLIER Glycine 0 C--O 1.226 -0.356 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.743 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.847 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 23.3 m -98.6 142.72 29.83 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 122.85 -0.206 . . . . 0.0 110.863 -175.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 15.3 ptt180 -79.38 168.65 24.94 Favored Pre-proline 0 CA--C 1.527 0.08 0 CA-C-O 117.729 -1.129 . . . . 0.0 108.485 171.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -26.55 96.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.999 3.133 . . . . 0.0 114.449 -170.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.66 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 28.8 p -116.09 164.93 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.477 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -85.31 96.97 9.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 362' ' ' PRO . 12.1 pt -79.77 130.15 68.38 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.297 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' PRO . . . . . 0.661 ' HD2' ' HZ ' ' A' ' 312' ' ' PHE . 63.9 Cg_endo -75.29 81.94 2.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.725 2.283 . . . . 0.0 112.021 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.717 HG12 HG13 ' A' ' 385' ' ' VAL . 10.5 m -100.22 116.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.993 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.4 ptt180 -126.61 179.82 5.15 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.431 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -152.06 139.78 19.84 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.818 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.15 171.4 7.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.927 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.59 116.45 32.62 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.454 ' HA ' ' CD ' ' A' ' 391' ' ' GLN . 8.9 p-80 41.04 59.68 2.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.515 0.726 . . . . 0.0 112.703 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.735 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.2 6.4 32.65 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.28 116.59 44.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.591 0.695 . . . . 0.0 111.045 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.09 55.98 3.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.198 2.599 . . . . 0.0 111.753 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.59 -52.22 5.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.64 123.0 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.283 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.76 107.74 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 376' ' ' LEU . 32.0 m -92.2 9.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.634 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.431 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -81.25 83.65 6.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.45 84.63 2.22 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.7 mt -74.02 128.32 35.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.816 -165.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 1.9 mm -75.94 -19.42 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.5 m -121.74 81.91 41.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.165 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.23 32.57 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.27 2.647 . . . . 0.0 114.156 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -177.01 70.78 0.23 Allowed Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.62 ' HB2' HD11 ' A' ' 340' ' ' ILE . 45.1 Cg_endo -88.19 136.75 3.55 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.503 2.136 . . . . 0.0 113.587 -176.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 40.5 p -118.1 130.59 56.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.545 175.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.847 ' HE3' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -99.51 143.59 29.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 31.3 mt-10 -95.04 -179.35 4.79 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.626 0.579 . . . . 0.0 109.941 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 333' ' ' SER . 21.1 p-10 -56.05 -24.79 41.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -108.49 -3.23 18.3 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.095 -0.378 . . . . 0.0 111.592 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.686 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 144.62 177.05 19.16 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.265 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -97.53 -16.19 35.09 Favored Glycine 0 CA--C 1.507 -0.458 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.905 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 74.52 -126.17 9.01 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 328' ' ' MET . 79.6 m-85 -105.88 147.38 28.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.02 0.438 . . . . 0.0 111.154 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.4 mt -132.48 152.96 37.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.742 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 30.6 mt-10 -110.81 134.59 52.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.955 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.92 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -145.0 165.35 28.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.741 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -174.03 163.89 4.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.384 0.612 . . . . 0.0 111.449 172.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.679 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.3 tp -165.02 143.87 5.47 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 165.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.679 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 16.2 Cg_exo -31.3 135.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.998 3.132 . . . . 0.0 113.486 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 377' ' ' PRO . 49.5 Cg_exo -37.0 128.43 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.704 3.602 . . . . 0.0 114.471 -166.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.11 178.06 35.68 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 0.0 OUTLIER -81.02 99.73 8.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.945 0.872 . . . . 0.0 110.826 -176.209 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.673 HD22 ' HG2' ' A' ' 394' ' ' GLN . 18.6 m-80 -108.19 126.7 53.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.302 0.572 . . . . 0.0 110.015 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.985 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.52 137.69 57.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.145 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.1 mt -99.78 127.1 52.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.792 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.405 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -95.64 102.73 14.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.932 171.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' A' ' 312' ' ' PHE . 2.1 t -92.59 78.56 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.295 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 69.56 -85.61 0.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.446 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 34.2 t70 -108.75 -25.58 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.523 0.678 . . . . 0.0 109.325 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.459 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.2 mp -65.45 151.81 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.536 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -151.94 144.35 24.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.402 ' C ' HG12 ' A' ' 382' ' ' ILE . 0.2 OUTLIER -164.79 109.9 0.94 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.111 0.482 . . . . 0.0 111.356 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.985 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 45.2 tt0 -84.25 149.09 26.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.386 -176.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 4.8 t-105 -158.77 142.27 15.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.822 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.3 p90 -92.72 114.83 27.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.583 -0.698 . . . . 0.0 110.062 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 381' ' ' ASN . 5.0 mm100 -72.6 115.42 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.229 -174.826 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.598 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 14.2 p90 -70.45 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.6 t -177.14 -171.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 77.7 t -67.57 107.29 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 340' ' ' ILE . 0.1 OUTLIER -69.15 148.77 49.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.007 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.572 ' OD1' HG22 ' A' ' 310' ' ' THR . 24.2 t0 -72.48 135.76 45.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.288 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.79 -16.1 56.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.139 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.572 HG22 ' OD1' ' A' ' 308' ' ' ASP . 8.1 t -96.6 2.41 52.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.132 0.492 . . . . 0.0 111.325 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 29.0 mtpp -95.29 37.48 1.17 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.229 -0.295 . . . . 0.0 111.589 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.824 ' CE1' ' HB ' ' A' ' 330' ' ' VAL . 0.0 OUTLIER -135.9 150.74 49.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.923 0.392 . . . . 0.0 110.994 -176.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 29.2 p -135.35 139.15 44.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.185 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -54.7 105.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.974 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.403 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.4 ttmm -92.52 -32.34 14.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.928 ' HB2' ' HB2' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -165.31 114.88 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.133 174.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.07 161.15 42.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.267 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.488 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 2.7 Cg_exo -39.22 119.6 0.5 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.83 2.354 . . . . 0.0 112.341 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -139.15 136.94 35.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.67 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.7 133.76 16.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.739 0.304 . . . . 0.0 110.964 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.48 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.8 p -70.75 -12.04 61.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.785 -172.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 91.74 -7.62 79.26 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -102.19 -59.19 1.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.124 0.488 . . . . 0.0 109.929 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 12.0 t70 170.2 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.394 1.092 . . . . 0.0 108.436 -169.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.67 -168.72 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.782 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 374' ' ' MET . 2.1 t -125.21 152.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.08 0.467 . . . . 0.0 111.056 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.836 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.5 m -130.45 168.16 23.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.529 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -155.01 157.85 38.25 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 316' ' ' ARG . 4.1 mt-10 -129.01 139.95 51.85 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.452 0.47 . . . . 0.0 110.301 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.824 ' HB ' ' CE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -147.94 146.42 18.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.006 -175.458 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.415 ' O ' ' HD1' ' A' ' 312' ' ' PHE . . . -117.18 137.43 13.41 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HD2' ' H ' ' A' ' 335' ' ' THR . 0.3 OUTLIER -90.0 179.27 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.814 0.816 . . . . 0.0 112.32 -173.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 48.1 t -106.15 -41.86 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 176.73 40.5 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.273 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.687 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 4.8 m -116.07 127.54 54.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.247 0.523 . . . . 0.0 109.856 173.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.697 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -71.17 171.55 8.43 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.076 174.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.697 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.52 95.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.974 3.116 . . . . 0.0 114.155 -177.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 305' ' ' THR . 20.1 p -117.38 174.5 6.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.768 -1.56 . . . . 0.0 111.619 -171.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.9 mmm180 -96.57 101.58 13.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.55 ' CG2' HG13 ' A' ' 342' ' ' VAL . 8.2 mm -80.15 130.78 64.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.257 0.551 . . . . 0.0 112.265 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.88 81.79 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.66 2.24 . . . . 0.0 111.653 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.996 HG21 ' HG2' ' A' ' 362' ' ' PRO . 0.0 OUTLIER -96.84 130.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.423 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -145.35 179.64 7.26 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -152.2 143.83 23.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.392 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 10.8 m -113.98 172.06 3.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -108.44 115.51 30.24 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.717 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 57.1 47.42 17.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.623 0.577 . . . . 0.0 110.583 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.672 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.24 4.54 37.12 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.75 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 40.8 t -107.37 108.19 61.43 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 117.088 0.444 . . . . 0.0 111.2 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -74.2 59.51 4.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.365 2.71 . . . . 0.0 112.419 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.03 -45.81 6.12 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.5 123.62 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.1 t30 -60.34 108.34 0.79 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.694 175.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.1 m -90.5 3.9 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.97 83.98 3.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.651 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.678 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.5 ttm -100.07 88.0 3.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 27.5 mt -66.32 126.52 29.03 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.985 -1.462 . . . . 0.0 111.664 -165.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.7 mm -73.37 -23.78 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.5 m -134.33 98.74 13.72 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.997 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.88 54.2 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.244 2.629 . . . . 0.0 113.379 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 63.6 t30 -157.96 58.73 1.47 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 172.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.996 ' HG2' HG21 ' A' ' 342' ' ' VAL . 15.0 Cg_exo -72.07 104.39 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.255 1.97 . . . . 0.0 112.155 175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.1 p -110.34 149.16 30.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.669 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 49.0 mtm -95.7 120.76 36.53 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.12 -165.47 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.903 1.377 . . . . 0.0 109.928 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -52.3 -25.19 8.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.335 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -105.58 10.14 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 110.689 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.9 -156.78 23.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 110.986 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.06 -14.61 59.34 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 66.21 -118.5 11.18 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.045 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -116.47 122.96 46.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.7 OUTLIER -113.24 161.47 12.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.082 177.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.836 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.7 mt-10 -132.87 130.92 40.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.563 ' HB3' ' CD2' ' A' ' 357' ' ' LEU . 4.0 ptp -159.77 151.6 20.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.12 -173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.678 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.0 tp60 -173.43 169.64 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.683 0.278 . . . . 0.0 111.039 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.0 tp -163.35 159.31 18.05 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 48.8 Cg_exo -29.97 130.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 113.978 173.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.0 Cg_exo -37.5 129.65 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.182 3.921 . . . . 0.0 114.516 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.19 -129.5 1.83 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.527 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 391' ' ' GLN . 19.7 m-20 -127.49 107.33 9.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.502 0.191 . . . . 0.0 110.647 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.27 127.7 55.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.065 0.46 . . . . 0.0 110.01 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.045 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.64 130.72 74.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.6 mt -92.11 131.62 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.336 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -102.64 92.0 4.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.267 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.66 76.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.42 -91.28 0.74 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.162 -171.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 19.6 t70 -110.25 -20.88 12.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.258 0.552 . . . . 0.0 109.96 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 2.1 tp -67.87 145.29 54.76 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.518 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.8 p30 -151.44 147.99 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.802 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.428 ' H ' HG12 ' A' ' 382' ' ' ILE . 0.5 OUTLIER -170.46 123.53 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.024 175.342 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.045 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -75.68 144.26 41.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.488 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 17.2 t-105 -143.32 130.4 20.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.204 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -82.53 117.34 22.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.464 ' HB2' HE22 ' A' ' 375' ' ' GLN . 2.6 pp0? -117.54 142.66 46.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 111.085 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.675 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 305' ' ' THR . 7.2 t . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.918 0.39 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.469 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 39.4 p90 -60.8 116.32 4.34 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.306 0.574 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 303' ' ' THR . 14.3 t -173.48 -166.59 0.33 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.118 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 13.7 t -61.19 114.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 144.64 55.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.909 0.861 . . . . 0.0 112.201 -170.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.63 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.7 t0 -59.76 141.58 54.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.704 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.699 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.24 -11.8 44.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.735 -175.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.63 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -105.41 -1.15 25.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 46.2 mttp -83.77 -30.08 26.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.699 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -86.92 147.93 25.56 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.678 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.1 p -135.5 145.26 46.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.524 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.485 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.9 m-90 -53.49 96.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.862 0.726 . . . . 0.0 111.462 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.419 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 76.9 tttt -87.84 -35.08 17.99 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.916 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.3 ttm180 -159.07 113.71 2.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.238 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.05 80.04 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 119.188 -0.434 . . . . 0.0 109.957 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -41.83 119.1 1.05 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.706 2.271 . . . . 0.0 112.461 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.3 m -139.61 142.41 37.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.322 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -40.66 130.77 2.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.863 0.465 . . . . 0.0 111.02 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.458 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -65.82 -23.75 66.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.61 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.37 -0.57 27.99 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.438 -174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -126.89 -56.46 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.348 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.31 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.548 0.689 . . . . 0.0 110.498 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.744 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 11.1 p -92.0 -172.04 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.953 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.7 148.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.387 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -130.55 158.15 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 122.743 0.417 . . . . 0.0 110.978 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.515 ' HB3' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -136.79 163.47 30.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 2.5 mt-10 -130.3 135.1 47.73 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.913 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.84 146.21 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.982 0.42 . . . . 0.0 111.367 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.11 145.8 18.55 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.547 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -89.78 178.34 6.27 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.569 0.7 . . . . 0.0 111.326 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.3 m -149.32 28.5 0.81 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.367 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 165.56 -70.52 0.19 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 119.663 -1.256 . . . . 0.0 113.946 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 336' ' ' ARG . 41.1 m -58.65 136.43 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.956 0.503 . . . . 0.0 112.15 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 335' ' ' THR . 12.3 ptm180 -70.19 170.4 10.36 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.442 171.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.703 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.9 97.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.975 3.117 . . . . 0.0 114.759 -171.066 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.542 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 6.3 p -113.47 152.76 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.297 -172.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 306' ' ' VAL . 9.2 mpt_? -82.41 105.41 13.45 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.3 pt -87.31 131.43 44.29 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.602 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.39 84.34 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.053 2.502 . . . . 0.0 112.364 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.631 HG11 HD13 ' A' ' 372' ' ' ILE . 19.3 m -96.72 129.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.796 0.807 . . . . 0.0 111.253 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 35.6 ptt180 -140.21 -172.44 3.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -159.37 143.41 15.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.286 0.565 . . . . 0.0 111.416 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 382' ' ' ILE . 16.0 m -119.69 171.31 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -103.06 116.38 32.41 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 3.7 p-80 40.14 60.11 1.84 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.928 0.768 . . . . 0.0 112.459 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.9 3.92 24.65 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.609 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.25 118.88 45.06 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.546 0.673 . . . . 0.0 111.164 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.71 55.33 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.067 2.511 . . . . 0.0 111.445 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -86.07 -35.78 20.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.868 0.842 . . . . 0.0 108.895 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.581 HG12 ' HG3' ' A' ' 351' ' ' GLU . 6.7 p -155.66 122.93 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.745 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.2 107.77 0.27 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.185 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 376' ' ' LEU . 31.4 m -88.65 5.2 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.394 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -79.84 82.7 5.89 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.349 0.595 . . . . 0.0 110.645 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 36.8 mtm -97.61 90.37 4.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.7 mt -75.93 117.01 17.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.473 -165.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.3 mm -68.95 -22.13 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -131.38 85.42 53.32 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.776 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -87.28 41.68 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.376 2.718 . . . . 0.0 114.035 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -165.61 73.55 1.34 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.221 0.534 . . . . 0.0 110.557 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.589 ' HB2' HD11 ' A' ' 340' ' ' ILE . 91.7 Cg_endo -87.67 120.2 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.411 2.074 . . . . 0.0 112.586 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.8 p -115.21 140.72 48.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.952 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.703 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 54.9 mtm -95.04 113.63 25.35 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.355 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 39.5 mt-10 -104.24 -165.8 1.18 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.506 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -55.2 -17.74 4.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -105.06 2.52 29.56 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.5 0.667 . . . . 0.0 110.368 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 98.02 -158.63 20.7 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.88 -1.84 74.53 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.953 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.0 -129.62 32.49 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -115.63 142.03 47.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.296 0.57 . . . . 0.0 110.801 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.631 HD13 HG11 ' A' ' 342' ' ' VAL . 2.0 mt -120.12 130.9 73.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.573 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.938 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.1 mt-10 -103.92 135.97 44.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 110.451 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.476 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 4.4 ppp? -147.46 159.33 43.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.512 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.744 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.1 OUTLIER -172.89 167.12 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.557 . . . . 0.0 112.269 174.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.965 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.1 tp -164.82 156.85 13.75 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 172.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.965 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 47.2 Cg_exo -37.08 138.2 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.766 2.31 . . . . 0.0 112.798 172.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.468 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 89.1 Cg_exo -34.92 136.45 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 125.08 3.853 . . . . 0.0 114.985 -174.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.21 -150.94 22.24 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.463 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 8.3 m-20 -108.08 105.64 15.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.146 0.473 . . . . 0.0 110.484 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 76.8 m-20 -105.0 125.1 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.031 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.093 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.44 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 328' ' ' MET . 22.4 mt -91.54 135.67 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -115.46 91.91 3.75 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.135 178.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 342' ' ' VAL . 6.3 t -83.79 92.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.64 0.12 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.867 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -110.57 -15.66 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.067 0.461 . . . . 0.0 110.108 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.564 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -63.29 139.96 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.8 p30 -149.41 148.1 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.587 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.8 OUTLIER -171.77 122.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 173.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.093 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 11.2 tt0 -76.82 148.89 36.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -143.54 129.52 19.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.484 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -86.34 112.18 21.18 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.5 pp0? -102.19 126.47 49.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 395' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.428 -169.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.705 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 35.4 p90 -65.46 117.08 7.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.65 0.738 . . . . 0.0 110.332 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t -168.63 -171.25 1.37 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 53.6 t -62.65 109.29 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 140.05 56.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.469 0.652 . . . . 0.0 111.551 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.8 t70 -64.84 143.95 57.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.645 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.683 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -64.34 -11.93 37.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.176 -1.375 . . . . 0.0 113.484 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 308' ' ' ASP . 3.7 t -104.92 12.22 32.7 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.059 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.453 ' HE2' ' HA3' ' A' ' 334' ' ' GLY . 25.7 mtpp -101.63 1.36 37.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.866 ' HD1' HD13 ' A' ' 388' ' ' LEU . 2.4 p90 -125.53 169.38 12.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.3 t -149.2 162.37 40.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.951 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.542 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.3 m-90 -69.74 111.04 5.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 60.1 tptt -86.21 -36.26 19.55 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.544 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 11.3 ttm180 -164.6 120.99 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.138 175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.25 161.12 59.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.522 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.82 116.08 0.39 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.769 2.313 . . . . 0.0 112.013 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -131.9 134.34 45.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.173 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.45 127.4 24.9 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.412 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.3 p -66.8 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.7 -4.34 42.77 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -139.71 59.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.548 0.213 . . . . 0.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 74.13 -24.73 0.2 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 21.4 p -101.33 -171.39 1.98 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.301 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.74 153.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.402 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.986 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -134.8 154.48 36.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.877 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.669 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -137.69 161.86 35.39 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 16.2 tt0 -134.15 131.26 38.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.508 ' CG2' HD11 ' A' ' 372' ' ' ILE . 1.2 m -135.96 145.46 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.623 0.249 . . . . 0.0 111.3 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.91 135.19 11.53 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.302 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.594 ' CE1' ' HD2' ' A' ' 312' ' ' PHE . 1.3 m-85 -122.08 172.75 8.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 70.8 m -157.25 52.84 0.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.453 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -163.86 -74.69 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.35 -1.405 . . . . 0.0 113.766 170.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.665 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 3.8 m -57.53 144.23 37.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.437 0.695 . . . . 0.0 111.919 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.705 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 13.9 ptm180 -76.69 168.9 24.08 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.555 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 364' ' ' MET . 1.0 OUTLIER -27.26 98.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.008 3.139 . . . . 0.0 114.373 -173.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.796 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 26.9 p -110.58 173.49 6.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.784 -169.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 24.2 mmm180 -90.37 102.32 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.909 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.871 HD11 ' HB3' ' A' ' 364' ' ' MET . 58.6 mt -74.67 122.96 88.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.575 0.226 . . . . 0.0 111.08 -176.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.6 81.75 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.471 2.114 . . . . 0.0 112.4 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 340' ' ' ILE . 6.4 m -102.9 126.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 111.504 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 21.0 ptt180 -139.07 -178.24 5.25 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.93 135.96 11.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.629 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.16 174.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -104.67 115.89 31.1 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 15.8 p80 42.98 55.45 4.44 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.913 0.758 . . . . 0.0 112.575 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.862 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.68 11.09 56.6 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.881 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.91 118.02 30.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.468 -0.43 . . . . 0.0 110.679 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.17 61.91 5.0 Favored 'Trans proline' 0 N--CA 1.463 -0.324 0 C-N-CA 123.024 2.483 . . . . 0.0 111.268 172.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.86 -38.68 12.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.8 p -151.45 126.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.296 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -60.75 106.37 0.56 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.802 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.8 m -88.01 3.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.36 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.421 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.68 82.0 4.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.56 0.695 . . . . 0.0 110.747 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.817 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 2.5 tpt -98.91 83.5 2.93 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.3 mt -68.05 125.92 27.85 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.118 -169.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.581 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 6.2 mm -70.03 -23.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.399 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 13.0 m -138.63 92.95 11.21 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.057 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -91.75 41.04 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.386 2.724 . . . . 0.0 113.624 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.94 65.84 5.85 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.264 0.554 . . . . 0.0 110.098 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.702 ' HB3' HG23 ' A' ' 372' ' ' ILE . 97.2 Cg_endo -87.95 118.0 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.414 2.076 . . . . 0.0 113.168 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.4 p -110.0 134.5 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.412 171.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.871 ' HB3' HD11 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -107.14 149.94 27.12 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.542 -176.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -111.03 -168.53 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.827 1.329 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -64.91 -16.04 62.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -86.47 -11.44 51.78 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.306 0.574 . . . . 0.0 110.171 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.534 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 113.2 -167.67 12.38 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.707 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 364' ' ' MET . . . -81.49 -15.18 76.79 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.986 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.4 -127.62 23.8 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.128 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.95 133.31 50.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.072 0.463 . . . . 0.0 111.184 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -125.12 165.14 22.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.986 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.1 mt-10 -134.43 137.28 43.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.216 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.605 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.77 159.74 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -175.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.817 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.2 tp60 -179.0 160.12 1.05 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 123.022 0.201 . . . . 0.0 110.579 174.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.802 HD22 ' HA ' ' A' ' 354' ' ' VAL . 13.8 tp -158.94 150.67 17.0 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.802 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.6 Cg_exo -32.93 136.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.49 2.793 . . . . 0.0 113.604 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -35.79 128.75 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.851 1 C-N-CA 125.725 4.283 . . . . 0.0 114.951 -169.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.5 -134.41 2.89 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.406 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 14.7 m-20 -127.12 102.0 6.77 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.506 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.8 m120 -102.88 123.0 45.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.102 0.477 . . . . 0.0 109.987 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.042 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.79 129.75 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' A' ' 374' ' ' MET . 29.7 mt -91.65 131.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.414 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.4 OUTLIER -108.03 91.47 3.66 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.039 174.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 342' ' ' VAL . 7.6 t -83.86 94.6 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.61 -97.49 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.952 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 28.0 t70 -104.73 -19.89 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.173 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.866 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.1 tp -64.31 146.43 54.41 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.4 p30 -158.84 143.22 15.66 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.492 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -166.18 124.69 1.51 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.421 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.042 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.5 tm0? -78.35 143.2 37.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.906 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 394' ' ' GLN . 26.8 t-105 -145.37 114.54 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.366 174.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 27.3 p90 -74.38 125.8 29.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.409 ' HB3' ' NE1' ' A' ' 392' ' ' TRP . 1.3 pp0? -120.08 140.53 50.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.67 0.748 . . . . 0.0 112.731 -171.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.314 168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.421 0.629 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -69.53 120.36 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.676 -0.64 . . . . 0.0 110.124 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.3 t -171.29 -167.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.719 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.45 113.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 143.78 55.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.791 0.805 . . . . 0.0 110.812 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.57 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.0 t70 -80.29 150.65 29.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.273 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 10.8 ptmt -58.51 -18.58 30.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.017 -173.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.57 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.0 t -100.19 -0.22 39.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.3 mmmt -80.86 -33.79 34.2 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -93.84 154.55 17.67 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.154 0.502 . . . . 0.0 111.535 -178.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.443 ' HA ' HD11 ' A' ' 388' ' ' LEU . 8.9 t -144.38 150.62 38.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.283 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -64.98 112.76 3.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.225 0.536 . . . . 0.0 111.999 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.484 ' HG2' ' OE2' ' A' ' 329' ' ' GLU . 38.2 tttm -94.99 -28.54 15.09 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 72.1 ttt180 -168.89 110.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.628 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.2 160.47 39.94 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.43 -175.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.765 ' HG3' HD12 ' A' ' 383' ' ' ILE . 69.6 Cg_exo -30.78 118.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.922 3.081 . . . . 0.0 113.498 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -137.21 134.55 36.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.738 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.564 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 14.3 t70 -52.16 130.17 29.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.945 0.402 . . . . 0.0 110.497 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 99.9 p -69.75 -24.14 63.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.354 -173.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 102.49 -12.68 56.82 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -125.11 57.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 4.9 p-10 47.41 23.08 0.32 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.131 0.972 . . . . 0.0 113.529 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.591 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -127.43 -172.7 2.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.7 OUTLIER -128.92 152.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.882 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 373' ' ' GLU . 25.8 m -137.6 153.26 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.687 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.59 ' CE ' HD12 ' A' ' 372' ' ' ILE . 18.0 ptt? -136.52 158.15 45.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.715 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.4 tt0 -121.29 118.82 30.49 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.263 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.82 148.86 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -120.49 157.07 15.88 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.87 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.443 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -95.75 178.74 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.825 -177.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 311' ' ' LYS . 37.6 p -136.2 -3.04 2.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.0 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 161.06 11.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 119.207 -1.473 . . . . 0.0 115.782 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 39.8 m -113.08 127.48 56.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.138 0.969 . . . . 0.0 109.903 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.591 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.6 ptt180 -75.03 171.48 11.6 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.033 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.9 OUTLIER -25.51 92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.986 3.124 . . . . 0.0 114.8 -166.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 363' ' ' THR . 9.2 p -110.54 144.72 38.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.709 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 6.1 mpt_? -73.47 103.95 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.713 HG21 ' HG3' ' A' ' 364' ' ' MET . 21.1 pt -88.28 128.71 52.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.252 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 312' ' ' PHE . 58.4 Cg_endo -74.5 82.53 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.73 2.287 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 385' ' ' VAL . 13.5 m -98.57 113.7 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.694 0.759 . . . . 0.0 111.31 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 383' ' ' ILE . 18.2 ptt180 -123.09 -178.74 4.05 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -154.6 142.27 19.88 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.195 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -114.38 169.65 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.544 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -112.44 116.79 30.86 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.974 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 380' ' ' ASP . 19.6 t60 63.95 39.07 8.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.6 0.562 . . . . 0.0 109.902 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 70.2 5.76 54.98 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.427 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 47.5 t -111.65 115.37 51.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 117.201 0.501 . . . . 0.0 111.348 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.8 Cg_exo -77.91 52.62 4.08 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.293 2.662 . . . . 0.0 112.298 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.63 -53.38 4.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.661 0.743 . . . . 0.0 109.108 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.33 117.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.603 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.8 t30 -53.29 108.67 0.35 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.244 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.876 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.9 m -87.13 8.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -81.69 80.89 7.91 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.515 0.674 . . . . 0.0 110.718 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 37.9 mtt -102.39 81.05 2.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.2 mt -63.68 125.25 23.68 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.271 -169.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 375' ' ' GLN . 4.6 mm -65.47 -20.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.4 m -136.61 92.27 15.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.489 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 357' ' ' LEU . 80.0 Cg_endo -92.07 48.93 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.6 2.867 . . . . 0.0 114.739 -168.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -170.47 70.11 0.56 Allowed Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 109.918 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.486 ' HB3' HG23 ' A' ' 372' ' ' ILE . 86.2 Cg_endo -90.91 138.32 2.4 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.949 2.433 . . . . 0.0 113.822 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 17.2 p -123.98 143.09 50.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.651 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.713 ' HG3' HG21 ' A' ' 340' ' ' ILE . 53.7 mtm -95.86 128.82 43.08 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.121 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 mm-40 -93.2 -172.22 2.89 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.348 1.03 . . . . 0.0 112.245 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -66.25 -6.23 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.838 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -112.87 -2.1 14.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.31 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 105.31 -175.34 21.87 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.0 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -75.29 -37.72 41.22 Favored Glycine 0 CA--C 1.509 -0.306 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.494 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.76 -124.11 6.46 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.431 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.2 134.94 45.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.106 0.479 . . . . 0.0 111.559 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.59 HD12 ' CE ' ' A' ' 328' ' ' MET . 0.9 OUTLIER -128.7 155.33 40.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.767 ' HG2' HG12 ' A' ' 327' ' ' VAL . 33.8 mt-10 -125.09 138.34 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.875 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -153.59 157.18 39.3 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.908 0.483 . . . . 0.0 110.709 -174.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.718 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -170.07 163.72 9.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 173.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.9 tp -165.51 163.41 12.97 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 72.1 Cg_exo -27.83 133.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.103 3.202 . . . . 0.0 114.348 168.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.839 ' HB3' ' HB2' ' A' ' 395' ' ' LYS . 5.2 Cg_exo -37.09 138.46 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.857 4.371 . . . . 0.0 115.362 -175.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 147.05 -179.76 23.73 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.063 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.5 m-20 -69.02 104.26 2.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 117.791 0.796 . . . . 0.0 110.561 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -94.34 112.54 24.33 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.011 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -114.78 127.56 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.863 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.765 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.8 mt -92.74 132.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.992 -175.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.676 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.6 OUTLIER -104.58 92.57 4.35 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.062 174.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.3 t -81.23 86.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.98 -91.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.533 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.542 ' HB2' ' HE3' ' A' ' 309' ' ' LYS . 10.5 t70 -108.75 -15.01 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 109.809 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -64.35 147.93 51.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.8 p-10 -158.34 140.87 14.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.585 0.231 . . . . 0.0 111.127 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.621 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -167.88 121.7 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.24 174.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.011 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 70.6 mt-30 -70.83 150.96 45.29 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.564 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 12.1 t-105 -151.04 110.7 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.985 169.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.9 p90 -74.39 111.36 9.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.652 0.739 . . . . 0.0 109.8 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 395' ' ' LYS . 1.7 pp0? -99.11 146.27 26.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.139 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' A' ' 378' ' ' PRO . 71.7 mmtt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.197 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.526 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 25.1 p90 -64.74 129.82 41.23 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.92 -0.488 . . . . 0.0 110.062 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.4 t 176.78 -173.61 0.1 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 17.3 t -69.56 106.09 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.482 ' SG ' HG22 ' A' ' 340' ' ' ILE . 0.3 OUTLIER -68.86 156.68 38.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.682 0.754 . . . . 0.0 112.393 -167.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.677 ' OD2' HG22 ' A' ' 310' ' ' THR . 18.4 t70 -67.8 143.16 55.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -66.11 -22.39 66.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.494 -170.022 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.677 HG22 ' OD2' ' A' ' 308' ' ' ASP . 2.6 t -100.0 -6.23 26.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.635 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 29.3 mtpp -83.02 38.19 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -175.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -123.93 173.69 8.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.261 0.553 . . . . 0.0 111.497 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 10.0 t -157.13 135.43 11.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.478 170.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -55.16 110.87 0.74 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.839 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.714 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 1.1 tpmt? -92.36 -41.68 10.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 69.9 ttt180 -161.16 126.16 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.2 162.57 71.84 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.648 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 4.9 Cg_exo -40.37 122.69 1.32 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.609 2.206 . . . . 0.0 111.718 175.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 12.3 m -142.85 142.17 31.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.259 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.12 125.58 6.66 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.176 0.298 . . . . 0.0 110.487 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.576 ' HB3' HG13 ' A' ' 327' ' ' VAL . 94.9 p -66.79 -20.15 65.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.902 -174.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.89 -2.19 79.29 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -140.01 55.33 1.64 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 110.97 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 72.96 12.92 5.02 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.716 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.68 ' HA ' HE21 ' A' ' 375' ' ' GLN . 5.1 p -144.62 -166.78 2.47 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.481 -0.137 . . . . 0.0 110.699 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.96 155.19 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.86 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.696 HG12 ' HG3' ' A' ' 373' ' ' GLU . 17.9 m -137.5 160.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.655 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.441 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 10.5 ptm -141.39 165.1 28.43 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.5 tt0 -130.19 124.68 33.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 385' ' ' VAL . 14.1 m -128.78 141.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.169 0.509 . . . . 0.0 111.599 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.03 161.04 14.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.0 OUTLIER -108.5 179.9 4.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.907 0.86 . . . . 0.0 112.833 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.2 t -98.8 -42.79 7.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.363 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.8 41.11 0.04 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.245 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.7 m -114.32 119.9 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.118 0.459 . . . . 0.0 110.33 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.575 ' HE ' ' HD2' ' A' ' 337' ' ' PRO . 2.6 ptm180 -69.87 171.22 7.73 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.253 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HD2' ' HE ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.05 92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 124.184 3.256 . . . . 0.0 114.532 -169.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 363' ' ' THR . 20.8 p -114.34 164.1 14.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.274 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 20.8 mmt180 -86.59 99.03 11.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.815 HG13 HG22 ' A' ' 342' ' ' VAL . 16.7 pt -81.0 130.03 64.97 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.548 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.94 78.97 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.173 1.915 . . . . 0.0 112.354 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -98.25 121.62 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.832 0.825 . . . . 0.0 112.411 175.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -126.67 -176.69 3.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.326 171.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.47 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.9 134.47 15.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.348 0.594 . . . . 0.0 110.647 176.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 18.3 m -110.74 167.63 4.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.37 114.41 28.66 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.349 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 57.35 46.79 17.78 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 123.721 0.638 . . . . 0.0 110.621 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.587 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 64.75 13.84 57.02 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.837 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 351' ' ' GLU . 46.9 t -114.66 112.95 45.2 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.51 0.655 . . . . 0.0 111.301 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.64 52.56 2.51 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.627 2.885 . . . . 0.0 112.134 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.475 ' HB2' HG12 ' A' ' 349' ' ' VAL . 10.5 tp10 -90.93 -51.59 5.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.945 0.879 . . . . 0.0 108.828 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.8 118.51 29.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.115 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -61.03 107.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.719 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.747 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 27.0 m -89.53 6.58 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.47 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.95 83.37 6.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.466 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -99.82 91.98 5.09 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 29.6 mt -73.24 118.7 16.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.208 -167.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -66.66 -22.95 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.361 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -131.12 93.43 30.36 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.951 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.71 43.3 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.035 2.49 . . . . 0.0 113.035 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 66.6 t30 -150.54 61.03 4.48 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.543 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.648 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.9 Cg_endo -88.53 118.96 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.528 2.152 . . . . 0.0 112.789 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 53.2 p -124.42 149.63 46.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.377 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.993 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 71.3 mtm -94.61 133.8 37.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -109.46 -168.72 1.37 Allowed 'General case' 0 C--N 1.318 -0.795 0 O-C-N 124.551 1.157 . . . . 0.0 111.891 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -52.51 -23.73 6.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -109.43 -7.93 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.077 -0.389 . . . . 0.0 111.156 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 127.75 -178.14 17.18 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.993 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -63.12 -29.66 75.09 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.63 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.9 -123.42 6.58 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.347 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -103.55 147.28 27.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.191 0.519 . . . . 0.0 111.644 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.648 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -136.54 137.67 47.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.962 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.7 mp0 -107.29 135.52 48.66 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.292 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.748 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -152.45 158.09 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.68 HE21 ' HA ' ' A' ' 325' ' ' THR . 6.4 tp-100 -176.04 145.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.725 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.788 HD22 ' HD2' ' A' ' 377' ' ' PRO . 0.8 OUTLIER -146.25 142.48 17.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 167.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.788 ' HD2' HD22 ' A' ' 376' ' ' LEU . 28.2 Cg_exo -23.94 136.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.844 3.696 . . . . 0.0 115.004 177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.547 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 6.3 Cg_exo -37.11 134.2 0.41 Allowed 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 125.79 4.327 . . . . 0.0 114.97 -171.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 161.51 -124.6 1.33 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.995 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -132.29 101.78 5.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.418 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.9 m120 -104.57 124.75 49.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.55 134.28 66.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 374' ' ' MET . 41.9 mt -95.27 134.1 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.176 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.23 94.24 4.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.133 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 342' ' ' VAL . 2.8 t -84.82 72.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.64 -80.66 0.77 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.504 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.506 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 1.9 t70 -110.54 -30.08 7.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.51 141.77 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.537 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.4 p30 -150.73 154.27 37.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -170.08 116.07 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 175.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.0 OUTLIER -73.13 139.97 46.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.438 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 29.9 t-105 -136.67 137.72 40.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.158 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -94.97 117.32 29.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -112.32 146.09 38.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.886 0.374 . . . . 0.0 110.495 -177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 395' ' ' LYS . 1.9 ttpm? . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.496 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 335' ' ' THR . 6.8 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HD1' ' H ' ' A' ' 304' ' ' TYR . 0.4 OUTLIER -70.84 108.48 4.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.783 0.802 . . . . 0.0 110.617 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.5 t -168.43 -167.18 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.582 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.69 113.43 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 170.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.98 144.23 56.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.658 0.742 . . . . 0.0 111.174 -171.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.93 148.33 40.15 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.13 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.81 -12.88 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.888 -173.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.477 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.5 t -98.15 -6.21 31.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.568 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.7 mmmt -75.9 -36.16 59.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.628 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -94.4 148.79 21.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 111.106 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.9 t -139.11 162.19 35.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.56 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.466 ' CZ3' ' HA ' ' A' ' 317' ' ' ALA . 93.8 m95 -67.37 111.39 4.02 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.958 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 73.3 tttt -102.52 -39.8 6.95 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.014 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.644 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 70.7 ttt180 -157.0 118.35 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.51 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.466 ' HA ' ' CZ3' ' A' ' 314' ' ' TRP . . . -67.42 161.21 66.83 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.462 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.866 ' HG3' HD12 ' A' ' 383' ' ' ILE . 74.0 Cg_exo -36.34 110.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.223 2.616 . . . . 0.0 113.251 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.5 m -134.9 137.45 43.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.591 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.4 131.66 13.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.162 0.505 . . . . 0.0 111.509 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.457 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.1 p -66.89 -23.32 65.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.77 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.05 -11.64 31.73 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -100.77 -54.13 2.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.516 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 21.9 t70 170.08 -24.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.323 1.058 . . . . 0.0 109.035 -171.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.563 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.46 -169.95 2.25 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.462 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.73 154.38 38.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.024 0.44 . . . . 0.0 111.001 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.3 m -135.22 156.61 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.76 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.568 ' SD ' HG22 ' A' ' 330' ' ' VAL . 2.0 ppp? -135.65 154.63 51.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.958 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 9.7 tt0 -126.44 123.13 37.17 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.116 0.484 . . . . 0.0 110.601 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -123.7 148.83 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.51 -177.167 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.23 139.35 15.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.78 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.521 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.8 OUTLIER -91.13 179.27 5.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.345 0.573 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.7 p -135.55 -17.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.118 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.99 -47.28 0.06 OUTLIER Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.339 -1.41 . . . . 0.0 114.213 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 303' ' ' THR . 26.3 m -56.27 125.27 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.213 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.584 ' HD2' ' HB3' ' A' ' 304' ' ' TYR . 0.0 OUTLIER -69.44 163.22 60.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 118.14 -0.933 . . . . 0.0 108.891 176.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.48 97.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.148 3.232 . . . . 0.0 114.688 -169.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 363' ' ' THR . 6.8 p -114.07 150.89 33.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.969 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -75.4 108.06 7.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.736 HG21 ' HG3' ' A' ' 364' ' ' MET . 28.8 pt -91.48 128.58 46.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.106 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.33 89.57 1.18 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.099 2.533 . . . . 0.0 112.881 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 372' ' ' ILE . 19.1 m -101.05 124.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.415 0.626 . . . . 0.0 110.938 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -132.78 -175.62 3.83 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.454 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 137.46 18.44 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.59 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 382' ' ' ILE . 10.7 m -115.23 166.82 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.54 117.74 34.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.535 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.5 t60 59.7 40.08 20.27 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.395 0.434 . . . . 0.0 110.519 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.432 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 69.1 6.96 55.77 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.231 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.1 113.09 62.75 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.897 0.349 . . . . 0.0 111.051 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.46 55.87 4.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.929 2.42 . . . . 0.0 111.88 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.32 -53.49 4.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.029 0.919 . . . . 0.0 108.621 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.6 120.89 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.787 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -54.37 107.99 0.33 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.663 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 1.049 ' HB ' ' HB3' ' A' ' 376' ' ' LEU . 2.6 m -87.9 -8.65 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.85 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.454 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -60.02 96.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.471 0.653 . . . . 0.0 112.222 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.637 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 67.4 mtm -108.18 85.38 2.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 45.4 mt -73.41 124.37 25.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.377 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.8 mm -69.62 -20.53 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.3 m -145.74 97.13 4.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.999 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -92.47 37.91 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.483 2.788 . . . . 0.0 113.288 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -144.53 63.04 10.42 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.883 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.741 ' HB3' HG23 ' A' ' 372' ' ' ILE . 88.4 Cg_endo -86.1 131.45 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.564 2.176 . . . . 0.0 113.016 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -130.4 142.16 50.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.399 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 59.0 mtm -95.24 117.08 29.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.722 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 38.5 mt-10 -100.12 -165.47 1.22 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.898 1.374 . . . . 0.0 109.886 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -62.8 -15.0 52.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 0.0 111.314 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.7 6.44 48.69 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.184 0.516 . . . . 0.0 109.678 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 83.48 -155.19 32.1 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -68.43 -16.43 69.4 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.826 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 71.45 -87.18 0.42 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.705 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.02 143.32 15.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.099 0.476 . . . . 0.0 109.871 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.8 mt -119.57 157.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.671 ' HG2' HG12 ' A' ' 327' ' ' VAL . 37.0 mt-10 -126.34 130.94 51.78 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.806 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.646 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -155.26 160.56 40.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.928 -173.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.637 ' O ' ' HB2' ' A' ' 356' ' ' MET . 4.7 tp60 -163.71 148.19 10.54 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 167.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.049 ' HB3' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -132.22 163.59 49.27 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -169.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 378' ' ' PRO . 3.5 Cg_endo -48.16 126.67 13.87 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.625 2.217 . . . . 0.0 112.147 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.5 Cg_exo -38.81 128.62 1.26 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.69 3.594 . . . . 0.0 113.711 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 134.32 -172.57 21.76 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.362 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.4 m-20 -71.21 101.44 2.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.931 0.365 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.546 ' HB2' HD23 ' A' ' 376' ' ' LEU . 31.9 m-80 -118.04 163.39 16.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.055 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -146.24 144.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.631 -173.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.5 mt -100.97 132.96 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.094 0.473 . . . . 0.0 110.339 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -103.84 97.15 7.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.24 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.1 t -86.5 84.68 2.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.32 -85.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.332 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.765 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 7.8 t70 -113.09 -16.23 12.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.681 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.4 mp -66.14 148.76 51.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.058 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.1 p30 -163.45 126.92 2.73 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.967 0.413 . . . . 0.0 111.494 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -153.75 119.81 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.25 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.055 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 9.7 tt0 -87.39 142.38 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.424 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.473 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 0.6 OUTLIER -153.33 141.02 19.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.83 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 7.7 p90 -74.55 107.08 6.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.288 0.566 . . . . 0.0 110.661 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.695 ' HG3' HD23 ' A' ' 376' ' ' LEU . 8.0 mm-40 -85.1 145.07 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 tptm . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.819 172.589 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 335' ' ' THR . 7.7 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.789 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.3 p90 -58.97 130.94 49.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 110.181 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.7 t -177.58 -165.45 0.11 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.02 107.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.538 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.5 OUTLIER -68.4 136.24 53.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.818 0.818 . . . . 0.0 110.877 -174.096 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.544 ' OD1' HG22 ' A' ' 310' ' ' THR . 8.7 t70 -65.92 147.75 52.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.924 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.792 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -61.56 -13.37 21.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.248 -177.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.544 HG22 ' OD1' ' A' ' 308' ' ' ASP . 15.3 t -104.29 6.19 35.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 41.4 mtpt -106.36 17.42 23.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.792 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.5 OUTLIER -132.74 158.32 42.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.2 t -138.71 154.08 48.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.503 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.524 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.5 m-90 -63.8 98.49 0.2 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.367 0.604 . . . . 0.0 110.885 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -83.51 -32.42 25.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 37.6 ttm180 -165.24 116.12 1.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.255 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.42 163.6 24.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.344 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.0 Cg_exo -41.7 117.91 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.638 2.226 . . . . 0.0 112.107 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.7 m -135.49 144.52 46.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.345 -172.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.82 130.3 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.529 ' HB3' HG13 ' A' ' 327' ' ' VAL . 80.6 p -71.15 -18.64 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.93 -2.59 72.53 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 9.1 t60 -109.09 -52.88 2.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 19.0 t70 169.19 -25.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.311 1.053 . . . . 0.0 108.915 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.456 ' CB ' HG13 ' A' ' 358' ' ' ILE . 9.4 p -92.83 -168.28 1.92 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.004 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.68 150.92 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -131.85 163.7 36.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.979 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.39 163.99 31.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 4.0 tt0 -132.06 126.68 34.42 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.656 0.597 . . . . 0.0 110.1 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.91 153.9 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.38 152.27 16.84 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.999 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.644 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -89.93 165.86 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.227 0.514 . . . . 0.0 111.798 -174.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 35.3 m -115.6 8.03 14.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.338 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 147.61 13.11 0.15 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.458 -1.354 . . . . 0.0 115.2 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 336' ' ' ARG . 98.4 m -114.29 132.71 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.292 1.046 . . . . 0.0 110.586 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.789 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 28.0 ptt180 -75.94 173.11 7.72 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.027 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.62 93.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 124.051 3.167 . . . . 0.0 115.166 -168.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 1.8 p -110.8 150.78 28.63 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.035 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.28 108.75 3.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.599 ' HB ' ' HG3' ' A' ' 364' ' ' MET . 15.6 tt -92.4 119.24 68.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 121.013 0.435 . . . . 0.0 110.24 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.47 82.23 2.13 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.987 2.458 . . . . 0.0 112.535 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -98.93 128.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.384 0.611 . . . . 0.0 111.477 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 32.0 ptt180 -135.17 -176.13 4.15 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.68 141.58 22.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.255 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 14.6 m -120.47 168.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.44 34.11 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.049 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.538 ' HA ' ' OD2' ' A' ' 380' ' ' ASP . 5.4 t60 56.91 46.54 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.514 0.509 . . . . 0.0 111.381 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.431 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 61.79 14.44 44.24 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.642 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 347' ' ' HIS . 38.7 t -115.78 115.86 41.13 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.155 0.478 . . . . 0.0 111.216 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.9 Cg_exo -79.16 51.29 3.8 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.231 2.62 . . . . 0.0 112.228 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -85.07 -41.4 15.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.739 0.781 . . . . 0.0 109.222 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 351' ' ' GLU . 4.4 p -144.11 118.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.602 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -55.78 108.09 0.41 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.948 ' HA ' HD22 ' A' ' 376' ' ' LEU . 28.2 m -84.99 0.18 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.124 0.487 . . . . 0.0 110.293 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.455 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.36 82.97 3.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.216 0.532 . . . . 0.0 110.835 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.744 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 8.5 tpt -97.59 91.96 5.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 166.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 39.3 mt -74.49 120.37 19.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.454 -165.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -70.32 -19.01 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 61.7 m -128.25 81.89 69.61 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.252 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -86.18 43.92 1.18 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.14 2.56 . . . . 0.0 113.811 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.14 67.62 0.41 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.473 ' HB3' HG23 ' A' ' 372' ' ' ILE . 68.9 Cg_endo -91.49 134.91 1.65 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.816 2.344 . . . . 0.0 114.01 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 2.8 p -116.65 155.94 27.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.93 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.933 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 76.7 mtp -95.43 103.72 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.981 0.42 . . . . 0.0 109.868 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -79.72 -165.56 0.83 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.732 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -46.85 -30.86 2.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -122.69 25.72 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.757 -0.59 . . . . 0.0 111.289 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.09 -177.6 20.37 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.008 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.933 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.12 -25.09 53.35 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.395 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.09 -110.98 3.71 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.642 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -108.1 131.9 54.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.152 0.501 . . . . 0.0 111.721 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.2 mt -134.98 141.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.857 ' HG2' HG12 ' A' ' 327' ' ' VAL . 30.9 mt-10 -114.46 137.09 52.28 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.492 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.524 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -144.46 156.08 44.03 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.744 ' O ' ' HB3' ' A' ' 356' ' ' MET . 24.1 tp60 -175.65 144.92 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.709 0.29 . . . . 0.0 110.96 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.017 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.2 tp -147.15 160.07 40.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 164.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 1.017 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 38.7 Cg_exo -29.47 133.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.147 3.231 . . . . 0.0 114.579 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.439 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 73.0 Cg_exo -35.37 135.69 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.016 1 C-N-CA 125.441 4.094 . . . . 0.0 115.562 -176.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.61 -135.71 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.7 p-10 -131.17 107.47 9.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.162 0.982 . . . . 0.0 109.977 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 354' ' ' VAL . 6.1 m-20 -102.26 128.65 48.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.632 -177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.968 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -119.63 135.73 59.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.524 HD11 ' HG2' ' A' ' 374' ' ' MET . 42.2 mt -91.07 129.48 41.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.873 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -108.93 91.84 3.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.971 176.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 342' ' ' VAL . 9.3 t -83.6 85.6 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.24 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.359 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 3.1 t0 -112.1 -22.64 10.89 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.643 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -64.13 140.08 58.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.226 177.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.489 ' H ' ' HZ2' ' A' ' 314' ' ' TRP . 25.7 p-10 -151.74 139.43 19.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.39 116.98 1.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.968 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 26.9 tt0 -67.38 141.57 57.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.763 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 27.9 t-105 -139.79 122.11 16.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.121 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 11.8 p90 -79.76 109.07 13.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.077 0.465 . . . . 0.0 109.908 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 3.2 pp0? -104.11 133.16 49.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.048 0.452 . . . . 0.0 110.511 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.61 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 335' ' ' THR . 6.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.185 0.516 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -57.99 131.15 49.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.792 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.9 t -176.39 -167.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.0 t -68.13 116.65 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 137.22 56.08 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.805 0.812 . . . . 0.0 111.446 -170.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.65 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.4 t0 -60.69 143.33 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.545 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.646 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.1 -171.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.65 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.2 t -108.58 3.96 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.508 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 37.3 mttp -80.19 -21.53 42.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -95.97 154.02 17.46 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.347 0.594 . . . . 0.0 110.958 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.8 t -136.95 156.44 48.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.226 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -59.98 99.9 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.762 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.536 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 27.6 tptp -89.34 -46.42 8.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.445 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 28.5 ttm180 -154.92 122.43 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.792 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.46 157.19 86.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.33 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 392' ' ' TRP . 2.4 Cg_endo -42.24 112.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.111 2.541 . . . . 0.0 112.689 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -127.61 144.64 51.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.02 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.75 128.02 6.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 93.4 p -64.96 -23.1 67.12 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.521 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.86 -12.4 20.36 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.753 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.0 -40.92 1.98 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -178.0 -28.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.384 0.611 . . . . 0.0 111.667 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.467 ' HB ' HG13 ' A' ' 358' ' ' ILE . 16.7 p -93.31 -170.88 2.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.035 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.0 OUTLIER -127.62 144.72 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 -177.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.915 HG12 ' HG2' ' A' ' 373' ' ' GLU . 21.9 m -129.23 142.73 43.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.603 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.7 ptm -125.91 166.88 16.08 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.536 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 15.6 tt0 -136.7 140.54 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.603 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -139.52 158.89 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.67 0.271 . . . . 0.0 111.335 -178.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.652 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.86 135.85 9.64 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.629 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD2' ' HA2' ' A' ' 368' ' ' GLY . 2.3 p90 -90.74 178.45 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.192 0.496 . . . . 0.0 109.941 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.0 m -152.45 19.1 0.63 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -160.82 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.486 -1.34 . . . . 0.0 114.11 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 336' ' ' ARG . 67.9 m -70.49 139.98 51.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 4.8 ptt180 -67.34 175.84 1.42 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 117.611 -1.185 . . . . 0.0 109.013 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 364' ' ' MET . 3.7 Cg_exo -26.02 92.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 124.002 3.134 . . . . 0.0 114.247 -174.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 1.6 p -113.34 151.85 30.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.152 -171.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 9.1 mpt_? -69.24 109.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.579 HD11 HG11 ' A' ' 385' ' ' VAL . 11.3 tt -89.22 118.7 69.4 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 120.946 0.403 . . . . 0.0 110.459 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.8 84.12 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.085 2.523 . . . . 0.0 112.798 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -100.7 130.63 49.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 41.0 ptt180 -138.29 -170.26 2.77 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' A' ' 355' ' ' ALA . . . -155.52 140.89 17.68 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.348 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.83 167.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.44 113.05 26.26 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.886 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 56.68 49.39 14.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.75 2.15 27.78 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.252 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 25.9 t -110.37 113.05 56.58 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 117.73 0.765 . . . . 0.0 111.484 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 3.0 Cg_exo -79.33 63.17 8.69 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.485 2.79 . . . . 0.0 112.906 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.73 -46.01 6.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.622 0.725 . . . . 0.0 109.369 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.92 124.52 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.074 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.5 t30 -63.02 107.98 1.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.62 HG11 HD21 ' A' ' 381' ' ' ASN . 34.3 m -90.94 11.56 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.549 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -83.3 83.19 7.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.548 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 36.7 ttm -96.92 87.26 4.21 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.6 mt -72.48 119.78 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.659 -165.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -69.79 -14.42 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -142.49 85.93 10.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.552 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 357' ' ' LEU . 96.9 Cg_endo -87.46 46.03 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.328 2.686 . . . . 0.0 113.944 -171.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -163.13 62.68 1.2 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.027 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.483 ' O ' HG22 ' A' ' 340' ' ' ILE . 86.1 Cg_endo -86.02 129.44 3.39 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.167 1.912 . . . . 0.0 113.405 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -116.96 150.56 38.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.502 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.839 ' HE1' ' HB3' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -99.81 118.78 37.01 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.974 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.94 -165.32 1.24 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 124.929 1.393 . . . . 0.0 110.697 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -55.89 -21.67 21.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -100.24 -0.43 38.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.313 0.577 . . . . 0.0 110.437 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.652 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.91 -160.14 13.58 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -65.6 -2.7 11.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 117.606 0.703 . . . . 0.0 112.505 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 56.21 -130.12 48.96 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -172.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 328' ' ' MET . 38.3 p90 -112.36 150.11 31.52 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.997 0.427 . . . . 0.0 110.432 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 342' ' ' VAL . 2.2 mt -134.0 143.68 37.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.418 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.915 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.0 mt-10 -112.4 139.71 47.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.541 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.6 ppp? -156.86 162.89 39.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.171 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.864 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.89 169.63 6.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.064 0.459 . . . . 0.0 111.829 172.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.7 tm? -166.12 141.03 3.8 Favored Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.809 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.4 Cg_exo -31.36 132.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.849 3.033 . . . . 0.0 114.12 175.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.541 ' CA ' HE22 ' A' ' 394' ' ' GLN . 6.0 Cg_exo -37.17 130.93 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.154 1 C-N-CA 125.783 4.322 . . . . 0.0 115.016 -170.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.99 -173.32 37.43 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.7 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.8 m-20 -90.1 101.53 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.037 0.419 . . . . 0.0 110.066 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.62 HD21 HG11 ' A' ' 354' ' ' VAL . 11.1 m120 -111.89 -179.64 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.506 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.77 139.3 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 O-C-N 122.268 -0.27 . . . . 0.0 110.322 178.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.628 ' HB ' ' CE1' ' A' ' 390' ' ' HIS . 29.9 mt -91.04 133.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 389' ' ' ASN . 1.8 t80 -112.95 104.25 12.21 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 342' ' ' VAL . 6.2 t -97.01 83.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.86 -88.74 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.516 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.41 -31.18 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.2 mp -63.62 140.92 58.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 5.0 p-10 -140.25 140.62 35.81 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.829 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.628 ' CE1' ' HB ' ' A' ' 383' ' ' ILE . 0.8 OUTLIER -162.86 102.23 1.01 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.597 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.4 tt0 -81.41 152.23 27.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.404 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.739 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.2 OUTLIER -159.53 150.37 19.47 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 35.5 p90 -94.14 128.94 40.85 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.371 -0.83 . . . . 0.0 109.665 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.541 HE22 ' CA ' ' A' ' 378' ' ' PRO . 3.6 pp0? -109.39 145.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.022 0.439 . . . . 0.0 110.474 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 395' ' ' LYS . 7.2 tmtt? . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.466 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.595 HG23 HG23 ' A' ' 335' ' ' THR . 8.7 t . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.365 0.602 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.71 113.78 5.11 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.685 0.755 . . . . 0.0 110.098 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.1 t -173.81 -166.45 0.31 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.91 104.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.729 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.6 OUTLIER -74.47 167.23 22.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.9 t70 -71.89 150.3 44.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.62 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 24.6 pttt -74.5 -19.82 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.613 -167.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 308' ' ' ASP . 15.3 t -107.69 22.65 15.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.077 0.465 . . . . 0.0 111.625 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -95.64 18.55 12.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -134.23 173.67 11.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.388 0.614 . . . . 0.0 111.187 -178.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 140.81 33.01 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.299 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -54.01 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.518 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.98 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 76.3 tttt -85.89 -43.64 13.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 24.9 ttm180 -148.84 126.77 11.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.226 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' A' ' 390' ' ' HIS . . . -70.9 160.64 81.61 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.75 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -42.35 115.39 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.292 1.995 . . . . 0.0 111.467 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 5.0 m -134.34 144.61 48.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.732 -172.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -46.3 128.15 9.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 0.0 111.239 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -74.98 -22.05 58.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.451 -173.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.25 84.55 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -169.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -124.81 32.51 5.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.394 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.3 t70 68.9 19.39 8.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.309 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.764 ' HA ' HE21 ' A' ' 375' ' ' GLN . 13.8 p -136.76 -168.26 2.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.51 151.36 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.982 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.9 m -139.44 147.62 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.193 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.57 ' HB3' HD12 ' A' ' 383' ' ' ILE . 11.9 ptm -126.7 163.02 24.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.555 171.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.98 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 11.5 tt0 -128.14 127.47 43.06 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.87 138.23 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.062 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -108.6 139.98 15.38 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.82 -179.87 4.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.249 1.025 . . . . 0.0 111.715 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.2 p -129.99 -24.47 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.656 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -144.54 -68.02 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.375 -1.393 . . . . 0.0 115.0 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 307' ' ' CYS . 7.1 m -56.24 122.19 11.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.811 0.306 . . . . 0.0 111.619 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.459 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.8 ptm180 -74.21 171.82 10.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 117.68 -1.152 . . . . 0.0 108.589 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.98 96.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.955 3.103 . . . . 0.0 114.929 -170.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.746 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.7 p -118.09 165.57 13.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.257 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.47 100.61 12.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 362' ' ' PRO . 18.9 pt -74.6 128.65 85.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.79 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.24 82.09 1.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.669 2.246 . . . . 0.0 112.089 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 20.5 m -97.63 133.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.536 0.684 . . . . 0.0 111.131 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -145.45 -177.73 5.72 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.516 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.15 137.18 18.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.811 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.1 m -113.66 172.76 3.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -100.96 115.9 31.55 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 6.1 p-80 41.38 59.82 2.27 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.887 0.742 . . . . 0.0 112.831 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.867 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.97 5.02 37.76 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.898 -0.592 . . . . 0.0 114.226 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 25.3 t -114.52 116.98 43.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 117.386 0.593 . . . . 0.0 111.026 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 9.6 Cg_exo -74.63 54.44 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.196 2.598 . . . . 0.0 111.471 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.561 ' HG3' HG12 ' A' ' 352' ' ' VAL . 7.8 pt-20 -86.22 -38.96 17.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.776 0.798 . . . . 0.0 108.951 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 351' ' ' GLU . 5.2 p -151.68 123.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.843 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -56.19 108.05 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.894 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.99 3.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.21 0.529 . . . . 0.0 110.2 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.93 82.66 5.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.318 -177.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -96.15 91.27 5.84 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 373' ' ' GLU . 20.9 mt -70.8 120.41 16.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.658 -167.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.7 mm -68.52 -21.03 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.287 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 10.3 m -136.98 92.38 14.24 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.845 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.4 43.65 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.218 2.612 . . . . 0.0 112.895 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.4 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.1 p-10 -150.37 58.65 3.17 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.722 ' HB2' HD11 ' A' ' 340' ' ' ILE . 92.5 Cg_endo -86.86 113.03 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.412 2.074 . . . . 0.0 113.244 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.2 p -114.06 140.09 48.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.913 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.746 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 24.6 ptt? -102.84 126.3 49.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.737 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.03 -166.24 1.18 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.307 -172.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -61.23 -12.88 14.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.26 -4.34 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.335 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.51 -165.47 12.71 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -78.52 -7.11 88.15 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.145 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 66.59 -120.66 15.35 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.688 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -116.04 140.22 49.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.217 0.532 . . . . 0.0 111.204 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.4 mt -124.42 126.6 72.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.1 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.982 ' HG2' HG12 ' A' ' 327' ' ' VAL . 38.1 mt-10 -104.75 132.58 50.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.217 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.464 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.764 HE21 ' HA ' ' A' ' 325' ' ' THR . 6.4 tp-100 -174.32 145.08 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.097 0.248 . . . . 0.0 110.592 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.0 tp -143.59 162.74 40.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 34.5 Cg_exo -36.48 141.8 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.269 2.646 . . . . 0.0 113.492 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.434 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 5.7 Cg_exo -37.53 134.64 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 125.325 4.017 . . . . 0.0 114.77 -173.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.37 -146.75 13.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.348 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 14.8 m-20 -112.55 101.36 9.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.481 0.641 . . . . 0.0 110.213 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 354' ' ' VAL . 6.6 m120 -100.05 118.81 37.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.609 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.016 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.88 133.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 328' ' ' MET . 30.7 mt -93.13 134.02 32.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.461 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.8 OUTLIER -109.74 92.76 4.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.342 174.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 342' ' ' VAL . 5.5 t -81.28 77.99 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.69 -91.68 0.27 Allowed Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.971 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.62 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -106.61 -18.0 14.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.342 0.592 . . . . 0.0 109.643 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.9 OUTLIER -74.37 128.26 35.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.534 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.99 143.68 48.29 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.534 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 0.1 OUTLIER -166.16 120.17 1.14 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.817 0.341 . . . . 0.0 110.806 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.016 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 47.1 tt0 -82.36 146.73 29.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.935 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 19.7 t-105 -141.97 132.97 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.76 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.87 119.48 29.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.434 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 3.2 pp0? -114.3 146.09 40.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.002 0.43 . . . . 0.0 110.343 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 pttt . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.847 -178.366 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.052 0.453 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.594 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 14.6 p90 -60.74 128.81 38.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -176.29 -172.42 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.04 110.44 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.494 ' HB2' ' HE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -68.67 134.73 50.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.684 0.754 . . . . 0.0 112.112 -172.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.632 ' OD1' HG22 ' A' ' 310' ' ' THR . 32.7 t70 -63.51 146.18 54.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.274 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.659 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.83 -14.66 62.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.321 -1.309 . . . . 0.0 114.309 -167.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.632 HG22 ' OD1' ' A' ' 308' ' ' ASP . 9.1 t -106.3 5.38 29.65 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.683 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -89.73 -21.16 22.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.08 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.72 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -95.87 147.45 23.65 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.21 0.529 . . . . 0.0 110.17 172.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 4.3 t -133.25 153.3 51.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.49 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.9 m-90 -61.98 99.12 0.12 Allowed 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 123.57 0.544 . . . . 0.0 111.232 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.629 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -84.44 -42.59 15.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 53.7 ttt180 -156.03 125.58 6.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.894 170.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.58 167.23 13.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.258 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.55 122.28 1.32 Allowed 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.925 2.417 . . . . 0.0 112.138 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -135.35 136.77 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.637 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -46.0 124.65 5.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 111.131 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -36.49 83.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.749 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 130.58 -10.71 5.78 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -114.84 -78.07 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.774 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.26 0.33 0.6 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.086 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.872 ' HA ' HE21 ' A' ' 375' ' ' GLN . 20.9 p -119.9 -174.28 2.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.142 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.4 153.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.884 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.816 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.6 m -133.44 163.99 36.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.557 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -147.71 153.71 39.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.649 -178.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.629 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 26.4 tt0 -129.6 118.07 21.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.597 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.721 HG13 ' SD ' ' A' ' 328' ' ' MET . 2.3 m -122.63 150.56 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.542 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.69 136.37 12.94 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.783 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.4 OUTLIER -90.93 -179.44 5.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.594 0.712 . . . . 0.0 111.241 -176.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.9 m -119.64 -25.78 5.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.993 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.21 -19.53 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.357 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 336' ' ' ARG . 5.5 m -75.3 134.75 40.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.021 0.91 . . . . 0.0 112.446 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.642 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.1 OUTLIER -78.3 173.7 7.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.611 171.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -25.46 95.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 124.021 3.147 . . . . 0.0 114.745 -173.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 305' ' ' THR . 21.8 p -110.67 166.87 10.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.336 -174.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.7 mpt_? -93.75 104.6 16.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.65 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.896 HD12 ' HB2' ' A' ' 362' ' ' PRO . 5.7 mt -75.79 123.82 88.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 81.42 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.311 2.007 . . . . 0.0 111.686 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 372' ' ' ILE . 14.5 m -100.58 133.62 43.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.416 0.627 . . . . 0.0 111.586 -177.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -143.24 -175.53 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.92 143.21 18.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.249 0.547 . . . . 0.0 111.459 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.4 m -115.17 172.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -102.5 115.67 31.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 2.6 p-80 37.86 64.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.728 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.44 6.34 33.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 38.9 t -115.69 113.66 42.45 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 117.616 0.708 . . . . 0.0 111.467 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.72 69.07 5.4 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.08 2.52 . . . . 0.0 111.364 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -95.19 -49.02 5.68 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.13 131.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.391 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 42.8 t30 -60.1 107.91 0.7 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.023 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.921 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.3 m -85.26 1.62 4.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 110.65 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.23 82.93 6.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.073 0.463 . . . . 0.0 110.479 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.04 92.24 5.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 28.5 mt -70.25 124.85 25.16 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.773 -165.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.0 mm -69.75 -21.53 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.702 -1.135 . . . . 0.0 107.994 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.8 m -137.33 94.82 11.97 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.7 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -86.01 41.22 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.396 2.731 . . . . 0.0 113.256 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -160.31 70.62 2.97 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.393 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.896 ' HB2' HD12 ' A' ' 340' ' ' ILE . 95.6 Cg_endo -82.19 133.6 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.492 2.128 . . . . 0.0 112.434 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.0 p -129.12 141.28 51.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.208 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.716 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 74.1 mtp -96.0 130.51 42.98 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.5 -168.72 1.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.271 0.982 . . . . 0.0 111.837 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . 12.3 p30 -70.08 -5.62 28.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.435 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -113.52 9.12 17.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.4 0.619 . . . . 0.0 109.871 171.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.58 -165.75 16.77 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.246 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.716 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.53 -12.86 70.56 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.035 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.47 -119.25 10.03 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.6 m-85 -121.87 131.51 54.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.688 0.756 . . . . 0.0 111.606 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -106.17 157.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.816 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.2 mt-10 -126.87 129.15 47.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.867 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.4 OUTLIER -147.99 156.41 42.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.531 -172.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.872 HE21 ' HA ' ' A' ' 325' ' ' THR . 6.8 tp-100 -177.65 146.73 0.46 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.645 0.259 . . . . 0.0 110.873 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.954 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.9 tp -145.26 154.46 53.77 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.954 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 41.5 Cg_exo -26.87 133.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 124.476 3.451 . . . . 0.0 115.134 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.527 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 54.6 Cg_exo -35.58 128.73 0.32 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 125.134 3.889 . . . . 0.0 115.114 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 167.68 -135.25 3.56 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.984 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.434 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 23.2 m-20 -119.72 101.03 7.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.156 0.478 . . . . 0.0 110.226 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.81 125.36 48.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.102 0.477 . . . . 0.0 109.893 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -124.15 129.13 74.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 16.9 mt -91.77 130.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.921 0.391 . . . . 0.0 110.66 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.8 m-85 -99.35 92.46 5.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.88 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.461 HG13 HG12 ' A' ' 342' ' ' VAL . 14.6 t -79.92 84.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.96 -86.62 0.13 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.479 -171.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.62 ' CB ' ' HD3' ' A' ' 309' ' ' LYS . 31.0 t0 -116.71 -19.77 9.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.324 0.583 . . . . 0.0 109.479 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.613 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 0.8 OUTLIER -59.34 142.83 51.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.164 174.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.3 p30 -152.32 138.78 18.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.804 0.335 . . . . 0.0 110.755 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.414 ' C ' HG12 ' A' ' 382' ' ' ILE . 33.7 t-80 -165.17 126.39 2.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.12 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.0 tt0 -79.04 152.01 31.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 19.9 t-105 -147.61 120.69 8.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.887 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -73.98 114.26 12.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.527 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.3 pp0? -112.27 144.06 42.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.699 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.246 0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.414 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 335' ' ' THR . 4.8 t . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 16.4 p90 -61.56 123.47 17.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.141 0.496 . . . . 0.0 110.958 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 11.6 t -171.93 -167.61 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.21 115.37 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.09 156.09 38.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.874 0.845 . . . . 0.0 111.665 -172.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.584 ' HB3' ' HD2' ' A' ' 311' ' ' LYS . 12.8 t70 -90.77 147.19 23.38 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.749 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.775 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.49 -13.56 14.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.063 -175.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.405 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 4.8 t -101.0 5.44 43.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 29.5 mttt -105.33 13.04 31.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.775 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -128.19 143.83 51.07 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 168.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -128.82 154.18 46.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.62 113.98 3.02 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.82 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 63.3 tttt -112.29 -53.91 2.67 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -140.71 117.89 11.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.22 161.37 32.76 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.09 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -44.69 119.59 2.36 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.643 2.229 . . . . 0.0 111.949 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -131.0 139.13 49.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.367 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.58 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 111.445 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 96.5 p -67.27 -21.8 65.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.487 -174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.36 -18.73 30.07 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.482 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -105.72 -54.23 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.058 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.59 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.739 0.781 . . . . 0.0 110.687 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.879 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 32.8 p -103.76 -168.19 1.47 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.689 -174.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.949 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.1 t -125.5 151.53 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 373' ' ' GLU . 18.4 m -136.32 144.89 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 123.31 0.644 . . . . 0.0 110.004 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.6 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.5 ptm -131.66 169.55 16.01 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.359 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.924 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 4.6 tt0 -136.39 133.04 36.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.144 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.6 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -131.42 154.53 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.203 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.36 138.79 14.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.902 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.798 ' HA ' ' O ' ' A' ' 311' ' ' LYS . 1.2 p90 -99.69 177.47 5.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.731 0.765 . . . . 0.0 110.815 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t -164.69 45.71 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.044 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.508 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -176.85 -63.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.905 172.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 338' ' ' CYS . 27.6 m -86.98 129.1 35.03 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.807 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 6.1 ptm180 -64.78 169.1 5.75 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.166 171.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.53 94.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.056 3.17 . . . . 0.0 114.383 -168.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 4.7 p -111.79 151.81 28.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.844 -173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.3 mpt_? -73.39 108.39 6.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.514 HD11 HG11 ' A' ' 385' ' ' VAL . 14.4 tt -85.19 126.98 65.95 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.64 -175.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.62 82.17 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.557 2.171 . . . . 0.0 112.092 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 372' ' ' ILE . 16.5 m -103.21 122.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 111.271 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 17.8 ptt-85 -129.85 -173.98 3.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -155.59 139.49 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.399 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -113.04 171.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.43 28.51 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.495 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 34.4 t-80 51.24 55.41 9.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.004 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.664 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 63.7 8.6 28.06 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.634 0.614 . . . . 0.0 114.634 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 52.4 t -110.2 111.53 57.91 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 117.821 0.81 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.3 Cg_exo -77.89 46.29 2.02 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.475 2.783 . . . . 0.0 112.912 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -92.21 -53.46 4.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.487 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.03 111.4 35.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.203 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 40.2 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.773 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.723 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.17 6.5 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.675 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.61 83.33 4.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.384 0.612 . . . . 0.0 110.35 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.8 ttp -102.8 87.9 3.07 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.9 mt -72.3 122.82 21.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.093 -165.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -67.96 -22.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 52.9 m -128.97 85.98 58.63 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.154 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.21 40.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.948 2.432 . . . . 0.0 113.925 -170.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -170.56 69.77 0.55 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.13 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 340' ' ' ILE . 70.0 Cg_endo -85.09 137.87 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.299 1.999 . . . . 0.0 112.84 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.4 p -119.54 145.93 45.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.681 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 74.4 mtp -95.82 107.55 19.81 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.855 0.36 . . . . 0.0 110.193 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.02 -167.32 1.84 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.079 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -63.73 -14.33 51.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -101.29 12.97 36.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.5 0.667 . . . . 0.0 109.885 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.56 -162.27 27.87 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -67.45 -16.48 67.42 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.41 -124.45 18.94 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 328' ' ' MET . 2.7 p90 -116.83 135.53 53.67 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 342' ' ' VAL . 2.7 mt -122.14 134.6 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.759 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.6 mp0 -103.05 133.01 48.89 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.191 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.8 ppp? -148.72 160.04 43.55 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -176.84 166.75 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.7 172.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.864 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.4 tp -164.9 151.34 9.22 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.864 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.3 Cg_exo -36.08 143.25 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.24 2.627 . . . . 0.0 113.595 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.628 ' HB3' ' HD3' ' A' ' 395' ' ' LYS . 3.7 Cg_exo -37.04 135.69 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.768 1 C-N-CA 125.52 4.147 . . . . 0.0 115.032 -170.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.47 -151.27 21.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.391 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.3 m-20 -109.93 101.24 10.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.212 0.506 . . . . 0.0 110.435 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.438 ' HA ' HG21 ' A' ' 354' ' ' VAL . 8.6 m120 -101.36 122.96 44.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.965 0.412 . . . . 0.0 109.945 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.102 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.4 130.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.241 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.9 mt -89.01 126.93 42.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.075 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.512 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.02 92.49 4.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.814 174.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.565 HG13 HG12 ' A' ' 342' ' ' VAL . 23.0 t -83.47 90.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.45 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.084 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -106.87 -22.7 12.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.161 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.536 HD23 ' CE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -66.14 141.11 58.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.617 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -135.66 142.42 45.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.536 ' CE1' HD23 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -163.05 102.76 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.102 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 16.9 tt0 -76.75 149.25 36.34 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -144.94 142.39 29.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.429 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -99.16 111.06 23.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.467 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.0 pp0? -96.79 129.16 44.26 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.651 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 378' ' ' PRO . 47.5 tttm . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.938 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 305' ' ' THR . 5.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.087 0.47 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.479 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 11.5 p90 -62.57 118.57 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t -179.57 -170.31 0.16 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.4 t -66.76 106.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.7 146.94 52.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.531 0.681 . . . . 0.0 112.452 -168.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.507 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.1 t70 -62.34 137.87 58.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.368 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.74 -23.21 67.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.256 -170.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.507 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.7 t -94.75 -4.91 46.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 111.363 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 24.4 mtpp -88.57 49.4 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 0.0 111.366 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.474 ' HZ ' HD13 ' A' ' 340' ' ' ILE . 1.8 m-85 -139.46 169.13 18.32 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.253 -177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -157.93 138.46 12.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.536 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.95 107.78 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.576 0.703 . . . . 0.0 111.527 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 315' ' ' LYS . 46.7 tptt -83.98 -36.81 22.93 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 9.2 ttm180 -160.04 109.18 1.76 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.833 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.43 156.41 52.38 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.185 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 392' ' ' TRP . 6.5 Cg_exo -32.72 118.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.931 3.087 . . . . 0.0 113.605 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.2 m -143.52 144.38 31.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.887 -171.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -44.44 136.55 4.11 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 111.478 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.636 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.2 p -69.43 -23.52 63.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.968 -173.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.92 -1.42 88.8 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -171.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -107.27 -54.76 2.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.12 -32.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.002 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.502 ' CB ' HG13 ' A' ' 358' ' ' ILE . 1.1 p -95.81 -166.88 1.51 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.845 -175.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 392' ' ' TRP . 0.9 OUTLIER -109.48 155.99 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.876 176.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -139.42 174.25 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.115 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.702 ' HE2' HD12 ' A' ' 372' ' ' ILE . 21.5 ptt? -151.71 158.87 43.97 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 25.8 tt0 -120.27 125.82 49.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 312' ' ' PHE . 13.5 m -130.02 137.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.061 0.457 . . . . 0.0 112.03 -173.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.25 13.91 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.574 ' HD1' ' H ' ' A' ' 335' ' ' THR . 0.2 OUTLIER -118.23 179.99 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.451 0.626 . . . . 0.0 111.47 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.9 p -130.47 11.19 5.31 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.86 31.3 0.13 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 119.477 -1.344 . . . . 0.0 115.479 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.845 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 31.0 m -112.67 122.56 48.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.537 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 20.6 ptt180 -76.95 167.02 40.26 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.052 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.13 98.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 124.225 3.283 . . . . 0.0 114.855 -165.395 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.86 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 13.2 p -109.64 173.13 6.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.552 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 19.9 mmm180 -95.45 102.91 14.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.795 HG22 HG13 ' A' ' 342' ' ' VAL . 48.8 mt -75.89 124.88 88.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.747 0.308 . . . . 0.0 111.575 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.33 82.01 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.884 2.389 . . . . 0.0 111.972 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.795 HG13 HG22 ' A' ' 340' ' ' ILE . 6.1 m -103.23 129.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.572 0.701 . . . . 0.0 111.325 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -142.49 -174.57 4.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -153.04 138.78 17.91 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.898 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 382' ' ' ILE . 16.8 m -110.34 175.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -109.03 114.08 27.52 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.554 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 50.68 47.98 23.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.688 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.34 16.7 67.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.484 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.86 109.85 46.98 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 110.861 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 61.76 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.48 2.786 . . . . 0.0 112.274 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -97.48 -47.2 5.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.842 0.829 . . . . 0.0 109.011 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -137.21 124.05 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.563 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.6 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.908 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.907 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.1 m -89.5 5.77 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.0 110.753 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.63 84.26 6.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.447 ' HB2' HD13 ' A' ' 376' ' ' LEU . 0.0 OUTLIER -97.5 87.02 3.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 170.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 38.1 mt -68.82 126.53 30.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.582 -167.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -71.22 -20.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 48.6 m -136.45 87.48 21.78 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.933 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -88.4 50.95 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.332 2.688 . . . . 0.0 113.272 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.518 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.0 p-10 -160.49 58.9 1.12 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 1.2 Cg_endo -82.09 139.28 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.582 2.188 . . . . 0.0 112.592 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 338' ' ' CYS . 14.6 p -134.39 142.39 47.16 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.363 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.86 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 17.0 ptp -94.64 130.41 41.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.72 -165.32 1.19 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 124.925 1.391 . . . . 0.0 109.031 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -55.61 -20.57 14.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -108.55 13.12 25.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 0.0 110.696 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.21 -161.18 31.32 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.49 -25.35 74.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.84 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.08 -123.94 7.13 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.92 138.31 47.47 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' A' ' 328' ' ' MET . 0.8 OUTLIER -129.94 166.14 28.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.848 ' HG2' HG12 ' A' ' 327' ' ' VAL . 46.0 mt-10 -129.49 138.23 51.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.739 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -152.67 151.82 31.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.073 -174.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.761 HE22 ' HB2' ' A' ' 394' ' ' GLN . 4.6 tp60 -176.58 165.91 2.64 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.161 0.288 . . . . 0.0 110.864 173.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 12.2 tp -164.8 163.94 13.71 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 63.0 Cg_exo -29.11 131.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.826 3.017 . . . . 0.0 114.343 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.71 ' HB3' ' HD2' ' A' ' 395' ' ' LYS . 6.0 Cg_exo -38.28 139.36 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.825 1 C-N-CA 125.633 4.222 . . . . 0.0 114.938 -175.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.09 -153.08 24.53 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -103.35 109.91 21.71 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.264 0.225 . . . . 0.0 110.691 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 27.8 m-20 -112.22 172.69 6.76 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.202 175.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.051 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -165.16 133.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.9 mt -93.8 133.02 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.385 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -107.64 96.97 6.77 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.322 175.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.92 67.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.86 -84.05 0.58 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.489 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 15.1 t70 -100.44 -34.99 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.1 mp -61.03 143.34 55.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.8 p30 -159.67 138.47 10.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 126.52 1.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.154 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.051 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 57.5 mt-30 -70.13 153.23 43.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.546 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -153.94 150.53 28.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.474 171.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.47 136.0 40.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.761 ' HB2' HE22 ' A' ' 375' ' ' GLN . 2.9 pp0? -132.31 147.37 52.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.772 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.71 ' HD2' ' HB3' ' A' ' 378' ' ' PRO . 23.5 tptm . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.683 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.607 ' HD2' ' HD3' ' A' ' 336' ' ' ARG . 21.5 p90 -53.57 125.83 19.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 111.298 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.7 t -175.9 -175.9 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.172 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.41 105.57 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.5 OUTLIER -72.35 153.35 41.52 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.6 t70 -72.3 154.67 40.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.468 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -70.97 -12.52 61.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.453 -172.279 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.5 t -100.05 7.03 44.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.911 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.665 ' HE3' ' CB ' ' A' ' 335' ' ' THR . 3.9 mtpm? -85.31 -27.45 25.94 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.915 -0.491 . . . . 0.0 112.303 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.78 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.7 OUTLIER -102.62 160.12 14.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.646 0.736 . . . . 0.0 111.936 -175.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.0 t -140.37 155.42 46.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.789 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.47 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.5 m-90 -65.33 96.48 0.23 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.254 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.0 tttt -86.46 -46.76 9.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 37.0 ttm180 -147.34 98.93 3.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.663 171.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -55.04 159.17 4.09 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.947 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 7.1 Cg_exo -34.25 115.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.581 2.854 . . . . 0.0 113.596 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -129.49 134.06 47.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.806 -173.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -47.8 125.1 8.19 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.465 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.4 p -67.83 -35.27 78.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.577 -172.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.72 -11.88 18.26 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.724 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -98.51 -71.48 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -171.61 18.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.57 ' HB ' HG13 ' A' ' 358' ' ' ILE . 18.1 p -131.74 -167.91 1.94 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.397 -171.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.904 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 1.9 t -130.04 149.78 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.272 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.991 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -135.83 140.96 43.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.394 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 11.1 ptm -130.03 150.84 51.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.958 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.791 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.9 tt0 -116.14 122.56 45.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.754 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 14.5 m -126.28 139.85 50.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.661 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.16 141.49 15.28 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.918 -176.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -90.61 178.68 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.22 0.51 . . . . 0.0 110.561 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.5 t -122.8 -62.78 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.78 -59.66 0.19 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.771 -176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.665 ' CB ' ' HE3' ' A' ' 311' ' ' LYS . 52.1 m -56.72 134.26 54.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.827 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.9 ptm180 -66.8 179.67 0.5 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.755 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.16 96.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 124.01 3.14 . . . . 0.0 114.573 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 305' ' ' THR . 31.4 p -113.93 160.08 19.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.428 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.02 104.25 9.53 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 362' ' ' PRO . 16.8 tt -87.72 127.47 58.06 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.326 0.584 . . . . 0.0 111.342 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.57 92.44 0.86 Allowed 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.857 2.371 . . . . 0.0 112.504 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.67 HG11 HD13 ' A' ' 372' ' ' ILE . 31.4 m -110.13 135.5 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.897 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 23.7 ptt180 -149.8 -174.2 4.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.41 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.72 143.21 18.35 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.412 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.48 169.49 10.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.51 114.4 27.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 27.1 p-80 35.29 61.76 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.684 0.794 . . . . 0.0 112.851 -175.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.585 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 76.06 0.09 64.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.402 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.23 114.32 55.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.516 0.658 . . . . 0.0 111.616 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -78.72 58.49 6.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.62 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 352' ' ' VAL . 9.4 tt0 -83.22 -37.0 24.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.061 0.934 . . . . 0.0 108.823 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 351' ' ' GLU . 2.1 p -161.06 122.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.49 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -51.82 107.82 0.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.268 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.742 HG21 HD21 ' A' ' 381' ' ' ASN . 27.7 m -90.4 6.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.688 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -76.91 83.39 3.46 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.342 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 16.7 mmt -95.15 85.22 4.25 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.0 mt -68.2 126.23 28.9 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.398 -167.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -71.61 -17.59 19.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.2 m -139.56 91.89 10.56 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.897 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.16 35.33 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.254 2.636 . . . . 0.0 113.511 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -149.52 64.12 6.97 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.102 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 372' ' ' ILE . 69.8 Cg_endo -88.13 128.09 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.583 2.189 . . . . 0.0 113.443 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 12.1 p -122.98 149.45 44.27 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.535 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.728 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 72.4 mtm -95.94 106.32 18.46 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.268 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.591 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 55.4 mm-40 -80.9 -167.64 1.48 Allowed 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.956 1.41 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -65.63 -7.19 13.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -110.48 -4.84 15.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.444 0.64 . . . . 0.0 109.513 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.18 -166.75 12.71 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.97 -9.6 60.13 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.118 -175.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.78 -114.38 6.38 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.93 117.81 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.185 0.517 . . . . 0.0 111.288 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.67 HD13 HG11 ' A' ' 342' ' ' VAL . 1.6 mt -93.11 143.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.991 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -121.59 132.0 54.43 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.084 -174.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.628 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.9 OUTLIER -153.63 157.29 39.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.59 -171.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.783 HE22 ' HB2' ' A' ' 394' ' ' GLN . 3.3 tp60 -174.6 168.67 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.224 172.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.871 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -164.64 143.92 5.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.871 ' HD2' HD22 ' A' ' 376' ' ' LEU . 23.3 Cg_exo -28.82 124.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.805 3.003 . . . . 0.0 114.281 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.494 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 5.4 Cg_exo -37.39 131.82 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.158 1 C-N-CA 125.475 4.116 . . . . 0.0 114.805 -171.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.437 ' N ' ' NE2' ' A' ' 394' ' ' GLN . . . 162.68 -161.09 33.45 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.791 -175.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -99.37 101.33 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.925 0.362 . . . . 0.0 111.025 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.742 HD21 HG21 ' A' ' 354' ' ' VAL . 14.9 m120 -121.04 -179.64 4.09 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.075 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.989 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.62 141.88 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 11.8 mt -96.22 133.55 37.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.639 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -111.9 92.17 3.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.353 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 11.9 t -86.42 90.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.41 -91.87 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.063 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -116.31 -4.7 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.78 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -78.06 142.38 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 23.9 p-10 -153.81 141.49 19.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.773 0.32 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.1 t-80 -162.08 116.25 1.86 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.771 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.989 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -78.26 143.19 37.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.544 177.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.904 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.8 OUTLIER -154.32 148.01 25.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -85.42 123.46 30.9 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.783 ' HB2' HE22 ' A' ' 375' ' ' GLN . 2.5 pp0? -105.73 144.86 31.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.017 0.437 . . . . 0.0 110.806 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.219 -175.454 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.714 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 23.5 p90 -68.52 112.29 5.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.933 0.873 . . . . 0.0 110.6 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 15.3 t -159.21 -165.97 1.71 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.451 -172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.0 113.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 143.89 55.15 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.8 0.81 . . . . 0.0 111.06 -174.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 8.9 t70 -75.44 147.35 39.98 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.325 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.773 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.58 -12.82 11.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.964 -173.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.459 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.2 t -103.66 9.35 37.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.674 0.273 . . . . 0.0 111.399 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 9.5 mtpp -96.39 -23.98 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.773 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -101.31 158.5 16.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 111.227 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 154.77 46.54 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.11 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.526 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 22.6 m-90 -60.36 96.34 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.7 tttm -80.52 -37.94 30.64 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.89 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 67.3 ttt180 -157.81 111.37 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.752 174.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -59.4 155.79 34.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.979 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.742 ' HG3' HD12 ' A' ' 383' ' ' ILE . 30.7 Cg_exo -34.27 115.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 123.294 2.663 . . . . 0.0 113.68 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.2 m -141.75 138.35 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.707 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.66 131.74 8.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.061 0.458 . . . . 0.0 112.074 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.649 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.5 p -73.9 -25.28 59.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -176.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.58 -5.35 73.71 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.362 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -119.44 39.22 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 69.97 4.84 4.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.512 0.725 . . . . 0.0 111.977 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 2.7 p -121.54 -170.26 2.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.797 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.4 OUTLIER -127.95 153.63 37.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.985 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.976 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -135.53 157.41 39.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 8.2 ptm -138.19 158.4 44.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.89 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.1 mt-10 -122.24 135.49 54.76 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.587 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.2 OUTLIER -132.34 152.27 36.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 177.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.691 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.89 149.68 18.15 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.922 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.479 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.4 p90 -94.08 178.94 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.291 0.567 . . . . 0.0 110.853 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.4 p -131.68 -17.62 2.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.102 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -170.03 -51.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.306 -1.426 . . . . 0.0 114.119 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 336' ' ' ARG . 24.6 m -57.17 129.66 42.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.714 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 11.7 ptm180 -69.79 167.32 24.52 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 117.982 -1.008 . . . . 0.0 108.514 171.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.79 96.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 123.894 3.062 . . . . 0.0 115.235 -167.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 5.9 p -108.8 147.24 32.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.131 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.39 108.24 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.55 HD11 HG11 ' A' ' 385' ' ' VAL . 12.5 tt -89.49 123.82 65.82 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.559 -176.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.69 92.22 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.902 2.401 . . . . 0.0 112.669 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.68 HG11 HD13 ' A' ' 372' ' ' ILE . 30.1 m -108.78 125.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.676 0.751 . . . . 0.0 111.451 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -134.19 -177.42 4.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -148.86 135.07 19.28 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.972 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -107.88 173.23 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -112.69 115.12 28.06 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.616 -174.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 33.4 t60 57.93 45.82 17.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.381 0.61 . . . . 0.0 110.227 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.441 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.02 6.57 46.19 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.001 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.16 111.42 60.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 117.361 0.58 . . . . 0.0 111.158 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -76.55 47.85 2.22 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.602 2.868 . . . . 0.0 113.032 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.35 -53.36 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.28 113.73 44.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.031 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 28.3 t30 -70.23 108.71 4.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.749 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.657 HG12 HD22 ' A' ' 376' ' ' LEU . 33.3 m -90.94 10.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.127 -175.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.459 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.23 84.37 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.116 0.484 . . . . 0.0 111.436 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.724 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 71.2 mtp -98.85 88.97 4.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 47.5 mt -76.66 120.76 22.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.157 -167.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.729 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -68.75 -16.9 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 91.5 m -135.19 87.73 27.75 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.906 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.57 40.36 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.127 2.551 . . . . 0.0 114.307 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.09 68.57 1.83 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.172 0.511 . . . . 0.0 111.389 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.502 ' HG3' HG21 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -85.48 135.59 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.444 2.096 . . . . 0.0 113.081 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.0 OUTLIER -129.72 146.85 51.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.679 174.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.651 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 29.0 mtm -94.61 104.98 16.92 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.315 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.6 -166.36 1.37 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.284 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -67.14 -10.59 51.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.147 0.499 . . . . 0.0 110.629 171.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -86.89 -7.03 58.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 90.27 -161.04 28.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -166.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -62.94 -19.77 61.55 Favored Glycine 0 C--N 1.322 -0.223 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.778 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 73.8 -124.68 8.71 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -112.06 127.0 55.77 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.68 HD13 HG11 ' A' ' 342' ' ' VAL . 1.0 OUTLIER -114.91 125.55 72.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.976 ' HG2' HG12 ' A' ' 327' ' ' VAL . 36.2 mt-10 -101.79 134.18 45.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.797 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -153.19 160.51 42.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.724 ' O ' ' HB2' ' A' ' 356' ' ' MET . 4.4 tp60 178.87 170.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.367 0.417 . . . . 0.0 110.725 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.854 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 7.8 tp -161.88 157.35 20.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.854 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 53.4 Cg_exo -39.25 131.74 1.46 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.342 2.028 . . . . 0.0 112.304 169.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.866 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.3 Cg_exo -38.05 129.49 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 125.297 3.998 . . . . 0.0 114.946 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 174.41 -133.57 2.55 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.589 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.67 101.59 7.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.289 0.236 . . . . 0.0 110.561 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.405 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 7.4 m120 -112.35 161.89 16.15 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.088 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.02 138.71 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.742 HD12 ' HG3' ' A' ' 318' ' ' PRO . 27.8 mt -94.65 132.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.376 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -109.03 91.71 3.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.2 t -83.88 84.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.34 -88.54 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.055 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.42 -14.17 13.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.226 0.536 . . . . 0.0 109.723 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.702 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -68.33 147.19 52.48 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.602 175.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 24.9 p-10 -156.76 140.31 15.87 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.669 0.271 . . . . 0.0 110.66 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 61.9 t-80 -165.88 115.2 0.99 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.546 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.088 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 44.5 tt0 -85.05 146.54 27.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.048 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.589 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.7 OUTLIER -147.97 150.03 33.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.35 132.78 36.46 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.952 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.475 ' HB3' ' NE1' ' A' ' 392' ' ' TRP . 3.2 pp0? -126.73 142.7 51.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 12.3 ptmm? . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.656 -0.688 . . . . 0.0 110.773 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.889 0.376 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.1 p90 -64.43 130.44 43.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.499 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.7 t 178.73 -166.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.83 114.65 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 143.0 56.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.702 0.763 . . . . 0.0 110.757 -173.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' ' HG2' ' A' ' 309' ' ' LYS . 5.8 t70 -86.48 150.57 24.18 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.693 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.703 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 23.4 pttm -52.03 -23.2 4.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.521 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 9.0 t -100.92 10.42 41.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.55 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 26.7 mmmt -92.5 -25.09 18.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.7 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.4 OUTLIER -112.44 157.9 20.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.323 0.582 . . . . 0.0 112.153 -176.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -133.92 158.18 44.11 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.717 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.463 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.7 m-90 -62.28 111.81 2.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.373 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.485 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -104.12 -40.3 6.21 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.212 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.818 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 32.5 ttm180 -158.74 129.94 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.419 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.28 163.11 70.58 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.234 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 3.0 Cg_exo -37.03 120.41 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.3 m -136.24 134.8 38.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.526 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -48.14 124.12 7.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.107 0.48 . . . . 0.0 110.946 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.1 p -65.17 -22.88 66.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.189 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.65 34.12 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -99.61 -71.89 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -175.06 21.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.912 0.863 . . . . 0.0 108.952 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.7 p -137.69 -169.18 2.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.418 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 374' ' ' MET . 0.2 OUTLIER -127.54 151.37 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.234 0.54 . . . . 0.0 111.633 -177.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.4 m -136.6 142.42 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.608 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 9.8 ptm -128.18 164.33 22.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.015 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.5 tt0 -126.46 126.07 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.048 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.42 153.07 32.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.397 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -126.28 144.0 14.78 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.431 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.408 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 1.3 p90 -91.07 179.18 5.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.252 0.549 . . . . 0.0 111.286 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.4 p -143.24 -7.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.868 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 179.14 -3.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 118.648 -1.739 . . . . 0.0 116.068 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 26.5 m -107.62 124.65 50.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.258 1.029 . . . . 0.0 110.57 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.823 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 9.3 ptm180 -70.73 168.79 17.49 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.399 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.799 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.3 OUTLIER -25.36 94.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 124.259 3.306 . . . . 0.0 114.712 -169.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 363' ' ' THR . 7.0 p -112.77 152.16 29.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.936 -174.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -74.48 106.27 6.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 362' ' ' PRO . 14.1 tt -81.89 129.24 65.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.444 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.37 81.58 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.802 HG11 HD13 ' A' ' 372' ' ' ILE . 15.6 m -102.28 119.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.691 0.758 . . . . 0.0 111.216 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -132.46 -178.68 5.03 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.36 139.14 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.891 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.474 HG22 HD12 ' A' ' 382' ' ' ILE . 11.0 m -111.22 168.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.55 114.52 28.73 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.119 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 50.7 t60 52.9 54.87 9.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.801 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.727 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 62.79 15.84 55.44 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.988 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 46.2 t -118.37 109.64 40.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 117.438 0.619 . . . . 0.0 111.222 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.15 50.27 2.18 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.229 2.619 . . . . 0.0 112.658 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.78 -53.87 3.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.71 115.3 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.298 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -63.26 108.78 1.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.9 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.566 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.6 m -93.93 7.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.034 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.42 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.41 83.27 6.26 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.427 0.632 . . . . 0.0 110.652 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.726 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 46.1 ttp -99.35 90.97 4.73 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.5 mt -71.66 125.1 26.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.532 -167.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 5.1 mm -68.46 -24.06 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.7 m -132.25 91.75 30.71 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.995 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.61 44.16 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.226 2.617 . . . . 0.0 114.057 -169.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.0 67.86 0.8 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.228 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.552 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.1 Cg_endo -82.74 133.63 7.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.229 1.952 . . . . 0.0 113.032 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -120.82 144.21 48.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.168 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 39.3 mtm -95.59 119.92 34.93 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.73 -167.01 1.53 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 124.41 1.069 . . . . 0.0 110.906 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -66.27 -11.72 52.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.892 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -99.23 0.23 42.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 109.506 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.24 -162.38 19.95 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -73.73 -16.71 79.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.276 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 67.15 -120.27 13.31 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.4 p90 -120.29 141.2 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.48 0.657 . . . . 0.0 110.902 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.802 HD13 HG11 ' A' ' 342' ' ' VAL . 4.0 mt -115.3 154.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.839 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.759 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 41.9 mt-10 -120.36 128.43 53.23 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.819 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.56 162.62 38.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.633 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.726 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.4 tp60 175.74 158.92 0.25 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.004 0.366 . . . . 0.0 110.983 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.783 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.0 tp -154.4 149.67 20.74 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 166.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.783 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 33.5 Cg_exo -27.06 125.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.918 3.078 . . . . 0.0 113.522 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -37.53 133.04 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.66 3.573 . . . . 0.0 114.493 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.72 -128.66 1.66 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.268 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.91 100.87 7.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 110.848 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.627 ' HB2' HE21 ' A' ' 394' ' ' GLN . 8.0 m120 -112.56 125.25 54.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 0.0 109.684 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.05 131.76 72.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.8 mt -92.32 128.92 43.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.189 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 91.95 3.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.007 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.4 t -83.56 78.28 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.41 -82.63 0.08 OUTLIER Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.423 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.703 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 22.3 t70 -106.35 -28.95 10.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.7 mp -63.67 149.43 46.6 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.525 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.7 p30 -163.12 143.12 8.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.245 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -164.95 118.44 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.2 tm0? -81.54 140.48 34.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.57 -178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.738 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 3.5 t-105 -149.54 147.47 28.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.736 172.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -95.04 119.16 33.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.738 ' NE2' ' HD1' ' A' ' 392' ' ' TRP . 30.0 mm-40 -85.12 114.44 22.25 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.329 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.271 0.558 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 42.6 p90 -62.43 121.52 13.46 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.339 0.59 . . . . 0.0 110.128 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.1 t -176.37 -172.11 0.45 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.56 105.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 340' ' ' ILE . 0.5 OUTLIER -70.35 155.08 41.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.621 -168.039 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.3 t70 -73.32 141.12 47.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.94 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 387' ' ' ASP . 24.3 pttt -50.95 -27.54 7.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.502 -1.681 . . . . 0.0 114.406 -172.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.427 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.9 t -105.21 7.25 33.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -169.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 27.2 mtpp -84.42 -22.65 30.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.443 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -82.63 157.0 23.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.992 0.425 . . . . 0.0 109.894 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -123.29 134.38 54.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.995 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.569 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 31.5 m-90 -50.99 96.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.595 168.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -96.39 -30.2 13.52 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 14.8 ttt180 -164.43 113.64 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.107 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.527 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.09 164.48 17.72 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.2 Cg_exo -39.41 118.35 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.634 2.222 . . . . 0.0 111.86 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 22.5 m -130.8 135.14 47.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.21 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.53 127.0 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.9 p -69.2 -16.13 63.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.16 72.87 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 69.5 t60 -108.14 -52.98 2.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.307 -178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 29.6 t70 166.18 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.467 1.127 . . . . 0.0 108.111 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.9 p -93.92 -170.94 2.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.661 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.95 151.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.723 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.0 m -136.04 144.48 33.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.249 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.744 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -127.58 150.62 49.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 2.6 tt0 -122.13 124.95 45.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.992 0.425 . . . . 0.0 110.514 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.744 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -122.45 150.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.363 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.52 160.43 15.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 172.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.449 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.5 p90 -106.52 178.16 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.078 0.939 . . . . 0.0 110.38 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -133.46 -13.15 2.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.16 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.95 -26.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.201 -1.476 . . . . 0.0 114.695 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.638 ' HB ' ' HE2' ' A' ' 364' ' ' MET . 19.8 m -82.7 135.81 34.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.632 0.716 . . . . 0.0 111.566 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.618 ' O ' HG22 ' A' ' 335' ' ' THR . 9.1 ptt180 -78.71 177.73 2.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -27.38 97.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.775 2.983 . . . . 0.0 114.807 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.841 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 18.1 p -110.24 166.74 10.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.719 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.77 99.3 12.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.613 HG22 HG13 ' A' ' 342' ' ' VAL . 46.1 mt -74.67 120.82 83.41 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.229 -172.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.33 80.27 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.227 1.952 . . . . 0.0 111.661 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.657 HG11 HD13 ' A' ' 372' ' ' ILE . 9.5 m -99.57 133.26 43.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.088 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.99 -178.07 5.52 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -155.24 135.29 12.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.77 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 382' ' ' ILE . 15.8 m -111.13 163.24 8.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.75 114.53 28.86 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.493 -174.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 10.9 t-80 53.9 52.16 13.46 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.486 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 65.8 5.7 26.36 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.888 -0.596 . . . . 0.0 114.188 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 110.6 61.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.391 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.65 54.58 4.84 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.079 2.519 . . . . 0.0 112.091 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.3 -47.72 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.49 0.662 . . . . 0.0 109.55 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.24 119.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.35 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -62.58 109.44 1.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.129 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.659 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 14.1 m -91.58 12.85 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -84.69 81.82 8.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 13.1 tpt -101.15 86.33 3.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 170.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 36.9 mt -70.82 126.26 29.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.615 -167.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -71.67 -17.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 15.6 m -140.08 91.46 10.12 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.505 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.44 41.35 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.091 2.527 . . . . 0.0 112.946 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -155.68 61.01 2.67 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.58 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -81.34 135.31 9.41 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.271 1.981 . . . . 0.0 112.935 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 25.2 p -131.3 133.65 45.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.717 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.85 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 25.7 ptt? -95.68 131.33 42.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.624 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 29.7 mt-10 -114.52 -165.1 0.98 Allowed 'General case' 0 C--N 1.321 -0.666 0 O-C-N 124.874 1.359 . . . . 0.0 110.318 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -62.01 -7.82 4.42 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -105.81 -3.99 21.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.577 0.703 . . . . 0.0 109.547 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 -166.22 17.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.85 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.15 -9.68 64.12 Favored Glycine 0 CA--C 1.51 -0.266 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.246 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.3 -126.35 30.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 111.361 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.657 HD13 HG11 ' A' ' 342' ' ' VAL . 2.8 mt -111.71 131.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.062 173.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.723 ' HG2' HG12 ' A' ' 327' ' ' VAL . 45.5 mt-10 -104.16 132.08 50.78 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.135 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.8 ppp? -148.52 161.99 40.53 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.715 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.2 tp60 -177.35 159.03 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.69 0.281 . . . . 0.0 110.953 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 354' ' ' VAL . 0.5 OUTLIER -164.98 143.92 5.52 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.653 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.2 Cg_exo -24.02 129.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.638 3.559 . . . . 0.0 114.689 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.6 Cg_exo -36.97 128.61 0.52 Allowed 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 125.583 4.189 . . . . 0.0 114.942 -171.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.09 -152.63 21.95 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.7 m-20 -98.45 101.23 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.974 0.887 . . . . 0.0 110.677 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -96.75 123.81 40.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.975 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -118.54 129.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.5 mt -92.71 133.62 33.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.46 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -107.16 91.82 3.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.358 176.196 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.5 t -79.36 77.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.82 -83.6 0.48 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 309' ' ' LYS . 20.3 t70 -116.26 -19.96 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.343 0.592 . . . . 0.0 109.55 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.5 OUTLIER -60.28 145.35 47.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.229 173.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.463 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.5 p30 -155.41 143.79 20.27 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.591 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.532 ' H ' HG12 ' A' ' 382' ' ' ILE . 2.3 t60 -173.31 123.75 0.39 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.285 0.366 . . . . 0.0 111.271 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.975 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.5 mt-30 -71.58 153.21 42.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.446 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 22.6 t-105 -151.36 119.84 6.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.859 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -74.65 113.25 11.7 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.423 ' HB3' ' CD1' ' A' ' 392' ' ' TRP . 2.3 pp0? -112.37 147.54 36.18 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.468 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.286 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 335' ' ' THR . 4.2 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.443 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.7 p90 -57.43 128.53 37.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.202 0.525 . . . . 0.0 110.998 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.0 t -177.42 -171.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.8 105.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.749 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.9 OUTLIER -79.06 161.7 26.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.818 0.818 . . . . 0.0 112.766 -171.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.0 t70 -78.39 155.73 29.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.935 -178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.747 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -76.83 -14.64 59.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.904 -172.12 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.4 t -91.19 2.74 56.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.137 0.494 . . . . 0.0 111.192 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.749 ' HD3' ' HB2' ' A' ' 307' ' ' CYS . 5.5 mtpm? -81.3 -44.43 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.981 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.747 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -84.88 159.37 20.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.466 0.651 . . . . 0.0 111.853 -172.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 t -140.04 147.84 40.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.2 m-90 -52.7 101.59 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.493 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.671 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.1 tttp -90.01 -45.5 9.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 77.9 ttt180 -152.75 118.97 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.692 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.83 162.82 49.0 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.39 -175.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.675 ' HG2' ' O ' ' A' ' 390' ' ' HIS . 53.4 Cg_exo -30.79 116.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.703 2.935 . . . . 0.0 113.558 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 52.9 m -127.9 124.84 38.4 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.98 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.27 127.02 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.212 0.53 . . . . 0.0 109.88 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.416 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.5 p -68.41 -21.55 64.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 -174.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.69 -0.19 86.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.514 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -112.38 28.82 8.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 11.7 t70 64.09 24.83 13.61 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.84 0.829 . . . . 0.0 110.05 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.411 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.5 p -140.1 -171.72 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.203 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.731 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.71 155.66 41.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 118.201 0.455 . . . . 0.0 111.665 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -141.2 144.98 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.354 175.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.531 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 13.1 ptm -136.62 167.0 22.23 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.465 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 26.8 tt0 -133.34 128.33 35.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.282 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.07 157.58 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.937 0.399 . . . . 0.0 111.842 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.92 153.02 17.57 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -95.01 178.78 5.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.342 0.571 . . . . 0.0 110.697 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.1 t -162.86 35.8 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.28 -92.46 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.241 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.659 ' HB ' ' HE3' ' A' ' 311' ' ' LYS . 21.5 m -54.67 134.42 47.13 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.182 0.593 . . . . 0.0 111.966 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.808 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.6 ptt180 -72.14 -177.58 0.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.125 172.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.808 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.64 94.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.852 3.035 . . . . 0.0 114.588 -173.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.8 p -116.05 158.06 23.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.788 -172.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -74.84 97.14 3.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.494 HG12 HG13 ' A' ' 342' ' ' VAL . 10.5 tt -77.34 122.85 86.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -173.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 82.66 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.772 2.314 . . . . 0.0 112.466 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.563 HG12 HG13 ' A' ' 385' ' ' VAL . 13.1 m -105.76 120.14 56.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.319 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 19.1 ptt180 -129.32 -175.29 3.53 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.16 147.56 21.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.586 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 382' ' ' ILE . 4.9 m -123.32 170.98 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.49 39.27 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.226 -173.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 32.8 t60 56.46 42.4 27.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.261 0.553 . . . . 0.0 110.47 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 67.07 9.94 55.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.423 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.78 107.84 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.115 0.458 . . . . 0.0 110.724 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.3 52.98 2.46 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.431 2.754 . . . . 0.0 112.644 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -97.59 -53.52 3.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.73 115.16 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.237 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.5 t30 -60.0 108.4 0.76 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.033 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.895 ' HA ' HD22 ' A' ' 376' ' ' LEU . 33.7 m -93.01 9.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.449 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -82.57 82.2 8.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.689 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.0 ttp -103.57 93.27 4.84 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 44.1 mt -76.33 125.94 30.09 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.66 -163.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -68.13 -23.62 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 11.9 m -126.4 90.21 50.47 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.82 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 89.2 Cg_endo -85.77 33.57 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.28 2.653 . . . . 0.0 114.317 -167.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -167.6 63.04 0.63 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.317 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.48 ' O ' HG22 ' A' ' 340' ' ' ILE . 61.4 Cg_endo -81.55 139.64 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.31 2.007 . . . . 0.0 113.049 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 20.4 p -124.15 133.01 53.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.73 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 6.5 ptp -95.18 125.1 39.59 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 25.9 mt-10 -81.28 -169.48 2.29 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.471 1.107 . . . . 0.0 111.21 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -73.93 -4.56 35.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.047 175.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -100.95 -14.61 17.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.355 0.598 . . . . 0.0 109.659 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.0 -169.85 16.15 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.465 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -77.68 -22.53 69.36 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.545 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.64 -118.45 11.66 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -114.77 143.39 45.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.211 0.529 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 3.1 mt -123.9 159.29 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.735 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 45.4 mt-10 -126.99 134.74 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.732 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.731 ' HG2' ' HB ' ' A' ' 326' ' ' VAL . 0.2 OUTLIER -149.57 169.81 20.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.977 -175.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.689 ' O ' ' HB3' ' A' ' 356' ' ' MET . 6.3 tp60 172.63 155.39 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.159 0.504 . . . . 0.0 111.679 170.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.029 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -160.43 153.53 18.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 165.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 1.029 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 46.9 Cg_exo -16.52 125.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 1 C-N-CA 125.468 4.112 . . . . 0.0 115.843 -175.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 395' ' ' LYS . 60.7 Cg_exo -40.17 139.84 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.692 3.595 . . . . 0.0 114.092 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 393' ' ' PHE . . . 138.93 -163.4 25.91 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -76.4 100.04 5.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.347 0.573 . . . . 0.0 111.239 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.583 ' HB2' HE21 ' A' ' 394' ' ' GLN . 8.0 m-80 -112.75 129.62 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.083 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.99 135.25 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 -179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.64 HD12 ' HG3' ' A' ' 318' ' ' PRO . 25.4 mt -96.1 133.65 36.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.926 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.539 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -109.77 91.39 3.63 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.887 175.669 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -81.84 87.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.97 -95.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.352 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.02 0.84 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.101 0.477 . . . . 0.0 110.549 175.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -75.41 148.28 39.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.503 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.1 p30 -159.63 149.12 18.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.568 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.675 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 4.2 t60 -170.81 119.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.849 173.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.083 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.7 tt0 -82.64 134.16 35.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.738 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.689 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.1 t-105 -140.01 143.75 36.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.462 175.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 379' ' ' GLY . 55.8 t80 -87.82 108.24 19.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.689 ' NE2' ' HD1' ' A' ' 392' ' ' TRP . 38.6 mm-40 -72.82 144.35 47.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.586 ' HA ' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.494 -173.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.677 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 21.8 p90 -60.67 129.6 42.36 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.0 t 178.55 -169.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 59.5 t -60.5 110.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 168.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 142.77 56.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.795 0.807 . . . . 0.0 111.108 -170.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.402 ' OD2' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -76.81 148.6 36.49 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.111 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.77 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.27 -13.23 17.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.935 -172.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.402 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.8 t -101.14 -0.61 35.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.503 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 28.5 mmmt -78.4 -36.45 45.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.837 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -89.93 157.57 17.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.266 0.555 . . . . 0.0 111.606 -177.47 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.1 t -142.48 147.5 36.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.02 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -60.28 110.73 1.31 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.395 0.617 . . . . 0.0 112.159 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.543 ' HE3' ' OE1' ' A' ' 329' ' ' GLU . 65.3 tttp -93.54 -34.42 13.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.492 170.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.971 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 64.8 ttt180 -164.33 119.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.91 157.38 75.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.991 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -40.36 117.54 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.395 2.73 . . . . 0.0 112.587 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.1 m -134.18 132.46 39.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.922 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.53 124.83 13.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 111.096 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.522 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.6 p -57.79 -30.45 65.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.974 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.86 -2.57 41.53 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -105.4 -73.26 0.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -165.87 15.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.607 0.717 . . . . 0.0 109.665 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.712 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 12.3 p -137.69 -166.79 2.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.541 -172.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -126.62 153.17 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.517 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 17.3 m -135.91 145.66 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.566 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 17.4 ptt? -135.43 169.59 17.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.971 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 14.0 mt-10 -138.04 136.4 36.8 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.345 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.67 151.07 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.3 155.12 16.33 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.787 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -101.97 -179.84 4.12 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 110.974 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.4 p -137.49 -41.13 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.635 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -156.07 4.58 0.2 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.158 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.503 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 33.1 m -113.12 127.03 56.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 117.425 0.612 . . . . 0.0 110.13 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.708 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 14.2 ptm180 -73.38 171.2 11.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.048 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.78 95.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.202 3.268 . . . . 0.0 114.608 -170.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 338' ' ' CYS . . . . . . . . . . . . . 6.0 p -112.14 154.34 25.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.969 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.4 mmt180 -74.57 107.83 6.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.672 HG22 HG13 ' A' ' 342' ' ' VAL . 38.8 mm -82.82 119.89 75.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.4 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.63 82.5 2.1 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.67 2.246 . . . . 0.0 112.088 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.672 HG13 HG22 ' A' ' 340' ' ' ILE . 13.9 m -101.5 124.94 55.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.575 0.702 . . . . 0.0 110.879 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.78 -175.38 4.01 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -153.41 144.62 23.03 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.323 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.65 164.56 15.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -96.83 114.34 25.97 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.126 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 39.25 63.88 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.633 0.773 . . . . 0.0 112.651 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.494 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.45 7.99 42.97 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.644 -0.707 . . . . 0.0 114.669 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.66 113.06 47.9 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 117.864 0.832 . . . . 0.0 111.557 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.15 62.19 5.93 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.198 2.599 . . . . 0.0 111.785 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.591 ' HG2' HG12 ' A' ' 352' ' ' VAL . 15.2 tt0 -86.65 -43.56 12.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.158 0.98 . . . . 0.0 108.939 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 351' ' ' GLU . 1.5 p -158.17 122.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.34 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -51.23 108.5 0.26 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.331 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 1.007 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.44 7.98 4.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.825 -176.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -82.66 84.18 7.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.182 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.97 84.9 2.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 40.2 mt -68.05 129.55 40.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.166 -165.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.678 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.5 mm -72.62 -23.96 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.2 m -131.52 88.26 43.89 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.715 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.66 53.13 3.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.16 2.573 . . . . 0.0 113.336 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -168.02 69.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.882 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' A' ' 372' ' ' ILE . 45.7 Cg_endo -91.1 136.29 1.98 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.552 2.168 . . . . 0.0 112.65 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.1 p -132.42 144.95 50.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.452 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.607 ' HG3' HD11 ' A' ' 340' ' ' ILE . 56.2 mtm -95.95 116.62 29.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.517 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 31.9 mt-10 -104.15 -165.68 1.17 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.386 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -59.11 -13.08 5.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.886 0.375 . . . . 0.0 111.769 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' A' ' 365' ' ' GLU . 10.2 p30 -103.83 -2.07 26.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.366 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.6 -160.71 22.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 364' ' ' MET . . . -77.27 -11.84 85.15 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.823 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 65.61 -124.03 26.03 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -125.87 147.47 49.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.869 0.366 . . . . 0.0 110.092 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.0 OUTLIER -128.5 160.46 38.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.678 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 61.4 mt-10 -123.4 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.674 0.273 . . . . 0.0 110.284 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -153.29 154.6 34.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.913 -174.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.864 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.03 167.53 4.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.978 171.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.007 ' HG ' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -168.21 178.08 1.15 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.169 174.549 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.703 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 52.0 Cg_exo -36.1 131.24 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.748 2.299 . . . . 0.0 113.65 174.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.91 137.39 52.37 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.676 2.918 . . . . 0.0 113.16 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.06 -176.85 29.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.156 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 12.7 m-20 -74.33 101.15 3.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.206 0.202 . . . . 0.0 111.116 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.87 ' HB2' HE21 ' A' ' 394' ' ' GLN . 38.9 m-80 -123.39 153.54 40.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.262 0.553 . . . . 0.0 110.96 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.96 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -134.45 139.89 46.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 -176.333 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 374' ' ' MET . 20.8 mt -94.18 132.89 36.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -109.62 92.66 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.026 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.78 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.4 t -79.99 76.35 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.69 -81.93 0.16 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.224 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.77 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 31.7 t70 -113.44 -12.27 12.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.449 0.642 . . . . 0.0 109.562 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.8 mp -78.32 148.37 33.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.216 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 4.4 p-10 -155.99 140.82 17.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.781 0.324 . . . . 0.0 111.214 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.409 ' H ' HG12 ' A' ' 382' ' ' ILE . 18.3 t-80 -166.28 123.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.624 171.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.96 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 9.7 tt0 -86.84 152.19 22.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.184 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.45 142.94 14.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.672 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.3 p90 -90.77 108.06 19.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.755 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.87 HE21 ' HB2' ' A' ' 381' ' ' ASN . 0.9 OUTLIER -70.29 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.544 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 C--O 1.247 0.956 0 O-C-N 124.371 1.044 . . . . 0.0 110.51 -179.286 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -62.36 124.4 20.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.341 0.591 . . . . 0.0 111.416 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -174.32 -169.83 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.36 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.43 106.56 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.2 149.02 43.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.698 0.761 . . . . 0.0 112.191 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' A' ' 310' ' ' THR . 21.2 t0 -72.28 146.51 47.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.129 -178.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.76 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.35 -13.28 60.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.949 -167.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -97.0 4.1 51.66 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.981 -0.45 . . . . 0.0 112.035 -175.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.817 ' HE3' ' HA3' ' A' ' 334' ' ' GLY . 34.1 mttp -89.2 -28.56 19.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.76 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -84.57 156.47 21.6 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.808 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.3 t -141.36 145.27 35.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.554 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.1 m-90 -56.06 104.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.269 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.554 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.3 tttt -97.17 -42.88 7.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 38.9 ttt180 -152.55 123.01 7.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.605 173.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -65.74 163.94 31.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.48 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 2.8 Cg_exo -38.52 107.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.39 2.727 . . . . 0.0 112.373 176.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.8 m -115.97 128.49 55.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.296 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -49.23 125.71 11.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.378 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.0 p -70.96 -20.19 62.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -173.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.55 -2.31 70.24 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -171.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.82 27.96 8.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.458 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 64.09 21.16 12.48 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.658 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.439 ' HA ' ' OE1' ' A' ' 375' ' ' GLN . 6.6 p -129.53 -168.53 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.452 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 374' ' ' MET . 0.1 OUTLIER -132.21 150.22 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.339 0.59 . . . . 0.0 112.317 -175.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.76 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -138.56 138.08 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.62 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 14.2 ptm -127.55 162.8 25.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.548 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 30.2 tt0 -126.33 127.96 46.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.76 147.43 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.183 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -106.01 147.8 16.32 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.31 179.03 4.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.121 0.961 . . . . 0.0 110.355 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.8 p -152.48 30.72 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.68 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.817 ' HA3' ' HE3' ' A' ' 311' ' ' LYS . . . -170.96 -83.28 0.05 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.876 -1.155 . . . . 0.0 113.764 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 303' ' ' THR . 12.9 m -69.52 128.46 36.59 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.111 0.565 . . . . 0.0 112.424 -172.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.755 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -67.1 176.1 1.27 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.147 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -24.88 93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.043 3.162 . . . . 0.0 114.538 -171.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 363' ' ' THR . 27.6 p -111.62 166.34 11.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.053 -171.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -87.43 96.81 10.51 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 362' ' ' PRO . 12.4 tt -80.44 126.03 79.6 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.295 -171.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.31 93.98 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.96 2.44 . . . . 0.0 112.331 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 372' ' ' ILE . 16.7 m -115.01 120.98 66.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.699 0.761 . . . . 0.0 111.384 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 29.8 ptt180 -132.63 -174.35 3.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.53 149.38 22.22 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.723 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -122.9 170.28 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.79 114.85 28.28 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.215 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 17.9 p80 40.04 57.07 2.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.847 . . . . 0.0 112.587 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.681 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 79.71 -10.42 38.7 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.164 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.48 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 27.5 t -101.91 114.01 65.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.307 0.554 . . . . 0.0 111.226 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.6 Cg_exo -77.14 38.67 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 123.466 2.777 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.44 -54.29 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.81 112.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.941 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 36.7 t30 -55.11 108.07 0.37 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.502 171.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.643 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 35.9 m -93.23 8.64 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.142 0.496 . . . . 0.0 111.159 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.436 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -80.83 82.81 6.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.378 0.609 . . . . 0.0 110.554 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.758 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.1 ttt -102.32 82.26 2.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 30.9 mt -64.26 130.11 42.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.862 -167.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -70.38 -26.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 360' ' ' PRO . 6.3 m -131.83 95.95 21.56 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.452 172.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 357' ' ' LEU . 4.1 Cg_endo -86.05 27.21 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.524 2.816 . . . . 0.0 113.523 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -147.88 64.32 8.24 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.123 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 340' ' ' ILE . 90.0 Cg_endo -82.66 144.65 12.61 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.532 2.155 . . . . 0.0 112.884 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 11.4 p -128.55 142.57 51.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.068 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.846 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 56.7 mtp -95.39 110.58 22.59 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.01 -171.29 1.94 Allowed 'General case' 0 C--N 1.32 -0.704 0 O-C-N 124.403 1.065 . . . . 0.0 111.24 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -66.81 -6.61 16.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.779 174.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -110.84 -6.75 14.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.229 0.537 . . . . 0.0 109.972 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.64 -171.92 14.13 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -64.68 -14.97 59.06 Favored Glycine 0 N--CA 1.458 0.127 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.532 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 72.03 -106.26 1.88 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 328' ' ' MET . 20.8 m-85 -132.33 135.91 46.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.285 0.564 . . . . 0.0 110.996 175.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.794 HD13 HG11 ' A' ' 342' ' ' VAL . 4.7 mt -115.32 136.53 51.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.343 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.76 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -106.7 128.63 54.36 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.198 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.692 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -144.64 163.14 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.047 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.761 HE21 ' H ' ' A' ' 376' ' ' LEU . 29.5 tp60 -176.05 152.08 1.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 110.036 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.828 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.0 OUTLIER -151.78 140.42 13.54 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 170.318 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.828 ' HD2' HD22 ' A' ' 376' ' ' LEU . 27.4 Cg_exo -19.97 130.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 125.144 3.896 . . . . 0.0 114.781 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -37.92 131.91 0.81 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.82 3.68 . . . . 0.0 114.38 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.85 -167.77 32.21 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.295 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 8.1 m-20 -80.57 100.12 8.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.913 0.356 . . . . 0.0 110.899 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 376' ' ' LEU . 21.5 m-80 -111.57 138.72 47.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.986 0.422 . . . . 0.0 110.249 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -135.76 136.42 50.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.612 HD11 ' HG2' ' A' ' 374' ' ' MET . 39.5 mt -95.25 130.78 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.086 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.674 175.258 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 6.7 t -84.87 81.9 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.75 -91.15 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.144 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.655 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 6.3 t70 -98.55 -18.89 17.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.613 0.721 . . . . 0.0 109.395 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.3 mp -76.44 148.85 37.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -154.77 137.21 15.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.036 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -164.59 123.73 1.86 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.751 0.31 . . . . 0.0 110.484 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.938 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -90.3 141.2 28.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.519 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.669 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.2 t-105 -144.64 137.01 26.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.006 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.8 p90 -80.6 110.25 15.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.947 -0.471 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.669 ' NE2' ' HD1' ' A' ' 392' ' ' TRP . 40.1 mm-40 -74.04 102.27 4.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 395' ' ' LYS . 12.1 ttpp . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.752 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 335' ' ' THR . 2.9 t . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -59.89 126.76 28.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.194 0.521 . . . . 0.0 109.871 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.8 t -179.24 -174.76 0.34 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.3 106.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.52 155.55 40.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.972 0.892 . . . . 0.0 112.608 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.606 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.1 t70 -81.01 140.65 35.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.106 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -60.41 -21.72 62.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.62 -173.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.637 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.6 t -87.05 -4.56 59.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.828 0.346 . . . . 0.0 111.46 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -93.92 16.5 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.814 ' HE2' HG12 ' A' ' 385' ' ' VAL . 1.3 m-85 -102.38 170.66 7.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.675 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -165.65 131.9 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.396 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.459 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -51.68 120.33 5.11 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.398 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 21.3 tptm -110.14 -48.67 3.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.583 172.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 10.6 ttm180 -156.1 127.96 7.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.113 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.14 155.67 93.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.823 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.492 ' HG3' HD12 ' A' ' 383' ' ' ILE . 84.1 Cg_exo -33.08 113.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.832 3.021 . . . . 0.0 113.153 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 20.3 m -128.95 135.06 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.055 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -44.96 124.66 4.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.612 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.5 p -71.47 -22.07 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.67 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.39 -2.62 74.56 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -121.89 33.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.88 16.68 8.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.823 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.554 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 8.5 p -124.23 -168.85 1.86 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.741 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.37 146.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.417 -177.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 14.8 m -128.51 138.83 53.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.101 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 16.4 ptt? -121.55 154.87 36.13 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 23.0 tt0 -114.28 127.66 55.98 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 385' ' ' VAL . 8.4 m -130.43 136.57 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.881 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -111.98 143.39 17.44 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.657 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.686 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.7 OUTLIER -141.44 163.03 34.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 366' ' ' ASN . 49.4 m -153.51 65.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.507 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -165.0 -50.71 0.02 OUTLIER Glycine 0 C--O 1.226 -0.356 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.743 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.847 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 23.3 m -98.6 142.72 29.83 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 122.85 -0.206 . . . . 0.0 110.863 -175.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 15.3 ptt180 -79.38 168.65 24.94 Favored Pre-proline 0 CA--C 1.527 0.08 0 CA-C-O 117.729 -1.129 . . . . 0.0 108.485 171.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -26.55 96.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.999 3.133 . . . . 0.0 114.449 -170.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.66 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 28.8 p -116.09 164.93 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.477 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -85.31 96.97 9.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 362' ' ' PRO . 12.1 pt -79.77 130.15 68.38 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.297 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.661 ' HD2' ' HZ ' ' A' ' 312' ' ' PHE . 63.9 Cg_endo -75.29 81.94 2.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.725 2.283 . . . . 0.0 112.021 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.717 HG12 HG13 ' A' ' 385' ' ' VAL . 10.5 m -100.22 116.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.993 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.4 ptt180 -126.61 179.82 5.15 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.431 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -152.06 139.78 19.84 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.818 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.15 171.4 7.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.927 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.59 116.45 32.62 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.454 ' HA ' ' CD ' ' A' ' 391' ' ' GLN . 8.9 p-80 41.04 59.68 2.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.515 0.726 . . . . 0.0 112.703 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.735 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.2 6.4 32.65 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.28 116.59 44.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.591 0.695 . . . . 0.0 111.045 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.09 55.98 3.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.198 2.599 . . . . 0.0 111.753 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.59 -52.22 5.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.64 123.0 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.283 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.76 107.74 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 376' ' ' LEU . 32.0 m -92.2 9.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.634 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.431 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -81.25 83.65 6.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.45 84.63 2.22 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.7 mt -74.02 128.32 35.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.816 -165.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 1.9 mm -75.94 -19.42 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.5 m -121.74 81.91 41.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.165 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.23 32.57 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.27 2.647 . . . . 0.0 114.156 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -177.01 70.78 0.23 Allowed Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.62 ' HB2' HD11 ' A' ' 340' ' ' ILE . 45.1 Cg_endo -88.19 136.75 3.55 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.503 2.136 . . . . 0.0 113.587 -176.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 40.5 p -118.1 130.59 56.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.545 175.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.847 ' HE3' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -99.51 143.59 29.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 31.3 mt-10 -95.04 -179.35 4.79 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.626 0.579 . . . . 0.0 109.941 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 333' ' ' SER . 21.1 p-10 -56.05 -24.79 41.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -108.49 -3.23 18.3 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.095 -0.378 . . . . 0.0 111.592 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.686 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 144.62 177.05 19.16 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.265 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -97.53 -16.19 35.09 Favored Glycine 0 CA--C 1.507 -0.458 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.905 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 74.52 -126.17 9.01 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -174.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 328' ' ' MET . 79.6 m-85 -105.88 147.38 28.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.02 0.438 . . . . 0.0 111.154 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.4 mt -132.48 152.96 37.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.742 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 30.6 mt-10 -110.81 134.59 52.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.955 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.92 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -145.0 165.35 28.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.741 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -174.03 163.89 4.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.384 0.612 . . . . 0.0 111.449 172.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.679 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.3 tp -165.02 143.87 5.47 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 165.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.679 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 16.2 Cg_exo -31.3 135.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.998 3.132 . . . . 0.0 113.486 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 377' ' ' PRO . 49.5 Cg_exo -37.0 128.43 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.704 3.602 . . . . 0.0 114.471 -166.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.11 178.06 35.68 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 0.0 OUTLIER -81.02 99.73 8.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.945 0.872 . . . . 0.0 110.826 -176.209 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.673 HD22 ' HG2' ' A' ' 394' ' ' GLN . 18.6 m-80 -108.19 126.7 53.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.302 0.572 . . . . 0.0 110.015 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.985 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.52 137.69 57.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.145 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.1 mt -99.78 127.1 52.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.792 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.405 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -95.64 102.73 14.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.932 171.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' A' ' 312' ' ' PHE . 2.1 t -92.59 78.56 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.295 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 69.56 -85.61 0.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.446 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 34.2 t70 -108.75 -25.58 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.523 0.678 . . . . 0.0 109.325 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.459 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.2 mp -65.45 151.81 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.536 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -151.94 144.35 24.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.402 ' C ' HG12 ' A' ' 382' ' ' ILE . 0.2 OUTLIER -164.79 109.9 0.94 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.111 0.482 . . . . 0.0 111.356 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.985 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 45.2 tt0 -84.25 149.09 26.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.386 -176.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 4.8 t-105 -158.77 142.27 15.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.822 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.3 p90 -92.72 114.83 27.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.583 -0.698 . . . . 0.0 110.062 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 381' ' ' ASN . 5.0 mm100 -72.6 115.42 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.229 -174.826 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.598 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 14.2 p90 -70.45 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.6 t -177.14 -171.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 77.7 t -67.57 107.29 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 340' ' ' ILE . 0.1 OUTLIER -69.15 148.77 49.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.007 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.572 ' OD1' HG22 ' A' ' 310' ' ' THR . 24.2 t0 -72.48 135.76 45.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.288 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.79 -16.1 56.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.139 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.572 HG22 ' OD1' ' A' ' 308' ' ' ASP . 8.1 t -96.6 2.41 52.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.132 0.492 . . . . 0.0 111.325 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 29.0 mtpp -95.29 37.48 1.17 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.229 -0.295 . . . . 0.0 111.589 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.824 ' CE1' ' HB ' ' A' ' 330' ' ' VAL . 0.0 OUTLIER -135.9 150.74 49.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.923 0.392 . . . . 0.0 110.994 -176.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 29.2 p -135.35 139.15 44.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.185 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -54.7 105.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.974 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.403 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.4 ttmm -92.52 -32.34 14.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.928 ' HB2' ' HB2' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -165.31 114.88 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.133 174.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.07 161.15 42.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.267 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.488 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 2.7 Cg_exo -39.22 119.6 0.5 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.83 2.354 . . . . 0.0 112.341 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -139.15 136.94 35.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.67 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.7 133.76 16.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.739 0.304 . . . . 0.0 110.964 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.48 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.8 p -70.75 -12.04 61.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.785 -172.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 91.74 -7.62 79.26 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -102.19 -59.19 1.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.124 0.488 . . . . 0.0 109.929 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 12.0 t70 170.2 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.394 1.092 . . . . 0.0 108.436 -169.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.67 -168.72 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.782 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 374' ' ' MET . 2.1 t -125.21 152.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.08 0.467 . . . . 0.0 111.056 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.836 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.5 m -130.45 168.16 23.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.529 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -155.01 157.85 38.25 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 316' ' ' ARG . 4.1 mt-10 -129.01 139.95 51.85 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.452 0.47 . . . . 0.0 110.301 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.824 ' HB ' ' CE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -147.94 146.42 18.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.006 -175.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.415 ' O ' ' HD1' ' A' ' 312' ' ' PHE . . . -117.18 137.43 13.41 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HD2' ' H ' ' A' ' 335' ' ' THR . 0.3 OUTLIER -90.0 179.27 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.814 0.816 . . . . 0.0 112.32 -173.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 48.1 t -106.15 -41.86 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 176.73 40.5 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.273 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.687 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 4.8 m -116.07 127.54 54.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.247 0.523 . . . . 0.0 109.856 173.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.697 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -71.17 171.55 8.43 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.076 174.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.697 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.52 95.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.974 3.116 . . . . 0.0 114.155 -177.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 305' ' ' THR . 20.1 p -117.38 174.5 6.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.768 -1.56 . . . . 0.0 111.619 -171.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.9 mmm180 -96.57 101.58 13.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.55 ' CG2' HG13 ' A' ' 342' ' ' VAL . 8.2 mm -80.15 130.78 64.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.257 0.551 . . . . 0.0 112.265 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.88 81.79 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.66 2.24 . . . . 0.0 111.653 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.996 HG21 ' HG2' ' A' ' 362' ' ' PRO . 0.0 OUTLIER -96.84 130.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.423 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -145.35 179.64 7.26 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -152.2 143.83 23.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.392 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 10.8 m -113.98 172.06 3.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -108.44 115.51 30.24 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.717 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 57.1 47.42 17.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.623 0.577 . . . . 0.0 110.583 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.672 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.24 4.54 37.12 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.75 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 40.8 t -107.37 108.19 61.43 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 117.088 0.444 . . . . 0.0 111.2 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -74.2 59.51 4.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.365 2.71 . . . . 0.0 112.419 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.03 -45.81 6.12 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.5 123.62 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.1 t30 -60.34 108.34 0.79 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.694 175.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.1 m -90.5 3.9 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.97 83.98 3.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.651 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.678 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.5 ttm -100.07 88.0 3.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 27.5 mt -66.32 126.52 29.03 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.985 -1.462 . . . . 0.0 111.664 -165.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.7 mm -73.37 -23.78 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.5 m -134.33 98.74 13.72 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.997 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.88 54.2 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.244 2.629 . . . . 0.0 113.379 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 63.6 t30 -157.96 58.73 1.47 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 172.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.996 ' HG2' HG21 ' A' ' 342' ' ' VAL . 15.0 Cg_exo -72.07 104.39 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.255 1.97 . . . . 0.0 112.155 175.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.1 p -110.34 149.16 30.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.669 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 49.0 mtm -95.7 120.76 36.53 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.12 -165.47 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.903 1.377 . . . . 0.0 109.928 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -52.3 -25.19 8.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.335 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -105.58 10.14 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 110.689 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.9 -156.78 23.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 110.986 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.06 -14.61 59.34 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 66.21 -118.5 11.18 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.045 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -116.47 122.96 46.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.7 OUTLIER -113.24 161.47 12.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.082 177.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.836 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.7 mt-10 -132.87 130.92 40.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.563 ' HB3' ' CD2' ' A' ' 357' ' ' LEU . 4.0 ptp -159.77 151.6 20.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.12 -173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.678 ' O ' ' HB3' ' A' ' 356' ' ' MET . 5.0 tp60 -173.43 169.64 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.683 0.278 . . . . 0.0 111.039 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.0 tp -163.35 159.31 18.05 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 48.8 Cg_exo -29.97 130.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 113.978 173.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.0 Cg_exo -37.5 129.65 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.182 3.921 . . . . 0.0 114.516 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.19 -129.5 1.83 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.527 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 391' ' ' GLN . 19.7 m-20 -127.49 107.33 9.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.502 0.191 . . . . 0.0 110.647 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.27 127.7 55.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.065 0.46 . . . . 0.0 110.01 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.045 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.64 130.72 74.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.6 mt -92.11 131.62 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.336 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -102.64 92.0 4.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.267 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.66 76.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.42 -91.28 0.74 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.162 -171.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 19.6 t70 -110.25 -20.88 12.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.258 0.552 . . . . 0.0 109.96 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 2.1 tp -67.87 145.29 54.76 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.518 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.8 p30 -151.44 147.99 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.802 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.428 ' H ' HG12 ' A' ' 382' ' ' ILE . 0.5 OUTLIER -170.46 123.53 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.024 175.342 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.045 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -75.68 144.26 41.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.488 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 17.2 t-105 -143.32 130.4 20.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.204 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -82.53 117.34 22.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.464 ' HB2' HE22 ' A' ' 375' ' ' GLN . 2.6 pp0? -117.54 142.66 46.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 111.085 -174.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.675 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 305' ' ' THR . 7.2 t . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.918 0.39 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.469 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 39.4 p90 -60.8 116.32 4.34 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.306 0.574 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 303' ' ' THR . 14.3 t -173.48 -166.59 0.33 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.118 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 13.7 t -61.19 114.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 144.64 55.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.909 0.861 . . . . 0.0 112.201 -170.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.63 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.7 t0 -59.76 141.58 54.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.704 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.699 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.24 -11.8 44.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.735 -175.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.63 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -105.41 -1.15 25.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 46.2 mttp -83.77 -30.08 26.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.699 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -86.92 147.93 25.56 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.678 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.1 p -135.5 145.26 46.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.524 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.485 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.9 m-90 -53.49 96.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.862 0.726 . . . . 0.0 111.462 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.419 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 76.9 tttt -87.84 -35.08 17.99 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.916 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.3 ttm180 -159.07 113.71 2.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.238 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.05 80.04 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 119.188 -0.434 . . . . 0.0 109.957 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -41.83 119.1 1.05 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.706 2.271 . . . . 0.0 112.461 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.3 m -139.61 142.41 37.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.322 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -40.66 130.77 2.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.863 0.465 . . . . 0.0 111.02 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.458 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -65.82 -23.75 66.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.61 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.37 -0.57 27.99 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.438 -174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -126.89 -56.46 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.348 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.31 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.548 0.689 . . . . 0.0 110.498 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.744 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 11.1 p -92.0 -172.04 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.953 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.7 148.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.387 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -130.55 158.15 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 122.743 0.417 . . . . 0.0 110.978 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.515 ' HB3' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -136.79 163.47 30.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 2.5 mt-10 -130.3 135.1 47.73 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.913 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.84 146.21 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.982 0.42 . . . . 0.0 111.367 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.11 145.8 18.55 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.547 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -89.78 178.34 6.27 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.569 0.7 . . . . 0.0 111.326 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.3 m -149.32 28.5 0.81 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.367 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 165.56 -70.52 0.19 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 119.663 -1.256 . . . . 0.0 113.946 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 336' ' ' ARG . 41.1 m -58.65 136.43 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.956 0.503 . . . . 0.0 112.15 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 335' ' ' THR . 12.3 ptm180 -70.19 170.4 10.36 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.442 171.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.703 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.9 97.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.975 3.117 . . . . 0.0 114.759 -171.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.542 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 6.3 p -113.47 152.76 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.297 -172.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 306' ' ' VAL . 9.2 mpt_? -82.41 105.41 13.45 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.3 pt -87.31 131.43 44.29 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.602 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.39 84.34 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.053 2.502 . . . . 0.0 112.364 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.631 HG11 HD13 ' A' ' 372' ' ' ILE . 19.3 m -96.72 129.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.796 0.807 . . . . 0.0 111.253 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 35.6 ptt180 -140.21 -172.44 3.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -159.37 143.41 15.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.286 0.565 . . . . 0.0 111.416 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 382' ' ' ILE . 16.0 m -119.69 171.31 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -103.06 116.38 32.41 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 3.7 p-80 40.14 60.11 1.84 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.928 0.768 . . . . 0.0 112.459 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.9 3.92 24.65 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.609 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.25 118.88 45.06 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.546 0.673 . . . . 0.0 111.164 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.71 55.33 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.067 2.511 . . . . 0.0 111.445 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -86.07 -35.78 20.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.868 0.842 . . . . 0.0 108.895 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.581 HG12 ' HG3' ' A' ' 351' ' ' GLU . 6.7 p -155.66 122.93 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.745 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.2 107.77 0.27 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.185 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 376' ' ' LEU . 31.4 m -88.65 5.2 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.394 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -79.84 82.7 5.89 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.349 0.595 . . . . 0.0 110.645 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 36.8 mtm -97.61 90.37 4.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.7 mt -75.93 117.01 17.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.473 -165.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.3 mm -68.95 -22.13 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -131.38 85.42 53.32 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.776 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -87.28 41.68 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.376 2.718 . . . . 0.0 114.035 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -165.61 73.55 1.34 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.221 0.534 . . . . 0.0 110.557 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.589 ' HB2' HD11 ' A' ' 340' ' ' ILE . 91.7 Cg_endo -87.67 120.2 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.411 2.074 . . . . 0.0 112.586 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.8 p -115.21 140.72 48.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.952 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.703 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 54.9 mtm -95.04 113.63 25.35 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.355 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 39.5 mt-10 -104.24 -165.8 1.18 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.506 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -55.2 -17.74 4.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -105.06 2.52 29.56 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.5 0.667 . . . . 0.0 110.368 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 98.02 -158.63 20.7 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.88 -1.84 74.53 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.953 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.0 -129.62 32.49 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -115.63 142.03 47.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.296 0.57 . . . . 0.0 110.801 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.631 HD13 HG11 ' A' ' 342' ' ' VAL . 2.0 mt -120.12 130.9 73.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.573 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.938 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.1 mt-10 -103.92 135.97 44.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 110.451 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.476 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 4.4 ppp? -147.46 159.33 43.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.512 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.744 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.1 OUTLIER -172.89 167.12 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.557 . . . . 0.0 112.269 174.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.965 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.1 tp -164.82 156.85 13.75 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 172.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.965 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 47.2 Cg_exo -37.08 138.2 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.766 2.31 . . . . 0.0 112.798 172.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.65 ' HA ' HE22 ' A' ' 394' ' ' GLN . 89.1 Cg_exo -34.92 136.45 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 125.08 3.853 . . . . 0.0 114.985 -174.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.21 -150.94 22.24 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.463 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 8.3 m-20 -108.08 105.64 15.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.146 0.473 . . . . 0.0 110.484 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 10.0 m120 -105.0 125.1 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.031 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.093 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.44 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 328' ' ' MET . 22.4 mt -91.54 135.67 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -115.46 91.91 3.75 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.135 178.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 342' ' ' VAL . 6.3 t -83.79 92.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.64 0.12 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.867 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -110.57 -15.66 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.067 0.461 . . . . 0.0 110.108 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.564 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -63.29 139.96 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.8 p30 -149.41 148.1 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.587 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.8 OUTLIER -171.77 122.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 173.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.093 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 11.2 tt0 -76.82 148.89 36.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -143.54 129.52 19.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.484 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -86.34 112.18 21.18 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.65 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -102.19 126.47 49.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 395' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.428 -169.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.705 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 35.4 p90 -65.46 117.08 7.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.65 0.738 . . . . 0.0 110.332 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t -168.63 -171.25 1.37 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 53.6 t -62.65 109.29 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 140.05 56.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.469 0.652 . . . . 0.0 111.551 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.8 t70 -64.84 143.95 57.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.645 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.683 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -64.34 -11.93 37.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.176 -1.375 . . . . 0.0 113.484 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 308' ' ' ASP . 3.7 t -104.92 12.22 32.7 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.059 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.453 ' HE2' ' HA3' ' A' ' 334' ' ' GLY . 25.7 mtpp -101.63 1.36 37.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.866 ' HD1' HD13 ' A' ' 388' ' ' LEU . 2.4 p90 -125.53 169.38 12.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.3 t -149.2 162.37 40.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.951 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.542 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.3 m-90 -69.74 111.04 5.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 60.1 tptt -86.21 -36.26 19.55 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.544 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 11.3 ttm180 -164.6 120.99 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.138 175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.25 161.12 59.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.522 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.82 116.08 0.39 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.769 2.313 . . . . 0.0 112.013 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -131.9 134.34 45.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.173 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.45 127.4 24.9 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.412 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.3 p -66.8 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.7 -4.34 42.77 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -139.71 59.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.548 0.213 . . . . 0.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 74.13 -24.73 0.2 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 21.4 p -101.33 -171.39 1.98 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.301 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.74 153.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.402 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.986 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -134.8 154.48 36.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.877 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.669 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -137.69 161.86 35.39 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 16.2 tt0 -134.15 131.26 38.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.508 ' CG2' HD11 ' A' ' 372' ' ' ILE . 1.2 m -135.96 145.46 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.623 0.249 . . . . 0.0 111.3 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.91 135.19 11.53 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.302 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.594 ' CE1' ' HD2' ' A' ' 312' ' ' PHE . 1.3 m-85 -122.08 172.75 8.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 70.8 m -157.25 52.84 0.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.453 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -163.86 -74.69 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.35 -1.405 . . . . 0.0 113.766 170.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.665 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 3.8 m -57.53 144.23 37.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.437 0.695 . . . . 0.0 111.919 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.705 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 13.9 ptm180 -76.69 168.9 24.08 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.555 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 364' ' ' MET . 1.0 OUTLIER -27.26 98.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.008 3.139 . . . . 0.0 114.373 -173.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.796 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 26.9 p -110.58 173.49 6.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.784 -169.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 24.2 mmm180 -90.37 102.32 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.909 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.871 HD11 ' HB3' ' A' ' 364' ' ' MET . 58.6 mt -74.67 122.96 88.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.575 0.226 . . . . 0.0 111.08 -176.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.6 81.75 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.471 2.114 . . . . 0.0 112.4 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 340' ' ' ILE . 6.4 m -102.9 126.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 111.504 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 21.0 ptt180 -139.07 -178.24 5.25 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.93 135.96 11.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.629 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.16 174.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -104.67 115.89 31.1 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 15.8 p80 42.98 55.45 4.44 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.913 0.758 . . . . 0.0 112.575 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.862 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.68 11.09 56.6 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.881 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.91 118.02 30.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.468 -0.43 . . . . 0.0 110.679 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.17 61.91 5.0 Favored 'Trans proline' 0 N--CA 1.463 -0.324 0 C-N-CA 123.024 2.483 . . . . 0.0 111.268 172.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.86 -38.68 12.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.8 p -151.45 126.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.296 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -60.75 106.37 0.56 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.802 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.8 m -88.01 3.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.36 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.421 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.68 82.0 4.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.56 0.695 . . . . 0.0 110.747 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.817 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 2.5 tpt -98.91 83.5 2.93 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.3 mt -68.05 125.92 27.85 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.118 -169.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.581 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 6.2 mm -70.03 -23.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.399 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 13.0 m -138.63 92.95 11.21 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.057 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -91.75 41.04 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.386 2.724 . . . . 0.0 113.624 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.94 65.84 5.85 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.264 0.554 . . . . 0.0 110.098 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.702 ' HB3' HG23 ' A' ' 372' ' ' ILE . 97.2 Cg_endo -87.95 118.0 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.414 2.076 . . . . 0.0 113.168 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.4 p -110.0 134.5 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.412 171.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.871 ' HB3' HD11 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -107.14 149.94 27.12 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.542 -176.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -111.03 -168.53 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.827 1.329 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.641 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -64.91 -16.04 62.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 174.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.641 ' N ' HD22 ' A' ' 366' ' ' ASN . 89.1 m-20 -86.47 -11.44 51.78 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.306 0.574 . . . . 0.0 110.171 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.534 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 113.2 -167.67 12.38 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.707 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 364' ' ' MET . . . -81.49 -15.18 76.79 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.986 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.4 -127.62 23.8 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.128 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.95 133.31 50.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.072 0.463 . . . . 0.0 111.184 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -125.12 165.14 22.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.986 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.1 mt-10 -134.43 137.28 43.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.216 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.605 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.77 159.74 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -175.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.882 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -179.0 160.12 1.05 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 123.022 0.201 . . . . 0.0 110.579 174.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.802 HD22 ' HA ' ' A' ' 354' ' ' VAL . 13.8 tp -158.94 150.67 17.0 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.802 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.6 Cg_exo -32.93 136.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.49 2.793 . . . . 0.0 113.604 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.589 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.1 Cg_exo -35.79 128.75 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.851 1 C-N-CA 125.725 4.283 . . . . 0.0 114.951 -169.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.5 -134.41 2.89 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.406 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 14.7 m-20 -127.12 102.0 6.77 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.506 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.8 m120 -102.88 123.0 45.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.102 0.477 . . . . 0.0 109.987 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.042 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.79 129.75 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' A' ' 374' ' ' MET . 29.7 mt -91.65 131.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.414 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.4 OUTLIER -108.03 91.47 3.66 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.039 174.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 342' ' ' VAL . 7.6 t -83.86 94.6 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.61 -97.49 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.952 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 28.0 t70 -104.73 -19.89 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.173 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.866 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.1 tp -64.31 146.43 54.41 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.4 p30 -158.84 143.22 15.66 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.492 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -166.18 124.69 1.51 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.421 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.042 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.5 tm0? -78.35 143.2 37.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.906 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 394' ' ' GLN . 26.8 t-105 -145.37 114.54 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.366 174.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 27.3 p90 -74.38 125.8 29.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.589 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -120.08 140.53 50.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.67 0.748 . . . . 0.0 112.731 -171.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.314 168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.421 0.629 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -69.53 120.36 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.676 -0.64 . . . . 0.0 110.124 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.3 t -171.29 -167.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.719 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.45 113.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 143.78 55.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.791 0.805 . . . . 0.0 110.812 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.57 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.0 t70 -80.29 150.65 29.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.273 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 10.8 ptmt -58.51 -18.58 30.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.017 -173.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.57 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.0 t -100.19 -0.22 39.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.3 mmmt -80.86 -33.79 34.2 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -93.84 154.55 17.67 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.154 0.502 . . . . 0.0 111.535 -178.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.443 ' HA ' HD11 ' A' ' 388' ' ' LEU . 8.9 t -144.38 150.62 38.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.283 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -64.98 112.76 3.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.225 0.536 . . . . 0.0 111.999 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.484 ' HG2' ' OE2' ' A' ' 329' ' ' GLU . 38.2 tttm -94.99 -28.54 15.09 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 72.1 ttt180 -168.89 110.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.628 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.2 160.47 39.94 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.43 -175.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.765 ' HG3' HD12 ' A' ' 383' ' ' ILE . 69.6 Cg_exo -30.78 118.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.922 3.081 . . . . 0.0 113.498 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -137.21 134.55 36.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.738 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.564 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 14.3 t70 -52.16 130.17 29.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.945 0.402 . . . . 0.0 110.497 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 99.9 p -69.75 -24.14 63.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.354 -173.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 102.49 -12.68 56.82 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -125.11 57.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 4.9 p-10 47.41 23.08 0.32 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.131 0.972 . . . . 0.0 113.529 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.591 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -127.43 -172.7 2.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.7 OUTLIER -128.92 152.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.882 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 373' ' ' GLU . 25.8 m -137.6 153.26 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.687 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.59 ' CE ' HD12 ' A' ' 372' ' ' ILE . 18.0 ptt? -136.52 158.15 45.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.715 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.4 tt0 -121.29 118.82 30.49 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.263 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.82 148.86 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -120.49 157.07 15.88 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.87 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.443 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -95.75 178.74 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.825 -177.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 311' ' ' LYS . 37.6 p -136.2 -3.04 2.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.0 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 161.06 11.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 119.207 -1.473 . . . . 0.0 115.782 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 39.8 m -113.08 127.48 56.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.138 0.969 . . . . 0.0 109.903 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.591 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.6 ptt180 -75.03 171.48 11.6 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.033 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.9 OUTLIER -25.51 92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.986 3.124 . . . . 0.0 114.8 -166.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 363' ' ' THR . 9.2 p -110.54 144.72 38.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.709 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 6.1 mpt_? -73.47 103.95 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.713 HG21 ' HG3' ' A' ' 364' ' ' MET . 21.1 pt -88.28 128.71 52.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.252 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 312' ' ' PHE . 58.4 Cg_endo -74.5 82.53 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.73 2.287 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 385' ' ' VAL . 13.5 m -98.57 113.7 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.694 0.759 . . . . 0.0 111.31 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 383' ' ' ILE . 18.2 ptt180 -123.09 -178.74 4.05 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -154.6 142.27 19.88 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.195 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -114.38 169.65 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.544 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -112.44 116.79 30.86 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.974 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.429 ' HD2' ' OD2' ' A' ' 380' ' ' ASP . 4.8 t-160 63.95 39.07 8.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.6 0.562 . . . . 0.0 109.902 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 70.2 5.76 54.98 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.427 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 47.5 t -111.65 115.37 51.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 117.201 0.501 . . . . 0.0 111.348 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.8 Cg_exo -77.91 52.62 4.08 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.293 2.662 . . . . 0.0 112.298 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.63 -53.38 4.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.661 0.743 . . . . 0.0 109.108 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.33 117.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.603 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.8 t30 -53.29 108.67 0.35 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.244 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.876 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.9 m -87.13 8.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -81.69 80.89 7.91 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.515 0.674 . . . . 0.0 110.718 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 37.9 mtt -102.39 81.05 2.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.2 mt -63.68 125.25 23.68 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.271 -169.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 375' ' ' GLN . 4.6 mm -65.47 -20.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.4 m -136.61 92.27 15.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.489 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 357' ' ' LEU . 80.0 Cg_endo -92.07 48.93 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.6 2.867 . . . . 0.0 114.739 -168.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -170.47 70.11 0.56 Allowed Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 109.918 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.486 ' HB3' HG23 ' A' ' 372' ' ' ILE . 86.2 Cg_endo -90.91 138.32 2.4 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.949 2.433 . . . . 0.0 113.822 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 17.2 p -123.98 143.09 50.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.651 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.713 ' HG3' HG21 ' A' ' 340' ' ' ILE . 53.7 mtm -95.86 128.82 43.08 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.121 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 mm-40 -93.2 -172.22 2.89 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.348 1.03 . . . . 0.0 112.245 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.606 ' C ' HD22 ' A' ' 366' ' ' ASN . 0.3 OUTLIER -66.25 -6.23 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.838 174.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.591 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.4 t-20 -112.87 -2.1 14.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.31 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 105.31 -175.34 21.87 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.0 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -75.29 -37.72 41.22 Favored Glycine 0 CA--C 1.509 -0.306 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.494 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.76 -124.11 6.46 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.431 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.2 134.94 45.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.106 0.479 . . . . 0.0 111.559 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.59 HD12 ' CE ' ' A' ' 328' ' ' MET . 0.9 OUTLIER -128.7 155.33 40.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.767 ' HG2' HG12 ' A' ' 327' ' ' VAL . 33.8 mt-10 -125.09 138.34 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.875 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -153.59 157.18 39.3 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.908 0.483 . . . . 0.0 110.709 -174.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.826 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -170.07 163.72 9.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 173.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.9 tp -165.51 163.41 12.97 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 72.1 Cg_exo -27.83 133.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.103 3.202 . . . . 0.0 114.348 168.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.839 ' HB3' ' HB2' ' A' ' 395' ' ' LYS . 5.2 Cg_exo -37.09 138.46 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.857 4.371 . . . . 0.0 115.362 -175.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 147.05 -179.76 23.73 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.063 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.5 m-20 -69.02 104.26 2.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 117.791 0.796 . . . . 0.0 110.561 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -94.34 112.54 24.33 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.011 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -114.78 127.56 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.863 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.765 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.8 mt -92.74 132.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.992 -175.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.676 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.6 OUTLIER -104.58 92.57 4.35 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.062 174.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.3 t -81.23 86.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.98 -91.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.533 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.542 ' HB2' ' HE3' ' A' ' 309' ' ' LYS . 10.5 t70 -108.75 -15.01 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 109.809 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -64.35 147.93 51.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.8 p-10 -158.34 140.87 14.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.585 0.231 . . . . 0.0 111.127 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.621 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -167.88 121.7 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.24 174.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.011 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 70.6 mt-30 -70.83 150.96 45.29 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.564 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 12.1 t-105 -151.04 110.7 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.985 169.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.9 p90 -74.39 111.36 9.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.652 0.739 . . . . 0.0 109.8 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.588 ' NE2' ' HG2' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -99.11 146.27 26.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.139 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' A' ' 378' ' ' PRO . 71.7 mmtt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.197 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.526 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 25.1 p90 -64.74 129.82 41.23 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.92 -0.488 . . . . 0.0 110.062 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.4 t 176.78 -173.61 0.1 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 17.3 t -69.56 106.09 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.482 ' SG ' HG22 ' A' ' 340' ' ' ILE . 0.3 OUTLIER -68.86 156.68 38.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.682 0.754 . . . . 0.0 112.393 -167.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.677 ' OD2' HG22 ' A' ' 310' ' ' THR . 18.4 t70 -67.8 143.16 55.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -66.11 -22.39 66.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.494 -170.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.677 HG22 ' OD2' ' A' ' 308' ' ' ASP . 2.6 t -100.0 -6.23 26.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.635 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 29.3 mtpp -83.02 38.19 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -175.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -123.93 173.69 8.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.261 0.553 . . . . 0.0 111.497 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 10.0 t -157.13 135.43 11.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.478 170.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -55.16 110.87 0.74 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.839 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.714 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 1.1 tpmt? -92.36 -41.68 10.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 69.9 ttt180 -161.16 126.16 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.2 162.57 71.84 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.648 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 4.9 Cg_exo -40.37 122.69 1.32 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.609 2.206 . . . . 0.0 111.718 175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 12.3 m -142.85 142.17 31.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.259 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.12 125.58 6.66 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.176 0.298 . . . . 0.0 110.487 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.576 ' HB3' HG13 ' A' ' 327' ' ' VAL . 94.9 p -66.79 -20.15 65.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.902 -174.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.89 -2.19 79.29 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -140.01 55.33 1.64 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 110.97 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 72.96 12.92 5.02 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.716 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.1 p -144.62 -166.78 2.47 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.481 -0.137 . . . . 0.0 110.699 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.96 155.19 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.86 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.696 HG12 ' HG3' ' A' ' 373' ' ' GLU . 17.9 m -137.5 160.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.655 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.441 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 10.5 ptm -141.39 165.1 28.43 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.5 tt0 -130.19 124.68 33.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 385' ' ' VAL . 14.1 m -128.78 141.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.169 0.509 . . . . 0.0 111.599 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.03 161.04 14.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.0 OUTLIER -108.5 179.9 4.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.907 0.86 . . . . 0.0 112.833 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.2 t -98.8 -42.79 7.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.363 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.8 41.11 0.04 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.245 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.7 m -114.32 119.9 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.118 0.459 . . . . 0.0 110.33 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.575 ' HE ' ' HD2' ' A' ' 337' ' ' PRO . 2.6 ptm180 -69.87 171.22 7.73 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.253 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HD2' ' HE ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.05 92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 124.184 3.256 . . . . 0.0 114.532 -169.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 363' ' ' THR . 20.8 p -114.34 164.1 14.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.274 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 20.8 mmt180 -86.59 99.03 11.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.815 HG13 HG22 ' A' ' 342' ' ' VAL . 16.7 pt -81.0 130.03 64.97 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.548 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.94 78.97 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.173 1.915 . . . . 0.0 112.354 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -98.25 121.62 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.832 0.825 . . . . 0.0 112.411 175.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -126.67 -176.69 3.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.326 171.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.47 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.9 134.47 15.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.348 0.594 . . . . 0.0 110.647 176.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 18.3 m -110.74 167.63 4.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.37 114.41 28.66 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.349 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 57.35 46.79 17.78 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 123.721 0.638 . . . . 0.0 110.621 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.587 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 64.75 13.84 57.02 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.837 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 351' ' ' GLU . 46.9 t -114.66 112.95 45.2 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.51 0.655 . . . . 0.0 111.301 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.64 52.56 2.51 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.627 2.885 . . . . 0.0 112.134 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.475 ' HB2' HG12 ' A' ' 349' ' ' VAL . 10.5 tp10 -90.93 -51.59 5.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.945 0.879 . . . . 0.0 108.828 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.8 118.51 29.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.115 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -61.03 107.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.719 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.747 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 27.0 m -89.53 6.58 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.47 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.95 83.37 6.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.466 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -99.82 91.98 5.09 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 29.6 mt -73.24 118.7 16.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.208 -167.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -66.66 -22.95 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.361 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -131.12 93.43 30.36 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.951 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.71 43.3 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.035 2.49 . . . . 0.0 113.035 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 66.6 t30 -150.54 61.03 4.48 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.543 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.648 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.9 Cg_endo -88.53 118.96 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.528 2.152 . . . . 0.0 112.789 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 53.2 p -124.42 149.63 46.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.377 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.993 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 71.3 mtm -94.61 133.8 37.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' A' ' 366' ' ' ASN . 1.2 mm-40 -109.46 -168.72 1.37 Allowed 'General case' 0 C--N 1.318 -0.795 0 O-C-N 124.551 1.157 . . . . 0.0 111.891 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.0 OUTLIER -52.51 -23.73 6.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -109.43 -7.93 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.077 -0.389 . . . . 0.0 111.156 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 127.75 -178.14 17.18 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.993 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -63.12 -29.66 75.09 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.63 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.9 -123.42 6.58 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.347 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -103.55 147.28 27.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.191 0.519 . . . . 0.0 111.644 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.648 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -136.54 137.67 47.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.962 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.7 mp0 -107.29 135.52 48.66 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.292 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.748 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -152.45 158.09 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.754 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.9 tp60 -176.04 145.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.725 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.788 HD22 ' HD2' ' A' ' 377' ' ' PRO . 0.8 OUTLIER -146.25 142.48 17.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 167.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.788 ' HD2' HD22 ' A' ' 376' ' ' LEU . 28.2 Cg_exo -23.94 136.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.844 3.696 . . . . 0.0 115.004 177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.859 ' HA ' HE22 ' A' ' 394' ' ' GLN . 6.3 Cg_exo -37.11 134.2 0.41 Allowed 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 125.79 4.327 . . . . 0.0 114.97 -171.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 161.51 -124.6 1.33 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.995 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.489 ' HB3' HE21 ' A' ' 391' ' ' GLN . 11.7 m-20 -132.29 101.78 5.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.418 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.9 m120 -104.57 124.75 49.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.55 134.28 66.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 374' ' ' MET . 41.9 mt -95.27 134.1 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.176 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.23 94.24 4.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.133 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 342' ' ' VAL . 2.8 t -84.82 72.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.64 -80.66 0.77 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.504 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.506 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 1.9 t70 -110.54 -30.08 7.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.51 141.77 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.537 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.4 p30 -150.73 154.27 37.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -170.08 116.07 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 175.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -73.13 139.97 46.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.438 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 29.9 t-105 -136.67 137.72 40.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.158 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -94.97 117.32 29.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.859 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.32 146.09 38.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.886 0.374 . . . . 0.0 110.495 -177.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 395' ' ' LYS . 1.9 ttpm? . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.496 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 335' ' ' THR . 6.8 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HD1' ' H ' ' A' ' 304' ' ' TYR . 0.4 OUTLIER -70.84 108.48 4.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.783 0.802 . . . . 0.0 110.617 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.5 t -168.43 -167.18 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.582 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.69 113.43 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 170.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.98 144.23 56.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.658 0.742 . . . . 0.0 111.174 -171.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.93 148.33 40.15 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.13 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.81 -12.88 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.888 -173.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.477 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.5 t -98.15 -6.21 31.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.568 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.7 mmmt -75.9 -36.16 59.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.628 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -94.4 148.79 21.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 111.106 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.9 t -139.11 162.19 35.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.56 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.466 ' CZ3' ' HA ' ' A' ' 317' ' ' ALA . 93.8 m95 -67.37 111.39 4.02 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.958 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 73.3 tttt -102.52 -39.8 6.95 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.014 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.644 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 70.7 ttt180 -157.0 118.35 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.51 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.466 ' HA ' ' CZ3' ' A' ' 314' ' ' TRP . . . -67.42 161.21 66.83 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.462 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.866 ' HG3' HD12 ' A' ' 383' ' ' ILE . 74.0 Cg_exo -36.34 110.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.223 2.616 . . . . 0.0 113.251 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.5 m -134.9 137.45 43.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.591 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.4 131.66 13.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.162 0.505 . . . . 0.0 111.509 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.457 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.1 p -66.89 -23.32 65.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.77 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.05 -11.64 31.73 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -100.77 -54.13 2.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.516 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 21.9 t70 170.08 -24.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.323 1.058 . . . . 0.0 109.035 -171.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.563 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.46 -169.95 2.25 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.462 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.574 HG11 HE22 ' A' ' 394' ' ' GLN . 2.1 t -127.73 154.38 38.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.024 0.44 . . . . 0.0 111.001 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.3 m -135.22 156.61 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.76 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.568 ' SD ' HG22 ' A' ' 330' ' ' VAL . 2.0 ppp? -135.65 154.63 51.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.958 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 9.7 tt0 -126.44 123.13 37.17 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.116 0.484 . . . . 0.0 110.601 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -123.7 148.83 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.51 -177.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.23 139.35 15.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.78 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.521 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.8 OUTLIER -91.13 179.27 5.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.345 0.573 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.7 p -135.55 -17.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.118 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.99 -47.28 0.06 OUTLIER Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.339 -1.41 . . . . 0.0 114.213 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 303' ' ' THR . 26.3 m -56.27 125.27 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.213 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.584 ' HD2' ' HB3' ' A' ' 304' ' ' TYR . 0.0 OUTLIER -69.44 163.22 60.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 118.14 -0.933 . . . . 0.0 108.891 176.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.48 97.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.148 3.232 . . . . 0.0 114.688 -169.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 363' ' ' THR . 6.8 p -114.07 150.89 33.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.969 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -75.4 108.06 7.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.736 HG21 ' HG3' ' A' ' 364' ' ' MET . 28.8 pt -91.48 128.58 46.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.106 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.33 89.57 1.18 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.099 2.533 . . . . 0.0 112.881 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 372' ' ' ILE . 19.1 m -101.05 124.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.415 0.626 . . . . 0.0 110.938 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -132.78 -175.62 3.83 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.454 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 137.46 18.44 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.59 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 382' ' ' ILE . 10.7 m -115.23 166.82 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.54 117.74 34.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.535 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.5 t60 59.7 40.08 20.27 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.395 0.434 . . . . 0.0 110.519 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.432 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 69.1 6.96 55.77 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.231 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.1 113.09 62.75 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.897 0.349 . . . . 0.0 111.051 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.46 55.87 4.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.929 2.42 . . . . 0.0 111.88 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.32 -53.49 4.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.029 0.919 . . . . 0.0 108.621 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.6 120.89 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.787 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -54.37 107.99 0.33 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.663 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 1.049 ' HB ' ' HB3' ' A' ' 376' ' ' LEU . 2.6 m -87.9 -8.65 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.85 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.454 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -60.02 96.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.471 0.653 . . . . 0.0 112.222 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.637 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 67.4 mtm -108.18 85.38 2.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 45.4 mt -73.41 124.37 25.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.377 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.8 mm -69.62 -20.53 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.3 m -145.74 97.13 4.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.999 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -92.47 37.91 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.483 2.788 . . . . 0.0 113.288 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -144.53 63.04 10.42 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.883 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.741 ' HB3' HG23 ' A' ' 372' ' ' ILE . 88.4 Cg_endo -86.1 131.45 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.564 2.176 . . . . 0.0 113.016 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -130.4 142.16 50.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.399 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 59.0 mtm -95.24 117.08 29.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.722 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 38.5 mt-10 -100.12 -165.47 1.22 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.898 1.374 . . . . 0.0 109.886 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.645 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -62.8 -15.0 52.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 0.0 111.314 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.645 ' N ' HD22 ' A' ' 366' ' ' ASN . 87.1 m-20 -96.7 6.44 48.69 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.184 0.516 . . . . 0.0 109.678 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 83.48 -155.19 32.1 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -68.43 -16.43 69.4 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.826 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 71.45 -87.18 0.42 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.705 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.02 143.32 15.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.099 0.476 . . . . 0.0 109.871 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.8 mt -119.57 157.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.671 ' HG2' HG12 ' A' ' 327' ' ' VAL . 37.0 mt-10 -126.34 130.94 51.78 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.806 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.646 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -155.26 160.56 40.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.928 -173.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.894 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -163.71 148.19 10.54 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 167.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.049 ' HB3' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -132.22 163.59 49.27 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -169.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 378' ' ' PRO . 3.5 Cg_endo -48.16 126.67 13.87 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.625 2.217 . . . . 0.0 112.147 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.5 Cg_exo -38.81 128.62 1.26 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.69 3.594 . . . . 0.0 113.711 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 134.32 -172.57 21.76 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.362 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.4 m-20 -71.21 101.44 2.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.931 0.365 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.546 ' HB2' HD23 ' A' ' 376' ' ' LEU . 31.9 m-80 -118.04 163.39 16.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.055 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -146.24 144.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.631 -173.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.5 mt -100.97 132.96 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.094 0.473 . . . . 0.0 110.339 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -103.84 97.15 7.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.24 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.1 t -86.5 84.68 2.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.32 -85.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.332 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.765 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 7.8 t70 -113.09 -16.23 12.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.681 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.4 mp -66.14 148.76 51.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.058 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.1 p30 -163.45 126.92 2.73 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.967 0.413 . . . . 0.0 111.494 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -153.75 119.81 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.25 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.055 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 41.5 tt0 -87.39 142.38 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.424 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.473 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 0.6 OUTLIER -153.33 141.02 19.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.83 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 7.7 p90 -74.55 107.08 6.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.288 0.566 . . . . 0.0 110.661 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.695 ' HG3' HD23 ' A' ' 376' ' ' LEU . 1.7 mm100 -85.1 145.07 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 tptm . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.819 172.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 335' ' ' THR . 7.7 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.789 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.3 p90 -58.97 130.94 49.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 110.181 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.7 t -177.58 -165.45 0.11 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.02 107.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.538 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.5 OUTLIER -68.4 136.24 53.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.818 0.818 . . . . 0.0 110.877 -174.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.544 ' OD1' HG22 ' A' ' 310' ' ' THR . 8.7 t70 -65.92 147.75 52.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.924 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.792 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -61.56 -13.37 21.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.248 -177.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.544 HG22 ' OD1' ' A' ' 308' ' ' ASP . 15.3 t -104.29 6.19 35.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 41.4 mtpt -106.36 17.42 23.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.792 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.5 OUTLIER -132.74 158.32 42.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.2 t -138.71 154.08 48.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.503 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.524 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.5 m-90 -63.8 98.49 0.2 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.367 0.604 . . . . 0.0 110.885 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -83.51 -32.42 25.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 37.6 ttm180 -165.24 116.12 1.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.255 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.42 163.6 24.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.344 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.0 Cg_exo -41.7 117.91 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.638 2.226 . . . . 0.0 112.107 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.7 m -135.49 144.52 46.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.345 -172.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.82 130.3 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.529 ' HB3' HG13 ' A' ' 327' ' ' VAL . 80.6 p -71.15 -18.64 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.93 -2.59 72.53 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 9.1 t60 -109.09 -52.88 2.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 19.0 t70 169.19 -25.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.311 1.053 . . . . 0.0 108.915 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.456 ' CB ' HG13 ' A' ' 358' ' ' ILE . 9.4 p -92.83 -168.28 1.92 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.004 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.68 150.92 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -131.85 163.7 36.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.979 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.39 163.99 31.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 4.0 tt0 -132.06 126.68 34.42 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.656 0.597 . . . . 0.0 110.1 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.91 153.9 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.38 152.27 16.84 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.999 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.644 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -89.93 165.86 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.227 0.514 . . . . 0.0 111.798 -174.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 35.3 m -115.6 8.03 14.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.338 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 147.61 13.11 0.15 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.458 -1.354 . . . . 0.0 115.2 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 336' ' ' ARG . 98.4 m -114.29 132.71 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.292 1.046 . . . . 0.0 110.586 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.789 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 28.0 ptt180 -75.94 173.11 7.72 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.027 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.62 93.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 124.051 3.167 . . . . 0.0 115.166 -168.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 1.8 p -110.8 150.78 28.63 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.035 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.28 108.75 3.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.599 ' HB ' ' HG3' ' A' ' 364' ' ' MET . 15.6 tt -92.4 119.24 68.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 121.013 0.435 . . . . 0.0 110.24 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.47 82.23 2.13 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.987 2.458 . . . . 0.0 112.535 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -98.93 128.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.384 0.611 . . . . 0.0 111.477 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 32.0 ptt180 -135.17 -176.13 4.15 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.68 141.58 22.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.255 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 14.6 m -120.47 168.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.44 34.11 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.049 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.538 ' HA ' ' OD2' ' A' ' 380' ' ' ASP . 5.4 t60 56.91 46.54 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.514 0.509 . . . . 0.0 111.381 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.431 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 61.79 14.44 44.24 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.642 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 347' ' ' HIS . 38.7 t -115.78 115.86 41.13 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.155 0.478 . . . . 0.0 111.216 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.9 Cg_exo -79.16 51.29 3.8 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.231 2.62 . . . . 0.0 112.228 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -85.07 -41.4 15.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.739 0.781 . . . . 0.0 109.222 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 351' ' ' GLU . 4.4 p -144.11 118.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.602 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -55.78 108.09 0.41 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.948 ' HA ' HD22 ' A' ' 376' ' ' LEU . 28.2 m -84.99 0.18 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.124 0.487 . . . . 0.0 110.293 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.455 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.36 82.97 3.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.216 0.532 . . . . 0.0 110.835 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.744 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 8.5 tpt -97.59 91.96 5.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 166.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 39.3 mt -74.49 120.37 19.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.454 -165.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -70.32 -19.01 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 61.7 m -128.25 81.89 69.61 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.252 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -86.18 43.92 1.18 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.14 2.56 . . . . 0.0 113.811 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.14 67.62 0.41 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.473 ' HB3' HG23 ' A' ' 372' ' ' ILE . 68.9 Cg_endo -91.49 134.91 1.65 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.816 2.344 . . . . 0.0 114.01 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 2.8 p -116.65 155.94 27.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.93 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.933 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 76.7 mtp -95.43 103.72 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.981 0.42 . . . . 0.0 109.868 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -79.72 -165.56 0.83 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.732 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.528 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -46.85 -30.86 2.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -122.69 25.72 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.757 -0.59 . . . . 0.0 111.289 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.09 -177.6 20.37 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.008 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.933 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.12 -25.09 53.35 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.395 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.09 -110.98 3.71 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.642 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -108.1 131.9 54.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.152 0.501 . . . . 0.0 111.721 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.2 mt -134.98 141.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.857 ' HG2' HG12 ' A' ' 327' ' ' VAL . 30.9 mt-10 -114.46 137.09 52.28 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.492 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.524 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -144.46 156.08 44.03 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.744 ' O ' ' HB3' ' A' ' 356' ' ' MET . 24.1 tp60 -175.65 144.92 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.709 0.29 . . . . 0.0 110.96 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.017 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.2 tp -147.15 160.07 40.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 164.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 1.017 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 38.7 Cg_exo -29.47 133.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.147 3.231 . . . . 0.0 114.579 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.609 ' HA ' HE22 ' A' ' 394' ' ' GLN . 73.0 Cg_exo -35.37 135.69 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.016 1 C-N-CA 125.441 4.094 . . . . 0.0 115.562 -176.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.61 -135.71 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.7 p-10 -131.17 107.47 9.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.162 0.982 . . . . 0.0 109.977 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.8 OUTLIER -102.26 128.65 48.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.632 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.968 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -119.63 135.73 59.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.524 HD11 ' HG2' ' A' ' 374' ' ' MET . 42.2 mt -91.07 129.48 41.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.873 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -108.93 91.84 3.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.971 176.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 342' ' ' VAL . 9.3 t -83.6 85.6 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.24 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.359 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 3.1 t0 -112.1 -22.64 10.89 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.643 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -64.13 140.08 58.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.226 177.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.489 ' H ' ' HZ2' ' A' ' 314' ' ' TRP . 25.7 p-10 -151.74 139.43 19.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.39 116.98 1.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.968 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 26.9 tt0 -67.38 141.57 57.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.763 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 27.9 t-105 -139.79 122.11 16.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.121 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 11.8 p90 -79.76 109.07 13.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.077 0.465 . . . . 0.0 109.908 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.609 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -104.11 133.16 49.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.048 0.452 . . . . 0.0 110.511 -178.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.61 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 335' ' ' THR . 6.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.185 0.516 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -57.99 131.15 49.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.792 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.9 t -176.39 -167.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.0 t -68.13 116.65 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 137.22 56.08 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.805 0.812 . . . . 0.0 111.446 -170.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.65 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.4 t0 -60.69 143.33 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.545 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.646 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.1 -171.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.65 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.2 t -108.58 3.96 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.508 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 37.3 mttp -80.19 -21.53 42.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -95.97 154.02 17.46 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.347 0.594 . . . . 0.0 110.958 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.8 t -136.95 156.44 48.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.226 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -59.98 99.9 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.762 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.536 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 27.6 tptp -89.34 -46.42 8.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.445 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 28.5 ttm180 -154.92 122.43 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.792 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.46 157.19 86.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.33 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 392' ' ' TRP . 2.4 Cg_endo -42.24 112.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.111 2.541 . . . . 0.0 112.689 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -127.61 144.64 51.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.02 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.75 128.02 6.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 93.4 p -64.96 -23.1 67.12 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.521 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.86 -12.4 20.36 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.753 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.0 -40.92 1.98 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -178.0 -28.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.384 0.611 . . . . 0.0 111.667 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.467 ' HB ' HG13 ' A' ' 358' ' ' ILE . 16.7 p -93.31 -170.88 2.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.035 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.0 OUTLIER -127.62 144.72 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 -177.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.915 HG12 ' HG2' ' A' ' 373' ' ' GLU . 21.9 m -129.23 142.73 43.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.603 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.7 ptm -125.91 166.88 16.08 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.536 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 15.6 tt0 -136.7 140.54 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.603 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -139.52 158.89 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.67 0.271 . . . . 0.0 111.335 -178.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.652 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.86 135.85 9.64 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.629 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD2' ' HA2' ' A' ' 368' ' ' GLY . 2.3 p90 -90.74 178.45 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.192 0.496 . . . . 0.0 109.941 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.0 m -152.45 19.1 0.63 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -160.82 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.486 -1.34 . . . . 0.0 114.11 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 336' ' ' ARG . 67.9 m -70.49 139.98 51.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 4.8 ptt180 -67.34 175.84 1.42 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 117.611 -1.185 . . . . 0.0 109.013 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 364' ' ' MET . 3.7 Cg_exo -26.02 92.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 124.002 3.134 . . . . 0.0 114.247 -174.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 1.6 p -113.34 151.85 30.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.152 -171.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 9.1 mpt_? -69.24 109.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.579 HD11 HG11 ' A' ' 385' ' ' VAL . 11.3 tt -89.22 118.7 69.4 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 120.946 0.403 . . . . 0.0 110.459 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.8 84.12 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.085 2.523 . . . . 0.0 112.798 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -100.7 130.63 49.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 41.0 ptt180 -138.29 -170.26 2.77 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' A' ' 355' ' ' ALA . . . -155.52 140.89 17.68 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.348 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.83 167.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.44 113.05 26.26 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.886 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 56.68 49.39 14.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.75 2.15 27.78 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.252 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 25.9 t -110.37 113.05 56.58 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 117.73 0.765 . . . . 0.0 111.484 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 3.0 Cg_exo -79.33 63.17 8.69 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.485 2.79 . . . . 0.0 112.906 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.73 -46.01 6.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.622 0.725 . . . . 0.0 109.369 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.92 124.52 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.074 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.5 t30 -63.02 107.98 1.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 381' ' ' ASN . 34.3 m -90.94 11.56 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.549 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -83.3 83.19 7.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.548 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 36.7 ttm -96.92 87.26 4.21 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.6 mt -72.48 119.78 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.659 -165.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -69.79 -14.42 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -142.49 85.93 10.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.552 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 357' ' ' LEU . 96.9 Cg_endo -87.46 46.03 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.328 2.686 . . . . 0.0 113.944 -171.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -163.13 62.68 1.2 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.027 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.483 ' O ' HG22 ' A' ' 340' ' ' ILE . 86.1 Cg_endo -86.02 129.44 3.39 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.167 1.912 . . . . 0.0 113.405 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -116.96 150.56 38.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.502 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.839 ' HE1' ' HB3' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -99.81 118.78 37.01 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.974 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.94 -165.32 1.24 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 124.929 1.393 . . . . 0.0 110.697 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -55.89 -21.67 21.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.24 -0.43 38.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.313 0.577 . . . . 0.0 110.437 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.652 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.91 -160.14 13.58 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -65.6 -2.7 11.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 117.606 0.703 . . . . 0.0 112.505 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 56.21 -130.12 48.96 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -172.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 328' ' ' MET . 38.3 p90 -112.36 150.11 31.52 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.997 0.427 . . . . 0.0 110.432 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 342' ' ' VAL . 2.2 mt -134.0 143.68 37.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.418 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.915 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.0 mt-10 -112.4 139.71 47.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.541 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.6 ppp? -156.86 162.89 39.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.171 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.864 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.89 169.63 6.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.064 0.459 . . . . 0.0 111.829 172.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.7 tm? -166.12 141.03 3.8 Favored Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.809 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.4 Cg_exo -31.36 132.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.849 3.033 . . . . 0.0 114.12 175.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.524 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 6.0 Cg_exo -37.17 130.93 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.154 1 C-N-CA 125.783 4.322 . . . . 0.0 115.016 -170.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.99 -173.32 37.43 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.7 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.8 m-20 -90.1 101.53 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.037 0.419 . . . . 0.0 110.066 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.565 ' HB3' HG21 ' A' ' 354' ' ' VAL . 16.8 m-80 -111.89 -179.64 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.506 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.77 139.3 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 O-C-N 122.268 -0.27 . . . . 0.0 110.322 178.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.628 ' HB ' ' CE1' ' A' ' 390' ' ' HIS . 29.9 mt -91.04 133.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 389' ' ' ASN . 1.8 t80 -112.95 104.25 12.21 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 342' ' ' VAL . 6.2 t -97.01 83.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.86 -88.74 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.516 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.41 -31.18 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.2 mp -63.62 140.92 58.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 5.0 p-10 -140.25 140.62 35.81 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.829 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.628 ' CE1' ' HB ' ' A' ' 383' ' ' ILE . 0.8 OUTLIER -162.86 102.23 1.01 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.597 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.4 tt0 -81.41 152.23 27.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.404 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.739 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.2 OUTLIER -159.53 150.37 19.47 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 35.5 p90 -94.14 128.94 40.85 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.371 -0.83 . . . . 0.0 109.665 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.775 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -109.39 145.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.022 0.439 . . . . 0.0 110.474 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 395' ' ' LYS . 7.2 tmtt? . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.466 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.595 HG23 HG23 ' A' ' 335' ' ' THR . 8.7 t . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.365 0.602 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.71 113.78 5.11 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.685 0.755 . . . . 0.0 110.098 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.1 t -173.81 -166.45 0.31 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.91 104.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.729 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.6 OUTLIER -74.47 167.23 22.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.9 t70 -71.89 150.3 44.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.62 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 24.6 pttt -74.5 -19.82 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.613 -167.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 308' ' ' ASP . 15.3 t -107.69 22.65 15.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.077 0.465 . . . . 0.0 111.625 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -95.64 18.55 12.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -134.23 173.67 11.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.388 0.614 . . . . 0.0 111.187 -178.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 140.81 33.01 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.299 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -54.01 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.518 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.98 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 76.3 tttt -85.89 -43.64 13.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 24.9 ttm180 -148.84 126.77 11.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.226 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' A' ' 390' ' ' HIS . . . -70.9 160.64 81.61 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.75 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -42.35 115.39 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.292 1.995 . . . . 0.0 111.467 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 5.0 m -134.34 144.61 48.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.732 -172.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -46.3 128.15 9.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 0.0 111.239 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -74.98 -22.05 58.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.451 -173.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.25 84.55 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -169.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -124.81 32.51 5.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.394 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.3 t70 68.9 19.39 8.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.309 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.448 ' HB ' HG13 ' A' ' 358' ' ' ILE . 13.8 p -136.76 -168.26 2.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.51 151.36 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.982 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.9 m -139.44 147.62 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.193 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.57 ' HB3' HD12 ' A' ' 383' ' ' ILE . 11.9 ptm -126.7 163.02 24.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.555 171.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.98 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 11.5 tt0 -128.14 127.47 43.06 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.87 138.23 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.062 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -108.6 139.98 15.38 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.82 -179.87 4.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.249 1.025 . . . . 0.0 111.715 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.2 p -129.99 -24.47 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.656 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -144.54 -68.02 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.375 -1.393 . . . . 0.0 115.0 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 307' ' ' CYS . 7.1 m -56.24 122.19 11.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.811 0.306 . . . . 0.0 111.619 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.459 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.8 ptm180 -74.21 171.82 10.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 117.68 -1.152 . . . . 0.0 108.589 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.98 96.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.955 3.103 . . . . 0.0 114.929 -170.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.746 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.7 p -118.09 165.57 13.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.257 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.47 100.61 12.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 362' ' ' PRO . 18.9 pt -74.6 128.65 85.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.79 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.24 82.09 1.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.669 2.246 . . . . 0.0 112.089 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 20.5 m -97.63 133.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.536 0.684 . . . . 0.0 111.131 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -145.45 -177.73 5.72 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.516 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.15 137.18 18.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.811 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.1 m -113.66 172.76 3.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -100.96 115.9 31.55 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 6.1 p-80 41.38 59.82 2.27 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.887 0.742 . . . . 0.0 112.831 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.867 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.97 5.02 37.76 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.898 -0.592 . . . . 0.0 114.226 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 25.3 t -114.52 116.98 43.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 117.386 0.593 . . . . 0.0 111.026 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 9.6 Cg_exo -74.63 54.44 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.196 2.598 . . . . 0.0 111.471 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.561 ' HG3' HG12 ' A' ' 352' ' ' VAL . 7.8 pt-20 -86.22 -38.96 17.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.776 0.798 . . . . 0.0 108.951 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 351' ' ' GLU . 5.2 p -151.68 123.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.843 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -56.19 108.05 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.894 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.99 3.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.21 0.529 . . . . 0.0 110.2 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.93 82.66 5.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.318 -177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -96.15 91.27 5.84 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 373' ' ' GLU . 20.9 mt -70.8 120.41 16.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.658 -167.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.7 mm -68.52 -21.03 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.287 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 10.3 m -136.98 92.38 14.24 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.845 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.4 43.65 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.218 2.612 . . . . 0.0 112.895 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.4 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.1 p-10 -150.37 58.65 3.17 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.722 ' HB2' HD11 ' A' ' 340' ' ' ILE . 92.5 Cg_endo -86.86 113.03 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.412 2.074 . . . . 0.0 113.244 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.2 p -114.06 140.09 48.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.913 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.746 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 24.6 ptt? -102.84 126.3 49.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.737 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.03 -166.24 1.18 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.307 -172.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -61.23 -12.88 14.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.64 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.2 p30 -101.26 -4.34 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.51 -165.47 12.71 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -78.52 -7.11 88.15 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.145 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 66.59 -120.66 15.35 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.688 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -116.04 140.22 49.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.217 0.532 . . . . 0.0 111.204 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.4 mt -124.42 126.6 72.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.1 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.982 ' HG2' HG12 ' A' ' 327' ' ' VAL . 38.1 mt-10 -104.75 132.58 50.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.217 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.464 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.646 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.3 tp60 -174.32 145.08 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.097 0.248 . . . . 0.0 110.592 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.0 tp -143.59 162.74 40.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 34.5 Cg_exo -36.48 141.8 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.269 2.646 . . . . 0.0 113.492 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.587 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.7 Cg_exo -37.53 134.64 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 125.325 4.017 . . . . 0.0 114.77 -173.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.37 -146.75 13.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.348 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 14.8 m-20 -112.55 101.36 9.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.481 0.641 . . . . 0.0 110.213 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 354' ' ' VAL . 6.6 m120 -100.05 118.81 37.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.609 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.016 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.88 133.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 328' ' ' MET . 30.7 mt -93.13 134.02 32.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.461 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.8 OUTLIER -109.74 92.76 4.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.342 174.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 342' ' ' VAL . 5.5 t -81.28 77.99 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.69 -91.68 0.27 Allowed Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.971 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.62 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -106.61 -18.0 14.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.342 0.592 . . . . 0.0 109.643 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.9 OUTLIER -74.37 128.26 35.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.534 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.99 143.68 48.29 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.534 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 0.1 OUTLIER -166.16 120.17 1.14 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.817 0.341 . . . . 0.0 110.806 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.016 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 47.1 tt0 -82.36 146.73 29.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.935 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 19.7 t-105 -141.97 132.97 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.76 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.87 119.48 29.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.587 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -114.3 146.09 40.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.002 0.43 . . . . 0.0 110.343 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 pttt . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.847 -178.366 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.052 0.453 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.594 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 14.6 p90 -60.74 128.81 38.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -176.29 -172.42 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.04 110.44 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.494 ' HB2' ' HE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -68.67 134.73 50.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.684 0.754 . . . . 0.0 112.112 -172.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.632 ' OD1' HG22 ' A' ' 310' ' ' THR . 32.7 t70 -63.51 146.18 54.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.274 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.659 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.83 -14.66 62.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.321 -1.309 . . . . 0.0 114.309 -167.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.632 HG22 ' OD1' ' A' ' 308' ' ' ASP . 9.1 t -106.3 5.38 29.65 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.683 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -89.73 -21.16 22.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.08 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.72 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -95.87 147.45 23.65 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.21 0.529 . . . . 0.0 110.17 172.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 4.3 t -133.25 153.3 51.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.49 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.9 m-90 -61.98 99.12 0.12 Allowed 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 123.57 0.544 . . . . 0.0 111.232 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.629 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -84.44 -42.59 15.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 53.7 ttt180 -156.03 125.58 6.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.894 170.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.58 167.23 13.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.258 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.55 122.28 1.32 Allowed 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.925 2.417 . . . . 0.0 112.138 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -135.35 136.77 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.637 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -46.0 124.65 5.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 111.131 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -36.49 83.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.749 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 130.58 -10.71 5.78 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -114.84 -78.07 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.774 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.26 0.33 0.6 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.086 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.43 ' HB ' HG13 ' A' ' 358' ' ' ILE . 20.9 p -119.9 -174.28 2.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.142 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.4 153.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.884 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.816 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.6 m -133.44 163.99 36.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.557 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -147.71 153.71 39.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.649 -178.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.629 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 26.4 tt0 -129.6 118.07 21.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.597 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.721 HG13 ' SD ' ' A' ' 328' ' ' MET . 2.3 m -122.63 150.56 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.542 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.69 136.37 12.94 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.783 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.4 OUTLIER -90.93 -179.44 5.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.594 0.712 . . . . 0.0 111.241 -176.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.9 m -119.64 -25.78 5.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.993 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.21 -19.53 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.357 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 336' ' ' ARG . 5.5 m -75.3 134.75 40.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.021 0.91 . . . . 0.0 112.446 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.642 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.1 OUTLIER -78.3 173.7 7.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.611 171.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -25.46 95.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 124.021 3.147 . . . . 0.0 114.745 -173.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 305' ' ' THR . 21.8 p -110.67 166.87 10.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.336 -174.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.7 mpt_? -93.75 104.6 16.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.65 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.896 HD12 ' HB2' ' A' ' 362' ' ' PRO . 5.7 mt -75.79 123.82 88.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 81.42 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.311 2.007 . . . . 0.0 111.686 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 372' ' ' ILE . 14.5 m -100.58 133.62 43.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.416 0.627 . . . . 0.0 111.586 -177.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -143.24 -175.53 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.92 143.21 18.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.249 0.547 . . . . 0.0 111.459 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.4 m -115.17 172.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -102.5 115.67 31.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 2.6 p-80 37.86 64.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.728 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.44 6.34 33.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 38.9 t -115.69 113.66 42.45 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 117.616 0.708 . . . . 0.0 111.467 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.72 69.07 5.4 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.08 2.52 . . . . 0.0 111.364 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -95.19 -49.02 5.68 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.13 131.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.391 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 42.8 t30 -60.1 107.91 0.7 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.023 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.921 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.3 m -85.26 1.62 4.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 110.65 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.23 82.93 6.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.073 0.463 . . . . 0.0 110.479 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.04 92.24 5.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 28.5 mt -70.25 124.85 25.16 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.773 -165.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.0 mm -69.75 -21.53 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.702 -1.135 . . . . 0.0 107.994 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.8 m -137.33 94.82 11.97 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.7 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -86.01 41.22 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.396 2.731 . . . . 0.0 113.256 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.31 70.62 2.97 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.393 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.896 ' HB2' HD12 ' A' ' 340' ' ' ILE . 95.6 Cg_endo -82.19 133.6 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.492 2.128 . . . . 0.0 112.434 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.0 p -129.12 141.28 51.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.208 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.716 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 74.1 mtp -96.0 130.51 42.98 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.5 -168.72 1.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.271 0.982 . . . . 0.0 111.837 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -70.08 -5.62 28.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.435 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 366' ' ' ASN . 65.4 m-80 -113.52 9.12 17.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.4 0.619 . . . . 0.0 109.871 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.58 -165.75 16.77 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.246 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.716 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.53 -12.86 70.56 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.035 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.47 -119.25 10.03 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.6 m-85 -121.87 131.51 54.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.688 0.756 . . . . 0.0 111.606 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -106.17 157.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.816 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.2 mt-10 -126.87 129.15 47.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.867 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.4 OUTLIER -147.99 156.41 42.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.531 -172.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.671 HE21 ' H ' ' A' ' 376' ' ' LEU . 26.6 tp60 -177.65 146.73 0.46 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.645 0.259 . . . . 0.0 110.873 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.954 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.9 tp -145.26 154.46 53.77 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.954 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 41.5 Cg_exo -26.87 133.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 124.476 3.451 . . . . 0.0 115.134 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.727 ' HA ' HE22 ' A' ' 394' ' ' GLN . 54.6 Cg_exo -35.58 128.73 0.32 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 125.134 3.889 . . . . 0.0 115.114 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 167.68 -135.25 3.56 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.984 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.434 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 23.2 m-20 -119.72 101.03 7.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.156 0.478 . . . . 0.0 110.226 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.81 125.36 48.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.102 0.477 . . . . 0.0 109.893 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -124.15 129.13 74.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 16.9 mt -91.77 130.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.921 0.391 . . . . 0.0 110.66 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.8 m-85 -99.35 92.46 5.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.88 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.461 HG13 HG12 ' A' ' 342' ' ' VAL . 14.6 t -79.92 84.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.96 -86.62 0.13 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.479 -171.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.62 ' CB ' ' HD3' ' A' ' 309' ' ' LYS . 31.0 t0 -116.71 -19.77 9.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.324 0.583 . . . . 0.0 109.479 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.613 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 0.8 OUTLIER -59.34 142.83 51.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.164 174.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.3 p30 -152.32 138.78 18.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.804 0.335 . . . . 0.0 110.755 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.414 ' C ' HG12 ' A' ' 382' ' ' ILE . 33.7 t-80 -165.17 126.39 2.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.12 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.0 tt0 -79.04 152.01 31.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 19.9 t-105 -147.61 120.69 8.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.887 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -73.98 114.26 12.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.727 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.27 144.06 42.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.699 -177.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.246 0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.414 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 335' ' ' THR . 4.8 t . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 16.4 p90 -61.56 123.47 17.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.141 0.496 . . . . 0.0 110.958 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 11.6 t -171.93 -167.61 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.21 115.37 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.09 156.09 38.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.874 0.845 . . . . 0.0 111.665 -172.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.584 ' HB3' ' HD2' ' A' ' 311' ' ' LYS . 12.8 t70 -90.77 147.19 23.38 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.749 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.775 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.49 -13.56 14.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.063 -175.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.405 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 4.8 t -101.0 5.44 43.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 29.5 mttt -105.33 13.04 31.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.775 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -128.19 143.83 51.07 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 168.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -128.82 154.18 46.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.62 113.98 3.02 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.82 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 63.3 tttt -112.29 -53.91 2.67 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -140.71 117.89 11.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.22 161.37 32.76 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.09 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -44.69 119.59 2.36 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.643 2.229 . . . . 0.0 111.949 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -131.0 139.13 49.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.367 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.58 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 111.445 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 96.5 p -67.27 -21.8 65.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.487 -174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.36 -18.73 30.07 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.482 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -105.72 -54.23 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.058 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.59 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.739 0.781 . . . . 0.0 110.687 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.879 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 32.8 p -103.76 -168.19 1.47 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.689 -174.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.949 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.1 t -125.5 151.53 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 373' ' ' GLU . 18.4 m -136.32 144.89 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 123.31 0.644 . . . . 0.0 110.004 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.6 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.5 ptm -131.66 169.55 16.01 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.359 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.924 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 4.6 tt0 -136.39 133.04 36.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.144 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.6 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -131.42 154.53 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.203 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.36 138.79 14.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.902 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.798 ' HA ' ' O ' ' A' ' 311' ' ' LYS . 1.2 p90 -99.69 177.47 5.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.731 0.765 . . . . 0.0 110.815 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t -164.69 45.71 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.044 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.508 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -176.85 -63.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.905 172.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 338' ' ' CYS . 27.6 m -86.98 129.1 35.03 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.807 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 6.1 ptm180 -64.78 169.1 5.75 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.166 171.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.53 94.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.056 3.17 . . . . 0.0 114.383 -168.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 4.7 p -111.79 151.81 28.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.844 -173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.3 mpt_? -73.39 108.39 6.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.514 HD11 HG11 ' A' ' 385' ' ' VAL . 14.4 tt -85.19 126.98 65.95 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.64 -175.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.62 82.17 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.557 2.171 . . . . 0.0 112.092 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 372' ' ' ILE . 16.5 m -103.21 122.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 111.271 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 17.8 ptt-85 -129.85 -173.98 3.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -155.59 139.49 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.399 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -113.04 171.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.43 28.51 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.495 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 34.4 t-80 51.24 55.41 9.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.004 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.664 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 63.7 8.6 28.06 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.634 0.614 . . . . 0.0 114.634 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 52.4 t -110.2 111.53 57.91 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 117.821 0.81 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.3 Cg_exo -77.89 46.29 2.02 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.475 2.783 . . . . 0.0 112.912 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -92.21 -53.46 4.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.487 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.03 111.4 35.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.203 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 40.2 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.773 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.723 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.17 6.5 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.675 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.61 83.33 4.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.384 0.612 . . . . 0.0 110.35 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.8 ttp -102.8 87.9 3.07 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.9 mt -72.3 122.82 21.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.093 -165.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -67.96 -22.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 52.9 m -128.97 85.98 58.63 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.154 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.21 40.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.948 2.432 . . . . 0.0 113.925 -170.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -170.56 69.77 0.55 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.13 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 340' ' ' ILE . 70.0 Cg_endo -85.09 137.87 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.299 1.999 . . . . 0.0 112.84 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.4 p -119.54 145.93 45.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.681 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 74.4 mtp -95.82 107.55 19.81 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.855 0.36 . . . . 0.0 110.193 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.02 -167.32 1.84 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.079 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.67 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -63.73 -14.33 51.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.67 ' N ' HD22 ' A' ' 366' ' ' ASN . 84.5 m-20 -101.29 12.97 36.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.5 0.667 . . . . 0.0 109.885 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.56 -162.27 27.87 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -67.45 -16.48 67.42 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.41 -124.45 18.94 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 328' ' ' MET . 2.7 p90 -116.83 135.53 53.67 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 342' ' ' VAL . 2.7 mt -122.14 134.6 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.759 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.6 mp0 -103.05 133.01 48.89 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.191 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.8 ppp? -148.72 160.04 43.55 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -176.84 166.75 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.7 172.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.864 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.4 tp -164.9 151.34 9.22 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.864 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.3 Cg_exo -36.08 143.25 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.24 2.627 . . . . 0.0 113.595 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.693 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.7 Cg_exo -37.04 135.69 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.768 1 C-N-CA 125.52 4.147 . . . . 0.0 115.032 -170.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.47 -151.27 21.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.391 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.3 m-20 -109.93 101.24 10.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.212 0.506 . . . . 0.0 110.435 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.438 ' HA ' HG21 ' A' ' 354' ' ' VAL . 8.6 m120 -101.36 122.96 44.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.965 0.412 . . . . 0.0 109.945 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.102 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.4 130.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.9 mt -89.01 126.93 42.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.075 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.512 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.02 92.49 4.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.814 174.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.565 HG13 HG12 ' A' ' 342' ' ' VAL . 23.0 t -83.47 90.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.45 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.084 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -106.87 -22.7 12.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.161 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.536 HD23 ' CE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -66.14 141.11 58.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.617 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -135.66 142.42 45.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.536 ' CE1' HD23 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -163.05 102.76 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.102 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 16.9 tt0 -76.75 149.25 36.34 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -144.94 142.39 29.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.429 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -99.16 111.06 23.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.693 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -96.79 129.16 44.26 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.651 -175.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 378' ' ' PRO . 47.5 tttm . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.938 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 305' ' ' THR . 5.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.087 0.47 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.479 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 11.5 p90 -62.57 118.57 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t -179.57 -170.31 0.16 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.4 t -66.76 106.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.7 146.94 52.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.531 0.681 . . . . 0.0 112.452 -168.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.507 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.1 t70 -62.34 137.87 58.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.368 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.74 -23.21 67.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.256 -170.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.507 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.7 t -94.75 -4.91 46.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 111.363 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 24.4 mtpp -88.57 49.4 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 0.0 111.366 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.474 ' HZ ' HD13 ' A' ' 340' ' ' ILE . 1.8 m-85 -139.46 169.13 18.32 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.253 -177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -157.93 138.46 12.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.536 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.95 107.78 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.576 0.703 . . . . 0.0 111.527 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 315' ' ' LYS . 46.7 tptt -83.98 -36.81 22.93 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 9.2 ttm180 -160.04 109.18 1.76 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.833 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.43 156.41 52.38 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.185 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 392' ' ' TRP . 6.5 Cg_exo -32.72 118.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.931 3.087 . . . . 0.0 113.605 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.2 m -143.52 144.38 31.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.887 -171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -44.44 136.55 4.11 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 111.478 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.636 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.2 p -69.43 -23.52 63.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.968 -173.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.92 -1.42 88.8 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -171.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -107.27 -54.76 2.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.12 -32.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.002 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.502 ' CB ' HG13 ' A' ' 358' ' ' ILE . 1.1 p -95.81 -166.88 1.51 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.845 -175.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 392' ' ' TRP . 0.9 OUTLIER -109.48 155.99 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.876 176.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -139.42 174.25 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.115 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.702 ' HE2' HD12 ' A' ' 372' ' ' ILE . 21.5 ptt? -151.71 158.87 43.97 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 25.8 tt0 -120.27 125.82 49.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 312' ' ' PHE . 13.5 m -130.02 137.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.061 0.457 . . . . 0.0 112.03 -173.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.25 13.91 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.574 ' HD1' ' H ' ' A' ' 335' ' ' THR . 0.2 OUTLIER -118.23 179.99 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.451 0.626 . . . . 0.0 111.47 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.9 p -130.47 11.19 5.31 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.86 31.3 0.13 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 119.477 -1.344 . . . . 0.0 115.479 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.845 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 31.0 m -112.67 122.56 48.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.537 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 20.6 ptt180 -76.95 167.02 40.26 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.052 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.13 98.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 124.225 3.283 . . . . 0.0 114.855 -165.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.86 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 13.2 p -109.64 173.13 6.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.552 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 19.9 mmm180 -95.45 102.91 14.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.795 HG22 HG13 ' A' ' 342' ' ' VAL . 48.8 mt -75.89 124.88 88.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.747 0.308 . . . . 0.0 111.575 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.33 82.01 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.884 2.389 . . . . 0.0 111.972 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.795 HG13 HG22 ' A' ' 340' ' ' ILE . 6.1 m -103.23 129.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.572 0.701 . . . . 0.0 111.325 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -142.49 -174.57 4.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -153.04 138.78 17.91 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.898 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 382' ' ' ILE . 16.8 m -110.34 175.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -109.03 114.08 27.52 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.554 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 50.68 47.98 23.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.688 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.34 16.7 67.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.484 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.86 109.85 46.98 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 110.861 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 61.76 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.48 2.786 . . . . 0.0 112.274 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -97.48 -47.2 5.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.842 0.829 . . . . 0.0 109.011 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -137.21 124.05 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.563 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.6 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.908 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.907 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.1 m -89.5 5.77 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.0 110.753 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.63 84.26 6.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.447 ' HB2' HD13 ' A' ' 376' ' ' LEU . 0.0 OUTLIER -97.5 87.02 3.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 170.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 38.1 mt -68.82 126.53 30.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.582 -167.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -71.22 -20.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 48.6 m -136.45 87.48 21.78 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.933 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -88.4 50.95 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.332 2.688 . . . . 0.0 113.272 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.518 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.0 p-10 -160.49 58.9 1.12 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 1.2 Cg_endo -82.09 139.28 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.582 2.188 . . . . 0.0 112.592 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 338' ' ' CYS . 14.6 p -134.39 142.39 47.16 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.363 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.86 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 17.0 ptp -94.64 130.41 41.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.72 -165.32 1.19 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 124.925 1.391 . . . . 0.0 109.031 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.675 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -55.61 -20.57 14.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.675 ' N ' HD22 ' A' ' 366' ' ' ASN . 12.4 m-20 -108.55 13.12 25.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 0.0 110.696 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.21 -161.18 31.32 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.49 -25.35 74.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.84 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.08 -123.94 7.13 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.92 138.31 47.47 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' A' ' 328' ' ' MET . 0.8 OUTLIER -129.94 166.14 28.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.848 ' HG2' HG12 ' A' ' 327' ' ' VAL . 46.0 mt-10 -129.49 138.23 51.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.739 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -152.67 151.82 31.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.073 -174.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 1.0 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.58 165.91 2.64 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.161 0.288 . . . . 0.0 110.864 173.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 12.2 tp -164.8 163.94 13.71 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 63.0 Cg_exo -29.11 131.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.826 3.017 . . . . 0.0 114.343 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.71 ' HB3' ' HD2' ' A' ' 395' ' ' LYS . 6.0 Cg_exo -38.28 139.36 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.825 1 C-N-CA 125.633 4.222 . . . . 0.0 114.938 -175.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.09 -153.08 24.53 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -103.35 109.91 21.71 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.264 0.225 . . . . 0.0 110.691 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.2 m120 -112.22 172.69 6.76 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.202 175.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.051 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -165.16 133.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.9 mt -93.8 133.02 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.385 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -107.64 96.97 6.77 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.322 175.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.92 67.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.86 -84.05 0.58 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.489 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 15.1 t70 -100.44 -34.99 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.1 mp -61.03 143.34 55.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.8 p30 -159.67 138.47 10.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 126.52 1.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.154 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.051 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 23.7 mt-30 -70.13 153.23 43.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.546 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -153.94 150.53 28.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.474 171.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.47 136.0 40.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.555 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -132.31 147.37 52.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.772 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.71 ' HD2' ' HB3' ' A' ' 378' ' ' PRO . 23.5 tptm . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.683 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.607 ' HD2' ' HD3' ' A' ' 336' ' ' ARG . 21.5 p90 -53.57 125.83 19.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 111.298 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.7 t -175.9 -175.9 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.172 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.41 105.57 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.5 OUTLIER -72.35 153.35 41.52 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.6 t70 -72.3 154.67 40.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.468 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -70.97 -12.52 61.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.453 -172.279 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.5 t -100.05 7.03 44.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.911 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.665 ' HE3' ' CB ' ' A' ' 335' ' ' THR . 3.9 mtpm? -85.31 -27.45 25.94 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.915 -0.491 . . . . 0.0 112.303 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.78 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.7 OUTLIER -102.62 160.12 14.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.646 0.736 . . . . 0.0 111.936 -175.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.0 t -140.37 155.42 46.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.789 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.47 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.5 m-90 -65.33 96.48 0.23 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.254 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.0 tttt -86.46 -46.76 9.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 37.0 ttm180 -147.34 98.93 3.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.663 171.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -55.04 159.17 4.09 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.947 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 7.1 Cg_exo -34.25 115.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.581 2.854 . . . . 0.0 113.596 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -129.49 134.06 47.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.806 -173.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -47.8 125.1 8.19 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.465 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.4 p -67.83 -35.27 78.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.577 -172.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.72 -11.88 18.26 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.724 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -98.51 -71.48 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -171.61 18.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.57 ' HB ' HG13 ' A' ' 358' ' ' ILE . 18.1 p -131.74 -167.91 1.94 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.397 -171.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.904 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 1.9 t -130.04 149.78 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.272 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.991 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -135.83 140.96 43.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.394 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 11.1 ptm -130.03 150.84 51.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.958 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.791 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.9 tt0 -116.14 122.56 45.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.754 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 14.5 m -126.28 139.85 50.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.661 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.16 141.49 15.28 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.918 -176.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -90.61 178.68 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.22 0.51 . . . . 0.0 110.561 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.5 t -122.8 -62.78 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.78 -59.66 0.19 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.771 -176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.665 ' CB ' ' HE3' ' A' ' 311' ' ' LYS . 52.1 m -56.72 134.26 54.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.827 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.9 ptm180 -66.8 179.67 0.5 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.755 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.16 96.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 124.01 3.14 . . . . 0.0 114.573 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 305' ' ' THR . 31.4 p -113.93 160.08 19.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.428 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.02 104.25 9.53 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 362' ' ' PRO . 16.8 tt -87.72 127.47 58.06 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.326 0.584 . . . . 0.0 111.342 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.57 92.44 0.86 Allowed 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.857 2.371 . . . . 0.0 112.504 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.67 HG11 HD13 ' A' ' 372' ' ' ILE . 31.4 m -110.13 135.5 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.897 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 23.7 ptt180 -149.8 -174.2 4.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.41 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.72 143.21 18.35 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.412 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.48 169.49 10.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.51 114.4 27.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 27.1 p-80 35.29 61.76 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.684 0.794 . . . . 0.0 112.851 -175.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.585 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 76.06 0.09 64.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.402 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.23 114.32 55.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.516 0.658 . . . . 0.0 111.616 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -78.72 58.49 6.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.62 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 352' ' ' VAL . 9.4 tt0 -83.22 -37.0 24.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.061 0.934 . . . . 0.0 108.823 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 351' ' ' GLU . 2.1 p -161.06 122.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.49 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -51.82 107.82 0.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.268 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.564 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.7 m -90.4 6.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.688 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -76.91 83.39 3.46 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.342 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 16.7 mmt -95.15 85.22 4.25 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.0 mt -68.2 126.23 28.9 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.398 -167.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -71.61 -17.59 19.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.2 m -139.56 91.89 10.56 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.897 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.16 35.33 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.254 2.636 . . . . 0.0 113.511 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -149.52 64.12 6.97 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.102 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 372' ' ' ILE . 69.8 Cg_endo -88.13 128.09 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.583 2.189 . . . . 0.0 113.443 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 12.1 p -122.98 149.45 44.27 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.535 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.728 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 72.4 mtm -95.94 106.32 18.46 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.268 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.591 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 55.4 mm-40 -80.9 -167.64 1.48 Allowed 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.956 1.41 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.57 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -65.63 -7.19 13.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.57 ' N ' HD22 ' A' ' 366' ' ' ASN . 9.0 p30 -110.48 -4.84 15.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.444 0.64 . . . . 0.0 109.513 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.18 -166.75 12.71 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.97 -9.6 60.13 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.118 -175.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.78 -114.38 6.38 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.93 117.81 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.185 0.517 . . . . 0.0 111.288 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.67 HD13 HG11 ' A' ' 342' ' ' VAL . 1.6 mt -93.11 143.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.991 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -121.59 132.0 54.43 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.084 -174.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.628 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.9 OUTLIER -153.63 157.29 39.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.59 -171.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.989 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -174.6 168.67 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.224 172.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.871 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -164.64 143.92 5.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.871 ' HD2' HD22 ' A' ' 376' ' ' LEU . 23.3 Cg_exo -28.82 124.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.805 3.003 . . . . 0.0 114.281 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.651 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.4 Cg_exo -37.39 131.82 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.158 1 C-N-CA 125.475 4.116 . . . . 0.0 114.805 -171.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.68 -161.09 33.45 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.791 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -99.37 101.33 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.925 0.362 . . . . 0.0 111.025 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.481 ' OD1' HG11 ' A' ' 354' ' ' VAL . 31.6 m-80 -121.04 -179.64 4.09 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.075 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.989 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.62 141.88 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 11.8 mt -96.22 133.55 37.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.639 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -111.9 92.17 3.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 11.9 t -86.42 90.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.41 -91.87 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.063 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -116.31 -4.7 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.78 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -78.06 142.38 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 23.9 p-10 -153.81 141.49 19.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.773 0.32 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.1 t-80 -162.08 116.25 1.86 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.771 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.989 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -78.26 143.19 37.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.544 177.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.904 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.8 OUTLIER -154.32 148.01 25.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -85.42 123.46 30.9 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.651 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -105.73 144.86 31.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.017 0.437 . . . . 0.0 110.806 -176.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.219 -175.454 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.714 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 23.5 p90 -68.52 112.29 5.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.933 0.873 . . . . 0.0 110.6 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 15.3 t -159.21 -165.97 1.71 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.451 -172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.0 113.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 143.89 55.15 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.8 0.81 . . . . 0.0 111.06 -174.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 8.9 t70 -75.44 147.35 39.98 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.325 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.773 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.58 -12.82 11.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.964 -173.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.459 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.2 t -103.66 9.35 37.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.674 0.273 . . . . 0.0 111.399 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 9.5 mtpp -96.39 -23.98 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.773 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -101.31 158.5 16.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 111.227 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 154.77 46.54 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.11 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.526 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 22.6 m-90 -60.36 96.34 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.7 tttm -80.52 -37.94 30.64 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.89 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 67.3 ttt180 -157.81 111.37 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.752 174.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -59.4 155.79 34.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.979 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.742 ' HG3' HD12 ' A' ' 383' ' ' ILE . 30.7 Cg_exo -34.27 115.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 123.294 2.663 . . . . 0.0 113.68 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.2 m -141.75 138.35 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.707 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.66 131.74 8.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.061 0.458 . . . . 0.0 112.074 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.649 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.5 p -73.9 -25.28 59.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -176.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.58 -5.35 73.71 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.362 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -119.44 39.22 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 69.97 4.84 4.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.512 0.725 . . . . 0.0 111.977 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 2.7 p -121.54 -170.26 2.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.797 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.4 OUTLIER -127.95 153.63 37.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.985 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.976 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -135.53 157.41 39.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 8.2 ptm -138.19 158.4 44.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.89 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.1 mt-10 -122.24 135.49 54.76 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.587 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.2 OUTLIER -132.34 152.27 36.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 177.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.691 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.89 149.68 18.15 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.922 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.479 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.4 p90 -94.08 178.94 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.291 0.567 . . . . 0.0 110.853 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.4 p -131.68 -17.62 2.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.102 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -170.03 -51.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.306 -1.426 . . . . 0.0 114.119 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 336' ' ' ARG . 24.6 m -57.17 129.66 42.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.714 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 11.7 ptm180 -69.79 167.32 24.52 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 117.982 -1.008 . . . . 0.0 108.514 171.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.79 96.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 123.894 3.062 . . . . 0.0 115.235 -167.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 5.9 p -108.8 147.24 32.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.131 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.39 108.24 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.55 HD11 HG11 ' A' ' 385' ' ' VAL . 12.5 tt -89.49 123.82 65.82 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.559 -176.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.69 92.22 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.902 2.401 . . . . 0.0 112.669 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.68 HG11 HD13 ' A' ' 372' ' ' ILE . 30.1 m -108.78 125.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.676 0.751 . . . . 0.0 111.451 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -134.19 -177.42 4.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -148.86 135.07 19.28 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.972 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -107.88 173.23 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -112.69 115.12 28.06 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.616 -174.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 33.4 t60 57.93 45.82 17.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.381 0.61 . . . . 0.0 110.227 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.441 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.02 6.57 46.19 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.001 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.16 111.42 60.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 117.361 0.58 . . . . 0.0 111.158 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -76.55 47.85 2.22 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.602 2.868 . . . . 0.0 113.032 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.35 -53.36 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.28 113.73 44.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.031 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 28.3 t30 -70.23 108.71 4.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.749 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.657 HG12 HD22 ' A' ' 376' ' ' LEU . 33.3 m -90.94 10.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.127 -175.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.459 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.23 84.37 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.116 0.484 . . . . 0.0 111.436 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.724 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 71.2 mtp -98.85 88.97 4.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 47.5 mt -76.66 120.76 22.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.157 -167.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.729 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -68.75 -16.9 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 91.5 m -135.19 87.73 27.75 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.906 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.57 40.36 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.127 2.551 . . . . 0.0 114.307 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.09 68.57 1.83 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.172 0.511 . . . . 0.0 111.389 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.502 ' HG3' HG21 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -85.48 135.59 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.444 2.096 . . . . 0.0 113.081 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.0 OUTLIER -129.72 146.85 51.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.679 174.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.651 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 29.0 mtm -94.61 104.98 16.92 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.315 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.6 -166.36 1.37 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.284 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -67.14 -10.59 51.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.147 0.499 . . . . 0.0 110.629 171.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.6 ' N ' HD22 ' A' ' 366' ' ' ASN . 47.0 m-20 -86.89 -7.03 58.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 90.27 -161.04 28.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -166.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -62.94 -19.77 61.55 Favored Glycine 0 C--N 1.322 -0.223 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.778 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 73.8 -124.68 8.71 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -112.06 127.0 55.77 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.68 HD13 HG11 ' A' ' 342' ' ' VAL . 1.0 OUTLIER -114.91 125.55 72.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.976 ' HG2' HG12 ' A' ' 327' ' ' VAL . 36.2 mt-10 -101.79 134.18 45.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.797 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -153.19 160.51 42.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.98 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 178.87 170.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.367 0.417 . . . . 0.0 110.725 177.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.854 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 7.8 tp -161.88 157.35 20.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.854 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 53.4 Cg_exo -39.25 131.74 1.46 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.342 2.028 . . . . 0.0 112.304 169.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.866 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.3 Cg_exo -38.05 129.49 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 125.297 3.998 . . . . 0.0 114.946 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 174.41 -133.57 2.55 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.589 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.67 101.59 7.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.289 0.236 . . . . 0.0 110.561 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.405 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 7.4 m120 -112.35 161.89 16.15 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.088 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.02 138.71 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.742 HD12 ' HG3' ' A' ' 318' ' ' PRO . 27.8 mt -94.65 132.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.376 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -109.03 91.71 3.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.2 t -83.88 84.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.34 -88.54 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.055 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.42 -14.17 13.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.226 0.536 . . . . 0.0 109.723 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.702 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -68.33 147.19 52.48 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.602 175.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 24.9 p-10 -156.76 140.31 15.87 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.669 0.271 . . . . 0.0 110.66 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.3 t60 -165.88 115.2 0.99 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.546 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.088 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 44.5 tt0 -85.05 146.54 27.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.048 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.589 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.7 OUTLIER -147.97 150.03 33.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.35 132.78 36.46 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.952 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -126.73 142.7 51.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 -177.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 12.3 ptmm? . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.656 -0.688 . . . . 0.0 110.773 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.889 0.376 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.1 p90 -64.43 130.44 43.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.499 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.7 t 178.73 -166.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.83 114.65 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 143.0 56.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.702 0.763 . . . . 0.0 110.757 -173.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' ' HG2' ' A' ' 309' ' ' LYS . 5.8 t70 -86.48 150.57 24.18 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.693 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.703 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 23.4 pttm -52.03 -23.2 4.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.521 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 9.0 t -100.92 10.42 41.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.55 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 26.7 mmmt -92.5 -25.09 18.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.7 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.4 OUTLIER -112.44 157.9 20.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.323 0.582 . . . . 0.0 112.153 -176.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -133.92 158.18 44.11 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.717 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.463 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.7 m-90 -62.28 111.81 2.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.373 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.485 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -104.12 -40.3 6.21 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.212 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.818 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 32.5 ttm180 -158.74 129.94 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.419 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.28 163.11 70.58 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.234 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 3.0 Cg_exo -37.03 120.41 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.3 m -136.24 134.8 38.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.526 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -48.14 124.12 7.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.107 0.48 . . . . 0.0 110.946 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.1 p -65.17 -22.88 66.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.189 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.65 34.12 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -99.61 -71.89 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -175.06 21.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.912 0.863 . . . . 0.0 108.952 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.7 p -137.69 -169.18 2.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.418 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.516 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -127.54 151.37 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.234 0.54 . . . . 0.0 111.633 -177.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.4 m -136.6 142.42 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.608 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 9.8 ptm -128.18 164.33 22.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.015 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.5 tt0 -126.46 126.07 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.048 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.42 153.07 32.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.397 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -126.28 144.0 14.78 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.431 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.408 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 1.3 p90 -91.07 179.18 5.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.252 0.549 . . . . 0.0 111.286 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.4 p -143.24 -7.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.868 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 179.14 -3.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 118.648 -1.739 . . . . 0.0 116.068 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 26.5 m -107.62 124.65 50.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.258 1.029 . . . . 0.0 110.57 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.823 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 9.3 ptm180 -70.73 168.79 17.49 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.399 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.799 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.3 OUTLIER -25.36 94.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 124.259 3.306 . . . . 0.0 114.712 -169.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 363' ' ' THR . 7.0 p -112.77 152.16 29.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.936 -174.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -74.48 106.27 6.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 362' ' ' PRO . 14.1 tt -81.89 129.24 65.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.444 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.37 81.58 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.802 HG11 HD13 ' A' ' 372' ' ' ILE . 15.6 m -102.28 119.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.691 0.758 . . . . 0.0 111.216 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -132.46 -178.68 5.03 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.36 139.14 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.891 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.474 HG22 HD12 ' A' ' 382' ' ' ILE . 11.0 m -111.22 168.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.55 114.52 28.73 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.119 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 50.7 t60 52.9 54.87 9.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.801 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.727 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 62.79 15.84 55.44 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.988 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 46.2 t -118.37 109.64 40.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 117.438 0.619 . . . . 0.0 111.222 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.15 50.27 2.18 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.229 2.619 . . . . 0.0 112.658 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.78 -53.87 3.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.71 115.3 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.298 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -63.26 108.78 1.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.9 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.566 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.6 m -93.93 7.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.034 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.42 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.41 83.27 6.26 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.427 0.632 . . . . 0.0 110.652 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.726 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 46.1 ttp -99.35 90.97 4.73 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.5 mt -71.66 125.1 26.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.532 -167.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 5.1 mm -68.46 -24.06 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.7 m -132.25 91.75 30.71 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.995 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.61 44.16 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.226 2.617 . . . . 0.0 114.057 -169.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.0 67.86 0.8 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.228 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.552 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.1 Cg_endo -82.74 133.63 7.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.229 1.952 . . . . 0.0 113.032 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -120.82 144.21 48.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.168 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 39.3 mtm -95.59 119.92 34.93 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.73 -167.01 1.53 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 124.41 1.069 . . . . 0.0 110.906 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.605 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -66.27 -11.72 52.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.892 176.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.605 ' N ' HD22 ' A' ' 366' ' ' ASN . 82.6 m-20 -99.23 0.23 42.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 109.506 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.24 -162.38 19.95 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -73.73 -16.71 79.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.276 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 67.15 -120.27 13.31 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.4 p90 -120.29 141.2 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.48 0.657 . . . . 0.0 110.902 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.802 HD13 HG11 ' A' ' 342' ' ' VAL . 4.0 mt -115.3 154.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.839 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.759 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 41.9 mt-10 -120.36 128.43 53.23 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.819 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.56 162.62 38.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.633 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.804 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 175.74 158.92 0.25 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.004 0.366 . . . . 0.0 110.983 172.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.783 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.0 tp -154.4 149.67 20.74 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 166.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.783 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 33.5 Cg_exo -27.06 125.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.918 3.078 . . . . 0.0 113.522 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -37.53 133.04 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.66 3.573 . . . . 0.0 114.493 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.72 -128.66 1.66 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.268 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.91 100.87 7.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 110.848 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.424 ' OD1' ' HG3' ' A' ' 394' ' ' GLN . 8.0 m120 -112.56 125.25 54.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 0.0 109.684 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.05 131.76 72.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.8 mt -92.32 128.92 43.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.189 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 91.95 3.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.007 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.4 t -83.56 78.28 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.41 -82.63 0.08 OUTLIER Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.423 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.703 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 22.3 t70 -106.35 -28.95 10.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.7 mp -63.67 149.43 46.6 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.525 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.7 p30 -163.12 143.12 8.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.245 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -164.95 118.44 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.2 tm0? -81.54 140.48 34.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.57 -178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.591 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 3.5 t-105 -149.54 147.47 28.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.736 172.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -95.04 119.16 33.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.591 ' OE1' ' HD1' ' A' ' 392' ' ' TRP . 4.3 mm100 -85.12 114.44 22.25 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.329 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.271 0.558 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 42.6 p90 -62.43 121.52 13.46 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.339 0.59 . . . . 0.0 110.128 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.1 t -176.37 -172.11 0.45 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.56 105.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 340' ' ' ILE . 0.5 OUTLIER -70.35 155.08 41.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.621 -168.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.3 t70 -73.32 141.12 47.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.94 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 387' ' ' ASP . 24.3 pttt -50.95 -27.54 7.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.502 -1.681 . . . . 0.0 114.406 -172.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.427 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.9 t -105.21 7.25 33.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -169.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 27.2 mtpp -84.42 -22.65 30.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.443 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -82.63 157.0 23.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.992 0.425 . . . . 0.0 109.894 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -123.29 134.38 54.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.995 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.569 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 31.5 m-90 -50.99 96.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.595 168.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -96.39 -30.2 13.52 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 14.8 ttt180 -164.43 113.64 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.107 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.527 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.09 164.48 17.72 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.2 Cg_exo -39.41 118.35 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.634 2.222 . . . . 0.0 111.86 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 22.5 m -130.8 135.14 47.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.21 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.53 127.0 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.9 p -69.2 -16.13 63.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.16 72.87 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 69.5 t60 -108.14 -52.98 2.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.307 -178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 29.6 t70 166.18 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.467 1.127 . . . . 0.0 108.111 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.9 p -93.92 -170.94 2.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.661 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.95 151.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.723 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.0 m -136.04 144.48 33.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.249 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.744 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -127.58 150.62 49.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 2.6 tt0 -122.13 124.95 45.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.992 0.425 . . . . 0.0 110.514 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.744 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -122.45 150.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.363 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.52 160.43 15.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 172.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.449 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.5 p90 -106.52 178.16 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.078 0.939 . . . . 0.0 110.38 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -133.46 -13.15 2.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.16 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.95 -26.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.201 -1.476 . . . . 0.0 114.695 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.638 ' HB ' ' HE2' ' A' ' 364' ' ' MET . 19.8 m -82.7 135.81 34.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.632 0.716 . . . . 0.0 111.566 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.618 ' O ' HG22 ' A' ' 335' ' ' THR . 9.1 ptt180 -78.71 177.73 2.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -27.38 97.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.775 2.983 . . . . 0.0 114.807 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.841 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 18.1 p -110.24 166.74 10.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.719 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.77 99.3 12.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.613 HG22 HG13 ' A' ' 342' ' ' VAL . 46.1 mt -74.67 120.82 83.41 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.229 -172.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.33 80.27 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.227 1.952 . . . . 0.0 111.661 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.657 HG11 HD13 ' A' ' 372' ' ' ILE . 9.5 m -99.57 133.26 43.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.088 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.99 -178.07 5.52 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -155.24 135.29 12.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.77 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 382' ' ' ILE . 15.8 m -111.13 163.24 8.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.75 114.53 28.86 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.493 -174.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 10.9 t-80 53.9 52.16 13.46 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.486 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 65.8 5.7 26.36 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.888 -0.596 . . . . 0.0 114.188 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 110.6 61.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.391 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.65 54.58 4.84 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.079 2.519 . . . . 0.0 112.091 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.3 -47.72 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.49 0.662 . . . . 0.0 109.55 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.24 119.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.35 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -62.58 109.44 1.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.129 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.659 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 14.1 m -91.58 12.85 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -84.69 81.82 8.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 13.1 tpt -101.15 86.33 3.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 170.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 36.9 mt -70.82 126.26 29.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.615 -167.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -71.67 -17.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 15.6 m -140.08 91.46 10.12 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.505 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.44 41.35 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.091 2.527 . . . . 0.0 112.946 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -155.68 61.01 2.67 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.58 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -81.34 135.31 9.41 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.271 1.981 . . . . 0.0 112.935 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 25.2 p -131.3 133.65 45.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.717 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.85 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 25.7 ptt? -95.68 131.33 42.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.624 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 29.7 mt-10 -114.52 -165.1 0.98 Allowed 'General case' 0 C--N 1.321 -0.666 0 O-C-N 124.874 1.359 . . . . 0.0 110.318 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.585 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -62.01 -7.82 4.42 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.009 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.585 ' N ' HD22 ' A' ' 366' ' ' ASN . 6.8 p30 -105.81 -3.99 21.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.577 0.703 . . . . 0.0 109.547 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 -166.22 17.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.85 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.15 -9.68 64.12 Favored Glycine 0 CA--C 1.51 -0.266 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.246 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.3 -126.35 30.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 111.361 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.657 HD13 HG11 ' A' ' 342' ' ' VAL . 2.8 mt -111.71 131.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.062 173.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.723 ' HG2' HG12 ' A' ' 327' ' ' VAL . 45.5 mt-10 -104.16 132.08 50.78 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.135 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.8 ppp? -148.52 161.99 40.53 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.918 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.35 159.03 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.69 0.281 . . . . 0.0 110.953 173.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 354' ' ' VAL . 0.5 OUTLIER -164.98 143.92 5.52 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.653 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.2 Cg_exo -24.02 129.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.638 3.559 . . . . 0.0 114.689 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.542 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.6 Cg_exo -36.97 128.61 0.52 Allowed 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 125.583 4.189 . . . . 0.0 114.942 -171.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.09 -152.63 21.95 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.7 m-20 -98.45 101.23 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.974 0.887 . . . . 0.0 110.677 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -96.75 123.81 40.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.975 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -118.54 129.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.5 mt -92.71 133.62 33.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.46 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -107.16 91.82 3.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.358 176.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.5 t -79.36 77.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.82 -83.6 0.48 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 309' ' ' LYS . 20.3 t70 -116.26 -19.96 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.343 0.592 . . . . 0.0 109.55 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.5 OUTLIER -60.28 145.35 47.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.229 173.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.463 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.5 p30 -155.41 143.79 20.27 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.591 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.532 ' H ' HG12 ' A' ' 382' ' ' ILE . 2.3 t60 -173.31 123.75 0.39 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.285 0.366 . . . . 0.0 111.271 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.975 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.5 mt-30 -71.58 153.21 42.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.446 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 22.6 t-105 -151.36 119.84 6.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.859 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -74.65 113.25 11.7 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.37 147.54 36.18 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.468 -175.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.286 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 335' ' ' THR . 4.2 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.443 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.7 p90 -57.43 128.53 37.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.202 0.525 . . . . 0.0 110.998 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.0 t -177.42 -171.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.8 105.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.749 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.9 OUTLIER -79.06 161.7 26.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.818 0.818 . . . . 0.0 112.766 -171.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.0 t70 -78.39 155.73 29.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.935 -178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.747 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -76.83 -14.64 59.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.904 -172.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.4 t -91.19 2.74 56.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.137 0.494 . . . . 0.0 111.192 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.749 ' HD3' ' HB2' ' A' ' 307' ' ' CYS . 5.5 mtpm? -81.3 -44.43 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.981 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.747 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -84.88 159.37 20.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.466 0.651 . . . . 0.0 111.853 -172.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 t -140.04 147.84 40.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.2 m-90 -52.7 101.59 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.493 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.671 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.1 tttp -90.01 -45.5 9.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 77.9 ttt180 -152.75 118.97 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.692 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.83 162.82 49.0 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.39 -175.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.675 ' HG2' ' O ' ' A' ' 390' ' ' HIS . 53.4 Cg_exo -30.79 116.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.703 2.935 . . . . 0.0 113.558 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 52.9 m -127.9 124.84 38.4 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.98 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.27 127.02 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.212 0.53 . . . . 0.0 109.88 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.416 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.5 p -68.41 -21.55 64.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 -174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.69 -0.19 86.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.514 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -112.38 28.82 8.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 11.7 t70 64.09 24.83 13.61 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.84 0.829 . . . . 0.0 110.05 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.411 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.5 p -140.1 -171.72 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.203 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.887 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -129.71 155.66 41.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 118.201 0.455 . . . . 0.0 111.665 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -141.2 144.98 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.354 175.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.531 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 13.1 ptm -136.62 167.0 22.23 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.465 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 26.8 tt0 -133.34 128.33 35.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.282 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.07 157.58 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.937 0.399 . . . . 0.0 111.842 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.92 153.02 17.57 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -95.01 178.78 5.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.342 0.571 . . . . 0.0 110.697 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.1 t -162.86 35.8 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.28 -92.46 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.241 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.659 ' HB ' ' HE3' ' A' ' 311' ' ' LYS . 21.5 m -54.67 134.42 47.13 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.182 0.593 . . . . 0.0 111.966 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.808 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.6 ptt180 -72.14 -177.58 0.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.125 172.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.808 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.64 94.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.852 3.035 . . . . 0.0 114.588 -173.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.8 p -116.05 158.06 23.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.788 -172.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -74.84 97.14 3.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.494 HG12 HG13 ' A' ' 342' ' ' VAL . 10.5 tt -77.34 122.85 86.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -173.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 82.66 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.772 2.314 . . . . 0.0 112.466 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.563 HG12 HG13 ' A' ' 385' ' ' VAL . 13.1 m -105.76 120.14 56.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.319 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 19.1 ptt180 -129.32 -175.29 3.53 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.16 147.56 21.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.586 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 382' ' ' ILE . 4.9 m -123.32 170.98 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.49 39.27 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.226 -173.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 32.8 t60 56.46 42.4 27.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.261 0.553 . . . . 0.0 110.47 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 67.07 9.94 55.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.423 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.78 107.84 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.115 0.458 . . . . 0.0 110.724 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.3 52.98 2.46 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.431 2.754 . . . . 0.0 112.644 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -97.59 -53.52 3.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.73 115.16 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.237 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.5 t30 -60.0 108.4 0.76 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.033 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.895 ' HA ' HD22 ' A' ' 376' ' ' LEU . 33.7 m -93.01 9.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.449 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -82.57 82.2 8.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.689 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.0 ttp -103.57 93.27 4.84 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 44.1 mt -76.33 125.94 30.09 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.66 -163.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -68.13 -23.62 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 11.9 m -126.4 90.21 50.47 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.82 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 89.2 Cg_endo -85.77 33.57 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.28 2.653 . . . . 0.0 114.317 -167.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -167.6 63.04 0.63 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.317 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.48 ' O ' HG22 ' A' ' 340' ' ' ILE . 61.4 Cg_endo -81.55 139.64 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.31 2.007 . . . . 0.0 113.049 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 20.4 p -124.15 133.01 53.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.73 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 6.5 ptp -95.18 125.1 39.59 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 25.9 mt-10 -81.28 -169.48 2.29 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.471 1.107 . . . . 0.0 111.21 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -73.93 -4.56 35.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.047 175.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 366' ' ' ASN . 15.6 m120 -100.95 -14.61 17.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.355 0.598 . . . . 0.0 109.659 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.0 -169.85 16.15 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.465 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -77.68 -22.53 69.36 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.545 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.64 -118.45 11.66 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -114.77 143.39 45.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.211 0.529 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 3.1 mt -123.9 159.29 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.735 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 45.4 mt-10 -126.99 134.74 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.732 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.731 ' HG2' ' HB ' ' A' ' 326' ' ' VAL . 0.2 OUTLIER -149.57 169.81 20.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.977 -175.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.857 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 172.63 155.39 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.159 0.504 . . . . 0.0 111.679 170.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.029 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -160.43 153.53 18.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 165.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 1.029 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 46.9 Cg_exo -16.52 125.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 1 C-N-CA 125.468 4.112 . . . . 0.0 115.843 -175.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 395' ' ' LYS . 60.7 Cg_exo -40.17 139.84 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.692 3.595 . . . . 0.0 114.092 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 393' ' ' PHE . . . 138.93 -163.4 25.91 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -76.4 100.04 5.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.347 0.573 . . . . 0.0 111.239 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -112.75 129.62 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.083 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.99 135.25 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 -179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.64 HD12 ' HG3' ' A' ' 318' ' ' PRO . 25.4 mt -96.1 133.65 36.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.926 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.539 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -109.77 91.39 3.63 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.887 175.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -81.84 87.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.97 -95.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.352 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.02 0.84 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.101 0.477 . . . . 0.0 110.549 175.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -75.41 148.28 39.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.1 p30 -159.63 149.12 18.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.568 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.675 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 4.2 t60 -170.81 119.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.849 173.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.083 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.7 tt0 -82.64 134.16 35.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.738 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.539 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.1 t-105 -140.01 143.75 36.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.462 175.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 379' ' ' GLY . 55.8 t80 -87.82 108.24 19.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.887 HE22 HG13 ' A' ' 326' ' ' VAL . 5.6 mm100 -72.82 144.35 47.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.586 ' HA ' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.494 -173.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.677 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 21.8 p90 -60.67 129.6 42.36 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.0 t 178.55 -169.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 59.5 t -60.5 110.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 168.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 142.77 56.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.795 0.807 . . . . 0.0 111.108 -170.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.402 ' OD2' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -76.81 148.6 36.49 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.111 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.77 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.27 -13.23 17.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.935 -172.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.402 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.8 t -101.14 -0.61 35.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.503 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 28.5 mmmt -78.4 -36.45 45.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.837 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -89.93 157.57 17.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.266 0.555 . . . . 0.0 111.606 -177.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.1 t -142.48 147.5 36.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.02 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -60.28 110.73 1.31 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.395 0.617 . . . . 0.0 112.159 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.543 ' HE3' ' OE1' ' A' ' 329' ' ' GLU . 65.3 tttp -93.54 -34.42 13.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.492 170.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.971 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 64.8 ttt180 -164.33 119.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.91 157.38 75.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.991 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -40.36 117.54 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.395 2.73 . . . . 0.0 112.587 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.1 m -134.18 132.46 39.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.922 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.53 124.83 13.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 111.096 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.522 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.6 p -57.79 -30.45 65.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.974 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.86 -2.57 41.53 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -105.4 -73.26 0.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -165.87 15.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.607 0.717 . . . . 0.0 109.665 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.712 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 12.3 p -137.69 -166.79 2.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.541 -172.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -126.62 153.17 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.517 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 17.3 m -135.91 145.66 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.566 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 17.4 ptt? -135.43 169.59 17.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.971 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 14.0 mt-10 -138.04 136.4 36.8 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.345 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.67 151.07 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.3 155.12 16.33 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.787 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -101.97 -179.84 4.12 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 110.974 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.4 p -137.49 -41.13 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.635 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -156.07 4.58 0.2 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.158 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.503 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 33.1 m -113.12 127.03 56.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 117.425 0.612 . . . . 0.0 110.13 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.708 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 14.2 ptm180 -73.38 171.2 11.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.048 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.78 95.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.202 3.268 . . . . 0.0 114.608 -170.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . . . . . . . . . 6.0 p -112.14 154.34 25.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.969 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.4 mmt180 -74.57 107.83 6.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.672 HG22 HG13 ' A' ' 342' ' ' VAL . 38.8 mm -82.82 119.89 75.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.4 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.63 82.5 2.1 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.67 2.246 . . . . 0.0 112.088 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.672 HG13 HG22 ' A' ' 340' ' ' ILE . 13.9 m -101.5 124.94 55.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.575 0.702 . . . . 0.0 110.879 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.78 -175.38 4.01 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -153.41 144.62 23.03 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.323 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.65 164.56 15.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -96.83 114.34 25.97 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.126 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 39.25 63.88 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.633 0.773 . . . . 0.0 112.651 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.494 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.45 7.99 42.97 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.644 -0.707 . . . . 0.0 114.669 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.66 113.06 47.9 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 117.864 0.832 . . . . 0.0 111.557 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.15 62.19 5.93 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.198 2.599 . . . . 0.0 111.785 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.591 ' HG2' HG12 ' A' ' 352' ' ' VAL . 15.2 tt0 -86.65 -43.56 12.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.158 0.98 . . . . 0.0 108.939 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 351' ' ' GLU . 1.5 p -158.17 122.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.34 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -51.23 108.5 0.26 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.331 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 1.007 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.44 7.98 4.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.825 -176.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -82.66 84.18 7.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.182 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.97 84.9 2.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 40.2 mt -68.05 129.55 40.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.166 -165.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.678 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.5 mm -72.62 -23.96 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.2 m -131.52 88.26 43.89 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.715 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.66 53.13 3.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.16 2.573 . . . . 0.0 113.336 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -168.02 69.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.882 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' A' ' 372' ' ' ILE . 45.7 Cg_endo -91.1 136.29 1.98 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.552 2.168 . . . . 0.0 112.65 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.1 p -132.42 144.95 50.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.452 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.607 ' HG3' HD11 ' A' ' 340' ' ' ILE . 56.2 mtm -95.95 116.62 29.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.517 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 31.9 mt-10 -104.15 -165.68 1.17 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.386 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.651 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -59.11 -13.08 5.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.886 0.375 . . . . 0.0 111.769 175.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . 0.651 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.2 p30 -103.83 -2.07 26.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.366 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.6 -160.71 22.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 364' ' ' MET . . . -77.27 -11.84 85.15 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.823 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 65.61 -124.03 26.03 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -125.87 147.47 49.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.869 0.366 . . . . 0.0 110.092 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.0 OUTLIER -128.5 160.46 38.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.678 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 61.4 mt-10 -123.4 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.674 0.273 . . . . 0.0 110.284 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -153.29 154.6 34.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.913 -174.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.889 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -173.03 167.53 4.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.978 171.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.007 ' HG ' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -168.21 178.08 1.15 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.169 174.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.703 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 52.0 Cg_exo -36.1 131.24 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.748 2.299 . . . . 0.0 113.65 174.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.91 137.39 52.37 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.676 2.918 . . . . 0.0 113.16 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.06 -176.85 29.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.156 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.658 ' HB3' HE21 ' A' ' 391' ' ' GLN . 12.7 m-20 -74.33 101.15 3.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.206 0.202 . . . . 0.0 111.116 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.559 ' CG ' HD11 ' A' ' 376' ' ' LEU . 38.9 m-80 -123.39 153.54 40.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.262 0.553 . . . . 0.0 110.96 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.96 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -134.45 139.89 46.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 -176.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 374' ' ' MET . 20.8 mt -94.18 132.89 36.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -109.62 92.66 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.026 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.78 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.4 t -79.99 76.35 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.69 -81.93 0.16 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.224 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.77 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 31.7 t70 -113.44 -12.27 12.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.449 0.642 . . . . 0.0 109.562 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.8 mp -78.32 148.37 33.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.216 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 4.4 p-10 -155.99 140.82 17.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.781 0.324 . . . . 0.0 111.214 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.409 ' H ' HG12 ' A' ' 382' ' ' ILE . 18.3 t-80 -166.28 123.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.624 171.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.96 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 43.4 tt0 -86.84 152.19 22.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.184 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.504 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.0 OUTLIER -159.45 142.94 14.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.672 175.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.3 p90 -90.77 108.06 19.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.755 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.889 ' HG3' HE22 ' A' ' 375' ' ' GLN . 0.1 OUTLIER -70.29 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.544 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 C--O 1.247 0.956 0 O-C-N 124.371 1.044 . . . . 0.0 110.51 -179.286 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -62.36 124.4 20.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.341 0.591 . . . . 0.0 111.416 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -174.32 -169.83 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.36 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.43 106.56 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.2 149.02 43.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.698 0.761 . . . . 0.0 112.191 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' A' ' 310' ' ' THR . 21.2 t0 -72.28 146.51 47.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.129 -178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.76 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.35 -13.28 60.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.949 -167.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -97.0 4.1 51.66 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.981 -0.45 . . . . 0.0 112.035 -175.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.817 ' HE3' ' HA3' ' A' ' 334' ' ' GLY . 34.1 mttp -89.2 -28.56 19.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.76 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -84.57 156.47 21.6 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.808 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.3 t -141.36 145.27 35.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.554 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.1 m-90 -56.06 104.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.269 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.554 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.3 tttt -97.17 -42.88 7.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 38.9 ttt180 -152.55 123.01 7.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.605 173.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -65.74 163.94 31.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.48 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 2.8 Cg_exo -38.52 107.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.39 2.727 . . . . 0.0 112.373 176.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.8 m -115.97 128.49 55.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.296 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -49.23 125.71 11.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.378 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.0 p -70.96 -20.19 62.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -173.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.55 -2.31 70.24 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -171.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.82 27.96 8.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.458 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 64.09 21.16 12.48 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.658 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.439 ' HA ' ' OE1' ' A' ' 375' ' ' GLN . 6.6 p -129.53 -168.53 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.452 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.662 HG13 HE22 ' A' ' 394' ' ' GLN . 0.1 OUTLIER -132.21 150.22 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.339 0.59 . . . . 0.0 112.317 -175.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.76 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -138.56 138.08 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.62 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 14.2 ptm -127.55 162.8 25.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.548 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 30.2 tt0 -126.33 127.96 46.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.76 147.43 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.183 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -106.01 147.8 16.32 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.31 179.03 4.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.121 0.961 . . . . 0.0 110.355 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.8 p -152.48 30.72 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.68 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.817 ' HA3' ' HE3' ' A' ' 311' ' ' LYS . . . -170.96 -83.28 0.05 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.876 -1.155 . . . . 0.0 113.764 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 303' ' ' THR . 12.9 m -69.52 128.46 36.59 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.111 0.565 . . . . 0.0 112.424 -172.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.755 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -67.1 176.1 1.27 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.147 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -24.88 93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.043 3.162 . . . . 0.0 114.538 -171.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 363' ' ' THR . 27.6 p -111.62 166.34 11.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.053 -171.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -87.43 96.81 10.51 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 362' ' ' PRO . 12.4 tt -80.44 126.03 79.6 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.295 -171.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.31 93.98 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.96 2.44 . . . . 0.0 112.331 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 372' ' ' ILE . 16.7 m -115.01 120.98 66.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.699 0.761 . . . . 0.0 111.384 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 29.8 ptt180 -132.63 -174.35 3.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.53 149.38 22.22 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.723 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -122.9 170.28 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.79 114.85 28.28 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.215 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 17.9 p80 40.04 57.07 2.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.847 . . . . 0.0 112.587 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.681 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 79.71 -10.42 38.7 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.164 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.48 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 27.5 t -101.91 114.01 65.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.307 0.554 . . . . 0.0 111.226 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.6 Cg_exo -77.14 38.67 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 123.466 2.777 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.44 -54.29 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.81 112.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.941 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 36.7 t30 -55.11 108.07 0.37 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.502 171.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.643 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 35.9 m -93.23 8.64 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.142 0.496 . . . . 0.0 111.159 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.436 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -80.83 82.81 6.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.378 0.609 . . . . 0.0 110.554 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.758 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.1 ttt -102.32 82.26 2.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 30.9 mt -64.26 130.11 42.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.862 -167.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -70.38 -26.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 360' ' ' PRO . 6.3 m -131.83 95.95 21.56 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.452 172.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 357' ' ' LEU . 4.1 Cg_endo -86.05 27.21 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.524 2.816 . . . . 0.0 113.523 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -147.88 64.32 8.24 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.123 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 340' ' ' ILE . 90.0 Cg_endo -82.66 144.65 12.61 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.532 2.155 . . . . 0.0 112.884 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 11.4 p -128.55 142.57 51.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.068 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.846 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 56.7 mtp -95.39 110.58 22.59 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.01 -171.29 1.94 Allowed 'General case' 0 C--N 1.32 -0.704 0 O-C-N 124.403 1.065 . . . . 0.0 111.24 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.512 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -66.81 -6.61 16.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.779 174.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -110.84 -6.75 14.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.229 0.537 . . . . 0.0 109.972 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.64 -171.92 14.13 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -64.68 -14.97 59.06 Favored Glycine 0 N--CA 1.458 0.127 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.532 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 72.03 -106.26 1.88 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 328' ' ' MET . 20.8 m-85 -132.33 135.91 46.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.285 0.564 . . . . 0.0 110.996 175.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.794 HD13 HG11 ' A' ' 342' ' ' VAL . 4.7 mt -115.32 136.53 51.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.343 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.76 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -106.7 128.63 54.36 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.198 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.692 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -144.64 163.14 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.047 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.761 HE21 ' H ' ' A' ' 376' ' ' LEU . 29.5 tp60 -176.05 152.08 1.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 110.036 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.828 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.0 OUTLIER -151.78 140.42 13.54 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 170.318 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.828 ' HD2' HD22 ' A' ' 376' ' ' LEU . 27.4 Cg_exo -19.97 130.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 125.144 3.896 . . . . 0.0 114.781 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -37.92 131.91 0.81 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.82 3.68 . . . . 0.0 114.38 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.85 -167.77 32.21 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.295 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 8.1 m-20 -80.57 100.12 8.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.913 0.356 . . . . 0.0 110.899 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 376' ' ' LEU . 21.5 m-80 -111.57 138.72 47.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.986 0.422 . . . . 0.0 110.249 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -135.76 136.42 50.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.612 HD11 ' HG2' ' A' ' 374' ' ' MET . 39.5 mt -95.25 130.78 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.086 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.674 175.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 6.7 t -84.87 81.9 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.75 -91.15 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.144 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.655 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 6.3 t70 -98.55 -18.89 17.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.613 0.721 . . . . 0.0 109.395 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.3 mp -76.44 148.85 37.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -154.77 137.21 15.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.036 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -164.59 123.73 1.86 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.751 0.31 . . . . 0.0 110.484 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.938 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -90.3 141.2 28.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.519 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.519 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.2 t-105 -144.64 137.01 26.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.006 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.8 p90 -80.6 110.25 15.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.947 -0.471 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.662 HE22 HG13 ' A' ' 326' ' ' VAL . 5.8 mm100 -74.04 102.27 4.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 395' ' ' LYS . 12.1 ttpp . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.752 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 335' ' ' THR . 2.9 t . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -59.89 126.76 28.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.194 0.521 . . . . 0.0 109.871 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.8 t -179.24 -174.76 0.34 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.3 106.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.52 155.55 40.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.972 0.892 . . . . 0.0 112.608 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.606 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.1 t70 -81.01 140.65 35.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.106 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -60.41 -21.72 62.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.62 -173.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.637 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.6 t -87.05 -4.56 59.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.828 0.346 . . . . 0.0 111.46 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -93.92 16.5 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.814 ' HE2' HG12 ' A' ' 385' ' ' VAL . 1.3 m-85 -102.38 170.66 7.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.675 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -165.65 131.9 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.396 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.459 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -51.68 120.33 5.11 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.398 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 21.3 tptm -110.14 -48.67 3.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.583 172.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 10.6 ttm180 -156.1 127.96 7.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.113 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.14 155.67 93.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.823 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.492 ' HG3' HD12 ' A' ' 383' ' ' ILE . 84.1 Cg_exo -33.08 113.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.832 3.021 . . . . 0.0 113.153 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 20.3 m -128.95 135.06 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.055 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -44.96 124.66 4.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.612 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.5 p -71.47 -22.07 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.67 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.39 -2.62 74.56 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -121.89 33.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.88 16.68 8.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.823 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.554 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 8.5 p -124.23 -168.85 1.86 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.741 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.37 146.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.417 -177.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 14.8 m -128.51 138.83 53.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.101 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 16.4 ptt? -121.55 154.87 36.13 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 23.0 tt0 -114.28 127.66 55.98 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 385' ' ' VAL . 8.4 m -130.43 136.57 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.881 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -111.98 143.39 17.44 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.657 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.686 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.7 OUTLIER -141.44 163.03 34.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 366' ' ' ASN . 49.4 m -153.51 65.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.507 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -165.0 -50.71 0.02 OUTLIER Glycine 0 C--O 1.226 -0.356 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.743 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.847 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 23.3 m -98.6 142.72 29.83 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 122.85 -0.206 . . . . 0.0 110.863 -175.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 15.3 ptt180 -79.38 168.65 24.94 Favored Pre-proline 0 CA--C 1.527 0.08 0 CA-C-O 117.729 -1.129 . . . . 0.0 108.485 171.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -26.55 96.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.999 3.133 . . . . 0.0 114.449 -170.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.66 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 28.8 p -116.09 164.93 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.477 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -85.31 96.97 9.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 362' ' ' PRO . 12.1 pt -79.77 130.15 68.38 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.297 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . 0.661 ' HD2' ' HZ ' ' A' ' 312' ' ' PHE . 63.9 Cg_endo -75.29 81.94 2.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.725 2.283 . . . . 0.0 112.021 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.717 HG12 HG13 ' A' ' 385' ' ' VAL . 10.5 m -100.22 116.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.993 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.4 ptt180 -126.61 179.82 5.15 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.431 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -152.06 139.78 19.84 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.818 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.15 171.4 7.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.927 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.59 116.45 32.62 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.454 ' HA ' ' CD ' ' A' ' 391' ' ' GLN . 8.9 p-80 41.04 59.68 2.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.515 0.726 . . . . 0.0 112.703 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.735 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.2 6.4 32.65 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.28 116.59 44.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.591 0.695 . . . . 0.0 111.045 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.09 55.98 3.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.198 2.599 . . . . 0.0 111.753 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.59 -52.22 5.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.64 123.0 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.283 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.76 107.74 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 376' ' ' LEU . 32.0 m -92.2 9.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.634 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.431 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -81.25 83.65 6.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.45 84.63 2.22 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.7 mt -74.02 128.32 35.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.816 -165.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 1.9 mm -75.94 -19.42 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.5 m -121.74 81.91 41.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.165 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.23 32.57 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.27 2.647 . . . . 0.0 114.156 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -177.01 70.78 0.23 Allowed Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.62 ' HB2' HD11 ' A' ' 340' ' ' ILE . 45.1 Cg_endo -88.19 136.75 3.55 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.503 2.136 . . . . 0.0 113.587 -176.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 40.5 p -118.1 130.59 56.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.545 175.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.847 ' HE3' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -99.51 143.59 29.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 31.3 mt-10 -95.04 -179.35 4.79 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.626 0.579 . . . . 0.0 109.941 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 333' ' ' SER . 0.1 OUTLIER -56.05 -24.79 41.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.49 -3.23 18.3 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.095 -0.378 . . . . 0.0 111.592 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.686 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 144.62 177.05 19.16 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.265 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -97.53 -16.19 35.09 Favored Glycine 0 CA--C 1.507 -0.458 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.905 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 74.52 -126.17 9.01 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 328' ' ' MET . 79.6 m-85 -105.88 147.38 28.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.02 0.438 . . . . 0.0 111.154 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.4 mt -132.48 152.96 37.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.742 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 30.6 mt-10 -110.81 134.59 52.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.955 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.92 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -145.0 165.35 28.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.741 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -174.03 163.89 4.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.384 0.612 . . . . 0.0 111.449 172.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.679 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.3 tp -165.02 143.87 5.47 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 165.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.679 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 16.2 Cg_exo -31.3 135.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.998 3.132 . . . . 0.0 113.486 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 377' ' ' PRO . 49.5 Cg_exo -37.0 128.43 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.704 3.602 . . . . 0.0 114.471 -166.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.11 178.06 35.68 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 0.0 OUTLIER -81.02 99.73 8.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.945 0.872 . . . . 0.0 110.826 -176.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.673 HD22 ' HG2' ' A' ' 394' ' ' GLN . 18.6 m-80 -108.19 126.7 53.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.302 0.572 . . . . 0.0 110.015 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.985 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.52 137.69 57.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.145 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.1 mt -99.78 127.1 52.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.792 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.405 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -95.64 102.73 14.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.932 171.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' A' ' 312' ' ' PHE . 2.1 t -92.59 78.56 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.295 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 69.56 -85.61 0.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.446 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 34.2 t70 -108.75 -25.58 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.523 0.678 . . . . 0.0 109.325 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.459 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.2 mp -65.45 151.81 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.536 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -151.94 144.35 24.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.402 ' C ' HG12 ' A' ' 382' ' ' ILE . 0.2 OUTLIER -164.79 109.9 0.94 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.111 0.482 . . . . 0.0 111.356 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.985 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.3 tt0 -84.25 149.09 26.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.386 -176.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 4.8 t-105 -158.77 142.27 15.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.822 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.3 p90 -92.72 114.83 27.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.583 -0.698 . . . . 0.0 110.062 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 381' ' ' ASN . 5.0 mm100 -72.6 115.42 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.229 -174.826 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.598 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 14.2 p90 -70.45 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.6 t -177.14 -171.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 77.7 t -67.57 107.29 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 340' ' ' ILE . 0.1 OUTLIER -69.15 148.77 49.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.007 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.572 ' OD1' HG22 ' A' ' 310' ' ' THR . 24.2 t0 -72.48 135.76 45.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.288 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.79 -16.1 56.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.572 HG22 ' OD1' ' A' ' 308' ' ' ASP . 8.1 t -96.6 2.41 52.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.132 0.492 . . . . 0.0 111.325 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 29.0 mtpp -95.29 37.48 1.17 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.229 -0.295 . . . . 0.0 111.589 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.824 ' CE1' ' HB ' ' A' ' 330' ' ' VAL . 0.0 OUTLIER -135.9 150.74 49.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.923 0.392 . . . . 0.0 110.994 -176.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 29.2 p -135.35 139.15 44.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.185 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -54.7 105.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.974 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.403 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.4 ttmm -92.52 -32.34 14.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.928 ' HB2' ' HB2' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -165.31 114.88 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.133 174.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.07 161.15 42.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.267 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.488 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 2.7 Cg_exo -39.22 119.6 0.5 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.83 2.354 . . . . 0.0 112.341 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -139.15 136.94 35.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.67 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.7 133.76 16.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.739 0.304 . . . . 0.0 110.964 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.48 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.8 p -70.75 -12.04 61.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.785 -172.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 91.74 -7.62 79.26 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -102.19 -59.19 1.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.124 0.488 . . . . 0.0 109.929 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 12.0 t70 170.2 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.394 1.092 . . . . 0.0 108.436 -169.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.67 -168.72 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.782 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 374' ' ' MET . 2.1 t -125.21 152.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.08 0.467 . . . . 0.0 111.056 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.836 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.5 m -130.45 168.16 23.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.529 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -155.01 157.85 38.25 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 316' ' ' ARG . 4.1 mt-10 -129.01 139.95 51.85 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.452 0.47 . . . . 0.0 110.301 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.824 ' HB ' ' CE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -147.94 146.42 18.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.006 -175.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.415 ' O ' ' HD1' ' A' ' 312' ' ' PHE . . . -117.18 137.43 13.41 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HD2' ' H ' ' A' ' 335' ' ' THR . 0.3 OUTLIER -90.0 179.27 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.814 0.816 . . . . 0.0 112.32 -173.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 48.1 t -106.15 -41.86 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 176.73 40.5 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.273 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.687 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 4.8 m -116.07 127.54 54.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.247 0.523 . . . . 0.0 109.856 173.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.697 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -71.17 171.55 8.43 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.076 174.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.697 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.52 95.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.974 3.116 . . . . 0.0 114.155 -177.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 305' ' ' THR . 20.1 p -117.38 174.5 6.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.768 -1.56 . . . . 0.0 111.619 -171.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.9 mmm180 -96.57 101.58 13.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.55 ' CG2' HG13 ' A' ' 342' ' ' VAL . 8.2 mm -80.15 130.78 64.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.257 0.551 . . . . 0.0 112.265 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.88 81.79 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.66 2.24 . . . . 0.0 111.653 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.996 HG21 ' HG2' ' A' ' 362' ' ' PRO . 0.0 OUTLIER -96.84 130.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.423 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -145.35 179.64 7.26 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -152.2 143.83 23.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.392 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 10.8 m -113.98 172.06 3.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -108.44 115.51 30.24 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.717 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 57.1 47.42 17.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.623 0.577 . . . . 0.0 110.583 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.672 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.24 4.54 37.12 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.75 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 40.8 t -107.37 108.19 61.43 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 117.088 0.444 . . . . 0.0 111.2 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -74.2 59.51 4.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.365 2.71 . . . . 0.0 112.419 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.03 -45.81 6.12 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.5 123.62 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.1 t30 -60.34 108.34 0.79 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.694 175.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.1 m -90.5 3.9 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.97 83.98 3.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.651 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.678 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.5 ttm -100.07 88.0 3.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 27.5 mt -66.32 126.52 29.03 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.985 -1.462 . . . . 0.0 111.664 -165.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.7 mm -73.37 -23.78 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.5 m -134.33 98.74 13.72 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.997 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.88 54.2 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.244 2.629 . . . . 0.0 113.379 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 63.6 t30 -157.96 58.73 1.47 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 172.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.996 ' HG2' HG21 ' A' ' 342' ' ' VAL . 15.0 Cg_exo -72.07 104.39 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.255 1.97 . . . . 0.0 112.155 175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.1 p -110.34 149.16 30.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.669 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 49.0 mtm -95.7 120.76 36.53 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.12 -165.47 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.903 1.377 . . . . 0.0 109.928 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ASN . . . . . 0.565 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -52.3 -25.19 8.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.335 174.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -105.58 10.14 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 110.689 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.9 -156.78 23.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 110.986 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.06 -14.61 59.34 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 66.21 -118.5 11.18 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.045 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -116.47 122.96 46.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.7 OUTLIER -113.24 161.47 12.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.082 177.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.836 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.7 mt-10 -132.87 130.92 40.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.563 ' HB3' ' CD2' ' A' ' 357' ' ' LEU . 4.0 ptp -159.77 151.6 20.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.12 -173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.937 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.43 169.64 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.683 0.278 . . . . 0.0 111.039 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.0 tp -163.35 159.31 18.05 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 48.8 Cg_exo -29.97 130.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 113.978 173.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.0 Cg_exo -37.5 129.65 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.182 3.921 . . . . 0.0 114.516 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.19 -129.5 1.83 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.527 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 391' ' ' GLN . 19.7 m-20 -127.49 107.33 9.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.502 0.191 . . . . 0.0 110.647 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.27 127.7 55.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.065 0.46 . . . . 0.0 110.01 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.045 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.64 130.72 74.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.6 mt -92.11 131.62 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.336 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -102.64 92.0 4.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.267 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.66 76.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.42 -91.28 0.74 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.162 -171.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 19.6 t70 -110.25 -20.88 12.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.258 0.552 . . . . 0.0 109.96 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 2.1 tp -67.87 145.29 54.76 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.518 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.8 p30 -151.44 147.99 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.802 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.428 ' H ' HG12 ' A' ' 382' ' ' ILE . 0.5 OUTLIER -170.46 123.53 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.024 175.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.045 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -75.68 144.26 41.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.488 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 17.2 t-105 -143.32 130.4 20.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.204 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -82.53 117.34 22.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -117.54 142.66 46.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 111.085 -174.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.675 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 305' ' ' THR . 7.2 t . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.918 0.39 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.469 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 39.4 p90 -60.8 116.32 4.34 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.306 0.574 . . . . 0.0 110.141 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 303' ' ' THR . 14.3 t -173.48 -166.59 0.33 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.118 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 13.7 t -61.19 114.87 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.41 144.64 55.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.909 0.861 . . . . 0.0 112.201 -170.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.63 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.7 t0 -59.76 141.58 54.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.619 -1.628 . . . . 0.0 110.704 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.699 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.24 -11.8 44.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.735 -175.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.63 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -105.41 -1.15 25.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.402 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 46.2 mttp -83.77 -30.08 26.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.699 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -86.92 147.93 25.56 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.678 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.1 p -135.5 145.26 46.92 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.524 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.485 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.9 m-90 -53.49 96.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 O-C-N 123.862 0.726 . . . . 0.0 111.462 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.419 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 76.9 tttt -87.84 -35.08 17.99 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.916 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.3 ttm180 -159.07 113.71 2.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.238 174.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.05 80.04 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 119.188 -0.434 . . . . 0.0 109.957 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -41.83 119.1 1.05 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.706 2.271 . . . . 0.0 112.461 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.3 m -139.61 142.41 37.07 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.322 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -40.66 130.77 2.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.863 0.465 . . . . 0.0 111.02 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.458 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -65.82 -23.75 66.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.61 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 111.37 -0.57 27.99 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.438 -174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -126.89 -56.46 1.36 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.348 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -175.31 -23.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.548 0.689 . . . . 0.0 110.498 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.744 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 11.1 p -92.0 -172.04 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.953 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.7 148.33 33.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.387 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.938 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -130.55 158.15 42.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 122.743 0.417 . . . . 0.0 110.978 -176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.515 ' HB3' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -136.79 163.47 30.57 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 2.5 mt-10 -130.3 135.1 47.73 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.913 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.84 146.21 32.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.982 0.42 . . . . 0.0 111.367 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.11 145.8 18.55 Favored Glycine 0 C--O 1.227 -0.324 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.547 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -89.78 178.34 6.27 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.569 0.7 . . . . 0.0 111.326 -174.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 22.3 m -149.32 28.5 0.81 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.367 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 165.56 -70.52 0.19 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 119.663 -1.256 . . . . 0.0 113.946 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 336' ' ' ARG . 41.1 m -58.65 136.43 57.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 122.956 0.503 . . . . 0.0 112.15 -174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.623 ' O ' HG22 ' A' ' 335' ' ' THR . 12.3 ptm180 -70.19 170.4 10.36 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.442 171.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.703 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.9 97.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.975 3.117 . . . . 0.0 114.759 -171.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.542 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 6.3 p -113.47 152.76 29.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.055 -1.429 . . . . 0.0 111.297 -172.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 306' ' ' VAL . 9.2 mpt_? -82.41 105.41 13.45 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.3 pt -87.31 131.43 44.29 Favored Pre-proline 0 C--N 1.322 -0.591 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.602 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.39 84.34 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.053 2.502 . . . . 0.0 112.364 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.631 HG11 HD13 ' A' ' 372' ' ' ILE . 19.3 m -96.72 129.48 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.796 0.807 . . . . 0.0 111.253 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 35.6 ptt180 -140.21 -172.44 3.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 174.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -159.37 143.41 15.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.286 0.565 . . . . 0.0 111.416 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 382' ' ' ILE . 16.0 m -119.69 171.31 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -103.06 116.38 32.41 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 3.7 p-80 40.14 60.11 1.84 Allowed 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.928 0.768 . . . . 0.0 112.459 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.9 3.92 24.65 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 115.666 -0.697 . . . . 0.0 114.609 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.25 118.88 45.06 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 117.546 0.673 . . . . 0.0 111.164 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.71 55.33 4.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.067 2.511 . . . . 0.0 111.445 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.581 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -86.07 -35.78 20.06 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.868 0.842 . . . . 0.0 108.895 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.581 HG12 ' HG3' ' A' ' 351' ' ' GLU . 6.7 p -155.66 122.93 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.745 176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -53.2 107.77 0.27 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.185 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.89 HG12 HD22 ' A' ' 376' ' ' LEU . 31.4 m -88.65 5.2 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.394 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.406 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -79.84 82.7 5.89 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.349 0.595 . . . . 0.0 110.645 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 36.8 mtm -97.61 90.37 4.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.7 mt -75.93 117.01 17.21 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.473 -165.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.3 mm -68.95 -22.13 26.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -131.38 85.42 53.32 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.776 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -87.28 41.68 0.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.376 2.718 . . . . 0.0 114.035 -169.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -165.61 73.55 1.34 Allowed Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.221 0.534 . . . . 0.0 110.557 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.589 ' HB2' HD11 ' A' ' 340' ' ' ILE . 91.7 Cg_endo -87.67 120.2 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.411 2.074 . . . . 0.0 112.586 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.8 p -115.21 140.72 48.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.952 175.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.703 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 54.9 mtm -95.04 113.63 25.35 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.355 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 39.5 mt-10 -104.24 -165.8 1.18 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.506 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -55.2 -17.74 4.84 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -105.06 2.52 29.56 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.5 0.667 . . . . 0.0 110.368 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.526 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 98.02 -158.63 20.7 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -173.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.88 -1.84 74.53 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.953 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.0 -129.62 32.49 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -115.63 142.03 47.28 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.296 0.57 . . . . 0.0 110.801 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.631 HD13 HG11 ' A' ' 342' ' ' VAL . 2.0 mt -120.12 130.9 73.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.573 178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.938 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.1 mt-10 -103.92 135.97 44.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.047 0.451 . . . . 0.0 110.451 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.476 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 4.4 ppp? -147.46 159.33 43.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.512 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.744 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.1 OUTLIER -172.89 167.12 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.271 0.557 . . . . 0.0 112.269 174.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.965 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.1 tp -164.82 156.85 13.75 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 172.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.965 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 47.2 Cg_exo -37.08 138.2 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.766 2.31 . . . . 0.0 112.798 172.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.65 ' HA ' HE22 ' A' ' 394' ' ' GLN . 89.1 Cg_exo -34.92 136.45 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 125.08 3.853 . . . . 0.0 114.985 -174.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.21 -150.94 22.24 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.463 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 8.3 m-20 -108.08 105.64 15.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 117.146 0.473 . . . . 0.0 110.484 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.466 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 10.0 m120 -105.0 125.1 50.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.031 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.093 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.44 132.47 71.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.515 HD12 ' HB3' ' A' ' 328' ' ' MET . 22.4 mt -91.54 135.67 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -177.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -115.46 91.91 3.75 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.135 178.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 342' ' ' VAL . 6.3 t -83.79 92.64 2.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.64 -93.64 0.12 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.867 -174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -110.57 -15.66 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.067 0.461 . . . . 0.0 110.108 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.564 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -63.29 139.96 58.82 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.492 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.8 p30 -149.41 148.1 29.06 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.587 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.8 OUTLIER -171.77 122.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.725 173.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.093 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 11.2 tt0 -76.82 148.89 36.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -143.54 129.52 19.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.484 173.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -86.34 112.18 21.18 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.65 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -102.19 126.47 49.17 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 395' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.926 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.428 -169.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.705 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 35.4 p90 -65.46 117.08 7.44 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.65 0.738 . . . . 0.0 110.332 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t -168.63 -171.25 1.37 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 53.6 t -62.65 109.29 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 140.05 56.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.469 0.652 . . . . 0.0 111.551 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.8 t70 -64.84 143.95 57.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.405 -1.271 . . . . 0.0 111.645 -175.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.683 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -64.34 -11.93 37.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.176 -1.375 . . . . 0.0 113.484 -173.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 308' ' ' ASP . 3.7 t -104.92 12.22 32.7 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.059 -175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.453 ' HE2' ' HA3' ' A' ' 334' ' ' GLY . 25.7 mtpp -101.63 1.36 37.61 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.866 ' HD1' HD13 ' A' ' 388' ' ' LEU . 2.4 p90 -125.53 169.38 12.49 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.3 t -149.2 162.37 40.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.951 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.542 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.3 m-90 -69.74 111.04 5.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.998 0.428 . . . . 0.0 111.435 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 60.1 tptt -86.21 -36.26 19.55 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 172.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.544 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 11.3 ttm180 -164.6 120.99 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.138 175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.25 161.12 59.95 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.522 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.82 116.08 0.39 Allowed 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.769 2.313 . . . . 0.0 112.013 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -131.9 134.34 45.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.173 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.45 127.4 24.9 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.412 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.3 p -66.8 -26.46 66.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.666 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.7 -4.34 42.77 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -139.71 59.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.548 0.213 . . . . 0.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 74.13 -24.73 0.2 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 21.4 p -101.33 -171.39 1.98 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.301 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.74 153.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 110.402 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.986 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.0 m -134.8 154.48 36.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.877 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.669 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -137.69 161.86 35.39 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 316' ' ' ARG . 16.2 tt0 -134.15 131.26 38.44 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.508 ' CG2' HD11 ' A' ' 372' ' ' ILE . 1.2 m -135.96 145.46 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 120.623 0.249 . . . . 0.0 111.3 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.91 135.19 11.53 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.302 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.594 ' CE1' ' HD2' ' A' ' 312' ' ' PHE . 1.3 m-85 -122.08 172.75 8.01 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 70.8 m -157.25 52.84 0.49 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.453 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -163.86 -74.69 0.03 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 119.35 -1.405 . . . . 0.0 113.766 170.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.665 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 3.8 m -57.53 144.23 37.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.437 0.695 . . . . 0.0 111.919 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.705 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 13.9 ptm180 -76.69 168.9 24.08 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 117.857 -1.068 . . . . 0.0 108.555 170.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 364' ' ' MET . 1.0 OUTLIER -27.26 98.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.008 3.139 . . . . 0.0 114.373 -173.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.796 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 26.9 p -110.58 173.49 6.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.784 -169.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.419 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 24.2 mmm180 -90.37 102.32 15.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.909 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.871 HD11 ' HB3' ' A' ' 364' ' ' MET . 58.6 mt -74.67 122.96 88.68 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.575 0.226 . . . . 0.0 111.08 -176.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.6 81.75 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.471 2.114 . . . . 0.0 112.4 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.669 HG13 HG22 ' A' ' 340' ' ' ILE . 6.4 m -102.9 126.63 57.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.586 0.708 . . . . 0.0 111.504 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 21.0 ptt180 -139.07 -178.24 5.25 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.421 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.93 135.96 11.85 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.629 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.16 174.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -104.67 115.89 31.1 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 15.8 p80 42.98 55.45 4.44 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.913 0.758 . . . . 0.0 112.575 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.862 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.68 11.09 56.6 Favored Glycine 0 CA--C 1.521 0.454 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.881 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.91 118.02 30.64 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.468 -0.43 . . . . 0.0 110.679 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.17 61.91 5.0 Favored 'Trans proline' 0 N--CA 1.463 -0.324 0 C-N-CA 123.024 2.483 . . . . 0.0 111.268 172.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.86 -38.68 12.18 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.8 p -151.45 126.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.296 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -60.75 106.37 0.56 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.802 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.8 m -88.01 3.72 5.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.36 -176.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.421 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.68 82.0 4.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.56 0.695 . . . . 0.0 110.747 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.817 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 2.5 tpt -98.91 83.5 2.93 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.3 mt -68.05 125.92 27.85 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.118 -169.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.581 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 6.2 mm -70.03 -23.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.399 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 13.0 m -138.63 92.95 11.21 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.057 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -91.75 41.04 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.386 2.724 . . . . 0.0 113.624 -174.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.94 65.84 5.85 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.264 0.554 . . . . 0.0 110.098 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.702 ' HB3' HG23 ' A' ' 372' ' ' ILE . 97.2 Cg_endo -87.95 118.0 1.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.414 2.076 . . . . 0.0 113.168 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.4 p -110.0 134.5 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.412 171.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.871 ' HB3' HD11 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -107.14 149.94 27.12 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.542 -176.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -111.03 -168.53 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.827 1.329 . . . . 0.0 109.692 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.641 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -64.91 -16.04 62.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.994 0.426 . . . . 0.0 111.046 174.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.641 ' N ' HD22 ' A' ' 366' ' ' ASN . 89.1 m-20 -86.47 -11.44 51.78 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.306 0.574 . . . . 0.0 110.171 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.534 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 113.2 -167.67 12.38 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.707 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 364' ' ' MET . . . -81.49 -15.18 76.79 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.986 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.4 -127.62 23.8 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.128 -176.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.95 133.31 50.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.072 0.463 . . . . 0.0 111.184 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.702 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -125.12 165.14 22.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.986 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.1 mt-10 -134.43 137.28 43.89 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.216 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.605 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -149.77 159.74 44.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -175.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.882 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -179.0 160.12 1.05 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 123.022 0.201 . . . . 0.0 110.579 174.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.802 HD22 ' HA ' ' A' ' 354' ' ' VAL . 13.8 tp -158.94 150.67 17.0 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.802 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.6 Cg_exo -32.93 136.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.49 2.793 . . . . 0.0 113.604 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.589 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.1 Cg_exo -35.79 128.75 0.35 Allowed 'Trans proline' 0 C--N 1.354 0.851 1 C-N-CA 125.725 4.283 . . . . 0.0 114.951 -169.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 173.5 -134.41 2.89 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.406 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 14.7 m-20 -127.12 102.0 6.77 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.506 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.8 m120 -102.88 123.0 45.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.102 0.477 . . . . 0.0 109.987 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.042 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.79 129.75 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' A' ' 374' ' ' MET . 29.7 mt -91.65 131.53 38.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.414 -174.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.58 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.4 OUTLIER -108.03 91.47 3.66 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.039 174.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 342' ' ' VAL . 7.6 t -83.86 94.6 3.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.61 -97.49 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.952 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 28.0 t70 -104.73 -19.89 13.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.063 0.459 . . . . 0.0 110.173 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.866 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.1 tp -64.31 146.43 54.41 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.4 p30 -158.84 143.22 15.66 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.492 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -166.18 124.69 1.51 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.421 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.042 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 1.5 tm0? -78.35 143.2 37.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.906 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.409 ' NE1' ' HB3' ' A' ' 394' ' ' GLN . 26.8 t-105 -145.37 114.54 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.366 174.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 27.3 p90 -74.38 125.8 29.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.589 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -120.08 140.53 50.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.67 0.748 . . . . 0.0 112.731 -171.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.744 0 CA-C-N 114.033 -1.44 . . . . 0.0 109.314 168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.421 0.629 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -69.53 120.36 15.2 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.676 -0.64 . . . . 0.0 110.124 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.3 t -171.29 -167.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.719 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.45 113.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 143.78 55.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.791 0.805 . . . . 0.0 110.812 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.57 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.0 t70 -80.29 150.65 29.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.273 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 10.8 ptmt -58.51 -18.58 30.34 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.173 -1.376 . . . . 0.0 113.017 -173.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.57 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.0 t -100.19 -0.22 39.18 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.589 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.3 mmmt -80.86 -33.79 34.2 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -93.84 154.55 17.67 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.154 0.502 . . . . 0.0 111.535 -178.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.443 ' HA ' HD11 ' A' ' 388' ' ' LEU . 8.9 t -144.38 150.62 38.05 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.283 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -64.98 112.76 3.46 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.225 0.536 . . . . 0.0 111.999 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.484 ' HG2' ' OE2' ' A' ' 329' ' ' GLU . 38.2 tttm -94.99 -28.54 15.09 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.715 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 72.1 ttt180 -168.89 110.24 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.628 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.2 160.47 39.94 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.43 -175.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.765 ' HG3' HD12 ' A' ' 383' ' ' ILE . 69.6 Cg_exo -30.78 118.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 123.922 3.081 . . . . 0.0 113.498 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -137.21 134.55 36.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.738 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.564 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 14.3 t70 -52.16 130.17 29.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.945 0.402 . . . . 0.0 110.497 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 99.9 p -69.75 -24.14 63.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.354 -173.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 102.49 -12.68 56.82 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -125.11 57.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 4.9 p-10 47.41 23.08 0.32 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.131 0.972 . . . . 0.0 113.529 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.591 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -127.43 -172.7 2.73 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.668 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.7 OUTLIER -128.92 152.99 37.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.882 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 373' ' ' GLU . 25.8 m -137.6 153.26 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.687 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.59 ' CE ' HD12 ' A' ' 372' ' ' ILE . 18.0 ptt? -136.52 158.15 45.12 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.715 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.4 tt0 -121.29 118.82 30.49 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.263 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 31.4 m -126.82 148.86 31.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -120.49 157.07 15.88 Favored Glycine 0 C--O 1.222 -0.626 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.87 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.443 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.0 OUTLIER -95.75 178.74 5.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 0.0 110.825 -177.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 311' ' ' LYS . 37.6 p -136.2 -3.04 2.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.0 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 161.06 11.09 0.04 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 119.207 -1.473 . . . . 0.0 115.782 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.589 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 39.8 m -113.08 127.48 56.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.138 0.969 . . . . 0.0 109.903 175.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.591 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.6 ptt180 -75.03 171.48 11.6 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.033 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.9 OUTLIER -25.51 92.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.986 3.124 . . . . 0.0 114.8 -166.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 363' ' ' THR . 9.2 p -110.54 144.72 38.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.709 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 6.1 mpt_? -73.47 103.95 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.713 HG21 ' HG3' ' A' ' 364' ' ' MET . 21.1 pt -88.28 128.71 52.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.252 -174.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 312' ' ' PHE . 58.4 Cg_endo -74.5 82.53 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.73 2.287 . . . . 0.0 111.772 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 385' ' ' VAL . 13.5 m -98.57 113.7 34.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.694 0.759 . . . . 0.0 111.31 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.422 ' O ' HG23 ' A' ' 383' ' ' ILE . 18.2 ptt180 -123.09 -178.74 4.05 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -154.6 142.27 19.88 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.195 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -114.38 169.65 5.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.544 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -112.44 116.79 30.86 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.974 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.429 ' HD2' ' OD2' ' A' ' 380' ' ' ASP . 4.8 t-160 63.95 39.07 8.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.6 0.562 . . . . 0.0 109.902 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 70.2 5.76 54.98 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.427 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 47.5 t -111.65 115.37 51.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 117.201 0.501 . . . . 0.0 111.348 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.8 Cg_exo -77.91 52.62 4.08 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.293 2.662 . . . . 0.0 112.298 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -86.63 -53.38 4.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.661 0.743 . . . . 0.0 109.108 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.33 117.88 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.603 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.8 t30 -53.29 108.67 0.35 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.244 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.876 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.9 m -87.13 8.26 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.483 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -81.69 80.89 7.91 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.515 0.674 . . . . 0.0 110.718 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 37.9 mtt -102.39 81.05 2.01 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.2 mt -63.68 125.25 23.68 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.013 -1.449 . . . . 0.0 111.271 -169.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 375' ' ' GLN . 4.6 mm -65.47 -20.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.4 m -136.61 92.27 15.15 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.489 171.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.427 ' HA ' HD12 ' A' ' 357' ' ' LEU . 80.0 Cg_endo -92.07 48.93 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.6 2.867 . . . . 0.0 114.739 -168.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -170.47 70.11 0.56 Allowed Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 109.918 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.486 ' HB3' HG23 ' A' ' 372' ' ' ILE . 86.2 Cg_endo -90.91 138.32 2.4 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.949 2.433 . . . . 0.0 113.822 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 17.2 p -123.98 143.09 50.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.651 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.713 ' HG3' HG21 ' A' ' 340' ' ' ILE . 53.7 mtm -95.86 128.82 43.08 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.121 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 1.9 mm-40 -93.2 -172.22 2.89 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 124.348 1.03 . . . . 0.0 112.245 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.606 ' C ' HD22 ' A' ' 366' ' ' ASN . 0.3 OUTLIER -66.25 -6.23 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.838 174.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.591 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.4 t-20 -112.87 -2.1 14.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.31 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 105.31 -175.34 21.87 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.0 -175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -75.29 -37.72 41.22 Favored Glycine 0 CA--C 1.509 -0.306 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.494 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.76 -124.11 6.46 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.431 -177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -103.2 134.94 45.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.106 0.479 . . . . 0.0 111.559 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.59 HD12 ' CE ' ' A' ' 328' ' ' MET . 0.9 OUTLIER -128.7 155.33 40.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.767 ' HG2' HG12 ' A' ' 327' ' ' VAL . 33.8 mt-10 -125.09 138.34 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.875 -172.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.649 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -153.59 157.18 39.3 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.908 0.483 . . . . 0.0 110.709 -174.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.826 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -170.07 163.72 9.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 173.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.9 tp -165.51 163.41 12.97 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 72.1 Cg_exo -27.83 133.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.103 3.202 . . . . 0.0 114.348 168.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.839 ' HB3' ' HB2' ' A' ' 395' ' ' LYS . 5.2 Cg_exo -37.09 138.46 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.857 4.371 . . . . 0.0 115.362 -175.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 147.05 -179.76 23.73 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.063 -177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.5 m-20 -69.02 104.26 2.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 117.791 0.796 . . . . 0.0 110.561 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -94.34 112.54 24.33 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.011 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -114.78 127.56 72.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.863 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.765 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.8 mt -92.74 132.72 36.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.992 -175.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.676 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.6 OUTLIER -104.58 92.57 4.35 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.062 174.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.3 t -81.23 86.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.98 -91.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.533 -172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.542 ' HB2' ' HE3' ' A' ' 309' ' ' LYS . 10.5 t70 -108.75 -15.01 14.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.199 0.523 . . . . 0.0 109.809 176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.687 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -64.35 147.93 51.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.8 p-10 -158.34 140.87 14.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.585 0.231 . . . . 0.0 111.127 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.621 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -167.88 121.7 0.94 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.24 174.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.011 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 70.6 mt-30 -70.83 150.96 45.29 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.564 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 12.1 t-105 -151.04 110.7 4.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.985 169.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.9 p90 -74.39 111.36 9.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.652 0.739 . . . . 0.0 109.8 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.588 ' NE2' ' HG2' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -99.11 146.27 26.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.139 -176.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' A' ' 378' ' ' PRO . 71.7 mmtt . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.197 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.831 0.348 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.526 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 25.1 p90 -64.74 129.82 41.23 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 121.92 -0.488 . . . . 0.0 110.062 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.586 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.4 t 176.78 -173.61 0.1 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 17.3 t -69.56 106.09 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.482 ' SG ' HG22 ' A' ' 340' ' ' ILE . 0.3 OUTLIER -68.86 156.68 38.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.682 0.754 . . . . 0.0 112.393 -167.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.677 ' OD2' HG22 ' A' ' 310' ' ' THR . 18.4 t70 -67.8 143.16 55.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.663 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -66.11 -22.39 66.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.494 -170.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.677 HG22 ' OD2' ' A' ' 308' ' ' ASP . 2.6 t -100.0 -6.23 26.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.635 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 29.3 mtpp -83.02 38.19 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -175.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -123.93 173.69 8.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.261 0.553 . . . . 0.0 111.497 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 10.0 t -157.13 135.43 11.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.478 170.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -55.16 110.87 0.74 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.839 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.714 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 1.1 tpmt? -92.36 -41.68 10.21 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.424 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 69.9 ttt180 -161.16 126.16 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.2 162.57 71.84 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.648 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 4.9 Cg_exo -40.37 122.69 1.32 Allowed 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.609 2.206 . . . . 0.0 111.718 175.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 12.3 m -142.85 142.17 31.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.259 -172.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.12 125.58 6.66 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.176 0.298 . . . . 0.0 110.487 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.576 ' HB3' HG13 ' A' ' 327' ' ' VAL . 94.9 p -66.79 -20.15 65.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.902 -174.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 90.89 -2.19 79.29 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -140.01 55.33 1.64 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.853 0.358 . . . . 0.0 110.97 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 72.96 12.92 5.02 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.716 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 5.1 p -144.62 -166.78 2.47 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 122.481 -0.137 . . . . 0.0 110.699 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.96 155.19 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.86 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.696 HG12 ' HG3' ' A' ' 373' ' ' GLU . 17.9 m -137.5 160.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.655 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.441 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 10.5 ptm -141.39 165.1 28.43 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.5 tt0 -130.19 124.68 33.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG21 ' A' ' 385' ' ' VAL . 14.1 m -128.78 141.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.169 0.509 . . . . 0.0 111.599 -176.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.03 161.04 14.46 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.0 OUTLIER -108.5 179.9 4.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.907 0.86 . . . . 0.0 112.833 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.2 t -98.8 -42.79 7.03 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.363 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.8 41.11 0.04 OUTLIER Glycine 0 C--N 1.339 0.733 0 C-N-CA 119.687 -1.244 . . . . 0.0 114.245 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.7 m -114.32 119.9 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 117.118 0.459 . . . . 0.0 110.33 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.575 ' HE ' ' HD2' ' A' ' 337' ' ' PRO . 2.6 ptm180 -69.87 171.22 7.73 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.768 -1.111 . . . . 0.0 109.253 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HD2' ' HE ' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.05 92.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 124.184 3.256 . . . . 0.0 114.532 -169.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 363' ' ' THR . 20.8 p -114.34 164.1 14.39 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.278 -1.783 . . . . 0.0 111.274 -174.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 20.8 mmt180 -86.59 99.03 11.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.815 HG13 HG22 ' A' ' 342' ' ' VAL . 16.7 pt -81.0 130.03 64.97 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.548 -175.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.94 78.97 3.52 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.173 1.915 . . . . 0.0 112.354 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -98.25 121.62 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.832 0.825 . . . . 0.0 112.411 175.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -126.67 -176.69 3.76 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.326 171.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.47 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.9 134.47 15.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.348 0.594 . . . . 0.0 110.647 176.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 18.3 m -110.74 167.63 4.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.37 114.41 28.66 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.349 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 57.35 46.79 17.78 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 123.721 0.638 . . . . 0.0 110.621 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.587 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 64.75 13.84 57.02 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.837 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 351' ' ' GLU . 46.9 t -114.66 112.95 45.2 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 117.51 0.655 . . . . 0.0 111.301 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.64 52.56 2.51 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.627 2.885 . . . . 0.0 112.134 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.475 ' HB2' HG12 ' A' ' 349' ' ' VAL . 10.5 tp10 -90.93 -51.59 5.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.945 0.879 . . . . 0.0 108.828 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.8 118.51 29.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.353 -1.294 . . . . 0.0 109.115 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -61.03 107.63 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.719 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.747 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 27.0 m -89.53 6.58 4.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.541 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.47 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.95 83.37 6.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.466 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.5 tmm? -99.82 91.98 5.09 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 169.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 29.6 mt -73.24 118.7 16.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.208 -167.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -66.66 -22.95 30.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.361 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -131.12 93.43 30.36 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 114.154 -1.385 . . . . 0.0 108.951 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.71 43.3 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.035 2.49 . . . . 0.0 113.035 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 66.6 t30 -150.54 61.03 4.48 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.543 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.648 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.9 Cg_endo -88.53 118.96 1.06 Allowed 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.528 2.152 . . . . 0.0 112.789 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 53.2 p -124.42 149.63 46.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.377 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.993 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 71.3 mtm -94.61 133.8 37.86 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.473 ' HB3' HD22 ' A' ' 366' ' ' ASN . 1.2 mm-40 -109.46 -168.72 1.37 Allowed 'General case' 0 C--N 1.318 -0.795 0 O-C-N 124.551 1.157 . . . . 0.0 111.891 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.0 OUTLIER -52.51 -23.73 6.79 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -109.43 -7.93 15.12 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.077 -0.389 . . . . 0.0 111.156 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 127.75 -178.14 17.18 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.993 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -63.12 -29.66 75.09 Favored Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.63 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.9 -123.42 6.58 Favored Glycine 0 N--CA 1.438 -1.167 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.347 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -103.55 147.28 27.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.191 0.519 . . . . 0.0 111.644 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.648 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -136.54 137.67 47.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.962 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.7 mp0 -107.29 135.52 48.66 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.292 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.748 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -152.45 158.09 42.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -174.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.754 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.9 tp60 -176.04 145.78 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.787 0.327 . . . . 0.0 110.725 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.788 HD22 ' HD2' ' A' ' 377' ' ' PRO . 0.8 OUTLIER -146.25 142.48 17.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 167.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.788 ' HD2' HD22 ' A' ' 376' ' ' LEU . 28.2 Cg_exo -23.94 136.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.844 3.696 . . . . 0.0 115.004 177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.859 ' HA ' HE22 ' A' ' 394' ' ' GLN . 6.3 Cg_exo -37.11 134.2 0.41 Allowed 'Trans proline' 0 C--N 1.358 1.053 1 C-N-CA 125.79 4.327 . . . . 0.0 114.97 -171.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 161.51 -124.6 1.33 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.995 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.489 ' HB3' HE21 ' A' ' 391' ' ' GLN . 11.7 m-20 -132.29 101.78 5.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.418 ' HA ' HG21 ' A' ' 354' ' ' VAL . 7.9 m120 -104.57 124.75 49.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.006 0.432 . . . . 0.0 109.927 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.55 134.28 66.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 175.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 374' ' ' MET . 41.9 mt -95.27 134.1 33.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.176 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.23 94.24 4.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.133 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.919 HG13 HG13 ' A' ' 342' ' ' VAL . 2.8 t -84.82 72.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 73.64 -80.66 0.77 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.504 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.506 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 1.9 t70 -110.54 -30.08 7.79 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.51 141.77 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.537 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.4 p30 -150.73 154.27 37.07 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 175.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -170.08 116.07 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.483 175.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -73.13 139.97 46.76 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.438 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 29.9 t-105 -136.67 137.72 40.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.158 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -94.97 117.32 29.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.859 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.32 146.09 38.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.886 0.374 . . . . 0.0 110.495 -177.212 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 395' ' ' LYS . 1.9 ttpm? . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.496 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 335' ' ' THR . 6.8 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.376 0.608 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.621 ' HD1' ' H ' ' A' ' 304' ' ' TYR . 0.4 OUTLIER -70.84 108.48 4.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.783 0.802 . . . . 0.0 110.617 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.5 t -168.43 -167.18 0.76 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.582 -172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.69 113.43 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 170.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.98 144.23 56.33 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.658 0.742 . . . . 0.0 111.174 -171.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.93 148.33 40.15 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.13 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.81 -12.88 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.888 -173.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.477 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.5 t -98.15 -6.21 31.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.568 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 30.7 mmmt -75.9 -36.16 59.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.628 -175.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -94.4 148.79 21.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.078 0.466 . . . . 0.0 111.106 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.9 t -139.11 162.19 35.56 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.56 176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.466 ' CZ3' ' HA ' ' A' ' 317' ' ' ALA . 93.8 m95 -67.37 111.39 4.02 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.958 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 73.3 tttt -102.52 -39.8 6.95 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.014 171.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.644 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 70.7 ttt180 -157.0 118.35 3.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.51 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.466 ' HA ' ' CZ3' ' A' ' 314' ' ' TRP . . . -67.42 161.21 66.83 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.462 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.866 ' HG3' HD12 ' A' ' 383' ' ' ILE . 74.0 Cg_exo -36.34 110.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 123.223 2.616 . . . . 0.0 113.251 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.5 m -134.9 137.45 43.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.591 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.4 131.66 13.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.162 0.505 . . . . 0.0 111.509 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.457 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.1 p -66.89 -23.32 65.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.77 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 110.05 -11.64 31.73 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -100.77 -54.13 2.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.516 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 21.9 t70 170.08 -24.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.323 1.058 . . . . 0.0 109.035 -171.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.563 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.46 -169.95 2.25 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.462 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.574 HG11 HE22 ' A' ' 394' ' ' GLN . 2.1 t -127.73 154.38 38.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.024 0.44 . . . . 0.0 111.001 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.671 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.3 m -135.22 156.61 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.76 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.568 ' SD ' HG22 ' A' ' 330' ' ' VAL . 2.0 ppp? -135.65 154.63 51.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.958 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 9.7 tt0 -126.44 123.13 37.17 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.116 0.484 . . . . 0.0 110.601 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -123.7 148.83 27.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.51 -177.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -114.23 139.35 15.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.78 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.521 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.8 OUTLIER -91.13 179.27 5.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.345 0.573 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.7 p -135.55 -17.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.118 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.99 -47.28 0.06 OUTLIER Glycine 0 C--N 1.335 0.521 0 C-N-CA 119.339 -1.41 . . . . 0.0 114.213 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.631 HG23 HG23 ' A' ' 303' ' ' THR . 26.3 m -56.27 125.27 21.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.213 -176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.584 ' HD2' ' HB3' ' A' ' 304' ' ' TYR . 0.0 OUTLIER -69.44 163.22 60.59 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 118.14 -0.933 . . . . 0.0 108.891 176.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.76 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.48 97.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.364 1.344 0 C-N-CA 124.148 3.232 . . . . 0.0 114.688 -169.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 363' ' ' THR . 6.8 p -114.07 150.89 33.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.969 -173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -75.4 108.06 7.93 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.736 HG21 ' HG3' ' A' ' 364' ' ' MET . 28.8 pt -91.48 128.58 46.19 Favored Pre-proline 0 C--N 1.321 -0.651 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.106 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.33 89.57 1.18 Allowed 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.099 2.533 . . . . 0.0 112.881 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 372' ' ' ILE . 19.1 m -101.05 124.56 54.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.415 0.626 . . . . 0.0 110.938 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -132.78 -175.62 3.83 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.454 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 137.46 18.44 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.59 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.564 HG22 HD12 ' A' ' 382' ' ' ILE . 10.7 m -115.23 166.82 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.54 117.74 34.89 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.535 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 3.5 t60 59.7 40.08 20.27 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.395 0.434 . . . . 0.0 110.519 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.432 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 69.1 6.96 55.77 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.231 -176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.1 113.09 62.75 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.897 0.349 . . . . 0.0 111.051 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.46 55.87 4.33 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.929 2.42 . . . . 0.0 111.88 173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -86.32 -53.49 4.99 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.029 0.919 . . . . 0.0 108.621 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -136.6 120.89 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 114.085 -1.416 . . . . 0.0 108.787 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -54.37 107.99 0.33 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.663 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 1.049 ' HB ' ' HB3' ' A' ' 376' ' ' LEU . 2.6 m -87.9 -8.65 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.85 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.454 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -60.02 96.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.471 0.653 . . . . 0.0 112.222 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.637 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 67.4 mtm -108.18 85.38 2.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 172.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 45.4 mt -73.41 124.37 25.65 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.377 -168.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.652 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.8 mm -69.62 -20.53 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.3 m -145.74 97.13 4.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.999 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -92.47 37.91 0.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.483 2.788 . . . . 0.0 113.288 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -144.53 63.04 10.42 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.883 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.741 ' HB3' HG23 ' A' ' 372' ' ' ILE . 88.4 Cg_endo -86.1 131.45 3.69 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.564 2.176 . . . . 0.0 113.016 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -130.4 142.16 50.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.399 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 59.0 mtm -95.24 117.08 29.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.722 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.404 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 38.5 mt-10 -100.12 -165.47 1.22 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 124.898 1.374 . . . . 0.0 109.886 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.645 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -62.8 -15.0 52.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.856 0.36 . . . . 0.0 111.314 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.645 ' N ' HD22 ' A' ' 366' ' ' ASN . 87.1 m-20 -96.7 6.44 48.69 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.184 0.516 . . . . 0.0 109.678 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 83.48 -155.19 32.1 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -68.43 -16.43 69.4 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.826 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.518 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 71.45 -87.18 0.42 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.705 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -159.02 143.32 15.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.099 0.476 . . . . 0.0 109.871 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.741 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.8 mt -119.57 157.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.671 ' HG2' HG12 ' A' ' 327' ' ' VAL . 37.0 mt-10 -126.34 130.94 51.78 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.806 -175.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.646 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -155.26 160.56 40.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.928 -173.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.894 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -163.71 148.19 10.54 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 167.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.049 ' HB3' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -132.22 163.59 49.27 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -169.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 378' ' ' PRO . 3.5 Cg_endo -48.16 126.67 13.87 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.625 2.217 . . . . 0.0 112.147 176.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 4.5 Cg_exo -38.81 128.62 1.26 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.69 3.594 . . . . 0.0 113.711 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 134.32 -172.57 21.76 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.362 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.83 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 1.4 m-20 -71.21 101.44 2.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.931 0.365 . . . . 0.0 111.288 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.546 ' HB2' HD23 ' A' ' 376' ' ' LEU . 31.9 m-80 -118.04 163.39 16.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.055 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -146.24 144.9 20.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.631 -173.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.866 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.5 mt -100.97 132.96 45.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.094 0.473 . . . . 0.0 110.339 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -103.84 97.15 7.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.24 174.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.681 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.1 t -86.5 84.68 2.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.32 -85.05 0.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.332 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.765 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 7.8 t70 -113.09 -16.23 12.65 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.681 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.4 mp -66.14 148.76 51.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.058 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.1 p30 -163.45 126.92 2.73 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.967 0.413 . . . . 0.0 111.494 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -153.75 119.81 5.38 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.25 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.055 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 41.5 tt0 -87.39 142.38 27.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.424 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.473 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 0.6 OUTLIER -153.33 141.02 19.98 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.83 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 7.7 p90 -74.55 107.08 6.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.288 0.566 . . . . 0.0 110.661 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.695 ' HG3' HD23 ' A' ' 376' ' ' LEU . 1.7 mm100 -85.1 145.07 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 21.0 tptm . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.819 172.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 335' ' ' THR . 7.7 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.921 0.391 . . . . 0.0 112.002 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.789 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.3 p90 -58.97 130.94 49.44 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.36 0.6 . . . . 0.0 110.181 177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.7 t -177.58 -165.45 0.11 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 6.0 p -69.02 107.64 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 169.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.538 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.5 OUTLIER -68.4 136.24 53.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.818 0.818 . . . . 0.0 110.877 -174.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.544 ' OD1' HG22 ' A' ' 310' ' ' THR . 8.7 t70 -65.92 147.75 52.87 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.924 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.792 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -61.56 -13.37 21.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.248 -177.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.544 HG22 ' OD1' ' A' ' 308' ' ' ASP . 15.3 t -104.29 6.19 35.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.783 0.325 . . . . 0.0 111.25 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 41.4 mtpt -106.36 17.42 23.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.792 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.5 OUTLIER -132.74 158.32 42.7 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.037 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.2 t -138.71 154.08 48.55 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.503 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.524 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.5 m-90 -63.8 98.49 0.2 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.367 0.604 . . . . 0.0 110.885 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -83.51 -32.42 25.93 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 37.6 ttm180 -165.24 116.12 1.11 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.255 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.42 163.6 24.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.344 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.0 Cg_exo -41.7 117.91 0.77 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.638 2.226 . . . . 0.0 112.107 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.7 m -135.49 144.52 46.42 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.345 -172.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.82 130.3 4.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 172.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.529 ' HB3' HG13 ' A' ' 327' ' ' VAL . 80.6 p -71.15 -18.64 62.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.93 -2.59 72.53 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 9.1 t60 -109.09 -52.88 2.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 19.0 t70 169.19 -25.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.311 1.053 . . . . 0.0 108.915 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.456 ' CB ' HG13 ' A' ' 358' ' ' ILE . 9.4 p -92.83 -168.28 1.92 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.004 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -120.68 150.92 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -131.85 163.7 36.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.979 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.39 163.99 31.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 169.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 4.0 tt0 -132.06 126.68 34.42 Favored 'General case' 0 C--N 1.314 -0.956 0 O-C-N 123.656 0.597 . . . . 0.0 110.1 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.91 153.9 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.745 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.38 152.27 16.84 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.999 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.644 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -89.93 165.86 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.227 0.514 . . . . 0.0 111.798 -174.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 35.3 m -115.6 8.03 14.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.338 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 147.61 13.11 0.15 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.458 -1.354 . . . . 0.0 115.2 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 336' ' ' ARG . 98.4 m -114.29 132.71 56.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 118.292 1.046 . . . . 0.0 110.586 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.789 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 28.0 ptt180 -75.94 173.11 7.72 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.027 174.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.741 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.62 93.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 124.051 3.167 . . . . 0.0 115.166 -168.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 1.8 p -110.8 150.78 28.63 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 111.035 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.28 108.75 3.31 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.599 ' HB ' ' HG3' ' A' ' 364' ' ' MET . 15.6 tt -92.4 119.24 68.18 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 121.013 0.435 . . . . 0.0 110.24 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.47 82.23 2.13 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.987 2.458 . . . . 0.0 112.535 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -98.93 128.47 50.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.384 0.611 . . . . 0.0 111.477 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 32.0 ptt180 -135.17 -176.13 4.15 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 171.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.68 141.58 22.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.255 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 14.6 m -120.47 168.32 12.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.25 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.44 34.11 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.049 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.538 ' HA ' ' OD2' ' A' ' 380' ' ' ASP . 5.4 t60 56.91 46.54 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.514 0.509 . . . . 0.0 111.381 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.431 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 61.79 14.44 44.24 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.96 -0.638 . . . . 0.0 113.642 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 347' ' ' HIS . 38.7 t -115.78 115.86 41.13 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 117.155 0.478 . . . . 0.0 111.216 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 4.9 Cg_exo -79.16 51.29 3.8 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.231 2.62 . . . . 0.0 112.228 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.613 ' HG3' HG12 ' A' ' 352' ' ' VAL . 8.8 pt-20 -85.07 -41.4 15.79 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.739 0.781 . . . . 0.0 109.222 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.613 HG12 ' HG3' ' A' ' 351' ' ' GLU . 4.4 p -144.11 118.1 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.602 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -55.78 108.09 0.41 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.261 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.948 ' HA ' HD22 ' A' ' 376' ' ' LEU . 28.2 m -84.99 0.18 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.124 0.487 . . . . 0.0 110.293 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.455 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.36 82.97 3.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.216 0.532 . . . . 0.0 110.835 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.744 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 8.5 tpt -97.59 91.96 5.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 166.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 39.3 mt -74.49 120.37 19.95 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.454 -165.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.705 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -70.32 -19.01 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 61.7 m -128.25 81.89 69.61 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 114.188 -1.369 . . . . 0.0 108.252 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -86.18 43.92 1.18 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.14 2.56 . . . . 0.0 113.811 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -172.14 67.62 0.41 Allowed Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.938 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.473 ' HB3' HG23 ' A' ' 372' ' ' ILE . 68.9 Cg_endo -91.49 134.91 1.65 Allowed 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.816 2.344 . . . . 0.0 114.01 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 2.8 p -116.65 155.94 27.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.93 170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.933 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 76.7 mtp -95.43 103.72 15.59 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.981 0.42 . . . . 0.0 109.868 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -79.72 -165.56 0.83 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.732 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.528 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -46.85 -30.86 2.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -122.69 25.72 8.59 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.757 -0.59 . . . . 0.0 111.289 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.745 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.09 -177.6 20.37 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.008 177.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.933 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.12 -25.09 53.35 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.395 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.09 -110.98 3.71 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.642 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -108.1 131.9 54.13 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.152 0.501 . . . . 0.0 111.721 -171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.2 mt -134.98 141.82 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.857 ' HG2' HG12 ' A' ' 327' ' ' VAL . 30.9 mt-10 -114.46 137.09 52.28 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.492 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.524 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -144.46 156.08 44.03 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.744 ' O ' ' HB3' ' A' ' 356' ' ' MET . 24.1 tp60 -175.65 144.92 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.709 0.29 . . . . 0.0 110.96 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.017 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.2 tp -147.15 160.07 40.79 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 164.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 1.017 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 38.7 Cg_exo -29.47 133.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.147 3.231 . . . . 0.0 114.579 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.609 ' HA ' HE22 ' A' ' 394' ' ' GLN . 73.0 Cg_exo -35.37 135.69 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.016 1 C-N-CA 125.441 4.094 . . . . 0.0 115.562 -176.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.61 -135.71 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.7 p-10 -131.17 107.47 9.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.162 0.982 . . . . 0.0 109.977 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 381' ' ' ASN . 0.8 OUTLIER -102.26 128.65 48.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.632 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.968 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -119.63 135.73 59.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.524 HD11 ' HG2' ' A' ' 374' ' ' MET . 42.2 mt -91.07 129.48 41.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.873 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -108.93 91.84 3.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.971 176.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 342' ' ' VAL . 9.3 t -83.6 85.6 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.24 -86.11 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.359 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.691 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 3.1 t0 -112.1 -22.64 10.89 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.643 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -64.13 140.08 58.83 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.226 177.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.489 ' H ' ' HZ2' ' A' ' 314' ' ' TRP . 25.7 p-10 -151.74 139.43 19.77 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.39 116.98 1.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.125 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.968 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 26.9 tt0 -67.38 141.57 57.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.763 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 27.9 t-105 -139.79 122.11 16.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.121 172.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 11.8 p90 -79.76 109.07 13.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.077 0.465 . . . . 0.0 109.908 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.609 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -104.11 133.16 49.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.048 0.452 . . . . 0.0 110.511 -178.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 26.6 tptp . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.61 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 335' ' ' THR . 6.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.185 0.516 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -57.99 131.15 49.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.073 0.463 . . . . 0.0 111.792 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.9 t -176.39 -167.4 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.0 t -68.13 116.65 8.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.18 137.22 56.08 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.805 0.812 . . . . 0.0 111.446 -170.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.65 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.4 t0 -60.69 143.33 54.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.545 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.646 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -65.44 -13.06 57.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.023 -0.99 . . . . 0.0 113.1 -171.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.65 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.2 t -108.58 3.96 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.508 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 37.3 mttp -80.19 -21.53 42.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -95.97 154.02 17.46 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.347 0.594 . . . . 0.0 110.958 177.107 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.8 t -136.95 156.44 48.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.226 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -59.98 99.9 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.762 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.536 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 27.6 tptp -89.34 -46.42 8.76 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.445 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 28.5 ttm180 -154.92 122.43 5.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.792 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -67.46 157.19 86.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.33 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 392' ' ' TRP . 2.4 Cg_endo -42.24 112.1 0.23 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 123.111 2.541 . . . . 0.0 112.689 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -127.61 144.64 51.05 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.02 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -44.75 128.02 6.55 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.034 0.445 . . . . 0.0 111.621 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 93.4 p -64.96 -23.1 67.12 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.521 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 114.86 -12.4 20.36 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.753 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -126.0 -40.92 1.98 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.161 0.801 . . . . 0.0 113.161 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -178.0 -28.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.384 0.611 . . . . 0.0 111.667 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.467 ' HB ' HG13 ' A' ' 358' ' ' ILE . 16.7 p -93.31 -170.88 2.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.035 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.0 OUTLIER -127.62 144.72 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 110.921 -177.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.915 HG12 ' HG2' ' A' ' 373' ' ' GLU . 21.9 m -129.23 142.73 43.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.603 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.7 ptm -125.91 166.88 16.08 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 174.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.536 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 15.6 tt0 -136.7 140.54 42.74 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.603 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -139.52 158.89 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.67 0.271 . . . . 0.0 111.335 -178.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.652 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.86 135.85 9.64 Favored Glycine 0 C--O 1.224 -0.483 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.629 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD2' ' HA2' ' A' ' 368' ' ' GLY . 2.3 p90 -90.74 178.45 6.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.192 0.496 . . . . 0.0 109.941 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 31.0 m -152.45 19.1 0.63 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -160.82 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 C-N-CA 119.486 -1.34 . . . . 0.0 114.11 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 336' ' ' ARG . 67.9 m -70.49 139.98 51.79 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 122.985 0.514 . . . . 0.0 111.884 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 4.8 ptt180 -67.34 175.84 1.42 Allowed Pre-proline 0 N--CA 1.466 0.345 0 CA-C-O 117.611 -1.185 . . . . 0.0 109.013 173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 364' ' ' MET . 3.7 Cg_exo -26.02 92.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 124.002 3.134 . . . . 0.0 114.247 -174.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.406 ' HB3' ' CG2' ' A' ' 335' ' ' THR . 1.6 p -113.34 151.85 30.69 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.715 -1.584 . . . . 0.0 111.152 -171.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 9.1 mpt_? -69.24 109.01 3.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.579 HD11 HG11 ' A' ' 385' ' ' VAL . 11.3 tt -89.22 118.7 69.4 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 120.946 0.403 . . . . 0.0 110.459 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -72.8 84.12 1.29 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.085 2.523 . . . . 0.0 112.798 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 372' ' ' ILE . 29.8 m -100.7 130.63 49.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 41.0 ptt180 -138.29 -170.26 2.77 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' A' ' 355' ' ' ALA . . . -155.52 140.89 17.68 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.348 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.83 167.93 10.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -103.44 113.05 26.26 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.886 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 56.68 49.39 14.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.533 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.499 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.75 2.15 27.78 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.252 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 25.9 t -110.37 113.05 56.58 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 117.73 0.765 . . . . 0.0 111.484 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 3.0 Cg_exo -79.33 63.17 8.69 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 123.485 2.79 . . . . 0.0 112.906 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.73 -46.01 6.14 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.622 0.725 . . . . 0.0 109.369 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.92 124.52 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.074 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.5 t30 -63.02 107.98 1.12 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.654 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 381' ' ' ASN . 34.3 m -90.94 11.56 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.549 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -83.3 83.19 7.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.548 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 36.7 ttm -96.92 87.26 4.21 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 172.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.6 mt -72.48 119.78 17.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.659 -165.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.766 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -69.79 -14.42 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -142.49 85.93 10.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.552 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 357' ' ' LEU . 96.9 Cg_endo -87.46 46.03 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 123.328 2.686 . . . . 0.0 113.944 -171.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -163.13 62.68 1.2 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.027 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.483 ' O ' HG22 ' A' ' 340' ' ' ILE . 86.1 Cg_endo -86.02 129.44 3.39 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.167 1.912 . . . . 0.0 113.405 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -116.96 150.56 38.35 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.502 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.839 ' HE1' ' HB3' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -99.81 118.78 37.01 Favored 'General case' 0 CA--C 1.507 -0.676 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.974 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -97.94 -165.32 1.24 Allowed 'General case' 0 C--N 1.316 -0.889 0 O-C-N 124.929 1.393 . . . . 0.0 110.697 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -55.89 -21.67 21.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -100.24 -0.43 38.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.313 0.577 . . . . 0.0 110.437 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.652 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.91 -160.14 13.58 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -65.6 -2.7 11.81 Favored Glycine 0 CA--C 1.505 -0.57 0 CA-C-N 117.606 0.703 . . . . 0.0 112.505 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 56.21 -130.12 48.96 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -172.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 328' ' ' MET . 38.3 p90 -112.36 150.11 31.52 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.997 0.427 . . . . 0.0 110.432 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 342' ' ' VAL . 2.2 mt -134.0 143.68 37.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.418 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.915 ' HG2' HG12 ' A' ' 327' ' ' VAL . 28.0 mt-10 -112.4 139.71 47.74 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.541 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.6 ppp? -156.86 162.89 39.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.171 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.864 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.89 169.63 6.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.064 0.459 . . . . 0.0 111.829 172.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.7 tm? -166.12 141.03 3.8 Favored Pre-proline 0 C--O 1.221 -0.398 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.809 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.4 Cg_exo -31.36 132.32 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.849 3.033 . . . . 0.0 114.12 175.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.524 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 6.0 Cg_exo -37.17 130.93 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.154 1 C-N-CA 125.783 4.322 . . . . 0.0 115.016 -170.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.99 -173.32 37.43 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.7 -176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 4.8 m-20 -90.1 101.53 14.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.037 0.419 . . . . 0.0 110.066 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.565 ' HB3' HG21 ' A' ' 354' ' ' VAL . 16.8 m-80 -111.89 -179.64 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.506 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.77 139.3 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 O-C-N 122.268 -0.27 . . . . 0.0 110.322 178.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.628 ' HB ' ' CE1' ' A' ' 390' ' ' HIS . 29.9 mt -91.04 133.57 32.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 389' ' ' ASN . 1.8 t80 -112.95 104.25 12.21 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.046 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 342' ' ' VAL . 6.2 t -97.01 83.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.86 -88.74 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.516 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -98.41 -31.18 12.14 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.2 mp -63.62 140.92 58.92 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.223 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 5.0 p-10 -140.25 140.62 35.81 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.829 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.628 ' CE1' ' HB ' ' A' ' 383' ' ' ILE . 0.8 OUTLIER -162.86 102.23 1.01 Allowed 'General case' 0 C--O 1.242 0.661 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.597 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.4 tt0 -81.41 152.23 27.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.404 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.739 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.2 OUTLIER -159.53 150.37 19.47 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 35.5 p90 -94.14 128.94 40.85 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.371 -0.83 . . . . 0.0 109.665 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.775 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -109.39 145.17 36.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.022 0.439 . . . . 0.0 110.474 -178.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 395' ' ' LYS . 7.2 tmtt? . . . . . 0 C--N 1.317 -0.808 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.466 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.595 HG23 HG23 ' A' ' 335' ' ' THR . 8.7 t . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 121.365 0.602 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -66.71 113.78 5.11 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.685 0.755 . . . . 0.0 110.098 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.1 t -173.81 -166.45 0.31 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -173.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 20.6 t -66.91 104.6 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 166.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.729 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.6 OUTLIER -74.47 167.23 22.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -166.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.9 t70 -71.89 150.3 44.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.62 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 24.6 pttt -74.5 -19.82 60.22 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.613 -167.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 308' ' ' ASP . 15.3 t -107.69 22.65 15.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.077 0.465 . . . . 0.0 111.625 -174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -95.64 18.55 12.68 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -134.23 173.67 11.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.388 0.614 . . . . 0.0 111.187 -178.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.4 t -141.86 140.81 33.01 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.299 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -54.01 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.518 175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.98 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 76.3 tttt -85.89 -43.64 13.08 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.597 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 24.9 ttm180 -148.84 126.77 11.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.226 172.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' A' ' 390' ' ' HIS . . . -70.9 160.64 81.61 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-O 119.115 -0.469 . . . . 0.0 109.75 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -42.35 115.39 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.292 1.995 . . . . 0.0 111.467 176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 5.0 m -134.34 144.61 48.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.732 -172.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -46.3 128.15 9.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 0.0 111.239 175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.8 p -74.98 -22.05 58.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.451 -173.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.76 2.25 84.55 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -169.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -124.81 32.51 5.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.394 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 13.3 t70 68.9 19.39 8.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.309 175.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.448 ' HB ' HG13 ' A' ' 358' ' ' ILE . 13.8 p -136.76 -168.26 2.23 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.821 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.51 151.36 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.273 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.982 HG12 ' HG2' ' A' ' 373' ' ' GLU . 18.9 m -139.44 147.62 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.193 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.57 ' HB3' HD12 ' A' ' 383' ' ' ILE . 11.9 ptm -126.7 163.02 24.43 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.555 171.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.98 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 11.5 tt0 -128.14 127.47 43.06 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 13.1 m -128.87 138.23 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.062 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -108.6 139.98 15.38 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.82 -179.87 4.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 118.249 1.025 . . . . 0.0 111.715 -175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 21.2 p -129.99 -24.47 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.656 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -144.54 -68.02 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.375 -1.393 . . . . 0.0 115.0 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 307' ' ' CYS . 7.1 m -56.24 122.19 11.21 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.811 0.306 . . . . 0.0 111.619 -173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.459 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.8 ptm180 -74.21 171.82 10.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 117.68 -1.152 . . . . 0.0 108.589 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.742 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.98 96.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.955 3.103 . . . . 0.0 114.929 -170.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.746 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.7 p -118.09 165.57 13.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.257 -175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.47 100.61 12.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 362' ' ' PRO . 18.9 pt -74.6 128.65 85.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.941 0.4 . . . . 0.0 110.79 -176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.24 82.09 1.12 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.669 2.246 . . . . 0.0 112.089 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.668 HG11 HD13 ' A' ' 372' ' ' ILE . 20.5 m -97.63 133.93 37.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.536 0.684 . . . . 0.0 111.131 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -145.45 -177.73 5.72 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.516 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.15 137.18 18.24 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.811 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.1 m -113.66 172.76 3.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -100.96 115.9 31.55 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 6.1 p-80 41.38 59.82 2.27 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.887 0.742 . . . . 0.0 112.831 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.867 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.97 5.02 37.76 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.898 -0.592 . . . . 0.0 114.226 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.459 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 25.3 t -114.52 116.98 43.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 117.386 0.593 . . . . 0.0 111.026 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 9.6 Cg_exo -74.63 54.44 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.196 2.598 . . . . 0.0 111.471 173.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.561 ' HG3' HG12 ' A' ' 352' ' ' VAL . 7.8 pt-20 -86.22 -38.96 17.09 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 121.776 0.798 . . . . 0.0 108.951 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.561 HG12 ' HG3' ' A' ' 351' ' ' GLU . 5.2 p -151.68 123.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.843 176.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -56.19 108.05 0.43 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.894 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.99 3.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.21 0.529 . . . . 0.0 110.2 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.93 82.66 5.97 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.318 -177.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -96.15 91.27 5.84 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 168.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 373' ' ' GLU . 20.9 mt -70.8 120.41 16.35 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.658 -167.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.671 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.7 mm -68.52 -21.03 25.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.287 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 10.3 m -136.98 92.38 14.24 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.845 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -86.4 43.65 1.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.218 2.612 . . . . 0.0 112.895 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.4 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.1 p-10 -150.37 58.65 3.17 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.722 ' HB2' HD11 ' A' ' 340' ' ' ILE . 92.5 Cg_endo -86.86 113.03 1.0 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.412 2.074 . . . . 0.0 113.244 -176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.2 p -114.06 140.09 48.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.913 173.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.746 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 24.6 ptt? -102.84 126.3 49.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.737 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -106.03 -166.24 1.18 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.307 -172.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -61.23 -12.88 14.74 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 178.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.64 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.2 p30 -101.26 -4.34 27.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.108 0.48 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.51 -165.47 12.71 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -78.52 -7.11 88.15 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 121.1 -0.571 . . . . 0.0 113.145 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 66.59 -120.66 15.35 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.688 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -116.04 140.22 49.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.217 0.532 . . . . 0.0 111.204 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.668 HD13 HG11 ' A' ' 342' ' ' VAL . 1.4 mt -124.42 126.6 72.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.1 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.982 ' HG2' HG12 ' A' ' 327' ' ' VAL . 38.1 mt-10 -104.75 132.58 50.82 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.217 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.464 ' HG2' ' CD1' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.646 HE21 ' H ' ' A' ' 376' ' ' LEU . 24.3 tp60 -174.32 145.08 0.97 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.097 0.248 . . . . 0.0 110.592 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.052 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.0 tp -143.59 162.74 40.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 165.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 1.052 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 34.5 Cg_exo -36.48 141.8 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.269 2.646 . . . . 0.0 113.492 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.587 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.7 Cg_exo -37.53 134.64 0.52 Allowed 'Trans proline' 0 C--N 1.354 0.845 1 C-N-CA 125.325 4.017 . . . . 0.0 114.77 -173.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.37 -146.75 13.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.251 -1.341 . . . . 0.0 110.348 -175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 346' ' ' ALA . 14.8 m-20 -112.55 101.36 9.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.481 0.641 . . . . 0.0 110.213 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.485 ' HA ' HG21 ' A' ' 354' ' ' VAL . 6.6 m120 -100.05 118.81 37.22 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.129 -0.628 . . . . 0.0 109.609 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.016 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -120.88 133.82 66.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.57 HD12 ' HB3' ' A' ' 328' ' ' MET . 30.7 mt -93.13 134.02 32.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.461 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.8 OUTLIER -109.74 92.76 4.18 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.342 174.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.504 HG13 HG12 ' A' ' 342' ' ' VAL . 5.5 t -81.28 77.99 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 68.69 -91.68 0.27 Allowed Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.971 -174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.62 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -106.61 -18.0 14.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.342 0.592 . . . . 0.0 109.643 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 0.9 OUTLIER -74.37 128.26 35.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.534 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -133.99 143.68 48.29 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.534 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 317' ' ' ALA . 0.1 OUTLIER -166.16 120.17 1.14 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.817 0.341 . . . . 0.0 110.806 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.016 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 47.1 tt0 -82.36 146.73 29.22 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.935 -172.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 19.7 t-105 -141.97 132.97 25.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.76 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.87 119.48 29.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.587 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -114.3 146.09 40.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.002 0.43 . . . . 0.0 110.343 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 52.7 pttt . . . . . 0 C--O 1.243 0.757 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.847 -178.366 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.052 0.453 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.594 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 14.6 p90 -60.74 128.81 38.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -176.29 -172.42 0.48 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.04 110.44 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 172.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.494 ' HB2' ' HE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -68.67 134.73 50.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.684 0.754 . . . . 0.0 112.112 -172.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.632 ' OD1' HG22 ' A' ' 310' ' ' THR . 32.7 t70 -63.51 146.18 54.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.274 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.659 ' HA ' ' CE2' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.83 -14.66 62.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.321 -1.309 . . . . 0.0 114.309 -167.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.632 HG22 ' OD1' ' A' ' 308' ' ' ASP . 9.1 t -106.3 5.38 29.65 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.683 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -89.73 -21.16 22.82 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.08 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.72 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -95.87 147.45 23.65 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.21 0.529 . . . . 0.0 110.17 172.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 4.3 t -133.25 153.3 51.68 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.49 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.9 m-90 -61.98 99.12 0.12 Allowed 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 123.57 0.544 . . . . 0.0 111.232 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.629 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -84.44 -42.59 15.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 53.7 ttt180 -156.03 125.58 6.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.894 170.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.58 167.23 13.82 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.258 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.61 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 5.7 Cg_exo -40.55 122.28 1.32 Allowed 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.925 2.417 . . . . 0.0 112.138 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -135.35 136.77 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.637 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -46.0 124.65 5.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.876 0.369 . . . . 0.0 111.131 173.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -36.49 83.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.749 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 130.58 -10.71 5.78 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -114.84 -78.07 0.58 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.774 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.26 0.33 0.6 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.086 -177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.43 ' HB ' HG13 ' A' ' 358' ' ' ILE . 20.9 p -119.9 -174.28 2.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.142 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.4 153.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.884 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.816 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.6 m -133.44 163.99 36.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.557 177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -147.71 153.71 39.64 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.649 -178.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.629 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 26.4 tt0 -129.6 118.07 21.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.597 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.721 HG13 ' SD ' ' A' ' 328' ' ' MET . 2.3 m -122.63 150.56 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.542 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.69 136.37 12.94 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.783 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.575 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.4 OUTLIER -90.93 -179.44 5.48 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.594 0.712 . . . . 0.0 111.241 -176.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.9 m -119.64 -25.78 5.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.993 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.21 -19.53 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.423 -1.37 . . . . 0.0 115.357 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 336' ' ' ARG . 5.5 m -75.3 134.75 40.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.021 0.91 . . . . 0.0 112.446 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.642 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.1 OUTLIER -78.3 173.7 7.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.611 171.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -25.46 95.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 124.021 3.147 . . . . 0.0 114.745 -173.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 305' ' ' THR . 21.8 p -110.67 166.87 10.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 113.78 -1.554 . . . . 0.0 110.336 -174.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.7 mpt_? -93.75 104.6 16.69 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.65 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.896 HD12 ' HB2' ' A' ' 362' ' ' PRO . 5.7 mt -75.79 123.82 88.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.044 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.06 81.42 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.311 2.007 . . . . 0.0 111.686 175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.626 HG11 HD13 ' A' ' 372' ' ' ILE . 14.5 m -100.58 133.62 43.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.416 0.627 . . . . 0.0 111.586 -177.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -143.24 -175.53 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.92 143.21 18.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.249 0.547 . . . . 0.0 111.459 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 13.4 m -115.17 172.92 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 380' ' ' ASP . . . -102.5 115.67 31.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 2.6 p-80 37.86 64.78 0.63 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.728 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.44 6.34 33.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.431 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 38.9 t -115.69 113.66 42.45 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 117.616 0.708 . . . . 0.0 111.467 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -74.72 69.07 5.4 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.08 2.52 . . . . 0.0 111.364 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -95.19 -49.02 5.68 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.13 131.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-N 113.745 -1.571 . . . . 0.0 108.391 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 42.8 t30 -60.1 107.91 0.7 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.023 177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.921 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.3 m -85.26 1.62 4.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 110.65 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.23 82.93 6.18 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.073 0.463 . . . . 0.0 110.479 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.04 92.24 5.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 28.5 mt -70.25 124.85 25.16 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.773 -165.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.0 mm -69.75 -21.53 24.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.702 -1.135 . . . . 0.0 107.994 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.8 m -137.33 94.82 11.97 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.7 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -86.01 41.22 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.396 2.731 . . . . 0.0 113.256 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.31 70.62 2.97 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.393 176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.896 ' HB2' HD12 ' A' ' 340' ' ' ILE . 95.6 Cg_endo -82.19 133.6 7.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.492 2.128 . . . . 0.0 112.434 178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.0 p -129.12 141.28 51.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.208 177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.716 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 74.1 mtp -96.0 130.51 42.98 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -108.5 -168.72 1.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 124.271 0.982 . . . . 0.0 111.837 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -70.08 -5.62 28.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.435 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 366' ' ' ASN . 65.4 m-80 -113.52 9.12 17.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.4 0.619 . . . . 0.0 109.871 171.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.58 -165.75 16.77 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.246 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.716 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.53 -12.86 70.56 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.035 -174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.47 -119.25 10.03 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.6 m-85 -121.87 131.51 54.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.688 0.756 . . . . 0.0 111.606 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.876 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.9 mt -106.17 157.68 6.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 172.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.816 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.2 mt-10 -126.87 129.15 47.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.867 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.4 OUTLIER -147.99 156.41 42.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.531 -172.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.671 HE21 ' H ' ' A' ' 376' ' ' LEU . 26.6 tp60 -177.65 146.73 0.46 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.645 0.259 . . . . 0.0 110.873 175.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.954 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.9 tp -145.26 154.46 53.77 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 164.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.954 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 41.5 Cg_exo -26.87 133.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 124.476 3.451 . . . . 0.0 115.134 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.727 ' HA ' HE22 ' A' ' 394' ' ' GLN . 54.6 Cg_exo -35.58 128.73 0.32 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 125.134 3.889 . . . . 0.0 115.114 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 167.68 -135.25 3.56 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.984 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.434 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 23.2 m-20 -119.72 101.03 7.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 117.156 0.478 . . . . 0.0 110.226 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -101.81 125.36 48.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.102 0.477 . . . . 0.0 109.893 177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -124.15 129.13 74.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 16.9 mt -91.77 130.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.921 0.391 . . . . 0.0 110.66 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.8 m-85 -99.35 92.46 5.43 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.88 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.461 HG13 HG12 ' A' ' 342' ' ' VAL . 14.6 t -79.92 84.75 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.96 -86.62 0.13 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.479 -171.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.62 ' CB ' ' HD3' ' A' ' 309' ' ' LYS . 31.0 t0 -116.71 -19.77 9.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.324 0.583 . . . . 0.0 109.479 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.613 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 0.8 OUTLIER -59.34 142.83 51.16 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.164 174.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.534 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.3 p30 -152.32 138.78 18.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.804 0.335 . . . . 0.0 110.755 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.414 ' C ' HG12 ' A' ' 382' ' ' ILE . 33.7 t-80 -165.17 126.39 2.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.12 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.0 tt0 -79.04 152.01 31.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.903 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 19.9 t-105 -147.61 120.69 8.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.887 175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -73.98 114.26 12.09 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.727 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.27 144.06 42.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.699 -177.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm . . . . . 0 C--O 1.246 0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.414 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 335' ' ' THR . 4.8 t . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.807 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 16.4 p90 -61.56 123.47 17.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.141 0.496 . . . . 0.0 110.958 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 11.6 t -171.93 -167.61 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.21 115.37 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.09 156.09 38.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.874 0.845 . . . . 0.0 111.665 -172.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.584 ' HB3' ' HD2' ' A' ' 311' ' ' LYS . 12.8 t70 -90.77 147.19 23.38 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.749 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.775 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.49 -13.56 14.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.063 -175.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.405 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 4.8 t -101.0 5.44 43.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.372 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.798 ' O ' ' HA ' ' A' ' 332' ' ' PHE . 29.5 mttt -105.33 13.04 31.0 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.775 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -128.19 143.83 51.07 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.883 0.373 . . . . 0.0 110.677 168.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -128.82 154.18 46.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -61.62 113.98 3.02 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.82 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.924 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 63.3 tttt -112.29 -53.91 2.67 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -140.71 117.89 11.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -63.22 161.37 32.76 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.09 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -44.69 119.59 2.36 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.643 2.229 . . . . 0.0 111.949 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -131.0 139.13 49.95 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.367 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.45 129.58 25.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.006 0.432 . . . . 0.0 111.445 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 96.5 p -67.27 -21.8 65.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.487 -174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.36 -18.73 30.07 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.482 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -105.72 -54.23 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.058 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -175.59 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.739 0.781 . . . . 0.0 110.687 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.879 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 32.8 p -103.76 -168.19 1.47 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.689 -174.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.949 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.1 t -125.5 151.53 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.711 HG12 ' HG3' ' A' ' 373' ' ' GLU . 18.4 m -136.32 144.89 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 123.31 0.644 . . . . 0.0 110.004 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.6 ' HE1' HG13 ' A' ' 330' ' ' VAL . 6.5 ptm -131.66 169.55 16.01 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.359 176.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.924 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 4.6 tt0 -136.39 133.04 36.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.144 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.6 HG13 ' HE1' ' A' ' 328' ' ' MET . 0.0 OUTLIER -131.42 154.53 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.203 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -115.36 138.79 14.98 Favored Glycine 0 C--O 1.226 -0.359 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.902 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.798 ' HA ' ' O ' ' A' ' 311' ' ' LYS . 1.2 p90 -99.69 177.47 5.13 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.731 0.765 . . . . 0.0 110.815 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t -164.69 45.71 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.044 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.508 ' HA3' ' HE2' ' A' ' 311' ' ' LYS . . . -176.85 -63.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.389 0 C-N-CA 119.462 -1.351 . . . . 0.0 113.905 172.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.499 ' CG2' ' HB3' ' A' ' 338' ' ' CYS . 27.6 m -86.98 129.1 35.03 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.807 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 6.1 ptm180 -64.78 169.1 5.75 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.166 171.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.745 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.5 OUTLIER -25.53 94.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 124.056 3.17 . . . . 0.0 114.383 -168.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 4.7 p -111.79 151.81 28.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.844 -173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 339' ' ' ARG . 4.3 mpt_? -73.39 108.39 6.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.514 HD11 HG11 ' A' ' 385' ' ' VAL . 14.4 tt -85.19 126.98 65.95 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.64 -175.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.62 82.17 2.17 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.557 2.171 . . . . 0.0 112.092 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 372' ' ' ILE . 16.5 m -103.21 122.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 111.271 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 17.8 ptt-85 -129.85 -173.98 3.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -155.59 139.49 16.28 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.399 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -113.04 171.22 3.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.43 28.51 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.495 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 34.4 t-80 51.24 55.41 9.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.004 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.664 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 63.7 8.6 28.06 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.634 0.614 . . . . 0.0 114.634 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 52.4 t -110.2 111.53 57.91 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 117.821 0.81 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.3 Cg_exo -77.89 46.29 2.02 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.475 2.783 . . . . 0.0 112.912 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -92.21 -53.46 4.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.389 0.614 . . . . 0.0 109.487 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.03 111.4 35.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.203 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 40.2 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.773 173.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.723 ' HA ' HD22 ' A' ' 376' ' ' LEU . 35.6 m -90.17 6.5 4.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.675 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.432 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.61 83.33 4.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 121.384 0.612 . . . . 0.0 110.35 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.8 ttp -102.8 87.9 3.07 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 105.523 -2.028 . . . . 0.0 105.523 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.9 mt -72.3 122.82 21.77 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.093 -165.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.786 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.6 mm -67.96 -22.6 28.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 52.9 m -128.97 85.98 58.63 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.154 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -82.21 40.7 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.948 2.432 . . . . 0.0 113.925 -170.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -170.56 69.77 0.55 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.13 176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.512 ' O ' HG22 ' A' ' 340' ' ' ILE . 70.0 Cg_endo -85.09 137.87 6.44 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.299 1.999 . . . . 0.0 112.84 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 3.4 p -119.54 145.93 45.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.681 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 74.4 mtp -95.82 107.55 19.81 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 120.855 0.36 . . . . 0.0 110.193 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.02 -167.32 1.84 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.079 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.67 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -63.73 -14.33 51.45 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.67 ' N ' HD22 ' A' ' 366' ' ' ASN . 84.5 m-20 -101.29 12.97 36.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.5 0.667 . . . . 0.0 109.885 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.56 -162.27 27.87 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -67.45 -16.48 67.42 Favored Glycine 0 CA--C 1.508 -0.401 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 68.41 -124.45 18.94 Favored Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 328' ' ' MET . 2.7 p90 -116.83 135.53 53.67 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 342' ' ' VAL . 2.7 mt -122.14 134.6 64.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.759 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.786 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.6 mp0 -103.05 133.01 48.89 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.191 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.672 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.8 ppp? -148.72 160.04 43.55 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.949 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -176.84 166.75 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.199 0.523 . . . . 0.0 111.7 172.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.864 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.4 tp -164.9 151.34 9.22 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.864 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 35.3 Cg_exo -36.08 143.25 0.1 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.24 2.627 . . . . 0.0 113.595 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.693 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.7 Cg_exo -37.04 135.69 0.33 Allowed 'Trans proline' 0 C--N 1.353 0.768 1 C-N-CA 125.52 4.147 . . . . 0.0 115.032 -170.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 160.47 -151.27 21.77 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.391 -175.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.3 m-20 -109.93 101.24 10.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.212 0.506 . . . . 0.0 110.435 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.438 ' HA ' HG21 ' A' ' 354' ' ' VAL . 8.6 m120 -101.36 122.96 44.68 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.965 0.412 . . . . 0.0 109.945 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.102 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.4 130.4 74.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 176.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.9 mt -89.01 126.93 42.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.075 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.512 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.02 92.49 4.57 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.814 174.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.565 HG13 HG12 ' A' ' 342' ' ' VAL . 23.0 t -83.47 90.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.45 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.084 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -106.87 -22.7 12.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.161 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.536 HD23 ' CE1' ' A' ' 390' ' ' HIS . 0.6 OUTLIER -66.14 141.11 58.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.617 -179.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -135.66 142.42 45.14 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.536 ' CE1' HD23 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -163.05 102.76 0.99 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -178.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.102 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 16.9 tt0 -76.75 149.25 36.34 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -144.94 142.39 29.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.429 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -99.16 111.06 23.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.693 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -96.79 129.16 44.26 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.651 -175.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 378' ' ' PRO . 47.5 tttm . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.938 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 305' ' ' THR . 5.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.087 0.47 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.479 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 11.5 p90 -62.57 118.57 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t -179.57 -170.31 0.16 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 5.4 t -66.76 106.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.7 146.94 52.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.531 0.681 . . . . 0.0 112.452 -168.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.507 ' OD1' HG22 ' A' ' 310' ' ' THR . 13.1 t70 -62.34 137.87 58.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.368 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.74 -23.21 67.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.582 -1.19 . . . . 0.0 113.256 -170.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.507 HG22 ' OD1' ' A' ' 308' ' ' ASP . 2.7 t -94.75 -4.91 46.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.961 0.41 . . . . 0.0 111.363 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 24.4 mtpp -88.57 49.4 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.373 0.606 . . . . 0.0 111.366 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.474 ' HZ ' HD13 ' A' ' 340' ' ' ILE . 1.8 m-85 -139.46 169.13 18.32 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.253 -177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -157.93 138.46 12.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.536 174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -64.95 107.78 1.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.576 0.703 . . . . 0.0 111.527 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 315' ' ' LYS . 46.7 tptt -83.98 -36.81 22.93 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.455 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 9.2 ttm180 -160.04 109.18 1.76 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.833 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.43 156.41 52.38 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.185 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.476 ' HB2' ' HB3' ' A' ' 392' ' ' TRP . 6.5 Cg_exo -32.72 118.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.931 3.087 . . . . 0.0 113.605 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.2 m -143.52 144.38 31.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.887 -171.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -44.44 136.55 4.11 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 111.478 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.636 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.2 p -69.43 -23.52 63.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.968 -173.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.92 -1.42 88.8 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -171.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -107.27 -54.76 2.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 23.9 t70 177.12 -32.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.002 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.502 ' CB ' HG13 ' A' ' 358' ' ' ILE . 1.1 p -95.81 -166.88 1.51 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.845 -175.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.533 HG11 ' CE2' ' A' ' 392' ' ' TRP . 0.9 OUTLIER -109.48 155.99 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.876 176.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -139.42 174.25 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.115 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.702 ' HE2' HD12 ' A' ' 372' ' ' ILE . 21.5 ptt? -151.71 158.87 43.97 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 169.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 25.8 tt0 -120.27 125.82 49.05 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 312' ' ' PHE . 13.5 m -130.02 137.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.061 0.457 . . . . 0.0 112.03 -173.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -110.81 159.25 13.91 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.574 ' HD1' ' H ' ' A' ' 335' ' ' THR . 0.2 OUTLIER -118.23 179.99 3.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.451 0.626 . . . . 0.0 111.47 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.9 p -130.47 11.19 5.31 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.86 31.3 0.13 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 119.477 -1.344 . . . . 0.0 115.479 169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.845 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 31.0 m -112.67 122.56 48.03 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 171.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.537 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 20.6 ptt180 -76.95 167.02 40.26 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.052 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.67 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.13 98.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 124.225 3.283 . . . . 0.0 114.855 -165.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.86 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 13.2 p -109.64 173.13 6.46 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.552 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 19.9 mmm180 -95.45 102.91 14.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.795 HG22 HG13 ' A' ' 342' ' ' VAL . 48.8 mt -75.89 124.88 88.71 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.747 0.308 . . . . 0.0 111.575 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.33 82.01 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.884 2.389 . . . . 0.0 111.972 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.795 HG13 HG22 ' A' ' 340' ' ' ILE . 6.1 m -103.23 129.09 55.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.572 0.701 . . . . 0.0 111.325 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -142.49 -174.57 4.17 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -153.04 138.78 17.91 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.898 177.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.421 HG22 HD12 ' A' ' 382' ' ' ILE . 16.8 m -110.34 175.96 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -109.03 114.08 27.52 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.554 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 50.68 47.98 23.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.025 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.688 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 67.34 16.7 67.48 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.484 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 57.9 t -114.86 109.85 46.98 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 120.764 0.316 . . . . 0.0 110.861 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 61.76 6.36 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.48 2.786 . . . . 0.0 112.274 176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -97.48 -47.2 5.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.842 0.829 . . . . 0.0 109.011 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -137.21 124.05 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.563 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.6 t30 -61.19 107.67 0.78 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.908 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.907 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.1 m -89.5 5.77 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.173 0.511 . . . . 0.0 110.753 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 344' ' ' ALA . . . -80.63 84.26 6.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.447 ' HB2' HD13 ' A' ' 376' ' ' LEU . 0.0 OUTLIER -97.5 87.02 3.99 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 170.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 38.1 mt -68.82 126.53 30.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.582 -167.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -71.22 -20.91 21.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 48.6 m -136.45 87.48 21.78 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 114.341 -1.299 . . . . 0.0 108.933 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -88.4 50.95 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 123.332 2.688 . . . . 0.0 113.272 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.518 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.0 p-10 -160.49 58.9 1.12 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.06 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 1.2 Cg_endo -82.09 139.28 10.62 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.582 2.188 . . . . 0.0 112.592 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 338' ' ' CYS . 14.6 p -134.39 142.39 47.16 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.363 177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.86 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 17.0 ptp -94.64 130.41 41.12 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.72 -165.32 1.19 Allowed 'General case' 0 C--N 1.313 -0.995 0 O-C-N 124.925 1.391 . . . . 0.0 109.031 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.675 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.4 OUTLIER -55.61 -20.57 14.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 178.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.675 ' N ' HD22 ' A' ' 366' ' ' ASN . 12.4 m-20 -108.55 13.12 25.54 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.128 0.489 . . . . 0.0 110.696 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 88.21 -161.18 31.32 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.49 -25.35 74.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.84 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 76.08 -123.94 7.13 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.92 138.31 47.47 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' A' ' 328' ' ' MET . 0.8 OUTLIER -129.94 166.14 28.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.848 ' HG2' HG12 ' A' ' 327' ' ' VAL . 46.0 mt-10 -129.49 138.23 51.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.739 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -152.67 151.82 31.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.073 -174.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 1.0 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.58 165.91 2.64 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.161 0.288 . . . . 0.0 110.864 173.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 12.2 tp -164.8 163.94 13.71 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 63.0 Cg_exo -29.11 131.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.826 3.017 . . . . 0.0 114.343 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.71 ' HB3' ' HD2' ' A' ' 395' ' ' LYS . 6.0 Cg_exo -38.28 139.36 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.825 1 C-N-CA 125.633 4.222 . . . . 0.0 114.938 -175.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.09 -153.08 24.53 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -103.35 109.91 21.71 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 122.264 0.225 . . . . 0.0 110.691 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.416 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.2 m120 -112.22 172.69 6.76 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.202 175.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.051 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -165.16 133.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.9 mt -93.8 133.02 36.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.385 -174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -107.64 96.97 6.77 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.322 175.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.92 67.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 72.86 -84.05 0.58 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.489 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 15.1 t70 -100.44 -34.99 9.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.1 mp -61.03 143.34 55.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.8 p30 -159.67 138.47 10.79 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.016 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.65 126.52 1.56 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.154 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.051 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 23.7 mt-30 -70.13 153.23 43.39 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.546 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -153.94 150.53 28.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.474 171.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -99.47 136.0 40.06 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.555 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -132.31 147.37 52.4 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.772 -178.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.71 ' HD2' ' HB3' ' A' ' 378' ' ' PRO . 23.5 tptm . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.683 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.607 ' HD2' ' HD3' ' A' ' 336' ' ' ARG . 21.5 p90 -53.57 125.83 19.51 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.213 0.53 . . . . 0.0 111.298 176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.7 t -175.9 -175.9 0.78 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.172 -175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 91.1 t -69.41 105.57 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.5 OUTLIER -72.35 153.35 41.52 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.6 t70 -72.3 154.67 40.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.468 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -70.97 -12.52 61.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.453 -172.279 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.5 t -100.05 7.03 44.99 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.911 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.665 ' HE3' ' CB ' ' A' ' 335' ' ' THR . 3.9 mtpm? -85.31 -27.45 25.94 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.915 -0.491 . . . . 0.0 112.303 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.78 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.7 OUTLIER -102.62 160.12 14.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.646 0.736 . . . . 0.0 111.936 -175.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 3.0 t -140.37 155.42 46.77 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.789 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.47 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.5 m-90 -65.33 96.48 0.23 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.254 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.716 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.0 tttt -86.46 -46.76 9.9 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.791 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 37.0 ttm180 -147.34 98.93 3.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.663 171.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -55.04 159.17 4.09 Favored Pre-proline 0 N--CA 1.467 0.403 0 CA-C-O 119.212 -0.423 . . . . 0.0 110.947 177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 7.1 Cg_exo -34.25 115.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.581 2.854 . . . . 0.0 113.596 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.5 m -129.49 134.06 47.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.806 -173.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -47.8 125.1 8.19 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.465 ' HB3' HG13 ' A' ' 327' ' ' VAL . 90.4 p -67.83 -35.27 78.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.577 -172.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.72 -11.88 18.26 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.724 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -98.51 -71.48 0.69 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -171.61 18.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.57 ' HB ' HG13 ' A' ' 358' ' ' ILE . 18.1 p -131.74 -167.91 1.94 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.397 -171.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.904 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 1.9 t -130.04 149.78 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.509 -0.477 . . . . 0.0 111.272 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.991 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -135.83 140.96 43.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.394 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 11.1 ptm -130.03 150.84 51.12 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.958 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.791 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.9 tt0 -116.14 122.56 45.44 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.754 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 14.5 m -126.28 139.85 50.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.661 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.16 141.49 15.28 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.918 -176.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -90.61 178.68 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.22 0.51 . . . . 0.0 110.561 -177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.5 t -122.8 -62.78 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.78 -59.66 0.19 Allowed Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.771 -176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.665 ' CB ' ' HE3' ' A' ' 311' ' ' LYS . 52.1 m -56.72 134.26 54.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.827 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.9 ptm180 -66.8 179.67 0.5 Allowed Pre-proline 0 N--CA 1.468 0.45 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.755 173.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.16 96.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 124.01 3.14 . . . . 0.0 114.573 178.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 305' ' ' THR . 31.4 p -113.93 160.08 19.19 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.428 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -79.02 104.25 9.53 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 362' ' ' PRO . 16.8 tt -87.72 127.47 58.06 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 121.326 0.584 . . . . 0.0 111.342 -172.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.57 92.44 0.86 Allowed 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.857 2.371 . . . . 0.0 112.504 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.67 HG11 HD13 ' A' ' 372' ' ' ILE . 31.4 m -110.13 135.5 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.342 0.591 . . . . 0.0 110.897 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 23.7 ptt180 -149.8 -174.2 4.63 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.41 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -156.72 143.21 18.35 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.412 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.2 m -119.48 169.49 10.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.51 114.4 27.36 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.122 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.465 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 27.1 p-80 35.29 61.76 0.63 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.684 0.794 . . . . 0.0 112.851 -175.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.585 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 76.06 0.09 64.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.025 -0.534 . . . . 0.0 114.402 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.23 114.32 55.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.516 0.658 . . . . 0.0 111.616 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -78.72 58.49 6.85 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.62 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.6 ' HG2' HG12 ' A' ' 352' ' ' VAL . 9.4 tt0 -83.22 -37.0 24.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.061 0.934 . . . . 0.0 108.823 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 351' ' ' GLU . 2.1 p -161.06 122.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.49 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -51.82 107.82 0.23 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.268 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.564 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.7 m -90.4 6.55 4.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.688 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -76.91 83.39 3.46 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.342 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.636 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 16.7 mmt -95.15 85.22 4.25 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 170.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 31.0 mt -68.2 126.23 28.9 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.398 -167.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.724 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.9 mm -71.61 -17.59 19.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 17.2 m -139.56 91.89 10.56 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.897 174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.16 35.33 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.254 2.636 . . . . 0.0 113.511 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -149.52 64.12 6.97 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.102 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 372' ' ' ILE . 69.8 Cg_endo -88.13 128.09 2.22 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.583 2.189 . . . . 0.0 113.443 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 12.1 p -122.98 149.45 44.27 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.535 173.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.728 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 72.4 mtm -95.94 106.32 18.46 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.268 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.591 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 55.4 mm-40 -80.9 -167.64 1.48 Allowed 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.956 1.41 . . . . 0.0 111.358 -176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.57 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -65.63 -7.19 13.83 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 178.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.57 ' N ' HD22 ' A' ' 366' ' ' ASN . 9.0 p30 -110.48 -4.84 15.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.444 0.64 . . . . 0.0 109.513 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.18 -166.75 12.71 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -171.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.728 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.97 -9.6 60.13 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.118 -175.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.78 -114.38 6.38 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.93 117.81 26.41 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.185 0.517 . . . . 0.0 111.288 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.67 HD13 HG11 ' A' ' 342' ' ' VAL . 1.6 mt -93.11 143.15 12.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.991 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -121.59 132.0 54.43 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.084 -174.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.628 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.9 OUTLIER -153.63 157.29 39.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.59 -171.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.989 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -174.6 168.67 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.949 0.404 . . . . 0.0 111.224 172.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.871 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -164.64 143.92 5.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.871 ' HD2' HD22 ' A' ' 376' ' ' LEU . 23.3 Cg_exo -28.82 124.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.805 3.003 . . . . 0.0 114.281 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.651 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 5.4 Cg_exo -37.39 131.82 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.158 1 C-N-CA 125.475 4.116 . . . . 0.0 114.805 -171.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.68 -161.09 33.45 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.791 -175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -99.37 101.33 12.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.925 0.362 . . . . 0.0 111.025 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.481 ' OD1' HG11 ' A' ' 354' ' ' VAL . 31.6 m-80 -121.04 -179.64 4.09 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.075 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.989 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.62 141.88 3.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 11.8 mt -96.22 133.55 37.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.639 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -111.9 92.17 3.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.138 177.353 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 11.9 t -86.42 90.72 3.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.41 -91.87 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.063 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 12.6 t70 -116.31 -4.7 11.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.328 0.585 . . . . 0.0 110.017 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.78 HD13 ' HD1' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -78.06 142.38 38.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 23.9 p-10 -153.81 141.49 19.96 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.773 0.32 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.1 t-80 -162.08 116.25 1.86 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.771 174.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.989 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -78.26 143.19 37.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.544 177.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.904 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.8 OUTLIER -154.32 148.01 25.33 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -85.42 123.46 30.9 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.651 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -105.73 144.86 31.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.017 0.437 . . . . 0.0 110.806 -176.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.219 -175.454 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.714 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 23.5 p90 -68.52 112.29 5.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.933 0.873 . . . . 0.0 110.6 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 15.3 t -159.21 -165.97 1.71 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.451 -172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.0 113.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 143.89 55.15 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 121.8 0.81 . . . . 0.0 111.06 -174.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 8.9 t70 -75.44 147.35 39.98 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.325 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.773 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -60.58 -12.82 11.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.964 -173.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.459 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 14.2 t -103.66 9.35 37.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.674 0.273 . . . . 0.0 111.399 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 9.5 mtpp -96.39 -23.98 16.36 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -175.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.773 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.2 OUTLIER -101.31 158.5 16.0 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.403 0.62 . . . . 0.0 111.227 178.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 154.77 46.54 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.11 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.526 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 22.6 m-90 -60.36 96.34 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.7 tttm -80.52 -37.94 30.64 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 173.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.89 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 67.3 ttt180 -157.81 111.37 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.752 174.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -59.4 155.79 34.75 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 119.192 -0.432 . . . . 0.0 110.979 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.742 ' HG3' HD12 ' A' ' 383' ' ' ILE . 30.7 Cg_exo -34.27 115.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 123.294 2.663 . . . . 0.0 113.68 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.2 m -141.75 138.35 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.707 -171.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.66 131.74 8.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.061 0.458 . . . . 0.0 112.074 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.649 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.5 p -73.9 -25.28 59.93 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -176.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.58 -5.35 73.71 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.362 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -119.44 39.22 3.65 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 69.97 4.84 4.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.512 0.725 . . . . 0.0 111.977 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 2.7 p -121.54 -170.26 2.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.797 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.4 OUTLIER -127.95 153.63 37.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.985 -179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.976 HG12 ' HG2' ' A' ' 373' ' ' GLU . 24.4 m -135.53 157.41 39.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.526 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 8.2 ptm -138.19 158.4 44.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.89 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 4.1 mt-10 -122.24 135.49 54.76 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.478 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.587 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.2 OUTLIER -132.34 152.27 36.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.828 177.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.691 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.89 149.68 18.15 Favored Glycine 0 C--O 1.226 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.922 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.479 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 1.4 p90 -94.08 178.94 5.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.291 0.567 . . . . 0.0 110.853 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.4 p -131.68 -17.62 2.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.102 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -170.03 -51.06 0.03 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.306 -1.426 . . . . 0.0 114.119 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 336' ' ' ARG . 24.6 m -57.17 129.66 42.74 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.714 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 11.7 ptm180 -69.79 167.32 24.52 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 117.982 -1.008 . . . . 0.0 108.514 171.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -25.79 96.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 123.894 3.062 . . . . 0.0 115.235 -167.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 5.9 p -108.8 147.24 32.36 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.131 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -70.39 108.24 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.55 HD11 HG11 ' A' ' 385' ' ' VAL . 12.5 tt -89.49 123.82 65.82 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.559 -176.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.69 92.22 0.96 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.902 2.401 . . . . 0.0 112.669 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.68 HG11 HD13 ' A' ' 372' ' ' ILE . 30.1 m -108.78 125.25 65.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.676 0.751 . . . . 0.0 111.451 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -134.19 -177.42 4.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -148.86 135.07 19.28 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.972 177.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -107.88 173.23 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -112.69 115.12 28.06 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.616 -174.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 33.4 t60 57.93 45.82 17.61 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.381 0.61 . . . . 0.0 110.227 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.441 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.02 6.57 46.19 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.001 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.16 111.42 60.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 117.361 0.58 . . . . 0.0 111.158 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -76.55 47.85 2.22 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.602 2.868 . . . . 0.0 113.032 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -97.35 -53.36 3.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.28 113.73 44.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.031 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 28.3 t30 -70.23 108.71 4.29 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.749 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.657 HG12 HD22 ' A' ' 376' ' ' LEU . 33.3 m -90.94 10.07 3.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.127 -175.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.459 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.23 84.37 3.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.116 0.484 . . . . 0.0 111.436 -177.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.724 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 71.2 mtp -98.85 88.97 4.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.513 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 47.5 mt -76.66 120.76 22.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.157 -167.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.729 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -68.75 -16.9 21.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 91.5 m -135.19 87.73 27.75 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.906 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.57 40.36 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.127 2.551 . . . . 0.0 114.307 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.09 68.57 1.83 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 121.172 0.511 . . . . 0.0 111.389 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.502 ' HG3' HG21 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -85.48 135.59 5.2 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.444 2.096 . . . . 0.0 113.081 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 1.0 OUTLIER -129.72 146.85 51.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.679 174.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.651 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 29.0 mtm -94.61 104.98 16.92 Favored 'General case' 0 CA--C 1.508 -0.635 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.315 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -83.6 -166.36 1.37 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.284 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -67.14 -10.59 51.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.147 0.499 . . . . 0.0 110.629 171.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.6 ' N ' HD22 ' A' ' 366' ' ' ASN . 47.0 m-20 -86.89 -7.03 58.58 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.438 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 90.27 -161.04 28.64 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -166.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -62.94 -19.77 61.55 Favored Glycine 0 C--N 1.322 -0.223 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.778 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 73.8 -124.68 8.71 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -112.06 127.0 55.77 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.68 HD13 HG11 ' A' ' 342' ' ' VAL . 1.0 OUTLIER -114.91 125.55 72.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 174.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.976 ' HG2' HG12 ' A' ' 327' ' ' VAL . 36.2 mt-10 -101.79 134.18 45.37 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.797 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -153.19 160.51 42.84 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.98 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 178.87 170.74 0.86 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.367 0.417 . . . . 0.0 110.725 177.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.854 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 7.8 tp -161.88 157.35 20.41 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.854 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 53.4 Cg_exo -39.25 131.74 1.46 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.342 2.028 . . . . 0.0 112.304 169.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.866 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.3 Cg_exo -38.05 129.49 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 125.297 3.998 . . . . 0.0 114.946 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 174.41 -133.57 2.55 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.589 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.67 101.59 7.69 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 122.289 0.236 . . . . 0.0 110.561 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.405 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 7.4 m120 -112.35 161.89 16.15 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.01 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.088 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.02 138.71 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.742 HD12 ' HG3' ' A' ' 318' ' ' PRO . 27.8 mt -94.65 132.53 38.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.376 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -109.03 91.71 3.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.674 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.2 t -83.88 84.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.34 -88.54 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.055 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -111.42 -14.17 13.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.226 0.536 . . . . 0.0 109.723 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.702 HD13 ' HD1' ' A' ' 312' ' ' PHE . 1.0 OUTLIER -68.33 147.19 52.48 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.602 175.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 24.9 p-10 -156.76 140.31 15.87 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.669 0.271 . . . . 0.0 110.66 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.595 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.3 t60 -165.88 115.2 0.99 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.546 174.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.088 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 44.5 tt0 -85.05 146.54 27.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.048 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.589 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.7 OUTLIER -147.97 150.03 33.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -92.35 132.78 36.46 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.952 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -126.73 142.7 51.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.309 -177.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 12.3 ptmm? . . . . . 0 C--O 1.245 0.818 0 CA-C-O 118.656 -0.688 . . . . 0.0 110.773 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.889 0.376 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.823 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 17.1 p90 -64.43 130.44 43.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.499 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.7 t 178.73 -166.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.6 p -62.83 114.65 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 143.0 56.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.702 0.763 . . . . 0.0 110.757 -173.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' ' HG2' ' A' ' 309' ' ' LYS . 5.8 t70 -86.48 150.57 24.18 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.693 -176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.703 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 23.4 pttm -52.03 -23.2 4.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.762 -1.563 . . . . 0.0 112.521 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 9.0 t -100.92 10.42 41.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.55 -174.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.493 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 26.7 mmmt -92.5 -25.09 18.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.7 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.4 OUTLIER -112.44 157.9 20.51 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.323 0.582 . . . . 0.0 112.153 -176.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -133.92 158.18 44.11 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.717 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.463 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.7 m-90 -62.28 111.81 2.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.373 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.485 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 57.1 tttm -104.12 -40.3 6.21 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.212 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.818 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 32.5 ttm180 -158.74 129.94 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.419 170.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.28 163.11 70.58 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.234 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 3.0 Cg_exo -37.03 120.41 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.44 2.76 . . . . 0.0 112.845 176.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.3 m -136.24 134.8 38.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.526 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -48.14 124.12 7.27 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.107 0.48 . . . . 0.0 110.946 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 89.1 p -65.17 -22.88 66.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.189 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.65 34.12 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -99.61 -71.89 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -175.06 21.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.912 0.863 . . . . 0.0 108.952 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.7 p -137.69 -169.18 2.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.418 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.516 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -127.54 151.37 34.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.234 0.54 . . . . 0.0 111.633 -177.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.4 m -136.6 142.42 38.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.608 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 9.8 ptm -128.18 164.33 22.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.015 174.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.818 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 27.5 tt0 -126.46 126.07 43.18 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.048 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.42 153.07 32.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.397 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.7 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -126.28 144.0 14.78 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.431 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.408 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 1.3 p90 -91.07 179.18 5.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.252 0.549 . . . . 0.0 111.286 -176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 14.4 p -143.24 -7.8 0.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.278 -0.873 . . . . 0.0 112.868 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 179.14 -3.3 0.02 OUTLIER Glycine 0 CA--C 1.526 0.728 0 C-N-CA 118.648 -1.739 . . . . 0.0 116.068 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.493 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 26.5 m -107.62 124.65 50.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.258 1.029 . . . . 0.0 110.57 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.823 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 9.3 ptm180 -70.73 168.79 17.49 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.399 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.799 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.3 OUTLIER -25.36 94.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 124.259 3.306 . . . . 0.0 114.712 -169.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 363' ' ' THR . 7.0 p -112.77 152.16 29.45 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.225 -1.807 . . . . 0.0 110.936 -174.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -74.48 106.27 6.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 362' ' ' PRO . 14.1 tt -81.89 129.24 65.57 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.444 -175.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.37 81.58 2.45 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.429 2.086 . . . . 0.0 112.066 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.802 HG11 HD13 ' A' ' 372' ' ' ILE . 15.6 m -102.28 119.78 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.691 0.758 . . . . 0.0 111.216 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -132.46 -178.68 5.03 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.36 139.14 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.891 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.474 HG22 HD12 ' A' ' 382' ' ' ILE . 11.0 m -111.22 168.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.55 114.52 28.73 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.119 -173.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 50.7 t60 52.9 54.87 9.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.801 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.727 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 62.79 15.84 55.44 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.988 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 46.2 t -118.37 109.64 40.19 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 117.438 0.619 . . . . 0.0 111.222 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.15 50.27 2.18 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.229 2.619 . . . . 0.0 112.658 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -96.78 -53.87 3.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.71 115.3 48.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.298 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -63.26 108.78 1.37 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.9 174.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.566 ' HA ' HD22 ' A' ' 376' ' ' LEU . 34.6 m -93.93 7.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.034 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.42 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -80.41 83.27 6.26 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.427 0.632 . . . . 0.0 110.652 178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.726 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 46.1 ttp -99.35 90.97 4.73 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 33.5 mt -71.66 125.1 26.23 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.532 -167.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.759 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 5.1 mm -68.46 -24.06 28.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.7 m -132.25 91.75 30.71 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.995 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -85.61 44.16 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.226 2.617 . . . . 0.0 114.057 -169.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.0 67.86 0.8 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.228 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.552 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.1 Cg_endo -82.74 133.63 7.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.229 1.952 . . . . 0.0 113.032 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 5.6 p -120.82 144.21 48.46 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.168 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.718 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 39.3 mtm -95.59 119.92 34.93 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -95.73 -167.01 1.53 Allowed 'General case' 0 C--N 1.319 -0.732 0 O-C-N 124.41 1.069 . . . . 0.0 110.906 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.605 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -66.27 -11.72 52.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.892 176.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.605 ' N ' HD22 ' A' ' 366' ' ' ASN . 82.6 m-20 -99.23 0.23 42.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 109.506 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 99.24 -162.38 19.95 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -73.73 -16.71 79.14 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.276 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 67.15 -120.27 13.31 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 328' ' ' MET . 29.4 p90 -120.29 141.2 50.22 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.48 0.657 . . . . 0.0 110.902 176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.802 HD13 HG11 ' A' ' 342' ' ' VAL . 4.0 mt -115.3 154.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.839 177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.759 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 41.9 mt-10 -120.36 128.43 53.23 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.819 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.56 162.62 38.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.633 -174.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.804 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 175.74 158.92 0.25 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.004 0.366 . . . . 0.0 110.983 172.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.783 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.0 tp -154.4 149.67 20.74 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 166.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.783 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 33.5 Cg_exo -27.06 125.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.918 3.078 . . . . 0.0 113.522 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -37.53 133.04 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.66 3.573 . . . . 0.0 114.493 -168.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.72 -128.66 1.66 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.268 -173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.91 100.87 7.49 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.641 0.258 . . . . 0.0 110.848 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.424 ' OD1' ' HG3' ' A' ' 394' ' ' GLN . 8.0 m120 -112.56 125.25 54.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.234 0.54 . . . . 0.0 109.684 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.048 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -123.05 131.76 72.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 174.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.8 mt -92.32 128.92 43.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.189 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 91.95 3.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.007 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.709 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 16.4 t -83.56 78.28 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.41 -82.63 0.08 OUTLIER Glycine 0 CA--C 1.521 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.423 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.703 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 22.3 t70 -106.35 -28.95 10.06 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 175.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.709 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.7 mp -63.67 149.43 46.6 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.525 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.7 p30 -163.12 143.12 8.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.245 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -164.95 118.44 1.26 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.281 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.048 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.2 tm0? -81.54 140.48 34.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.57 -178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.591 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 3.5 t-105 -149.54 147.47 28.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.736 172.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -95.04 119.16 33.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.591 ' OE1' ' HD1' ' A' ' 392' ' ' TRP . 4.3 mm100 -85.12 114.44 22.25 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.329 -177.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.271 0.558 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 336' ' ' ARG . 42.6 p90 -62.43 121.52 13.46 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.339 0.59 . . . . 0.0 110.128 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.1 t -176.37 -172.11 0.45 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -174.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.56 105.65 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 166.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 340' ' ' ILE . 0.5 OUTLIER -70.35 155.08 41.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.707 0.765 . . . . 0.0 112.621 -168.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.3 t70 -73.32 141.12 47.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.94 -177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.713 ' HD2' ' HB2' ' A' ' 387' ' ' ASP . 24.3 pttt -50.95 -27.54 7.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.502 -1.681 . . . . 0.0 114.406 -172.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.427 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.9 t -105.21 7.25 33.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -169.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.437 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 27.2 mtpp -84.42 -22.65 30.33 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.443 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -82.63 157.0 23.58 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 120.992 0.425 . . . . 0.0 109.894 -178.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 76.2 p -123.29 134.38 54.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.995 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.569 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 31.5 m-90 -50.99 96.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.595 168.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -96.39 -30.2 13.52 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 14.8 ttt180 -164.43 113.64 1.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.107 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.527 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.09 164.48 17.72 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.527 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.2 Cg_exo -39.41 118.35 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.634 2.222 . . . . 0.0 111.86 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 22.5 m -130.8 135.14 47.47 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.21 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -47.53 127.0 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 87.9 p -69.2 -16.13 63.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.16 72.87 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 69.5 t60 -108.14 -52.98 2.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.029 -0.586 . . . . 0.0 110.307 -178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 29.6 t70 166.18 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.467 1.127 . . . . 0.0 108.111 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.525 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.9 p -93.92 -170.94 2.44 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.661 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.95 151.54 35.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.867 0.365 . . . . 0.0 110.982 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.723 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.0 m -136.04 144.48 33.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.249 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.744 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -127.58 150.62 49.63 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 2.6 tt0 -122.13 124.95 45.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.992 0.425 . . . . 0.0 110.514 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.744 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -122.45 150.98 26.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.363 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -104.52 160.43 15.65 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 172.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.449 ' HD2' ' H ' ' A' ' 332' ' ' PHE . 1.5 p90 -106.52 178.16 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.078 0.939 . . . . 0.0 110.38 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 6.1 p -133.46 -13.15 2.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.16 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -175.95 -26.14 0.03 OUTLIER Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.201 -1.476 . . . . 0.0 114.695 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.638 ' HB ' ' HE2' ' A' ' 364' ' ' MET . 19.8 m -82.7 135.81 34.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.632 0.716 . . . . 0.0 111.566 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.618 ' O ' HG22 ' A' ' 335' ' ' THR . 9.1 ptt180 -78.71 177.73 2.67 Favored Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -27.38 97.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.775 2.983 . . . . 0.0 114.807 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.841 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 18.1 p -110.24 166.74 10.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.719 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -90.77 99.3 12.35 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.613 HG22 HG13 ' A' ' 342' ' ' VAL . 46.1 mt -74.67 120.82 83.41 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.229 -172.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.33 80.27 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.227 1.952 . . . . 0.0 111.661 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.657 HG11 HD13 ' A' ' 372' ' ' ILE . 9.5 m -99.57 133.26 43.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.088 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -141.99 -178.07 5.52 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -155.24 135.29 12.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.77 178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 382' ' ' ILE . 15.8 m -111.13 163.24 8.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.75 114.53 28.86 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.493 -174.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 10.9 t-80 53.9 52.16 13.46 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.486 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 65.8 5.7 26.36 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.888 -0.596 . . . . 0.0 114.188 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 110.6 61.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 117.481 0.641 . . . . 0.0 111.391 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.65 54.58 4.84 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.079 2.519 . . . . 0.0 112.091 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.3 -47.72 5.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.49 0.662 . . . . 0.0 109.55 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.3 p -129.24 119.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.35 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -62.58 109.44 1.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.129 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.659 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 14.1 m -91.58 12.85 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.749 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -84.69 81.82 8.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.504 0.669 . . . . 0.0 110.019 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.715 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 13.1 tpt -101.15 86.33 3.0 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 170.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 36.9 mt -70.82 126.26 29.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.615 -167.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.704 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -71.67 -17.18 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 15.6 m -140.08 91.46 10.12 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.505 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.44 41.35 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.091 2.527 . . . . 0.0 112.946 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -155.68 61.01 2.67 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.924 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.58 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -81.34 135.31 9.41 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.271 1.981 . . . . 0.0 112.935 -177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 25.2 p -131.3 133.65 45.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.717 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.85 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 25.7 ptt? -95.68 131.33 42.05 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.624 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 29.7 mt-10 -114.52 -165.1 0.98 Allowed 'General case' 0 C--N 1.321 -0.666 0 O-C-N 124.874 1.359 . . . . 0.0 110.318 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.585 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -62.01 -7.82 4.42 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 178.009 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.585 ' N ' HD22 ' A' ' 366' ' ' ASN . 6.8 p30 -105.81 -3.99 21.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.577 0.703 . . . . 0.0 109.547 175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 102.38 -166.22 17.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -171.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.85 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -70.15 -9.68 64.12 Favored Glycine 0 CA--C 1.51 -0.266 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.246 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.3 -126.35 30.75 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -174.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.222 0.534 . . . . 0.0 111.361 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.657 HD13 HG11 ' A' ' 342' ' ' VAL . 2.8 mt -111.71 131.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.062 173.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.723 ' HG2' HG12 ' A' ' 327' ' ' VAL . 45.5 mt-10 -104.16 132.08 50.78 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.135 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.638 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 4.8 ppp? -148.52 161.99 40.53 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -176.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.918 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.35 159.03 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.69 0.281 . . . . 0.0 110.953 173.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 354' ' ' VAL . 0.5 OUTLIER -164.98 143.92 5.52 Favored Pre-proline 0 N--CA 1.451 -0.419 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.653 ' HD2' HD22 ' A' ' 376' ' ' LEU . 22.2 Cg_exo -24.02 129.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.638 3.559 . . . . 0.0 114.689 177.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.542 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.6 Cg_exo -36.97 128.61 0.52 Allowed 'Trans proline' 0 C--N 1.357 0.976 1 C-N-CA 125.583 4.189 . . . . 0.0 114.942 -171.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 166.09 -152.63 21.95 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.7 m-20 -98.45 101.23 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.974 0.887 . . . . 0.0 110.677 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -96.75 123.81 40.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.975 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -118.54 129.25 75.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.589 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.5 mt -92.71 133.62 33.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.46 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.4 OUTLIER -107.16 91.82 3.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.358 176.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.5 t -79.36 77.27 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 71.82 -83.6 0.48 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.738 -174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.713 ' HB2' ' HD2' ' A' ' 309' ' ' LYS . 20.3 t70 -116.26 -19.96 9.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.343 0.592 . . . . 0.0 109.55 176.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.5 OUTLIER -60.28 145.35 47.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.229 173.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.463 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 7.5 p30 -155.41 143.79 20.27 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.591 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.532 ' H ' HG12 ' A' ' 382' ' ' ILE . 2.3 t60 -173.31 123.75 0.39 Allowed 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.285 0.366 . . . . 0.0 111.271 173.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.975 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.5 mt-30 -71.58 153.21 42.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.446 177.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 22.6 t-105 -151.36 119.84 6.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.859 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -74.65 113.25 11.7 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -112.37 147.54 36.18 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.468 -175.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 C--O 1.249 1.065 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.286 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 335' ' ' THR . 4.2 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.443 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.7 p90 -57.43 128.53 37.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.202 0.525 . . . . 0.0 110.998 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.0 t -177.42 -171.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 58.1 t -64.8 105.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 168.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.749 ' HB2' ' HD3' ' A' ' 311' ' ' LYS . 0.9 OUTLIER -79.06 161.7 26.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.818 0.818 . . . . 0.0 112.766 -171.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.498 ' OD2' HG22 ' A' ' 310' ' ' THR . 13.0 t70 -78.39 155.73 29.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.935 -178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.747 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -76.83 -14.64 59.88 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.904 -172.12 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.563 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.4 t -91.19 2.74 56.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.137 0.494 . . . . 0.0 111.192 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.749 ' HD3' ' HB2' ' A' ' 307' ' ' CYS . 5.5 mtpm? -81.3 -44.43 17.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.981 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.747 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -84.88 159.37 20.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.466 0.651 . . . . 0.0 111.853 -172.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 7.1 t -140.04 147.84 40.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.21 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 23.2 m-90 -52.7 101.59 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.493 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.671 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.1 tttp -90.01 -45.5 9.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.753 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 77.9 ttt180 -152.75 118.97 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.692 170.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.83 162.82 49.0 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.39 -175.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.675 ' HG2' ' O ' ' A' ' 390' ' ' HIS . 53.4 Cg_exo -30.79 116.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 123.703 2.935 . . . . 0.0 113.558 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 52.9 m -127.9 124.84 38.4 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.98 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.27 127.02 25.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.212 0.53 . . . . 0.0 109.88 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.416 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.5 p -68.41 -21.55 64.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 -174.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 86.69 -0.19 86.47 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.514 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -112.38 28.82 8.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 11.7 t70 64.09 24.83 13.61 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.84 0.829 . . . . 0.0 110.05 -176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.411 ' HB ' HG13 ' A' ' 358' ' ' ILE . 21.5 p -140.1 -171.72 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.203 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.887 HG13 HE22 ' A' ' 394' ' ' GLN . 0.2 OUTLIER -129.71 155.66 41.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 118.201 0.455 . . . . 0.0 111.665 -177.104 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.633 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -141.2 144.98 25.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.354 175.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.531 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 13.1 ptm -136.62 167.0 22.23 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.465 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 26.8 tt0 -133.34 128.33 35.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.282 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.07 157.58 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.937 0.399 . . . . 0.0 111.842 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.92 153.02 17.57 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -95.01 178.78 5.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 117.342 0.571 . . . . 0.0 110.697 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 13.1 t -162.86 35.8 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 172.28 -92.46 0.09 OUTLIER Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.241 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.659 ' HB ' ' HE3' ' A' ' 311' ' ' LYS . 21.5 m -54.67 134.42 47.13 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.182 0.593 . . . . 0.0 111.966 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.808 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.6 ptt180 -72.14 -177.58 0.53 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 117.468 -1.253 . . . . 0.0 109.125 172.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.808 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.64 94.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.852 3.035 . . . . 0.0 114.588 -173.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.8 p -116.05 158.06 23.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.788 -172.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -74.84 97.14 3.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.494 HG12 HG13 ' A' ' 342' ' ' VAL . 10.5 tt -77.34 122.85 86.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.769 -173.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 82.66 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.772 2.314 . . . . 0.0 112.466 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.563 HG12 HG13 ' A' ' 385' ' ' VAL . 13.1 m -105.76 120.14 56.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.319 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 19.1 ptt180 -129.32 -175.29 3.53 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.16 147.56 21.16 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.586 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.577 HG22 HD12 ' A' ' 382' ' ' ILE . 4.9 m -123.32 170.98 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -110.86 119.49 39.27 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.226 -173.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 32.8 t60 56.46 42.4 27.49 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.261 0.553 . . . . 0.0 110.47 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 67.07 9.94 55.19 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.423 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.78 107.84 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.115 0.458 . . . . 0.0 110.724 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -73.3 52.98 2.46 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.431 2.754 . . . . 0.0 112.644 176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -97.59 -53.52 3.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.0 p -115.73 115.16 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.237 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.5 t30 -60.0 108.4 0.76 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.033 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.895 ' HA ' HD22 ' A' ' 376' ' ' LEU . 33.7 m -93.01 9.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.988 0.423 . . . . 0.0 110.954 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.449 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -82.57 82.2 8.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.478 0.656 . . . . 0.0 110.317 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.689 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.0 ttp -103.57 93.27 4.84 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 169.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 44.1 mt -76.33 125.94 30.09 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.537 -1.211 . . . . 0.0 111.66 -163.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.735 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -68.13 -23.62 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 11.9 m -126.4 90.21 50.47 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.82 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 89.2 Cg_endo -85.77 33.57 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.28 2.653 . . . . 0.0 114.317 -167.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -167.6 63.04 0.63 Allowed Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.317 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.48 ' O ' HG22 ' A' ' 340' ' ' ILE . 61.4 Cg_endo -81.55 139.64 11.45 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.31 2.007 . . . . 0.0 113.049 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 20.4 p -124.15 133.01 53.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.73 176.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.642 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 6.5 ptp -95.18 125.1 39.59 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.477 ' HA ' ' HG3' ' A' ' 337' ' ' PRO . 25.9 mt-10 -81.28 -169.48 2.29 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.471 1.107 . . . . 0.0 111.21 -173.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -73.93 -4.56 35.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.047 175.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 366' ' ' ASN . 15.6 m120 -100.95 -14.61 17.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.355 0.598 . . . . 0.0 109.659 175.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 124.0 -169.85 16.15 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.465 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -77.68 -22.53 69.36 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.545 -176.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 65.64 -118.45 11.66 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -176.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -114.77 143.39 45.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.211 0.529 . . . . 0.0 111.26 178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 3.1 mt -123.9 159.29 29.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.735 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 45.4 mt-10 -126.99 134.74 50.29 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.732 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.731 ' HG2' ' HB ' ' A' ' 326' ' ' VAL . 0.2 OUTLIER -149.57 169.81 20.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.977 -175.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.857 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 172.63 155.39 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.159 0.504 . . . . 0.0 111.679 170.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.029 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -160.43 153.53 18.22 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 165.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 1.029 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 46.9 Cg_exo -16.52 125.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 1 C-N-CA 125.468 4.112 . . . . 0.0 115.843 -175.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 395' ' ' LYS . 60.7 Cg_exo -40.17 139.84 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.692 3.595 . . . . 0.0 114.092 -175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 393' ' ' PHE . . . 138.93 -163.4 25.91 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -76.4 100.04 5.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.347 0.573 . . . . 0.0 111.239 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -112.75 129.62 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.083 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.99 135.25 64.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 -179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.64 HD12 ' HG3' ' A' ' 318' ' ' PRO . 25.4 mt -96.1 133.65 36.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.926 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.539 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -109.77 91.39 3.63 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.887 175.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -81.84 87.22 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.97 -95.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.352 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.02 0.84 14.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.101 0.477 . . . . 0.0 110.549 175.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -75.41 148.28 39.28 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.1 p30 -159.63 149.12 18.24 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.568 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.675 ' O ' ' HG2' ' A' ' 318' ' ' PRO . 4.2 t60 -170.81 119.45 0.52 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.849 173.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.083 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.7 tt0 -82.64 134.16 35.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.738 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.539 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.1 t-105 -140.01 143.75 36.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.462 175.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 379' ' ' GLY . 55.8 t80 -87.82 108.24 19.06 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.887 HE22 HG13 ' A' ' 326' ' ' VAL . 5.6 mm100 -72.82 144.35 47.52 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.586 ' HA ' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.494 -173.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.677 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 21.8 p90 -60.67 129.6 42.36 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.0 t 178.55 -169.72 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.433 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 59.5 t -60.5 110.35 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 168.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.44 142.77 56.56 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.795 0.807 . . . . 0.0 111.108 -170.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.402 ' OD2' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -76.81 148.6 36.49 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.024 -1.444 . . . . 0.0 110.111 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.77 ' HB2' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -61.27 -13.23 17.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.935 -172.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.402 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.8 t -101.14 -0.61 35.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.503 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 28.5 mmmt -78.4 -36.45 45.74 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.837 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.6 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -89.93 157.57 17.8 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.266 0.555 . . . . 0.0 111.606 -177.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.1 t -142.48 147.5 36.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.02 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m95 -60.28 110.73 1.31 Allowed 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.395 0.617 . . . . 0.0 112.159 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.543 ' HE3' ' OE1' ' A' ' 329' ' ' GLU . 65.3 tttp -93.54 -34.42 13.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.492 170.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.971 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 64.8 ttt180 -164.33 119.12 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -64.91 157.38 75.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.991 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -40.36 117.54 0.48 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.395 2.73 . . . . 0.0 112.587 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.1 m -134.18 132.46 39.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.922 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.53 124.83 13.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.207 0.527 . . . . 0.0 111.096 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.522 ' HB3' HG13 ' A' ' 327' ' ' VAL . 87.6 p -57.79 -30.45 65.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.974 -171.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.86 -2.57 41.53 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -105.4 -73.26 0.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -165.87 15.89 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.607 0.717 . . . . 0.0 109.665 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.712 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 12.3 p -137.69 -166.79 2.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.541 -172.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.864 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -126.62 153.17 35.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.668 0.271 . . . . 0.0 110.517 179.62 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 17.3 m -135.91 145.66 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.984 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.566 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 17.4 ptt? -135.43 169.59 17.25 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.971 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 14.0 mt-10 -138.04 136.4 36.8 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.345 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.67 151.07 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.219 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -117.3 155.12 16.33 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.787 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 364' ' ' MET . 0.8 OUTLIER -101.97 -179.84 4.12 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.274 0.559 . . . . 0.0 110.974 -178.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.4 p -137.49 -41.13 0.56 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.635 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -156.07 4.58 0.2 Allowed Glycine 0 C--N 1.336 0.54 0 C-N-CA 119.344 -1.408 . . . . 0.0 115.158 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.503 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 33.1 m -113.12 127.03 56.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 117.425 0.612 . . . . 0.0 110.13 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.708 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 14.2 ptm180 -73.38 171.2 11.18 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.12 -0.943 . . . . 0.0 109.048 175.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -26.78 95.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.202 3.268 . . . . 0.0 114.608 -170.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . . . . . . . . . 6.0 p -112.14 154.34 25.63 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.969 -175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.4 mmt180 -74.57 107.83 6.95 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.672 HG22 HG13 ' A' ' 342' ' ' VAL . 38.8 mm -82.82 119.89 75.29 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.4 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.63 82.5 2.1 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.67 2.246 . . . . 0.0 112.088 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.672 HG13 HG22 ' A' ' 340' ' ' ILE . 13.9 m -101.5 124.94 55.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.575 0.702 . . . . 0.0 110.879 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.78 -175.38 4.01 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -153.41 144.62 23.03 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.323 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.65 164.56 15.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -96.83 114.34 25.97 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.126 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 39.25 63.88 0.9 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.633 0.773 . . . . 0.0 112.651 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.494 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.45 7.99 42.97 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.644 -0.707 . . . . 0.0 114.669 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.66 113.06 47.9 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 117.864 0.832 . . . . 0.0 111.557 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.15 62.19 5.93 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.198 2.599 . . . . 0.0 111.785 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.591 ' HG2' HG12 ' A' ' 352' ' ' VAL . 15.2 tt0 -86.65 -43.56 12.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.158 0.98 . . . . 0.0 108.939 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 351' ' ' GLU . 1.5 p -158.17 122.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.34 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -51.23 108.5 0.26 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.331 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 1.007 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.44 7.98 4.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.825 -176.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -82.66 84.18 7.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.182 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.97 84.9 2.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 40.2 mt -68.05 129.55 40.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.166 -165.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.678 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.5 mm -72.62 -23.96 21.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.2 m -131.52 88.26 43.89 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 114.414 -1.267 . . . . 0.0 108.715 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.66 53.13 3.28 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.16 2.573 . . . . 0.0 113.336 -173.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -168.02 69.87 0.85 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.882 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' A' ' 372' ' ' ILE . 45.7 Cg_endo -91.1 136.29 1.98 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.552 2.168 . . . . 0.0 112.65 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.1 p -132.42 144.95 50.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.452 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.607 ' HG3' HD11 ' A' ' 340' ' ' ILE . 56.2 mtm -95.95 116.62 29.21 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 174.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.517 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 31.9 mt-10 -104.15 -165.68 1.17 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.386 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.651 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -59.11 -13.08 5.98 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.886 0.375 . . . . 0.0 111.769 175.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.651 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.2 p30 -103.83 -2.07 26.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.28 0.562 . . . . 0.0 110.366 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 95.6 -160.71 22.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -173.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 364' ' ' MET . . . -77.27 -11.84 85.15 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.823 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.556 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 65.61 -124.03 26.03 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -125.87 147.47 49.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.869 0.366 . . . . 0.0 110.092 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.0 OUTLIER -128.5 160.46 38.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.052 -179.384 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.678 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 61.4 mt-10 -123.4 137.99 54.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.674 0.273 . . . . 0.0 110.284 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -153.29 154.6 34.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.913 -174.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.889 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -173.03 167.53 4.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.978 171.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.007 ' HG ' ' HB ' ' A' ' 354' ' ' VAL . 0.0 OUTLIER -168.21 178.08 1.15 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 114.015 -1.448 . . . . 0.0 107.169 174.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.703 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 52.0 Cg_exo -36.1 131.24 0.35 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.748 2.299 . . . . 0.0 113.65 174.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.91 137.39 52.37 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.676 2.918 . . . . 0.0 113.16 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.06 -176.85 29.4 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.156 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.658 ' HB3' HE21 ' A' ' 391' ' ' GLN . 12.7 m-20 -74.33 101.15 3.97 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.206 0.202 . . . . 0.0 111.116 -178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.559 ' CG ' HD11 ' A' ' 376' ' ' LEU . 38.9 m-80 -123.39 153.54 40.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.262 0.553 . . . . 0.0 110.96 175.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.96 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -134.45 139.89 46.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 -176.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' A' ' 374' ' ' MET . 20.8 mt -94.18 132.89 36.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -109.62 92.66 4.14 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.052 -0.977 . . . . 0.0 109.026 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.78 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 3.4 t -79.99 76.35 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.69 -81.93 0.16 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.224 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.77 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 31.7 t70 -113.44 -12.27 12.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.449 0.642 . . . . 0.0 109.562 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.78 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.8 mp -78.32 148.37 33.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.216 176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 384' ' ' TYR . 4.4 p-10 -155.99 140.82 17.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.781 0.324 . . . . 0.0 111.214 177.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.409 ' H ' HG12 ' A' ' 382' ' ' ILE . 18.3 t-80 -166.28 123.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.624 171.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.96 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 43.4 tt0 -86.84 152.19 22.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.184 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.504 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 1.0 OUTLIER -159.45 142.94 14.57 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.672 175.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.3 p90 -90.77 108.06 19.58 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.755 178.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.889 ' HG3' HE22 ' A' ' 375' ' ' GLN . 0.1 OUTLIER -70.29 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.544 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 27.9 tptp . . . . . 0 C--O 1.247 0.956 0 O-C-N 124.371 1.044 . . . . 0.0 110.51 -179.286 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -62.36 124.4 20.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.341 0.591 . . . . 0.0 111.416 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t -174.32 -169.83 0.48 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.36 -175.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.43 106.56 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.2 149.02 43.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.698 0.761 . . . . 0.0 112.191 -173.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' A' ' 310' ' ' THR . 21.2 t0 -72.28 146.51 47.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.129 -178.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.76 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -66.35 -13.28 60.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.949 -167.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.517 HG22 ' OD1' ' A' ' 308' ' ' ASP . 14.9 t -97.0 4.1 51.66 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.981 -0.45 . . . . 0.0 112.035 -175.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.817 ' HE3' ' HA3' ' A' ' 334' ' ' GLY . 34.1 mttp -89.2 -28.56 19.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -175.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.76 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.0 OUTLIER -84.57 156.47 21.6 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.808 -179.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 9.3 t -141.36 145.27 35.18 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.554 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.613 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 17.1 m-90 -56.06 104.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.269 177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.554 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 87.3 tttt -97.17 -42.88 7.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.653 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 38.9 ttt180 -152.55 123.01 7.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.605 173.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -65.74 163.94 31.09 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.48 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.449 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 2.8 Cg_exo -38.52 107.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.39 2.727 . . . . 0.0 112.373 176.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.8 m -115.97 128.49 55.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.296 -175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -49.23 125.71 11.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.378 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.0 p -70.96 -20.19 62.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.539 -173.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 93.55 -2.31 70.24 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -171.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -116.82 27.96 8.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.678 0.275 . . . . 0.0 110.458 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 64.09 21.16 12.48 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.658 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.439 ' HA ' ' OE1' ' A' ' 375' ' ' GLN . 6.6 p -129.53 -168.53 1.96 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.452 175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.662 HG13 HE22 ' A' ' 394' ' ' GLN . 0.1 OUTLIER -132.21 150.22 33.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.339 0.59 . . . . 0.0 112.317 -175.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.76 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -138.56 138.08 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.62 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 14.2 ptm -127.55 162.8 25.59 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.548 178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.653 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 30.2 tt0 -126.33 127.96 46.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.363 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.76 147.43 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.183 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -106.01 147.8 16.32 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.31 179.03 4.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.121 0.961 . . . . 0.0 110.355 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 3.8 p -152.48 30.72 0.53 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.68 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.817 ' HA3' ' HE3' ' A' ' 311' ' ' LYS . . . -170.96 -83.28 0.05 OUTLIER Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.876 -1.155 . . . . 0.0 113.764 179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 303' ' ' THR . 12.9 m -69.52 128.46 36.59 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.111 0.565 . . . . 0.0 112.424 -172.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.755 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -67.1 176.1 1.27 Allowed Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.147 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -24.88 93.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 124.043 3.162 . . . . 0.0 114.538 -171.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 363' ' ' THR . 27.6 p -111.62 166.34 11.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.053 -171.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -87.43 96.81 10.51 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.508 HG23 ' HG2' ' A' ' 362' ' ' PRO . 12.4 tt -80.44 126.03 79.6 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.295 -171.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.31 93.98 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.96 2.44 . . . . 0.0 112.331 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 372' ' ' ILE . 16.7 m -115.01 120.98 66.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.699 0.761 . . . . 0.0 111.384 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 29.8 ptt180 -132.63 -174.35 3.43 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -157.53 149.38 22.22 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.723 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 382' ' ' ILE . 11.4 m -122.9 170.28 13.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -99.79 114.85 28.28 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.215 -177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 391' ' ' GLN . 17.9 p80 40.04 57.07 2.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.847 . . . . 0.0 112.587 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.681 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 79.71 -10.42 38.7 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 115.953 -0.567 . . . . 0.0 114.164 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.48 ' HA ' ' HD3' ' A' ' 350' ' ' PRO . 27.5 t -101.91 114.01 65.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.307 0.554 . . . . 0.0 111.226 -174.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 349' ' ' VAL . 6.6 Cg_exo -77.14 38.67 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 123.466 2.777 . . . . 0.0 113.059 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.44 -54.29 6.62 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.81 112.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.941 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 36.7 t30 -55.11 108.07 0.37 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.502 171.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.643 ' HA ' ' HG ' ' A' ' 376' ' ' LEU . 35.9 m -93.23 8.64 4.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.142 0.496 . . . . 0.0 111.159 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.436 ' N ' ' HB3' ' A' ' 344' ' ' ALA . . . -80.83 82.81 6.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.378 0.609 . . . . 0.0 110.554 178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.758 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.1 ttt -102.32 82.26 2.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 30.9 mt -64.26 130.11 42.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.862 -167.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -70.38 -26.78 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 360' ' ' PRO . 6.3 m -131.83 95.95 21.56 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.452 172.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.44 ' HA ' HD12 ' A' ' 357' ' ' LEU . 4.1 Cg_endo -86.05 27.21 0.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.524 2.816 . . . . 0.0 113.523 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -147.88 64.32 8.24 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.123 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 340' ' ' ILE . 90.0 Cg_endo -82.66 144.65 12.61 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.532 2.155 . . . . 0.0 112.884 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 11.4 p -128.55 142.57 51.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.068 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.846 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 56.7 mtp -95.39 110.58 22.59 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -77.01 -171.29 1.94 Allowed 'General case' 0 C--N 1.32 -0.704 0 O-C-N 124.403 1.065 . . . . 0.0 111.24 -177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.512 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -66.81 -6.61 16.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.779 174.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -110.84 -6.75 14.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.229 0.537 . . . . 0.0 109.972 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 117.64 -171.92 14.13 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -64.68 -14.97 59.06 Favored Glycine 0 N--CA 1.458 0.127 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.532 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 72.03 -106.26 1.88 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.618 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 328' ' ' MET . 20.8 m-85 -132.33 135.91 46.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.285 0.564 . . . . 0.0 110.996 175.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.794 HD13 HG11 ' A' ' 342' ' ' VAL . 4.7 mt -115.32 136.53 51.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.343 176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.76 ' HG2' HG12 ' A' ' 327' ' ' VAL . 41.8 mt-10 -106.7 128.63 54.36 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.198 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.692 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -144.64 163.14 34.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.047 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.761 HE21 ' H ' ' A' ' 376' ' ' LEU . 29.5 tp60 -176.05 152.08 1.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.032 0.444 . . . . 0.0 110.036 169.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.828 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.0 OUTLIER -151.78 140.42 13.54 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 170.318 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.828 ' HD2' HD22 ' A' ' 376' ' ' LEU . 27.4 Cg_exo -19.97 130.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 125.144 3.896 . . . . 0.0 114.781 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -37.92 131.91 0.81 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 124.82 3.68 . . . . 0.0 114.38 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.85 -167.77 32.21 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.295 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 8.1 m-20 -80.57 100.12 8.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.913 0.356 . . . . 0.0 110.899 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 376' ' ' LEU . 21.5 m-80 -111.57 138.72 47.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.986 0.422 . . . . 0.0 110.249 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.938 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -135.76 136.42 50.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.612 HD11 ' HG2' ' A' ' 374' ' ' MET . 39.5 mt -95.25 130.78 43.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.086 -177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.524 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.22 91.42 3.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.674 175.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.655 HG13 HG12 ' A' ' 342' ' ' VAL . 6.7 t -84.87 81.9 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.75 -91.15 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.144 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.655 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 6.3 t70 -98.55 -18.89 17.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.613 0.721 . . . . 0.0 109.395 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.3 mp -76.44 148.85 37.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.343 -177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -154.77 137.21 15.01 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.036 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -164.59 123.73 1.86 Allowed 'General case' 0 C--O 1.24 0.595 0 CA-C-O 120.751 0.31 . . . . 0.0 110.484 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.938 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -90.3 141.2 28.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.519 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.519 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 1.2 t-105 -144.64 137.01 26.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.006 170.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 19.8 p90 -80.6 110.25 15.9 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.947 -0.471 . . . . 0.0 110.443 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.662 HE22 HG13 ' A' ' 326' ' ' VAL . 5.8 mm100 -74.04 102.27 4.13 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 395' ' ' LYS . 12.1 ttpp . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.752 -176.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 335' ' ' THR . 2.9 t . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -59.89 126.76 28.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.194 0.521 . . . . 0.0 109.871 176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.8 t -179.24 -174.76 0.34 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.3 106.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 168.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.52 155.55 40.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.972 0.892 . . . . 0.0 112.608 -170.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.606 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.1 t70 -81.01 140.65 35.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.106 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.637 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -60.41 -21.72 62.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.62 -173.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.637 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.6 t -87.05 -4.56 59.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.828 0.346 . . . . 0.0 111.46 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -93.92 16.5 14.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.814 ' HE2' HG12 ' A' ' 385' ' ' VAL . 1.3 m-85 -102.38 170.66 7.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.675 -176.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -165.65 131.9 2.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.396 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.459 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -51.68 120.33 5.11 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.398 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 21.3 tptm -110.14 -48.67 3.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.583 172.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.413 ' HB3' ' CB ' ' A' ' 329' ' ' GLU . 10.6 ttm180 -156.1 127.96 7.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.113 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.14 155.67 93.08 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.823 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.492 ' HG3' HD12 ' A' ' 383' ' ' ILE . 84.1 Cg_exo -33.08 113.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 123.832 3.021 . . . . 0.0 113.153 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 20.3 m -128.95 135.06 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.055 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -44.96 124.66 4.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.224 0.535 . . . . 0.0 111.612 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 90.5 p -71.47 -22.07 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.67 -175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 92.39 -2.62 74.56 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -121.89 33.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.88 16.68 8.22 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.823 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.554 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 8.5 p -124.23 -168.85 1.86 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.741 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.37 146.78 33.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.417 -177.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 14.8 m -128.51 138.83 53.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.101 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 371' ' ' PHE . 16.4 ptt? -121.55 154.87 36.13 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 23.0 tt0 -114.28 127.66 55.98 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 385' ' ' VAL . 8.4 m -130.43 136.57 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.881 -175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -111.98 143.39 17.44 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.657 -177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.686 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.7 OUTLIER -141.44 163.03 34.04 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 366' ' ' ASN . 49.4 m -153.51 65.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.507 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -165.0 -50.71 0.02 OUTLIER Glycine 0 C--O 1.226 -0.356 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.743 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.847 ' HB ' ' HE3' ' A' ' 364' ' ' MET . 23.3 m -98.6 142.72 29.83 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 122.85 -0.206 . . . . 0.0 110.863 -175.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.689 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 15.3 ptt180 -79.38 168.65 24.94 Favored Pre-proline 0 CA--C 1.527 0.08 0 CA-C-O 117.729 -1.129 . . . . 0.0 108.485 171.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.7 OUTLIER -26.55 96.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 123.999 3.133 . . . . 0.0 114.449 -170.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.66 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 28.8 p -116.09 164.93 13.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.477 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -85.31 96.97 9.7 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 362' ' ' PRO . 12.1 pt -79.77 130.15 68.38 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.297 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.661 ' HD2' ' HZ ' ' A' ' 312' ' ' PHE . 63.9 Cg_endo -75.29 81.94 2.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.725 2.283 . . . . 0.0 112.021 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.717 HG12 HG13 ' A' ' 385' ' ' VAL . 10.5 m -100.22 116.41 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.993 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.4 ptt180 -126.61 179.82 5.15 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.431 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -152.06 139.78 19.84 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.818 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.15 171.4 7.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.927 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -102.59 116.45 32.62 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.454 ' HA ' ' CD ' ' A' ' 391' ' ' GLN . 8.9 p-80 41.04 59.68 2.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.515 0.726 . . . . 0.0 112.703 -176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.735 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 66.2 6.4 32.65 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 114.522 0.569 . . . . 0.0 114.522 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.28 116.59 44.14 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 117.591 0.695 . . . . 0.0 111.045 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -74.09 55.98 3.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.198 2.599 . . . . 0.0 111.753 173.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.59 -52.22 5.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.64 123.0 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.283 175.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.76 107.74 0.74 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.657 ' HA ' HD22 ' A' ' 376' ' ' LEU . 32.0 m -92.2 9.11 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.233 0.54 . . . . 0.0 110.634 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.431 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -81.25 83.65 6.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.957 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.45 84.63 2.22 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.7 mt -74.02 128.32 35.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.816 -165.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.742 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 1.9 mm -75.94 -19.42 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 172.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.5 m -121.74 81.91 41.43 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.165 170.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.23 32.57 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.27 2.647 . . . . 0.0 114.156 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -177.01 70.78 0.23 Allowed Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.62 ' HB2' HD11 ' A' ' 340' ' ' ILE . 45.1 Cg_endo -88.19 136.75 3.55 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.503 2.136 . . . . 0.0 113.587 -176.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 338' ' ' CYS . 40.5 p -118.1 130.59 56.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.545 175.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.847 ' HE3' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -99.51 143.59 29.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -178.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.513 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 31.3 mt-10 -95.04 -179.35 4.79 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 123.626 0.579 . . . . 0.0 109.941 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 333' ' ' SER . 0.1 OUTLIER -56.05 -24.79 41.89 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.49 -3.23 18.3 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 122.095 -0.378 . . . . 0.0 111.592 -175.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.686 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 144.62 177.05 19.16 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.265 177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -97.53 -16.19 35.09 Favored Glycine 0 CA--C 1.507 -0.458 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.905 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 74.52 -126.17 9.01 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -174.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 328' ' ' MET . 79.6 m-85 -105.88 147.38 28.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.02 0.438 . . . . 0.0 111.154 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.4 mt -132.48 152.96 37.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.742 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 30.6 mt-10 -110.81 134.59 52.38 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.955 -174.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.92 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -145.0 165.35 28.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.741 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -174.03 163.89 4.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.384 0.612 . . . . 0.0 111.449 172.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.679 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.3 tp -165.02 143.87 5.47 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 165.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.679 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 16.2 Cg_exo -31.3 135.42 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.998 3.132 . . . . 0.0 113.486 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 377' ' ' PRO . 49.5 Cg_exo -37.0 128.43 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 124.704 3.602 . . . . 0.0 114.471 -166.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.11 178.06 35.68 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 -171.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 0.0 OUTLIER -81.02 99.73 8.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.945 0.872 . . . . 0.0 110.826 -176.209 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.673 HD22 ' HG2' ' A' ' 394' ' ' GLN . 18.6 m-80 -108.19 126.7 53.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.302 0.572 . . . . 0.0 110.015 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.985 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -126.52 137.69 57.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.145 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 374' ' ' MET . 30.1 mt -99.78 127.1 52.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.792 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.405 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -95.64 102.73 14.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.428 -0.806 . . . . 0.0 108.932 171.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.814 HG12 ' HE2' ' A' ' 312' ' ' PHE . 2.1 t -92.59 78.56 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.295 -176.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 69.56 -85.61 0.26 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.446 -177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 34.2 t70 -108.75 -25.58 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.523 0.678 . . . . 0.0 109.325 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.459 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.2 mp -65.45 151.81 45.46 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.536 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -151.94 144.35 24.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.402 ' C ' HG12 ' A' ' 382' ' ' ILE . 0.2 OUTLIER -164.79 109.9 0.94 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.111 0.482 . . . . 0.0 111.356 179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.985 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.3 tt0 -84.25 149.09 26.34 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.386 -176.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 318' ' ' PRO . 4.8 t-105 -158.77 142.27 15.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.822 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.855 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 16.3 p90 -92.72 114.83 27.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.583 -0.698 . . . . 0.0 110.062 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.673 ' HG2' HD22 ' A' ' 381' ' ' ASN . 5.0 mm100 -72.6 115.42 11.84 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -174.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.0 tttp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.706 -0.664 . . . . 0.0 110.229 -174.826 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.218 0.532 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.598 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 14.2 p90 -70.45 119.95 15.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.6 t -177.14 -171.48 0.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 77.7 t -67.57 107.29 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 170.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 340' ' ' ILE . 0.1 OUTLIER -69.15 148.77 49.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.418 0.628 . . . . 0.0 111.007 -173.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.572 ' OD1' HG22 ' A' ' 310' ' ' THR . 24.2 t0 -72.48 135.76 45.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.288 -178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.679 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -62.79 -16.1 56.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -169.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.572 HG22 ' OD1' ' A' ' 308' ' ' ASP . 8.1 t -96.6 2.41 52.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.132 0.492 . . . . 0.0 111.325 -175.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.439 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 29.0 mtpp -95.29 37.48 1.17 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.229 -0.295 . . . . 0.0 111.589 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.824 ' CE1' ' HB ' ' A' ' 330' ' ' VAL . 0.0 OUTLIER -135.9 150.74 49.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.923 0.392 . . . . 0.0 110.994 -176.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 29.2 p -135.35 139.15 44.04 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.185 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -54.7 105.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.974 175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.403 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.4 ttmm -92.52 -32.34 14.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.928 ' HB2' ' HB2' ' A' ' 329' ' ' GLU . 0.9 OUTLIER -165.31 114.88 1.06 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.133 174.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -64.07 161.15 42.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.267 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.488 ' HB2' ' CB ' ' A' ' 392' ' ' TRP . 2.7 Cg_exo -39.22 119.6 0.5 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.83 2.354 . . . . 0.0 112.341 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 17.9 m -139.15 136.94 35.64 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.67 -173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -48.7 133.76 16.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.739 0.304 . . . . 0.0 110.964 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.48 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.8 p -70.75 -12.04 61.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.785 -172.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 91.74 -7.62 79.26 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -102.19 -59.19 1.74 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.124 0.488 . . . . 0.0 109.929 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 12.0 t70 170.2 -24.92 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.394 1.092 . . . . 0.0 108.436 -169.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.3 p -93.67 -168.72 1.95 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.696 -1.593 . . . . 0.0 110.782 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 374' ' ' MET . 2.1 t -125.21 152.0 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.08 0.467 . . . . 0.0 111.056 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.836 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.5 m -130.45 168.16 23.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.529 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -155.01 157.85 38.25 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 316' ' ' ARG . 4.1 mt-10 -129.01 139.95 51.85 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.452 0.47 . . . . 0.0 110.301 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.824 ' HB ' ' CE1' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -147.94 146.42 18.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.006 -175.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.415 ' O ' ' HD1' ' A' ' 312' ' ' PHE . . . -117.18 137.43 13.41 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.687 ' HD2' ' H ' ' A' ' 335' ' ' THR . 0.3 OUTLIER -90.0 179.27 5.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.814 0.816 . . . . 0.0 112.32 -173.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 48.1 t -106.15 -41.86 5.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.264 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 176.73 40.5 0.06 OUTLIER Glycine 0 C--N 1.338 0.656 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.273 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.687 ' H ' ' HD2' ' A' ' 332' ' ' PHE . 4.8 m -116.07 127.54 54.96 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.247 0.523 . . . . 0.0 109.856 173.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.697 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.7 OUTLIER -71.17 171.55 8.43 Favored Pre-proline 0 N--CA 1.463 0.208 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.076 174.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.697 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.52 95.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 123.974 3.116 . . . . 0.0 114.155 -177.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 305' ' ' THR . 20.1 p -117.38 174.5 6.11 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.768 -1.56 . . . . 0.0 111.619 -171.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.423 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 23.9 mmm180 -96.57 101.58 13.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.55 ' CG2' HG13 ' A' ' 342' ' ' VAL . 8.2 mm -80.15 130.78 64.83 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.257 0.551 . . . . 0.0 112.265 -174.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.88 81.79 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.66 2.24 . . . . 0.0 111.653 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.996 HG21 ' HG2' ' A' ' 362' ' ' PRO . 0.0 OUTLIER -96.84 130.61 45.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.423 179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -145.35 179.64 7.26 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -152.2 143.83 23.53 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.392 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 349' ' ' VAL . 10.8 m -113.98 172.06 3.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -108.44 115.51 30.24 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.717 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 57.1 47.42 17.33 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.623 0.577 . . . . 0.0 110.583 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.672 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 68.24 4.54 37.12 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.879 -0.601 . . . . 0.0 113.75 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 345' ' ' VAL . 40.8 t -107.37 108.19 61.43 Favored Pre-proline 0 C--O 1.236 0.393 0 CA-C-N 117.088 0.444 . . . . 0.0 111.2 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -74.2 59.51 4.56 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.365 2.71 . . . . 0.0 112.419 175.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.03 -45.81 6.12 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.5 123.62 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.065 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.1 t30 -60.34 108.34 0.79 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.694 175.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.1 m -90.5 3.9 6.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.97 83.98 3.5 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.651 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.678 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.5 ttm -100.07 88.0 3.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.563 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 27.5 mt -66.32 126.52 29.03 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.985 -1.462 . . . . 0.0 111.664 -165.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.684 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 6.7 mm -73.37 -23.78 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.5 m -134.33 98.74 13.72 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.997 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.88 54.2 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.244 2.629 . . . . 0.0 113.379 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.584 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 63.6 t30 -157.96 58.73 1.47 Allowed Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.349 172.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.996 ' HG2' HG21 ' A' ' 342' ' ' VAL . 15.0 Cg_exo -72.07 104.39 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.255 1.97 . . . . 0.0 112.155 175.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 9.1 p -110.34 149.16 30.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.669 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 49.0 mtm -95.7 120.76 36.53 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -103.12 -165.47 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.903 1.377 . . . . 0.0 109.928 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.565 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -52.3 -25.19 8.89 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.335 174.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -105.58 10.14 33.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 110.689 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.9 -156.78 23.93 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 110.986 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -65.06 -14.61 59.34 Favored Glycine 0 C--O 1.229 -0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.172 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 66.21 -118.5 11.18 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.045 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -116.47 122.96 46.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.7 OUTLIER -113.24 161.47 12.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.082 177.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.836 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.7 mt-10 -132.87 130.92 40.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.563 ' HB3' ' CD2' ' A' ' 357' ' ' LEU . 4.0 ptp -159.77 151.6 20.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.12 -173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.937 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.43 169.64 4.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.683 0.278 . . . . 0.0 111.039 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.955 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.0 tp -163.35 159.31 18.05 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.955 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 48.8 Cg_exo -29.97 130.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 113.978 173.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 395' ' ' LYS . 5.0 Cg_exo -37.5 129.65 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.182 3.921 . . . . 0.0 114.516 -176.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 170.19 -129.5 1.83 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.527 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.473 ' HB3' ' OE1' ' A' ' 391' ' ' GLN . 19.7 m-20 -127.49 107.33 9.85 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.502 0.191 . . . . 0.0 110.647 178.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -111.27 127.7 55.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.065 0.46 . . . . 0.0 110.01 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.045 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -122.64 130.72 74.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 9.6 mt -92.11 131.62 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.336 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.1 m-85 -102.64 92.0 4.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.267 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 4.4 t -82.66 76.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 74.42 -91.28 0.74 Allowed Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.162 -171.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 19.6 t70 -110.25 -20.88 12.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.258 0.552 . . . . 0.0 109.96 178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 2.1 tp -67.87 145.29 54.76 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.518 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.8 p30 -151.44 147.99 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.802 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.428 ' H ' HG12 ' A' ' 382' ' ' ILE . 0.5 OUTLIER -170.46 123.53 0.67 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.024 175.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.045 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.0 OUTLIER -75.68 144.26 41.7 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.488 ' CB ' ' HB2' ' A' ' 318' ' ' PRO . 17.2 t-105 -143.32 130.4 20.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.204 175.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -82.53 117.34 22.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -117.54 142.66 46.91 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.961 0.41 . . . . 0.0 111.085 -174.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.555 ' HA ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.768 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.675 -179.651 . . . . . . . . 2 2 . 1 stop_ save_